"","miRNA","mRNA","PCC.cor","p_value","adjusted_p_value","score","energy","query_start_end","subject_start_end","total_bp_shared","query_similar","subject_similar","region","V3","Protein.names","Organism","Gene.Ontology..biological.process.","Gene.Ontology.IDs"
"20","Cluster_15726","Peve_00027432",-0.99995514319204,0.00602991134659825,0.573710369894872,156,-20.62,"2 21","242 264",22,"72.73%","77.27%","3UTR","Q7RTR2","NLR family CARD domain-containing protein 3 (CARD15-like protein) (Caterpiller protein 16.2) (CLR16.2) (NACHT, LRR and CARD domains-containing protein 3) (Nucleotide-binding oligomerization domain protein 3)","Homo sapiens (Human)","I-kappaB kinase/NF-kappaB signaling [GO:0007249]; intracellular signal transduction [GO:0035556]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of interferon-alpha production [GO:0032687]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of tumor necrosis factor production [GO:0032720]; T cell activation [GO:0042110]","GO:0005524; GO:0005737; GO:0005829; GO:0007249; GO:0014067; GO:0032088; GO:0032687; GO:0032688; GO:0032715; GO:0032720; GO:0034451; GO:0035556; GO:0036312; GO:0042110; GO:0043124; GO:0043231; GO:0045824; GO:0048147; GO:0048471; GO:0050680; GO:0050728; GO:1900016; GO:1900226; GO:1901223"
"42","Cluster_4629","Peve_00017735",0.997938030915672,0.0408894104551393,0.909359886114279,145,-20.33,"2 20","661 685",21,"66.67%","71.43%","3UTR",NA,NA,NA,NA,NA
"66","Cluster_1167","Peve_00020387",0.997608159669892,0.0440400511406639,0.923878309135209,156,-20.73,"2 21","935 956",19,"68.42%","73.68%","3UTR","C3YWU0","Alpha-L-fucosidase (EC 3.2.1.51) (Alpha-L-fucoside fucohydrolase)","Branchiostoma floridae (Florida lancelet) (Amphioxus)","fucose metabolic process [GO:0006004]; glycoside catabolic process [GO:0016139]","GO:0004560; GO:0005576; GO:0005764; GO:0006004; GO:0016139"
"74","Cluster_796","Peve_00020926",0.99976239721897,0.0138780829858655,0.720093853779252,161,-25.6,"2 21","197 216",19,"78.95%","78.95%","3UTR",NA,NA,NA,NA,NA
"82","Cluster_13502","Peve_00015952",0.997844556977271,0.0418062711782387,0.909359886114279,162,-21.27,"2 19","471 492",17,"76.47%","82.35%","3UTR",NA,NA,NA,NA,NA
"117","Cluster_15890","Peve_00013095",-0.99757658370632,0.0443299128918105,0.926127022176621,180,-23.84,"2 21","676 697",19,"84.21%","89.47%","3UTR",NA,NA,NA,NA,NA
"137","Cluster_4629","Peve_00034505",0.997938030915673,0.0408894104551382,0.909359886114279,158,-20.97,"2 20","824 846",19,"68.42%","84.21%","3UTR",NA,NA,NA,NA,NA
"170","Cluster_4629","Peve_00029667",0.997938030915673,0.0408894104551382,0.909359886114279,154,-20.44,"2 19","313 334",17,"70.59%","76.47%","3UTR","Q9I8C7","Neuronal acetylcholine receptor subunit alpha-10 (Alpha 10 nAChR) (Nicotinic acetylcholine receptor subunit alpha-10) (NACHR alpha-10)","Gallus gallus (Chicken)","chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; membrane depolarization [GO:0051899]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; response to auditory stimulus [GO:0010996]; signal transduction [GO:0007165]","GO:0004888; GO:0005231; GO:0005262; GO:0005886; GO:0005892; GO:0007165; GO:0007268; GO:0010996; GO:0022848; GO:0030594; GO:0034220; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:0051899; GO:1904315"
"184","Cluster_796","Peve_00031940",-0.999663016871668,0.0165276609923165,0.773377054133803,155,-20.27,"2 21","182 200",19,"78.95%","78.95%","3UTR","Q90WU3","ATP-dependent RNA helicase DDX1 (EC 3.6.4.13) (DEAD box protein 1)","Gallus gallus (Chicken)","DNA duplex unwinding [GO:0032508]; double-strand break repair [GO:0006302]; mRNA processing [GO:0006397]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]","GO:0003677; GO:0003682; GO:0003712; GO:0003724; GO:0004518; GO:0004527; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006302; GO:0006388; GO:0006397; GO:0008143; GO:0016887; GO:0032508; GO:0033677; GO:0072669"
"204","Cluster_9149","Peve_00008275",1,0,0,159,-24.67,"2 20","190 211",18,"66.67%","83.33%","3UTR",NA,NA,NA,NA,NA
"205","Cluster_1167","Peve_00008279",0.999909726776791,0.00855416971793915,0.573710369894872,146,-21.82,"2 20","557 582",22,"63.64%","68.18%","3UTR",NA,NA,NA,NA,NA
"219","Cluster_6904","Peve_00026650",-0.998173851896017,0.0384794833063837,0.909359886114279,147,-20.08,"2 21","106 132",24,"58.33%","70.83%","3UTR","Q7ZVH1","Membrane progestin receptor gamma-A (mPR gamma-A) (Progestin and adipoQ receptor family member V-A)","Danio rerio (Zebrafish) (Brachydanio rerio)","oogenesis [GO:0048477]","GO:0005496; GO:0016020; GO:0038023; GO:0048477"
"246","Cluster_4629","Peve_00010128",0.997938030915672,0.0408894104551393,0.909359886114279,142,-20.17,"2 20","86 111",22,"59.09%","68.18%","3UTR",NA,NA,NA,NA,NA
"251","Cluster_6906","Peve_00029665",-0.997478929018431,0.0452146257420912,0.931728931996319,159,-21.73,"2 21","933 956",21,"71.43%","76.19%","3UTR",NA,NA,NA,NA,NA
"274","Cluster_9149","Peve_00034585",1,9.48637384723993e-09,6.86838308108347e-06,147,-22.51,"2 12","409 430",10,"80.00%","100.00%","3UTR",NA,NA,NA,NA,NA
"303","Cluster_4115","Peve_00008964",-0.999794894490907,0.0128941051315395,0.697679744941,171,-22.26,"2 20","61 82",18,"77.78%","88.89%","3UTR","Q6P9Z4","Protein fem-1 homolog A (FEM1a) (FEM1-alpha)","Danio rerio (Zebrafish) (Brachydanio rerio)","negative regulation of inflammatory response [GO:0050728]; positive regulation of inflammatory response [GO:0050729]; protein ubiquitination [GO:0016567]; regulation of ubiquitin-protein transferase activity [GO:0051438]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent protein catabolic process via the C-end degron rule pathway [GO:0140627]","GO:0000151; GO:0005739; GO:0006511; GO:0016567; GO:0031462; GO:0050728; GO:0050729; GO:0051438; GO:0140627; GO:1990756"
"311","Cluster_2854","Peve_00023739",0.999976082283725,0.004403072548434,0.54328949385489,157,-22.98,"2 20","334 359",22,"72.73%","77.27%","3UTR",NA,NA,NA,NA,NA
"357","Cluster_15726","Peve_00020651",-0.998224476405987,0.0379422100483605,0.909359886114279,149,-26.8,"2 21","742 771",27,"66.67%","70.37%","3UTR","Q6ZPR4","Potassium channel subfamily T member 1","Mus musculus (Mouse)","potassium ion transport [GO:0006813]","GO:0005228; GO:0005267; GO:0005886; GO:0006813; GO:0015271; GO:0016020"
"365","Cluster_1167","Peve_00027965",0.999909726776791,0.00855416971793389,0.573710369894872,147,-23.67,"2 18","436 460",19,"68.42%","78.95%","3UTR","Q96AY4","Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio)","Homo sapiens (Human)","cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0000922; GO:0005737; GO:0005815; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301"
"371","Cluster_4080","Peve_00002333",-0.99984182162055,0.0113233363162533,0.656276085828034,159,-25.73,"2 21","460 487",25,"64.00%","76.00%","3UTR","Q6DIV6","Vesicular inhibitory amino acid transporter (GABA and glycine transporter) (Solute carrier family 32 member 1) (Vesicular GABA transporter)","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","beta-alanine transport [GO:0001762]; gamma-aminobutyric acid import [GO:0051939]; gamma-aminobutyric acid transport [GO:0015812]; glycine transport [GO:0015816]; neurotransmitter transport [GO:0006836]","GO:0001762; GO:0006836; GO:0008021; GO:0015185; GO:0015187; GO:0015812; GO:0015816; GO:0030659; GO:0042995; GO:0051939; GO:0098793; GO:0140799; GO:0140800"
"388","Cluster_9149","Peve_00032772",1,9.48637384723993e-09,6.86838308108347e-06,141,-20.73,"2 14","548 569",12,"66.67%","83.33%","3UTR",NA,NA,NA,NA,NA
"391","Cluster_15726","Peve_00027699",-0.99781061214271,0.0421342959844262,0.911075865480802,168,-24.61,"2 21","27 48",19,"78.95%","78.95%","3UTR",NA,NA,NA,NA,NA
"457","Cluster_1167","Peve_00023767",0.999909726776791,0.00855416971793389,0.573710369894872,158,-20.46,"2 21","87 107",19,"73.68%","78.95%","3UTR","Q566X8","Diencephalon/mesencephalon homeobox protein 1-B","Danio rerio (Zebrafish) (Brachydanio rerio)","midbrain development [GO:0030901]; regulation of cell cycle [GO:0051726]; regulation of mitotic cell cycle [GO:0007346]; regulation of neural retina development [GO:0061074]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; retina development in camera-type eye [GO:0060041]","GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0007346; GO:0030901; GO:0050767; GO:0051726; GO:0060041; GO:0061074"
"468","Cluster_11134","Peve_00030028",-0.999412779421733,0.0218181040468405,0.829411399113453,170,-26.78,"2 20","224 247",20,"75.00%","90.00%","3UTR",NA,NA,NA,NA,NA
"478","Cluster_15890","Peve_00015742",-0.998127395584257,0.0389660099841794,0.909359886114279,157,-20.18,"2 21","849 868",19,"73.68%","78.95%","3UTR",NA,NA,NA,NA,NA
"486","Cluster_4080","Peve_00017580",-0.999998957645573,0.000919184867929113,0.240277133272295,167,-21.45,"2 20","777 798",18,"77.78%","83.33%","3UTR","Q864U6","UDP-GalNAc:beta-1,3-N-acetylgalactosaminyltransferase 1 (Beta-1,3-GalNAc-T1) (EC 2.4.1.79) (Beta-1,3-galactosyltransferase 3) (Beta-1,3-GalTase 3) (Beta3Gal-T3) (Beta3GalT3) (b3Gal-T3) (Beta-3-Gx-T3) (Galactosylgalactosylglucosylceramide beta-D-acetyl-galactosaminyltransferase) (Globoside synthase) (UDP-N-acetylgalactosamine:globotriaosylceramide beta-1,3-N-acetylgalactosaminyltransferase)","Sus scrofa (Pig)","lipid metabolic process [GO:0006629]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]","GO:0000139; GO:0006486; GO:0006629; GO:0008194; GO:0008499; GO:0009312; GO:0016757; GO:0047273"
"509","Cluster_9149","Peve_00037587",-0.997642761939907,0.0437202051657,0.921378164792108,140,-21.11,"2 9","365 386",7,"100.00%","100.00%","3UTR","Q29496","Cytochrome P450 3A24 (EC 1.14.14.1) (CYPIIIA24)","Ovis aries (Sheep)","","GO:0004497; GO:0005506; GO:0005789; GO:0020037; GO:0070330"
"542","Cluster_2787","Peve_00040680",0.999851452010528,0.0109732149417988,0.647820986329688,170,-24.52,"2 21","126 149",21,"80.95%","85.71%","3UTR","Q9HAT8","E3 ubiquitin-protein ligase pellino homolog 2 (Pellino-2) (EC 2.3.2.27) (RING-type E3 ubiquitin transferase pellino homolog 2)","Homo sapiens (Human)","positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein phosphorylation [GO:0001934]; protein polyubiquitination [GO:0000209]; regulation of Toll signaling pathway [GO:0008592]","GO:0000209; GO:0001934; GO:0005829; GO:0008592; GO:0034450; GO:0043123; GO:0043410; GO:0061630"
"574","Cluster_1167","Peve_00043419",0.999909726776791,0.00855416971793389,0.573710369894872,158,-20.65,"2 20","290 312",19,"73.68%","78.95%","3UTR",NA,NA,NA,NA,NA
"577","Cluster_14999","Peve_00024854",-0.999571546587002,0.0186364175217764,0.782669382293497,163,-20.02,"2 21","853 876",21,"71.43%","80.95%","3UTR","Q75ZP8","Pyranose 2-oxidase (P2Ox) (POD) (POx) (PROD) (Pyranose oxidase) (EC 1.1.3.10) (FAD-oxidoreductase) (Glucose 2-oxidase) (Pyranose:oxygen 2-oxidoreductase)","Lyophyllum shimeji (Hon-shimeji) (Tricholoma shimeji)","","GO:0050233; GO:0050660"
"642","Cluster_589","Peve_00035783",-0.997488611107799,0.0451276831430894,0.931124593466766,163,-30.37,"2 21","547 571",22,"72.73%","77.27%","3UTR",NA,NA,NA,NA,NA
"661","Cluster_5882","Peve_00018121",-0.998399871033844,0.0360189079935825,0.909359886114279,165,-20.08,"2 19","46 68",18,"83.33%","83.33%","3UTR",NA,NA,NA,NA,NA
"670","Cluster_9149","Peve_00006544",0.999971585054582,0.00479920788265011,0.551398425649056,145,-20.18,"2 10","1 16",8,"100.00%","100.00%","3UTR","Q9ZQ31","Serine/threonine-protein kinase STY13 (EC 2.7.11.1) (AtSTYPK) (Serine/threonine/tyrosine-protein kinase 13)","Arabidopsis thaliana (Mouse-ear cress)","protein phosphorylation [GO:0006468]; regulation of embryonic development [GO:0045995]; seed oilbody biogenesis [GO:0010344]; signal transduction [GO:0007165]","GO:0004672; GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005737; GO:0006468; GO:0007165; GO:0010344; GO:0045995; GO:0106310"
"687","Cluster_9149","Peve_00022361",-0.999345600152943,0.0230324640380137,0.844680676561554,160,-24.22,"2 13","11 32",11,"100.00%","100.00%","3UTR","P98160","Basement membrane-specific heparan sulfate proteoglycan core protein (HSPG) (Perlecan) (PLC) [Cleaved into: Endorepellin; LG3 peptide]","Homo sapiens (Human)","angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; brain development [GO:0007420]; cell differentiation [GO:0030154]; circulatory system development [GO:0072359]; inflammatory response [GO:0006954]; lipid metabolic process [GO:0006629]; negative regulation of amyloid fibril formation [GO:1905907]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell death [GO:0060548]; receptor-mediated endocytosis [GO:0006898]; tissue development [GO:0009888]","GO:0001525; GO:0001540; GO:0005178; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005796; GO:0005886; GO:0005925; GO:0006629; GO:0006898; GO:0006954; GO:0007420; GO:0008022; GO:0009887; GO:0009888; GO:0016525; GO:0030021; GO:0030154; GO:0043202; GO:0050750; GO:0060548; GO:0062023; GO:0070062; GO:0072359; GO:0098797; GO:1905907"
"695","Cluster_8884","Peve_00013542",-0.998136715854457,0.0388688885892676,0.909359886114279,161,-21.36,"2 19","214 238",21,"76.19%","76.19%","3UTR",NA,NA,NA,NA,NA
"712","Cluster_589","Peve_00034862",-0.996949252337422,0.0497403384974724,0.952281411175107,155,-23.55,"2 12","279 300",10,"100.00%","100.00%","3UTR","Q96CG8","Collagen triple helix repeat-containing protein 1","Homo sapiens (Human)","cell migration [GO:0016477]; cochlea morphogenesis [GO:0090103]; establishment of planar polarity involved in neural tube closure [GO:0090177]; inner ear receptor cell stereocilium organization [GO:0060122]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; ossification involved in bone remodeling [GO:0043932]; osteoblast differentiation [GO:0001649]; osteoblast proliferation [GO:0033687]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of protein binding [GO:0032092]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]","GO:0001649; GO:0005109; GO:0005576; GO:0005581; GO:0005615; GO:0016477; GO:0016528; GO:0017147; GO:0032092; GO:0033687; GO:0033690; GO:0043932; GO:0045669; GO:0060071; GO:0060122; GO:0062023; GO:0090090; GO:0090103; GO:0090177"
"721","Cluster_1167","Peve_00004995",0.999909726776791,0.00855416971793389,0.573710369894872,142,-20.57,"2 11","93 114",9,"88.89%","88.89%","3UTR",NA,NA,NA,NA,NA
"724","Cluster_4079","Peve_00015748",-0.999044377811527,0.0278338206502373,0.899469696283718,149,-22.68,"2 20","227 252",22,"68.18%","72.73%","3UTR","P0CI65","Nephrocystin-3","Danio rerio (Zebrafish) (Brachydanio rerio)","cilium assembly [GO:0060271]; convergent extension [GO:0060026]; determination of left/right symmetry [GO:0007368]; heart jogging [GO:0003146]; kidney development [GO:0001822]; Kupffer's vesicle development [GO:0070121]; left/right pattern formation [GO:0060972]; pronephros development [GO:0048793]; visual perception [GO:0007601]; Wnt signaling pathway [GO:0016055]","GO:0001822; GO:0003146; GO:0005929; GO:0007368; GO:0007601; GO:0016055; GO:0048793; GO:0060026; GO:0060271; GO:0060972; GO:0070121; GO:0097543; GO:0097546"
"747","Cluster_1167","Peve_00041754",0.999909726776791,0.00855416971793389,0.573710369894872,142,-20.26,"2 11","782 803",9,"88.89%","88.89%","3UTR",NA,NA,NA,NA,NA
"753","Cluster_4629","Peve_00014587",0.997938030915673,0.0408894104551382,0.909359886114279,160,-22.43,"2 21","545 566",19,"68.42%","78.95%","3UTR",NA,NA,NA,NA,NA
"758","Cluster_10934","Peve_00042220",0.998758250045999,0.0317290557481559,0.903929377050813,155,-22.16,"2 21","131 158",25,"64.00%","72.00%","3UTR",NA,NA,NA,NA,NA
"762","Cluster_1167","Peve_00031993",0.999909726776791,0.00855416971793915,0.573710369894872,148,-22.03,"2 20","269 290",19,"68.42%","78.95%","3UTR",NA,NA,NA,NA,NA
"785","Cluster_1167","Peve_00024388",0.999909726776791,0.00855416971793389,0.573710369894872,151,-23.33,"2 12","579 600",10,"90.00%","100.00%","3UTR",NA,NA,NA,NA,NA
"810","Cluster_4080","Peve_00031324",0.999992290678624,0.00249978970397961,0.417409525382424,171,-20.17,"2 20","9 30",18,"77.78%","88.89%","3UTR","Q9CQW0","ER membrane protein complex subunit 6 (Transmembrane protein 93)","Mus musculus (Mouse)","autophagosome assembly [GO:0000045]; protein insertion into ER membrane by stop-transfer membrane-anchor sequence [GO:0045050]; tail-anchored membrane protein insertion into ER membrane [GO:0071816]","GO:0000045; GO:0005789; GO:0016020; GO:0032977; GO:0045050; GO:0071816; GO:0072546; GO:1903349"
"817","Cluster_11134","Peve_00035315",0.997089150362585,0.0485859177132707,0.947668828184205,163,-24.46,"2 21","718 740",20,"75.00%","80.00%","3UTR","Q9VW71","Fat-like cadherin-related tumor suppressor homolog (Protein kugelei)","Drosophila melanogaster (Fruit fly)","calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; centripetally migrating follicle cell migration [GO:0060269]; defense response to Gram-negative bacterium [GO:0050829]; establishment of planar polarity of follicular epithelium [GO:0042247]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; foregut morphogenesis [GO:0007440]; growth of a germarium-derived egg chamber [GO:0007295]; hindgut morphogenesis [GO:0007442]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of innate immune response [GO:0045089]; protein localization to cell leading edge [GO:1902463]; salivary gland development [GO:0007431]","GO:0005509; GO:0005886; GO:0005925; GO:0007156; GO:0007295; GO:0007424; GO:0007431; GO:0007440; GO:0007442; GO:0009925; GO:0016339; GO:0030950; GO:0031254; GO:0042247; GO:0044331; GO:0044877; GO:0045089; GO:0048477; GO:0050829; GO:0050839; GO:0051491; GO:0060269; GO:0098609; GO:0098858; GO:1902463"
"834","Cluster_4115","Peve_00043301",-0.999473741771815,0.0206544492090428,0.814021076298899,169,-22.8,"2 19","351 374",19,"78.95%","89.47%","3UTR","Q8N3X1","Formin-binding protein 4 (Formin-binding protein 30)","Homo sapiens (Human)","","GO:0016607"
"858","Cluster_4079","Peve_00030841",-0.997945022574284,0.0408200045387614,0.909359886114279,160,-22.37,"2 13","341 362",11,"100.00%","100.00%","3UTR","A0A481NSZ4",NA,NA,NA,NA
"861","Cluster_6914","Peve_00006285",0.999973885825882,0.00460080910062486,0.545608313504719,158,-20.29,"2 20","107 128",19,"73.68%","78.95%","3UTR",NA,NA,NA,NA,NA
"870","Cluster_6906","Peve_00011900",0.999023739066517,0.0281328295255526,0.902005420309698,157,-22.41,"2 18","850 871",16,"75.00%","81.25%","3UTR",NA,NA,NA,NA,NA
"904","Cluster_4629","Peve_00021553",0.997938030915672,0.0408894104551393,0.909359886114279,150,-20.07,"2 20","95 120",22,"63.64%","72.73%","3UTR",NA,NA,NA,NA,NA
"909","Cluster_4735","Peve_00013205",-0.999762368280092,0.013878928135551,0.720093853779252,158,-24.01,"2 21","196 221",23,"73.91%","73.91%","3UTR",NA,NA,NA,NA,NA
"926","Cluster_16738","Peve_00032724",0.999974190676381,0.00457387578916138,0.54328949385489,169,-21.23,"2 18","554 575",16,"87.50%","87.50%","3UTR",NA,NA,NA,NA,NA
"935","Cluster_10061","Peve_00031409",0.999873400436456,0.0101301483856458,0.62545365403098,161,-20.62,"2 18","964 985",16,"75.00%","87.50%","3UTR",NA,NA,NA,NA,NA
"954","Cluster_7053","Peve_00013596",0.999599711713374,0.0180134147972475,0.782669382293497,155,-20.38,"2 20","415 434",18,"72.22%","88.89%","3UTR","Q9JI70","Molecular chaperone MKKS (McKusick-Kaufman/Bardet-Biedl syndromes putative chaperonin) (Protein Bbs6 homolog)","Mus musculus (Mouse)","artery smooth muscle contraction [GO:0014824]; brain morphogenesis [GO:0048854]; cartilage development [GO:0051216]; cerebral cortex development [GO:0021987]; chaperone-mediated protein complex assembly [GO:0051131]; cilium assembly [GO:0060271]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; developmental process [GO:0032502]; face development [GO:0060324]; fat cell differentiation [GO:0045444]; gene expression [GO:0010467]; hippocampus development [GO:0021766]; intracellular transport [GO:0046907]; leptin-mediated signaling pathway [GO:0033210]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of appetite by leptin-mediated signaling pathway [GO:0038108]; negative regulation of blood pressure [GO:0045776]; negative regulation of gene expression [GO:0010629]; negative regulation of GTPase activity [GO:0034260]; non-motile cilium assembly [GO:1905515]; photoreceptor cell maintenance [GO:0045494]; positive regulation of multicellular organism growth [GO:0040018]; protein folding [GO:0006457]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296]; regulation of stress fiber assembly [GO:0051492]; response to leptin [GO:0044321]; sensory perception of smell [GO:0007608]; social behavior [GO:0035176]; spermatid development [GO:0007286]; striatum development [GO:0021756]; vasodilation [GO:0042311]","GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0006457; GO:0007286; GO:0007608; GO:0010467; GO:0010629; GO:0014824; GO:0021756; GO:0021766; GO:0021987; GO:0030837; GO:0031514; GO:0032502; GO:0033210; GO:0034260; GO:0035176; GO:0036064; GO:0038108; GO:0040018; GO:0042311; GO:0044321; GO:0045444; GO:0045494; GO:0045776; GO:0046907; GO:0048854; GO:0050910; GO:0051082; GO:0051131; GO:0051216; GO:0051492; GO:0060271; GO:0060296; GO:0060324; GO:0061629; GO:1902636; GO:1905515"
"984","Cluster_1167","Peve_00043468",0.999909726776791,0.00855416971793915,0.573710369894872,155,-21.49,"2 21","742 764",20,"70.00%","75.00%","3UTR","Q9VBW3","Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14)","Drosophila melanogaster (Fruit fly)","calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of kinase activity [GO:0033674]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; wound healing [GO:0042060]","GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007156; GO:0007169; GO:0014068; GO:0016339; GO:0033674; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0090303"
"1063","Cluster_9149","Peve_00008133",-0.999965637301935,0.00527764279292991,0.551398425649056,164,-20.98,"2 20","190 209",18,"83.33%","83.33%","3UTR","P58027","Amine oxidase [flavin-containing] A (EC 1.4.3.21) (EC 1.4.3.4) (Monoamine oxidase type A) (MAO-A)","Canis lupus familiaris (Dog) (Canis familiaris)","catecholamine metabolic process [GO:0006584]; neurotransmitter catabolic process [GO:0042135]","GO:0005739; GO:0005741; GO:0006584; GO:0008131; GO:0042135; GO:0050660; GO:0052595; GO:0052596; GO:0097621"
"1083","Cluster_4080","Peve_00001878",-0.997498841901557,0.045035631247519,0.930829896493262,169,-21.99,"2 20","37 57",18,"83.33%","88.89%","3UTR",NA,NA,NA,NA,NA
"1121","Cluster_9149","Peve_00036519",-0.999042227116386,0.0278651290317038,0.899642249848007,145,-20.73,"2 16","885 905",14,"71.43%","85.71%","3UTR","O00468","Agrin [Cleaved into: Agrin N-terminal 110 kDa subunit; Agrin C-terminal 110 kDa subunit; Agrin C-terminal 90 kDa fragment (C90); Agrin C-terminal 22 kDa fragment (C22)]","Homo sapiens (Human)","animal organ morphogenesis [GO:0009887]; clustering of voltage-gated sodium channels [GO:0045162]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; neuromuscular junction development [GO:0007528]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; positive regulation of synaptic assembly at neuromuscular junction [GO:0045887]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor clustering [GO:0043113]; signal transduction [GO:0007165]; synapse organization [GO:0050808]; tissue development [GO:0009888]","GO:0002162; GO:0005200; GO:0005509; GO:0005576; GO:0005604; GO:0005796; GO:0005886; GO:0007165; GO:0007213; GO:0007528; GO:0009887; GO:0009888; GO:0033691; GO:0035374; GO:0043113; GO:0043202; GO:0043236; GO:0043395; GO:0043547; GO:0045162; GO:0045202; GO:0045887; GO:0045944; GO:0050808; GO:0051491; GO:0062023; GO:0070062"
"1135","Cluster_15726","Peve_00030612",1,1.34157585525081e-08,8.89340150118664e-06,159,-23.05,"2 21","67 89",20,"70.00%","80.00%","3UTR",NA,NA,NA,NA,NA
"1139","Cluster_10934","Peve_00037399",0.998758250045998,0.0317290557481601,0.903929377050813,171,-22.4,"2 20","479 500",18,"83.33%","83.33%","3UTR","Q924H0","Neuropeptide FF receptor 2 (G-protein coupled receptor 74) (Neuropeptide NPFF receptor)","Mus musculus (Mouse)","G protein-coupled receptor signaling pathway [GO:0007186]; regulation of adenylate cyclase activity [GO:0045761]; regulation of cAMP-dependent protein kinase activity [GO:2000479]; regulation of MAPK cascade [GO:0043408]","GO:0004930; GO:0005886; GO:0007186; GO:0008188; GO:0015629; GO:0031628; GO:0042277; GO:0043408; GO:0045761; GO:2000479"
"1195","Cluster_2854","Peve_00038107",-0.997755955103144,0.042657179825614,0.914411088077857,148,-20.08,"2 15","945 965",13,"84.62%","84.62%","3UTR",NA,NA,NA,NA,NA
"1206","Cluster_5882","Peve_00034300",-0.999810125119312,0.0124061134927224,0.685998477593919,160,-22.36,"2 17","412 433",15,"73.33%","93.33%","3UTR","O75976","Carboxypeptidase D (EC 3.4.17.22) (Metallocarboxypeptidase D) (gp180)","Homo sapiens (Human)","peptide metabolic process [GO:0006518]; protein processing [GO:0016485]","GO:0004181; GO:0004185; GO:0005615; GO:0005886; GO:0006518; GO:0008270; GO:0016020; GO:0016485; GO:0070062"
"1213","Cluster_2854","Peve_00019126",-0.997565388064538,0.0444322335382886,0.926725506280974,174,-25.76,"2 21","237 260",21,"80.95%","90.48%","3UTR",NA,NA,NA,NA,NA
"1222","Cluster_14500","Peve_00006413",-0.999945819357893,0.0066270333402645,0.573710369894872,162,-21.66,"2 21","758 783",23,"73.91%","78.26%","3UTR","Q9Y2I7","1-phosphatidylinositol 3-phosphate 5-kinase (Phosphatidylinositol 3-phosphate 5-kinase) (EC 2.7.1.150) (FYVE finger-containing phosphoinositide kinase) (PIKfyve) (Phosphatidylinositol 3-phosphate 5-kinase type III) (PIPkin-III) (Type III PIP kinase) (Serine-protein kinase PIKFYVE) (EC 2.7.11.1)","Homo sapiens (Human)","1-phosphatidyl-1D-myo-inositol 3,5-bisphosphate metabolic process [GO:1903100]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; intracellular signal transduction [GO:0035556]; melanosome organization [GO:0032438]; myelin assembly [GO:0032288]; neutrophil chemotaxis [GO:0030593]; peptidyl-serine autophosphorylation [GO:0036289]; phagosome maturation [GO:0090382]; phagosome-lysosome fusion [GO:0090385]; phosphatidylinositol 5-phosphate metabolic process [GO:1904562]; phosphatidylinositol biosynthetic process [GO:0006661]; protein localization to nucleus [GO:0034504]; protein targeting to membrane [GO:0006612]; receptor-mediated endocytosis of virus by host cell [GO:0019065]; regulation of autophagosome assembly [GO:2000785]; regulation of reactive oxygen species biosynthetic process [GO:1903426]; retrograde transport, endosome to Golgi [GO:0042147]","GO:0000139; GO:0000285; GO:0004674; GO:0005524; GO:0005829; GO:0005911; GO:0006612; GO:0006661; GO:0008270; GO:0010008; GO:0012506; GO:0016308; GO:0019065; GO:0019886; GO:0030593; GO:0030670; GO:0031410; GO:0031901; GO:0031902; GO:0032288; GO:0032438; GO:0034504; GO:0035556; GO:0036289; GO:0042147; GO:0043813; GO:0045121; GO:0048471; GO:0052810; GO:0090382; GO:0090385; GO:0106310; GO:1903100; GO:1903426; GO:1904562; GO:2000785"
"1240","Cluster_1167","Peve_00013947",0.999909726776791,0.00855416971793389,0.573710369894872,141,-21.45,"2 12","681 701",10,"90.00%","90.00%","3UTR",NA,NA,NA,NA,NA
"1241","Cluster_9149","Peve_00043123",1,0,0,157,-23.58,"2 21","803 824",20,"75.00%","80.00%","3UTR",NA,NA,NA,NA,NA
"1246","Cluster_6906","Peve_00030693",0.999488224375111,0.0203682371525405,0.810097073649321,155,-20.73,"2 21","558 576",19,"73.68%","84.21%","3UTR","Q86VD9","GPI mannosyltransferase 4 (EC 2.4.1.-) (GPI mannosyltransferase IV) (GPI-MT-IV) (Phosphatidylinositol-glycan biosynthesis class Z protein) (PIG-Z) (SMP3 homolog) (hSMP3)","Homo sapiens (Human)","GPI anchor biosynthetic process [GO:0006506]; preassembly of GPI anchor in ER membrane [GO:0016254]","GO:0000026; GO:0000030; GO:0005783; GO:0005789; GO:0006506; GO:0016254"
"1262","Cluster_13502","Peve_00000601",0.997844556977271,0.0418062711782387,0.909359886114279,153,-21.15,"2 19","925 950",21,"66.67%","76.19%","3UTR",NA,NA,NA,NA,NA
"1284","Cluster_4629","Peve_00012638",0.997938030915672,0.0408894104551393,0.909359886114279,162,-20.05,"2 20","206 228",19,"73.68%","84.21%","3UTR","Q92626","Peroxidasin homolog (EC 1.11.2.-) (Melanoma-associated antigen MG50) (Peroxidasin 1) (hsPxd01) (Vascular peroxidase 1) (p53-responsive gene 2 protein) [Cleaved into: PXDN active fragment]","Homo sapiens (Human)","angiogenesis [GO:0001525]; basement membrane assembly [GO:0070831]; basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; eye development [GO:0001654]; hydrogen peroxide catabolic process [GO:0042744]; immune response [GO:0006955]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; response to oxidative stress [GO:0006979]","GO:0001525; GO:0001654; GO:0004601; GO:0005152; GO:0005201; GO:0005576; GO:0005604; GO:0005615; GO:0005783; GO:0006955; GO:0006979; GO:0007155; GO:0009986; GO:0016684; GO:0020037; GO:0030198; GO:0030199; GO:0031012; GO:0042744; GO:0043237; GO:0046872; GO:0051260; GO:0062023; GO:0070062; GO:0070207; GO:0070831; GO:0071711; GO:0140825"
"1289","Cluster_14999","Peve_00003000",-0.998266557633023,0.0374897530420475,0.909359886114279,161,-21.13,"2 14","905 926",12,"91.67%","100.00%","3UTR",NA,NA,NA,NA,NA
"1363","Cluster_2854","Peve_00021216",0.999962448044095,0.00551712420276166,0.551398425649056,156,-20.4,"2 20","190 209",18,"72.22%","83.33%","3UTR",NA,NA,NA,NA,NA
"1372","Cluster_1167","Peve_00015043",0.999909726776791,0.00855416971793915,0.573710369894872,155,-29.94,"2 21","395 419",22,"68.18%","72.73%","3UTR",NA,NA,NA,NA,NA
"1373","Cluster_11135","Peve_00002637",0.999511573163594,0.019898143482347,0.802868112010331,168,-21.37,"2 21","948 969",19,"68.42%","89.47%","3UTR","Q8K2J9","BTB/POZ domain-containing protein 6","Mus musculus (Mouse)","neurogenesis [GO:0022008]","GO:0005829; GO:0022008"
"1379","Cluster_796","Peve_00001935",0.998840928019511,0.030654361989868,0.903929377050813,159,-24.54,"2 21","302 328",24,"70.83%","70.83%","3UTR","O08726","Galanin receptor type 2 (GAL2-R) (GALR-2)","Rattus norvegicus (Rat)","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; G protein-coupled receptor signaling pathway [GO:0007186]; galanin-activated signaling pathway [GO:0090663]; inositol phosphate metabolic process [GO:0043647]; negative regulation of adenylate cyclase activity [GO:0007194]; neuron projection development [GO:0031175]; neuropeptide signaling pathway [GO:0007218]; phosphatidylinositol metabolic process [GO:0046488]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of large conductance calcium-activated potassium channel activity [GO:1902608]; positive regulation of transcription by RNA polymerase II [GO:0045944]","GO:0004966; GO:0005886; GO:0005929; GO:0007186; GO:0007188; GO:0007189; GO:0007194; GO:0007200; GO:0007204; GO:0007218; GO:0008528; GO:0017046; GO:0031175; GO:0042923; GO:0043647; GO:0045944; GO:0046488; GO:0090663; GO:1902608"
"1392","Cluster_589","Peve_00044964",-0.999852293886836,0.0109420753621189,0.647820986329688,160,-23.7,"2 17","733 754",15,"80.00%","86.67%","3UTR",NA,NA,NA,NA,NA
"1393","Cluster_4735","Peve_00036516",0.999722156026375,0.0150074072356261,0.742836432891574,155,-20.6,"2 16","301 322",14,"78.57%","85.71%","3UTR",NA,NA,NA,NA,NA
"1407","Cluster_4629","Peve_00011858",-0.999998482798634,0.00110896231522268,0.278265881456726,162,-22.01,"2 21","146 170",22,"77.27%","77.27%","3UTR","O43147","Small G protein signaling modulator 2 (RUN and TBC1 domain-containing protein 1)","Homo sapiens (Human)","activation of GTPase activity [GO:0090630]; late endosome to Golgi transport [GO:0034499]; positive regulation of GTPase activity [GO:0043547]","GO:0005096; GO:0005737; GO:0031267; GO:0034499; GO:0042470; GO:0043547; GO:0090630"
"1408","Cluster_4629","Peve_00011858",-0.999998482798634,0.00110896231522268,0.278265881456726,162,-22.01,"2 21","586 610",22,"77.27%","77.27%","3UTR","O43147","Small G protein signaling modulator 2 (RUN and TBC1 domain-containing protein 1)","Homo sapiens (Human)","activation of GTPase activity [GO:0090630]; late endosome to Golgi transport [GO:0034499]; positive regulation of GTPase activity [GO:0043547]","GO:0005096; GO:0005737; GO:0031267; GO:0034499; GO:0042470; GO:0043547; GO:0090630"
"1423","Cluster_1167","Peve_00029393",0.999909726776791,0.00855416971793389,0.573710369894872,149,-22.43,"2 20","154 174",18,"72.22%","72.22%","3UTR","P34992","Neuropeptide Y receptor type 1 (NPY1-R)","Xenopus laevis (African clawed frog)","","GO:0004983; GO:0005886"
"1432","Cluster_11134","Peve_00019237",0.99895412821558,0.0291187147996283,0.903929377050813,157,-25.17,"2 21","142 163",20,"70.00%","85.00%","3UTR","P56407","Homeobox protein ceh-9","Caenorhabditis elegans","cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0030154"
"1449","Cluster_2787","Peve_00039724",-0.999918519895221,0.0081268802250093,0.573710369894872,161,-22.45,"2 19","175 197",18,"72.22%","88.89%","3UTR","Q9Z2L6","Multiple inositol polyphosphate phosphatase 1 (EC 3.1.3.62) (2,3-bisphosphoglycerate 3-phosphatase) (2,3-BPG phosphatase) (EC 3.1.3.80) (Inositol (1,3,4,5)-tetrakisphosphate 3-phosphatase) (Ins(1,3,4,5)P(4) 3-phosphatase)","Mus musculus (Mouse)","","GO:0003993; GO:0005788; GO:0005886; GO:0030351; GO:0030352; GO:0034417; GO:0052745; GO:0052826"
"1459","Cluster_4629","Peve_00022350",0.997938030915673,0.0408894104551382,0.909359886114279,160,-21.85,"2 21","166 187",19,"63.16%","84.21%","3UTR",NA,NA,NA,NA,NA
"1497","Cluster_589","Peve_00001193",-0.99919278413099,0.0255810981953082,0.875092164569788,154,-23.1,"2 20","676 698",19,"68.42%","78.95%","3UTR","P22127","Ras-related protein Rab-10 (ORA1)","Diplobatis ommata (Ocellated electric ray) (Discopyge ommata)","axonogenesis [GO:0007409]; cellular response to insulin stimulus [GO:0032869]; endoplasmic reticulum tubular network organization [GO:0071786]; endosomal transport [GO:0016197]; establishment of neuroblast polarity [GO:0045200]; establishment of protein localization to endoplasmic reticulum membrane [GO:0097051]; Golgi to plasma membrane protein transport [GO:0043001]; Golgi to plasma membrane transport [GO:0006893]; polarized epithelial cell differentiation [GO:0030859]; protein localization to basolateral plasma membrane [GO:1903361]; protein localization to plasma membrane [GO:0072659]; vesicle-mediated transport [GO:0016192]","GO:0003924; GO:0005525; GO:0005768; GO:0005789; GO:0005794; GO:0005802; GO:0005929; GO:0006893; GO:0007409; GO:0016192; GO:0016197; GO:0019003; GO:0030670; GO:0030859; GO:0032593; GO:0032869; GO:0043001; GO:0045200; GO:0055037; GO:0055038; GO:0071782; GO:0071786; GO:0072659; GO:0097051; GO:1903361"
"1502","Cluster_796","Peve_00012907",-0.999864535075281,0.0104788458953449,0.635656620419967,156,-20.81,"2 21","643 664",19,"68.42%","73.68%","3UTR",NA,NA,NA,NA,NA
"1519","Cluster_4079","Peve_00037614",-0.997292545957876,0.0468569161220451,0.939542385262084,169,-28.14,"2 21","495 517",21,"80.95%","85.71%","3UTR","P41250","Glycine--tRNA ligase (EC 6.1.1.14) (Diadenosine tetraphosphate synthetase) (Ap4A synthetase) (EC 2.7.7.-) (Glycyl-tRNA synthetase) (GlyRS) (Glycyl-tRNA synthetase 1)","Homo sapiens (Human)","diadenosine tetraphosphate biosynthetic process [GO:0015966]; glycyl-tRNA aminoacylation [GO:0006426]; mitochondrial glycyl-tRNA aminoacylation [GO:0070150]; tRNA aminoacylation for protein translation [GO:0006418]","GO:0004081; GO:0004820; GO:0005524; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0006418; GO:0006426; GO:0015966; GO:0016740; GO:0030141; GO:0030424; GO:0042802; GO:0046983; GO:0070062; GO:0070150"
"1545","Cluster_9149","Peve_00018844",-0.998768459381639,0.031598325746414,0.903929377050813,148,-22.4,"2 17","795 813",15,"80.00%","80.00%","3UTR","Q9UA35","Solute carrier family 28 member 3 (Concentrative Na(+)-nucleoside cotransporter 3) (hfCNT)","Eptatretus stoutii (Pacific hagfish)","","GO:0005337; GO:0005886; GO:0015293"
"1553","Cluster_4629","Peve_00000256",0.997938030915672,0.0408894104551393,0.909359886114279,150,-20.58,"2 19","641 662",17,"70.59%","70.59%","3UTR",NA,NA,NA,NA,NA
"1566","Cluster_15726","Peve_00007613",0.999883443510219,0.00972002918842882,0.612877211000455,157,-20.89,"2 15","292 315",15,"86.67%","86.67%","3UTR","P28175","Clotting factor C (FC) (EC 3.4.21.84) (Limulus factor C) [Cleaved into: Clotting factor C heavy chain; Clotting factor C light chain; Clotting factor C chain A; Clotting factor C chain B]","Tachypleus tridentatus (Japanese horseshoe crab)","cell adhesion [GO:0007155]; hemolymph coagulation [GO:0042381]; protein processing [GO:0016485]","GO:0004252; GO:0005576; GO:0007155; GO:0016485; GO:0030246; GO:0042381"
"1572","Cluster_11135","Peve_00022342",0.999706721854346,0.0154186228806241,0.751144232060475,153,-21.16,"2 21","882 905",22,"68.18%","77.27%","3UTR",NA,NA,NA,NA,NA
"1624","Cluster_6904","Peve_00014436",-0.999185657644639,0.0256937863850763,0.876505990190277,167,-27.12,"2 21","703 725",20,"75.00%","85.00%","3UTR",NA,NA,NA,NA,NA
"1651","Cluster_796","Peve_00023049",0.9999733342158,0.00464914686852433,0.548889669521695,151,-21.71,"2 21","271 297",24,"62.50%","70.83%","3UTR","P54357","Myosin-2 essential light chain (Myosin II essential light chain) (Non-muscle myosin essential light chain)","Drosophila melanogaster (Fruit fly)","actin filament-based movement [GO:0030048]","GO:0005509; GO:0005829; GO:0016460; GO:0017022; GO:0030048; GO:0031475; GO:0031476; GO:0031477; GO:0032036"
"1664","Cluster_6914","Peve_00012607",0.997809832643678,0.0421417987017475,0.911075865480802,166,-23.44,"2 20","358 379",19,"78.95%","84.21%","3UTR","Q8CG08","Collagen triple helix repeat-containing protein 1","Rattus norvegicus (Rat)","cell migration [GO:0016477]; cochlea morphogenesis [GO:0090103]; establishment of planar polarity involved in neural tube closure [GO:0090177]; inner ear receptor cell stereocilium organization [GO:0060122]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; ossification involved in bone remodeling [GO:0043932]; osteoblast differentiation [GO:0001649]; osteoblast proliferation [GO:0033687]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of protein binding [GO:0032092]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]","GO:0001649; GO:0005109; GO:0005581; GO:0005615; GO:0005737; GO:0016477; GO:0016528; GO:0017147; GO:0031012; GO:0032092; GO:0033687; GO:0033690; GO:0043932; GO:0045669; GO:0060071; GO:0060122; GO:0090090; GO:0090103; GO:0090177"
"1687","Cluster_2787","Peve_00006347",0.997397732644906,0.0459372826693576,0.934604794067411,163,-22.73,"2 21","273 297",22,"72.73%","77.27%","3UTR","Q86WI1","Fibrocystin-L (Polycystic kidney and hepatic disease 1-like protein 1) (PKHD1-like protein 1)","Homo sapiens (Human)","immune response [GO:0006955]; sensory perception of sound [GO:0007605]","GO:0005615; GO:0005829; GO:0006955; GO:0007605; GO:0016020; GO:0032426; GO:0038023; GO:0120234"
"1700","Cluster_11134","Peve_00043325",0.999679946581222,0.0161071216942691,0.766206870688277,154,-20.57,"2 21","535 555",19,"63.16%","84.21%","3UTR","Q7TPS5","C2 domain-containing protein 5 (138 kDa C2 domain-containing phosphoprotein)","Mus musculus (Mouse)","cellular response to insulin stimulus [GO:0032869]; insulin receptor signaling pathway via phosphatidylinositol 3-kinase [GO:0038028]; intracellular protein transmembrane transport [GO:0065002]; positive regulation of glucose import [GO:0046326]; positive regulation of glucose transmembrane transport [GO:0010828]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of vesicle fusion [GO:0031340]; protein localization to plasma membrane [GO:0072659]; vesicle fusion [GO:0006906]","GO:0005509; GO:0005544; GO:0005829; GO:0005886; GO:0005938; GO:0006906; GO:0010828; GO:0030659; GO:0031340; GO:0032587; GO:0032869; GO:0034451; GO:0038028; GO:0046326; GO:0065002; GO:0072659; GO:0090314"
"1748","Cluster_9149","Peve_00021224",1,0,0,144,-21.08,"2 18","333 357",19,"68.42%","68.42%","3UTR",NA,NA,NA,NA,NA
"1779","Cluster_8888","Peve_00025328",0.999964597582385,0.00535689165213977,0.551398425649056,154,-22.08,"2 20","922 939",18,"77.78%","83.33%","3UTR","Q6GL87","Growth hormone-regulated TBC protein 1","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","","GO:0005096"
"1794","Cluster_9149","Peve_00026910",1,0,0,165,-22,"2 19","663 685",18,"83.33%","83.33%","3UTR",NA,NA,NA,NA,NA
"1838","Cluster_4629","Peve_00025489",0.997938030915672,0.0408894104551393,0.909359886114279,143,-20.34,"2 12","908 929",10,"80.00%","90.00%","3UTR",NA,NA,NA,NA,NA
"1842","Cluster_14999","Peve_00021676",0.999075146741859,0.0273819903750951,0.894692732264905,167,-25.85,"2 16","820 841",14,"85.71%","100.00%","3UTR",NA,NA,NA,NA,NA
"1856","Cluster_9149","Peve_00012722",1,0,0,152,-25.13,"2 15","768 788",13,"84.62%","92.31%","3UTR",NA,NA,NA,NA,NA
"1868","Cluster_7658","Peve_00014491",-0.999687209109476,0.0159233151265928,0.762215157405503,167,-22.5,"2 21","16 38",20,"75.00%","85.00%","3UTR","Q8L7S6","Beta-hexosaminidase 3 (EC 3.2.1.52) (Beta-GlcNAcase 3) (Beta-N-acetylhexosaminidase 3) (Beta-hexosaminidase 1) (AtHEX1) (N-acetyl-beta-glucosaminidase 3)","Arabidopsis thaliana (Mouse-ear cress)","carbohydrate metabolic process [GO:0005975]; glycosaminoglycan metabolic process [GO:0030203]","GO:0004563; GO:0005634; GO:0005886; GO:0005975; GO:0015929; GO:0016020; GO:0030203; GO:0102148"
"1904","Cluster_16498","Peve_00011733",0.99999477106698,0.00205874164373314,0.362847063101065,169,-20.57,"2 21","10 31",20,"80.00%","90.00%","3UTR","Q96AY4","Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio)","Homo sapiens (Human)","cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0000922; GO:0005737; GO:0005815; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301"
"1920","Cluster_9149","Peve_00004871",1,0,0,147,-21.53,"2 12","622 643",10,"80.00%","100.00%","3UTR",NA,NA,NA,NA,NA
"1939","Cluster_589","Peve_00028810",-0.999776252592975,0.0134673523968407,0.710997774681485,155,-22.76,"2 12","405 426",10,"100.00%","100.00%","3UTR",NA,NA,NA,NA,NA
"1964","Cluster_15726","Peve_00014069",1,9.48637384723993e-09,6.86838308108347e-06,154,-23.14,"2 20","861 888",24,"66.67%","70.83%","3UTR",NA,NA,NA,NA,NA
"1974","Cluster_9149","Peve_00002661",-0.998403640393818,0.0359764475202205,0.909359886114279,149,-25.07,"2 18","337 356",16,"75.00%","87.50%","3UTR","E7FAM5","E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71)","Danio rerio (Zebrafish) (Brachydanio rerio)","embryonic body morphogenesis [GO:0010172]; fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA metabolic process [GO:0010586]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; negative regulation of translation [GO:0017148]; neural tube development [GO:0021915]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; regulation of miRNA-mediated gene silencing [GO:0060964]; regulation of neural precursor cell proliferation [GO:2000177]; stem cell proliferation [GO:0072089]","GO:0000082; GO:0000209; GO:0000932; GO:0004842; GO:0008270; GO:0008543; GO:0010172; GO:0010586; GO:0017148; GO:0021915; GO:0030371; GO:0035198; GO:0035278; GO:0043161; GO:0051865; GO:0060964; GO:0061630; GO:0072089; GO:2000177"
"2003","Cluster_2854","Peve_00013531",-0.999994747981342,0.00206328129499564,0.363213043883873,176,-25.43,"2 21","596 617",19,"84.21%","84.21%","3UTR","O00116","Alkyldihydroxyacetonephosphate synthase, peroxisomal (Alkyl-DHAP synthase) (EC 2.5.1.26) (Aging-associated gene 5 protein) (Alkylglycerone-phosphate synthase)","Homo sapiens (Human)","ether lipid biosynthetic process [GO:0008611]; lipid biosynthetic process [GO:0008610]","GO:0005730; GO:0005739; GO:0005777; GO:0005778; GO:0005782; GO:0005829; GO:0008609; GO:0008610; GO:0008611; GO:0016020; GO:0071949"
"2019","Cluster_11134","Peve_00000891",-0.999479069517375,0.0205496231198021,0.812495585628734,156,-25.76,"2 21","699 718",19,"73.68%","84.21%","3UTR","Q3KR37","Protein Aster-B (GRAM domain-containing protein 1B)","Homo sapiens (Human)","cellular response to cholesterol [GO:0071397]; cholesterol homeostasis [GO:0042632]; intracellular sterol transport [GO:0032366]","GO:0001786; GO:0005789; GO:0005886; GO:0015485; GO:0016020; GO:0032366; GO:0032934; GO:0042632; GO:0070300; GO:0071397; GO:0120015; GO:0120020; GO:0140268"
"2024","Cluster_5563","Peve_00029721",0.999970783906393,0.00486639381889994,0.551398425649056,168,-22.23,"2 21","925 945",19,"84.21%","89.47%","3UTR",NA,NA,NA,NA,NA
"2026","Cluster_15890","Peve_00032829",-0.999967287119389,0.00514938897746555,0.551398425649056,162,-22.12,"2 21","284 304",19,"73.68%","84.21%","3UTR",NA,NA,NA,NA,NA
"2061","Cluster_15726","Peve_00043724",-0.998403640393818,0.0359764475202192,0.909359886114279,165,-27.25,"2 20","949 973",21,"80.95%","80.95%","3UTR","Q9MYM7","Beta-1,3-galactosyltransferase 1 (Beta-1,3-GalTase 1) (Beta3Gal-T1) (Beta3GalT1) (EC 2.4.1.86) (UDP-galactose:beta-N-acetyl-glucosamine-beta-1,3-galactosyltransferase 1)","Pongo pygmaeus (Bornean orangutan)","lipid metabolic process [GO:0006629]; protein glycosylation [GO:0006486]","GO:0000139; GO:0006486; GO:0006629; GO:0047275"
"2085","Cluster_14999","Peve_00025970",-0.999571546587002,0.0186364175217764,0.782669382293497,178,-27.37,"2 20","596 618",19,"84.21%","94.74%","3UTR",NA,NA,NA,NA,NA
"2088","Cluster_16738","Peve_00025028",-0.9981690675047,0.0385298725994388,0.909359886114279,176,-25.72,"2 21","741 762",19,"78.95%","89.47%","3UTR",NA,NA,NA,NA,NA
"2092","Cluster_1167","Peve_00043521",0.999909606796706,0.00855985249202504,0.574004478614831,146,-23.91,"2 21","190 214",22,"63.64%","72.73%","3UTR",NA,NA,NA,NA,NA
"2100","Cluster_9149","Peve_00039320",-0.99707405830425,0.048711769379337,0.94828359635183,153,-25.57,"2 14","871 892",12,"75.00%","100.00%","3UTR",NA,NA,NA,NA,NA
"2111","Cluster_4629","Peve_00000786",0.997938030915673,0.0408894104551371,0.909359886114279,162,-24.67,"2 21","469 493",22,"72.73%","81.82%","3UTR",NA,NA,NA,NA,NA
"2150","Cluster_8988","Peve_00040282",-0.999041633391172,0.0278737658962114,0.899642249848007,162,-21.05,"2 21","329 354",23,"69.57%","82.61%","3UTR",NA,NA,NA,NA,NA
"2175","Cluster_796","Peve_00033364",0.999260034938896,0.0244921839031936,0.862029780817471,145,-20.01,"2 10","259 280",8,"100.00%","100.00%","3UTR","P22045","9,11-endoperoxide prostaglandin H2 reductase (EC 1.1.1.-) (Prostaglandin F2-alpha synthase)","Leishmania major","prostaglandin biosynthetic process [GO:0001516]","GO:0000166; GO:0001516; GO:0005737; GO:0036130"
"2177","Cluster_29","Peve_00022058",-0.997453781157211,0.0454396710191659,0.933005102504876,162,-20.17,"2 19","370 391",17,"70.59%","88.24%","3UTR",NA,NA,NA,NA,NA
"2194","Cluster_9149","Peve_00024049",0.999779696086058,0.0133633148443657,0.708804190981816,168,-24.07,"2 21","603 624",19,"73.68%","84.21%","3UTR",NA,NA,NA,NA,NA
"2198","Cluster_4629","Peve_00007535",0.997938030915672,0.0408894104551393,0.909359886114279,159,-21.98,"2 21","431 453",20,"70.00%","80.00%","3UTR",NA,NA,NA,NA,NA
"2208","Cluster_10934","Peve_00044580",0.998038064060883,0.0398849050546989,0.909359886114279,161,-21.63,"2 20","74 94",18,"77.78%","83.33%","3UTR","A2RV01","Diphthine--ammonia ligase (EC 6.3.1.14) (ATP-binding domain-containing protein 4) (Diphthamide synthase) (Diphthamide synthetase) (Protein DPH6 homolog)","Danio rerio (Zebrafish) (Brachydanio rerio)","peptidyl-diphthamide biosynthetic process from peptidyl-histidine [GO:0017183]","GO:0005524; GO:0017178; GO:0017183"
"2209","Cluster_11134","Peve_00044581",0.999774208746349,0.0135287244184117,0.712341789037769,162,-21.68,"2 20","878 900",19,"78.95%","78.95%","3UTR","Q28DS0","SUMO-activating enzyme subunit 1 (Ubiquitin-like 1-activating enzyme E1A)","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","definitive hemopoiesis [GO:0060216]; hematopoietic stem cell homeostasis [GO:0061484]; protein sumoylation [GO:0016925]","GO:0008022; GO:0008641; GO:0016925; GO:0031510; GO:0060216; GO:0061484"
"2212","Cluster_9149","Peve_00021049",-0.999226469305183,0.0250415897127703,0.869034288843014,162,-20.26,"2 19","468 489",17,"76.47%","82.35%","3UTR",NA,NA,NA,NA,NA
"2222","Cluster_8634","Peve_00036804",0.999713854690073,0.0152299610722912,0.747042277261995,165,-22.16,"2 18","575 596",16,"81.25%","87.50%","3UTR",NA,NA,NA,NA,NA
"2241","Cluster_1167","Peve_00023227",0.999689275367834,0.0158706315126451,0.761370369638947,145,-20.39,"2 10","656 677",8,"100.00%","100.00%","3UTR","O54988","STE20-like serine/threonine-protein kinase (STE20-like kinase) (mSLK) (EC 2.7.11.1) (Etk4) (STE20-related kinase SMAK) (STE20-related serine/threonine-protein kinase) (STE20-related kinase) (Serine/threonine-protein kinase 2)","Mus musculus (Mouse)","apoptotic process [GO:0006915]; cellular response to type II interferon [GO:0071346]; cytoplasmic microtubule organization [GO:0031122]; positive regulation of apoptotic process [GO:0043065]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of apoptotic process [GO:0042981]; regulation of cell migration [GO:0030334]; regulation of focal adhesion assembly [GO:0051893]","GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0006468; GO:0006915; GO:0030334; GO:0031122; GO:0031252; GO:0035173; GO:0042802; GO:0042803; GO:0042981; GO:0043065; GO:0046777; GO:0048471; GO:0051893; GO:0071346; GO:0106310"
"2247","Cluster_2787","Peve_00020556",0.997105325686941,0.0484506705316052,0.946735628940312,168,-25.54,"2 21","856 877",19,"73.68%","84.21%","3UTR",NA,NA,NA,NA,NA
"2250","Cluster_2854","Peve_00001444",0.999962776498024,0.00549294287464855,0.551398425649056,158,-21.78,"2 21","203 228",23,"69.57%","78.26%","3UTR","Q0ZZJ6","A.superbus venom factor 1 (AVF-1) (CVF-like) (Complement C3 homolog) [Cleaved into: AVF-1 alpha chain; AVF-1 gamma chain; AVF-1 beta chain]","Austrelaps superbus (Lowland copperhead snake) (Hoplocephalus superbus)","complement activation [GO:0006956]; inflammatory response [GO:0006954]","GO:0004866; GO:0005615; GO:0006954; GO:0006956; GO:0046872; GO:0090729"
"2262","Cluster_4629","Peve_00013823",-0.996949447613843,0.0497387457379489,0.952281411175107,154,-20.35,"2 15","722 743",13,"84.62%","84.62%","3UTR","A0A2J6RX17",NA,NA,NA,NA
"2312","Cluster_4115","Peve_00040371",-0.998463578089383,0.0352944149574942,0.909359886114279,166,-23.07,"2 19","609 630",17,"70.59%","94.12%","3UTR","P35658","Nuclear pore complex protein Nup214 (214 kDa nucleoporin) (Nucleoporin Nup214) (Protein CAN)","Homo sapiens (Human)","mitotic cell cycle [GO:0000278]; mRNA export from nucleus [GO:0006406]; nucleocytoplasmic transport [GO:0006913]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; regulation of cell cycle [GO:0051726]; regulation of nucleocytoplasmic transport [GO:0046822]; RNA export from nucleus [GO:0006405]","GO:0000278; GO:0005049; GO:0005635; GO:0005643; GO:0005654; GO:0005829; GO:0006405; GO:0006406; GO:0006606; GO:0006611; GO:0006913; GO:0008139; GO:0017056; GO:0046822; GO:0051726; GO:1990876"
"2315","Cluster_9149","Peve_00040370",1,0,0,161,-25.16,"2 19","356 380",20,"75.00%","80.00%","3UTR",NA,NA,NA,NA,NA
"2319","Cluster_11134","Peve_00041130",0.998868511449619,0.0302873419647936,0.903929377050813,162,-24.53,"2 19","497 518",17,"64.71%","94.12%","3UTR","Q9WV98","Mitochondrial import inner membrane translocase subunit Tim9","Mus musculus (Mouse)","protein insertion into mitochondrial inner membrane [GO:0045039]","GO:0005739; GO:0005743; GO:0005758; GO:0032977; GO:0042719; GO:0042721; GO:0042803; GO:0045039; GO:0046872; GO:0051087"
"2321","Cluster_9149","Peve_00000334",1,0,0,162,-28.39,"2 21","482 502",19,"73.68%","84.21%","3UTR",NA,NA,NA,NA,NA
"2331","Cluster_1167","Peve_00008498",0.999909726776791,0.00855416971793915,0.573710369894872,149,-22.35,"2 21","811 830",19,"68.42%","73.68%","3UTR",NA,NA,NA,NA,NA
"2340","Cluster_15890","Peve_00029820",-0.998956013089957,0.02909245946257,0.903929377050813,152,-21.12,"2 21","158 178",20,"70.00%","80.00%","3UTR","Q504H8","Homeobox protein HMX3 (Homeobox protein H6 family member 3) (Homeobox protein Nkx-5.1)","Danio rerio (Zebrafish) (Brachydanio rerio)","cell differentiation [GO:0030154]; inner ear morphogenesis [GO:0042472]; nervous system development [GO:0007399]; posterior lateral line development [GO:0048916]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0007399; GO:0030154; GO:0042472; GO:0048916"
"2346","Cluster_4735","Peve_00037304",0.99999940598563,0.000693894776259953,0.239778920002343,151,-24.43,"2 18","62 87",20,"70.00%","80.00%","3UTR",NA,NA,NA,NA,NA
"2348","Cluster_2882","Peve_00027617",-0.997171486654887,0.0478935089731376,0.945312205299076,162,-20.21,"2 21","400 420",19,"73.68%","84.21%","3UTR","Q6PHG8","DNA-directed RNA polymerase I subunit RPA43 (DNA-directed RNA polymerase I subunit F) (Twist neighbor protein)","Danio rerio (Zebrafish) (Brachydanio rerio)","DNA-templated transcription initiation [GO:0006352]","GO:0005736; GO:0006352"
"2359","Cluster_796","Peve_00017540",0.997011731357393,0.0492281083654383,0.950396228648067,156,-25.69,"2 19","770 790",17,"76.47%","82.35%","3UTR","P51693","Amyloid beta precursor like protein 1 (Amyloid beta (A4) precursor-like protein 1) (Amyloid-like protein 1) (APLP) (APLP-1) [Cleaved into: C30]","Homo sapiens (Human)","animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; cellular response to norepinephrine stimulus [GO:0071874]; central nervous system development [GO:0007417]; endocytosis [GO:0006897]; extracellular matrix organization [GO:0030198]; forebrain development [GO:0030900]; mRNA polyadenylation [GO:0006378]; negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106072]; nervous system development [GO:0007399]; regulation of translation [GO:0006417]","GO:0005604; GO:0005654; GO:0005794; GO:0005886; GO:0006378; GO:0006417; GO:0006897; GO:0006915; GO:0007155; GO:0007399; GO:0007409; GO:0007417; GO:0008201; GO:0009887; GO:0030198; GO:0030900; GO:0031694; GO:0031695; GO:0031696; GO:0042802; GO:0046914; GO:0048471; GO:0071874; GO:0106072"
"2373","Cluster_2854","Peve_00029618",-0.999816725191885,0.0121885808006402,0.68064733699131,177,-23.34,"2 18","870 891",16,"93.75%","93.75%","3UTR","Q8K2X2","RNA-binding protein 48","Mus musculus (Mouse)","","GO:0003723; GO:0005654"
"2407","Cluster_10061","Peve_00019763",0.998126576037554,0.0389745384665604,0.909359886114279,171,-20.53,"2 21","470 492",20,"75.00%","90.00%","3UTR","B8V7S0","CUB and peptidase domain-containing protein 1","Acropora millepora (Staghorn coral) (Heteropora millepora)","proteolysis [GO:0006508]","GO:0004252; GO:0005576; GO:0006508"
"2424","Cluster_6914","Peve_00007832",-0.999985569263183,0.00342010859677409,0.509766725418101,165,-25.93,"2 20","603 625",20,"80.00%","85.00%","3UTR","Q8WVP7","Limb region 1 protein homolog (Differentiation-related gene 14 protein)","Homo sapiens (Human)","embryonic digit morphogenesis [GO:0042733]; signal transduction [GO:0007165]","GO:0004888; GO:0005886; GO:0007165; GO:0042733"
"2485","Cluster_11134","Peve_00002105",0.999968584764073,0.00504622278903583,0.551398425649056,148,-20.4,"2 19","607 630",19,"68.42%","78.95%","3UTR","Q9JID6","Long-chain-fatty-acid--CoA ligase 1 (EC 6.2.1.3) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain acyl-CoA synthetase 1) (LACS 1) (Palmitoyl-CoA ligase) (Phytanate--CoA ligase) (EC 6.2.1.24)","Cavia porcellus (Guinea pig)","long-chain fatty acid metabolic process [GO:0001676]; very long-chain fatty acid metabolic process [GO:0000038]","GO:0000038; GO:0001676; GO:0004467; GO:0005524; GO:0005741; GO:0005778; GO:0005783; GO:0005789; GO:0047676; GO:0050197; GO:0070251"
"2493","Cluster_796","Peve_00028990",0.999428282268221,0.0215281467469576,0.825175158091499,165,-26.57,"2 21","452 471",19,"78.95%","84.21%","3UTR",NA,NA,NA,NA,NA
"2514","Cluster_7855","Peve_00003561",0.998823748059417,0.0308807526265784,0.903929377050813,165,-20.1,"2 19","121 145",20,"80.00%","80.00%","3UTR","O62714","Extracellular calcium-sensing receptor (CaSR) (Parathyroid cell calcium-sensing receptor) (PCaR1)","Sus scrofa (Pig)","cellular calcium ion homeostasis [GO:0006874]; detection of calcium ion [GO:0005513]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of calcium ion transport [GO:0051924]","GO:0004930; GO:0005509; GO:0005513; GO:0005886; GO:0006874; GO:0007186; GO:0016597; GO:0042803; GO:0051924"
"2530","Cluster_4735","Peve_00045236",-0.999310671556481,0.023639221558204,0.851916223620059,166,-20.89,"2 21","859 883",22,"77.27%","81.82%","3UTR","Q7TMK9","Heterogeneous nuclear ribonucleoprotein Q (hnRNP Q) (Glycine- and tyrosine-rich RNA-binding protein) (GRY-RBP) (NS1-associated protein 1) (Synaptotagmin-binding, cytoplasmic RNA-interacting protein) (pp68)","Mus musculus (Mouse)","cellular response to type II interferon [GO:0071346]; CRD-mediated mRNA stabilization [GO:0070934]; mRNA modification [GO:0016556]; mRNA processing [GO:0006397]; negative regulation of mRNA modification [GO:0090367]; negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900152]; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000623]; negative regulation of translation [GO:0017148]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of DNA demethylation [GO:1901537]; positive regulation of translation [GO:0045727]; RNA splicing [GO:0008380]","GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005829; GO:0006397; GO:0008143; GO:0008380; GO:0016020; GO:0016556; GO:0017148; GO:0043025; GO:0045293; GO:0045727; GO:0048027; GO:0070934; GO:0070937; GO:0071013; GO:0071204; GO:0071346; GO:0090367; GO:0097452; GO:0106002; GO:1900152; GO:1901537; GO:1990635; GO:1990904; GO:2000623; GO:2000767"
"2545","Cluster_1167","Peve_00000213",0.999909726776791,0.00855416971793915,0.573710369894872,143,-21.79,"2 21","370 395",23,"60.87%","65.22%","3UTR",NA,NA,NA,NA,NA
"2561","Cluster_796","Peve_00038927",0.999994129428633,0.00218140105711895,0.379078774249685,164,-21.21,"2 20","939 958",18,"83.33%","83.33%","3UTR","Q14832","Metabotropic glutamate receptor 3 (mGluR3)","Homo sapiens (Human)","chemical synaptic transmission [GO:0007268]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; gene expression [GO:0010467]; negative regulation of adenylate cyclase activity [GO:0007194]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; regulation of synaptic transmission, glutamatergic [GO:0051966]","GO:0001640; GO:0001641; GO:0004930; GO:0005246; GO:0005886; GO:0007194; GO:0007216; GO:0007268; GO:0008066; GO:0010467; GO:0014069; GO:0030424; GO:0042734; GO:0043197; GO:0045211; GO:0051966; GO:0097110; GO:0097449; GO:0098978; GO:0099170"
"2574","Cluster_8884","Peve_00026145",0.997253647308052,0.047192471195222,0.941791888778827,158,-20.56,"2 20","712 734",20,"65.00%","85.00%","3UTR",NA,NA,NA,NA,NA
"2583","Cluster_4735","Peve_00042916",0.999824590062268,0.011924181187447,0.672885963152335,173,-22.62,"2 18","311 332",16,"87.50%","93.75%","3UTR","Q9DBL7","Bifunctional coenzyme A synthase (CoA synthase) [Includes: Phosphopantetheine adenylyltransferase (EC 2.7.7.3) (Dephospho-CoA pyrophosphorylase) (Pantetheine-phosphate adenylyltransferase) (PPAT); Dephospho-CoA kinase (DPCK) (EC 2.7.1.24) (Dephosphocoenzyme A kinase) (DPCOAK)]","Mus musculus (Mouse)","coenzyme A biosynthetic process [GO:0015937]; phosphorylation [GO:0016310]","GO:0004140; GO:0004595; GO:0005524; GO:0005759; GO:0015937; GO:0016310"
"2594","Cluster_6904","Peve_00002033",-0.997924541017077,0.0410229927440064,0.909359886114279,164,-24.82,"2 21","320 341",19,"68.42%","84.21%","3UTR",NA,NA,NA,NA,NA
"2604","Cluster_10934","Peve_00019364",0.998758250045998,0.0317290557481573,0.903929377050813,162,-21.28,"2 20","488 511",20,"75.00%","80.00%","3UTR",NA,NA,NA,NA,NA
"2627","Cluster_9149","Peve_00020364",1,0,0,148,-20.73,"2 14","333 355",13,"76.92%","92.31%","3UTR","Q0IH72","Nuclease EXOG, mitochondrial (EC 3.1.30.-) (Endonuclease G-like 1) (Endo G-like 1)","Xenopus laevis (African clawed frog)","","GO:0003676; GO:0004519; GO:0005743; GO:0046872"
"2653","Cluster_1167","Peve_00006941",0.999909726776791,0.00855416971793915,0.573710369894872,153,-20.61,"2 21","29 48",19,"63.16%","84.21%","3UTR",NA,NA,NA,NA,NA
"2662","Cluster_11134","Peve_00031444",0.999598010096097,0.0180516640819476,0.782669382293497,147,-25.38,"2 21","93 117",22,"63.64%","68.18%","3UTR","Q99JY0","Trifunctional enzyme subunit beta, mitochondrial (TP-beta) [Includes: 3-ketoacyl-CoA thiolase (EC 2.3.1.155) (EC 2.3.1.16) (Acetyl-CoA acyltransferase) (Beta-ketothiolase)]","Mus musculus (Mouse)","cellular response to lipopolysaccharide [GO:0071222]; fatty acid beta-oxidation [GO:0006635]; gene expression [GO:0010467]","GO:0003985; GO:0003988; GO:0005739; GO:0005741; GO:0005743; GO:0005783; GO:0006635; GO:0010467; GO:0016507; GO:0042645; GO:0044877; GO:0050633; GO:0071222; GO:0106222"
"2682","Cluster_6904","Peve_00016785",-0.99999862897499,0.0010541874922422,0.267974802126026,162,-24.85,"2 17","770 790",15,"86.67%","93.33%","3UTR","A0JM23","Nephrocystin-3","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","cilium assembly [GO:0060271]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000095]; Wnt signaling pathway [GO:0016055]","GO:0005929; GO:0016055; GO:0060271; GO:0090090; GO:2000095"
"2742","Cluster_10934","Peve_00012516",0.998758250045999,0.0317290557481559,0.903929377050813,143,-21.64,"2 21","280 304",22,"63.64%","63.64%","3UTR",NA,NA,NA,NA,NA
"2757","Cluster_2854","Peve_00038025",0.999962448044095,0.00551712420276166,0.551398425649056,157,-20.06,"2 21","561 583",21,"76.19%","76.19%","3UTR",NA,NA,NA,NA,NA
"2763","Cluster_8988","Peve_00039177",-0.999730689576333,0.0147751347211111,0.738007302447873,153,-22.68,"2 21","615 637",21,"66.67%","80.95%","3UTR",NA,NA,NA,NA,NA
"2784","Cluster_4080","Peve_00012704",0.997873729717017,0.0415222938742972,0.909359886114279,159,-21.02,"2 21","191 215",22,"68.18%","77.27%","3UTR","Q9DC58","DNA damage-regulated autophagy modulator protein 1 (Damage-regulated autophagy modulator)","Mus musculus (Mouse)","apoptotic process [GO:0006915]; autophagy [GO:0006914]; regulation of autophagy [GO:0010506]","GO:0005737; GO:0005764; GO:0005765; GO:0006914; GO:0006915; GO:0010506"
"2797","Cluster_2854","Peve_00034569",0.999603958340296,0.0179176022280377,0.782669382293497,159,-22.75,"2 21","832 856",22,"63.64%","81.82%","3UTR",NA,NA,NA,NA,NA
"2808","Cluster_15726","Peve_00023336",-0.998934950217099,0.0293845218273416,0.903929377050813,160,-21.55,"2 21","685 705",20,"80.00%","80.00%","3UTR","Q9NYR8","Retinol dehydrogenase 8 (EC 1.1.1.300) (Photoreceptor outer segment all-trans retinol dehydrogenase) (Short chain dehydrogenase/reductase family 28C member 2)","Homo sapiens (Human)","estrogen biosynthetic process [GO:0006703]; response to stimulus [GO:0050896]; retinol metabolic process [GO:0042572]; steroid biosynthetic process [GO:0006694]; visual perception [GO:0007601]","GO:0004303; GO:0004745; GO:0005829; GO:0005886; GO:0006694; GO:0006703; GO:0007601; GO:0016491; GO:0042572; GO:0050896; GO:0052650"
"2837","Cluster_1167","Peve_00028838",0.999909726776791,0.00855416971793915,0.573710369894872,150,-24.63,"2 20","439 461",19,"68.42%","73.68%","3UTR","Q8CG08","Collagen triple helix repeat-containing protein 1","Rattus norvegicus (Rat)","cell migration [GO:0016477]; cochlea morphogenesis [GO:0090103]; establishment of planar polarity involved in neural tube closure [GO:0090177]; inner ear receptor cell stereocilium organization [GO:0060122]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; ossification involved in bone remodeling [GO:0043932]; osteoblast differentiation [GO:0001649]; osteoblast proliferation [GO:0033687]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of protein binding [GO:0032092]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]","GO:0001649; GO:0005109; GO:0005581; GO:0005615; GO:0005737; GO:0016477; GO:0016528; GO:0017147; GO:0031012; GO:0032092; GO:0033687; GO:0033690; GO:0043932; GO:0045669; GO:0060071; GO:0060122; GO:0090090; GO:0090103; GO:0090177"
"2862","Cluster_1167","Peve_00035609",0.999615266464435,0.0176599336484992,0.782669382293497,148,-21.67,"2 14","99 121",13,"84.62%","84.62%","3UTR",NA,NA,NA,NA,NA
"2874","Cluster_4079","Peve_00044680",0.999969908751759,0.00493874168584727,0.551398425649056,155,-20.12,"2 21","269 291",20,"60.00%","85.00%","3UTR",NA,NA,NA,NA,NA
"2893","Cluster_4629","Peve_00023421",0.997938030915672,0.0408894104551393,0.909359886114279,155,-24.89,"2 12","259 280",10,"100.00%","100.00%","3UTR","P48040","Melatonin receptor type 1A (Mel-1A-R) (Mel1a receptor)","Ovis aries (Sheep)","","GO:0005886; GO:0008502"
"2905","Cluster_589","Peve_00026462",-0.999999797342096,0.00040530027750834,0.219367948732634,156,-21.22,"2 21","265 286",19,"68.42%","73.68%","3UTR",NA,NA,NA,NA,NA
"2930","Cluster_2854","Peve_00006824",0.999627383900334,0.0173795855218949,0.782669382293497,166,-26.08,"2 15","909 930",13,"92.31%","100.00%","3UTR",NA,NA,NA,NA,NA
"2968","Cluster_1167","Peve_00041291",-0.999403063667998,0.0219978751741613,0.831331530166709,155,-26.97,"2 21","510 535",23,"65.22%","73.91%","3UTR",NA,NA,NA,NA,NA
"2969","Cluster_10934","Peve_00021707",0.998758250045998,0.0317290557481587,0.903929377050813,172,-23.08,"2 21","819 840",19,"78.95%","84.21%","3UTR","Q4I963","Cofilin (Actin-depolymerizing factor 1)","Gibberella zeae (strain ATCC MYA-4620 / CBS 123657 / FGSC 9075 / NRRL 31084 / PH-1) (Wheat head blight fungus) (Fusarium graminearum)","actin filament depolymerization [GO:0030042]; cell cycle [GO:0007049]; cell division [GO:0051301]","GO:0003779; GO:0005737; GO:0007049; GO:0015629; GO:0016363; GO:0030042; GO:0051301"
"2979","Cluster_1167","Peve_00033304",0.999582222238082,0.018402757417117,0.782669382293497,142,-21.21,"2 11","413 434",9,"88.89%","88.89%","3UTR","Q62868","Rho-associated protein kinase 2 (EC 2.7.11.1) (Rho-associated, coiled-coil-containing protein kinase 2) (Rho-associated, coiled-coil-containing protein kinase II) (ROCK-II) (RhoA-binding kinase 2) (p150 ROK-alpha) (ROKalpha) (p164 ROCK-2)","Rattus norvegicus (Rat)","actin cytoskeleton organization [GO:0030036]; actomyosin structure organization [GO:0031032]; blood vessel diameter maintenance [GO:0097746]; cellular response to acetylcholine [GO:1905145]; cellular response to testosterone stimulus [GO:0071394]; centrosome duplication [GO:0051298]; chromosome condensation [GO:0030261]; cortical actin cytoskeleton organization [GO:0030866]; dendrite morphogenesis [GO:0048813]; embryonic morphogenesis [GO:0048598]; epithelial to mesenchymal transition [GO:0001837]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; mitotic cytokinesis [GO:0000281]; mRNA destabilization [GO:0061157]; negative regulation of angiogenesis [GO:0016525]; negative regulation of bicellular tight junction assembly [GO:1903347]; negative regulation of gene expression [GO:0010629]; negative regulation of myosin-light-chain-phosphatase activity [GO:0035509]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of protein localization to lysosome [GO:0150033]; neural tube closure [GO:0001843]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of amyloid precursor protein catabolic process [GO:1902993]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902961]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cell migration [GO:0030335]; positive regulation of centrosome duplication [GO:0010825]; positive regulation of connective tissue growth factor production [GO:0032723]; positive regulation of connective tissue replacement [GO:1905205]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of fibroblast growth factor production [GO:0090271]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; postsynaptic actin cytoskeleton organization [GO:0098974]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; regulation of angiotensin-activated signaling pathway [GO:0110061]; regulation of cell junction assembly [GO:1901888]; regulation of cellular response to hypoxia [GO:1900037]; regulation of circadian rhythm [GO:0042752]; regulation of establishment of endothelial barrier [GO:1903140]; regulation of keratinocyte differentiation [GO:0045616]; regulation of nervous system process [GO:0031644]; regulation of protein metabolic process [GO:0051246]; regulation of synapse maturation [GO:0090128]; response to angiotensin [GO:1990776]; response to ischemia [GO:0002931]; response to transforming growth factor beta [GO:0071559]; Rho protein signal transduction [GO:0007266]; rhythmic process [GO:0048511]; smooth muscle contraction [GO:0006939]; viral RNA genome replication [GO:0039694]","GO:0000281; GO:0001837; GO:0001843; GO:0001934; GO:0002931; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005856; GO:0005886; GO:0006468; GO:0006939; GO:0007249; GO:0007266; GO:0008625; GO:0010595; GO:0010613; GO:0010628; GO:0010629; GO:0010825; GO:0016301; GO:0016525; GO:0018105; GO:0018107; GO:0030036; GO:0030261; GO:0030335; GO:0030866; GO:0031032; GO:0031267; GO:0031616; GO:0031644; GO:0032723; GO:0035509; GO:0036464; GO:0039694; GO:0042752; GO:0043410; GO:0045019; GO:0045616; GO:0046872; GO:0048511; GO:0048598; GO:0048813; GO:0051246; GO:0051298; GO:0051496; GO:0061157; GO:0071394; GO:0071559; GO:0072518; GO:0072659; GO:0090128; GO:0090271; GO:0097746; GO:0098685; GO:0098974; GO:0098978; GO:0106310; GO:0110061; GO:0150033; GO:1900037; GO:1901888; GO:1902004; GO:1902961; GO:1902966; GO:1902993; GO:1903140; GO:1903347; GO:1905145; GO:1905205; GO:1990776"
"2996","Cluster_9149","Peve_00010520",-0.998460036492421,0.03533508044945,0.909359886114279,143,-20.42,"2 12","373 394",10,"80.00%","90.00%","3UTR",NA,NA,NA,NA,NA
"3000","Cluster_8634","Peve_00000224",0.997367783055753,0.0462009887636632,0.936455415403062,170,-21.44,"2 20","157 179",19,"78.95%","89.47%","3UTR",NA,NA,NA,NA,NA
"3021","Cluster_14999","Peve_00021191",-0.999571546587002,0.018636417521774,0.782669382293497,165,-22.61,"2 21","804 826",21,"80.95%","80.95%","3UTR",NA,NA,NA,NA,NA
"3029","Cluster_1167","Peve_00021645",0.999509218369495,0.0199460559964703,0.803582979632007,146,-21.9,"2 18","23 44",17,"76.47%","76.47%","3UTR",NA,NA,NA,NA,NA
"3037","Cluster_9149","Peve_00038441",1,0,0,143,-23.7,"2 12","945 966",10,"80.00%","90.00%","3UTR",NA,NA,NA,NA,NA
"3058","Cluster_1167","Peve_00042442",0.999909726776791,0.00855416971793915,0.573710369894872,149,-21.05,"2 14","426 447",12,"83.33%","83.33%","3UTR",NA,NA,NA,NA,NA
"3064","Cluster_8888","Peve_00037191",-0.999035100566406,0.0279686222680646,0.900066868667072,154,-22.08,"2 20","356 373",18,"77.78%","83.33%","3UTR",NA,NA,NA,NA,NA
"3117","Cluster_9149","Peve_00014601",1,0,0,156,-22.38,"2 21","899 920",19,"63.16%","78.95%","3UTR",NA,NA,NA,NA,NA
"3161","Cluster_16738","Peve_00033630",0.996966316145993,0.0496009660033097,0.951817778779317,163,-23.49,"2 21","382 405",21,"76.19%","76.19%","3UTR","Q9K9H0","Isocitrate lyase (ICL) (EC 4.1.3.1) (Isocitrase) (Isocitratase)","Halalkalibacterium halodurans (strain ATCC BAA-125 / DSM 18197 / FERM 7344 / JCM 9153 / C-125) (Bacillus halodurans)","glyoxylate cycle [GO:0006097]; tricarboxylic acid cycle [GO:0006099]","GO:0004451; GO:0006097; GO:0006099; GO:0046872"
"3170","Cluster_6904","Peve_00007302",-0.999602697635797,0.0179460996686937,0.782669382293497,151,-22.2,"2 13","313 335",12,"91.67%","91.67%","3UTR","B5DF45","TNF receptor-associated factor 6 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRAF6) (RING-type E3 ubiquitin transferase TRAF6)","Rattus norvegicus (Rat)","activation of NF-kappaB-inducing kinase activity [GO:0007250]; activation of protein kinase activity [GO:0032147]; animal organ morphogenesis [GO:0009887]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; bone remodeling [GO:0046849]; bone resorption [GO:0045453]; cell development [GO:0048468]; cellular response to cytokine stimulus [GO:0071345]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to lipopolysaccharide [GO:0071222]; cytokine-mediated signaling pathway [GO:0019221]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; immune response [GO:0006955]; in utero embryonic development [GO:0001701]; interleukin-1-mediated signaling pathway [GO:0070498]; interleukin-17-mediated signaling pathway [GO:0097400]; JNK cascade [GO:0007254]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube closure [GO:0001843]; odontogenesis of dentin-containing tooth [GO:0042475]; ossification [GO:0001503]; osteoclast differentiation [GO:0030316]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of lipopolysaccharide-mediated signaling pathway [GO:0031666]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; protein autoubiquitination [GO:0051865]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of immunoglobulin production [GO:0002637]; response to interleukin-1 [GO:0070555]; response to ischemia [GO:0002931]; signal transduction [GO:0007165]; T cell receptor signaling pathway [GO:0050852]; T-helper 1 type immune response [GO:0042088]; tumor necrosis factor-mediated signaling pathway [GO:0033209]","GO:0000122; GO:0000209; GO:0001503; GO:0001701; GO:0001843; GO:0002637; GO:0002726; GO:0002931; GO:0004842; GO:0005164; GO:0005634; GO:0005737; GO:0005811; GO:0005829; GO:0005886; GO:0005938; GO:0006955; GO:0006974; GO:0007165; GO:0007249; GO:0007250; GO:0007254; GO:0008270; GO:0009887; GO:0009898; GO:0016567; GO:0019221; GO:0019886; GO:0019901; GO:0030316; GO:0031435; GO:0031624; GO:0031625; GO:0031666; GO:0031996; GO:0032147; GO:0032735; GO:0032743; GO:0032755; GO:0032813; GO:0032991; GO:0033209; GO:0035631; GO:0042088; GO:0042102; GO:0042475; GO:0042802; GO:0042826; GO:0042981; GO:0043011; GO:0043122; GO:0043123; GO:0043422; GO:0043507; GO:0045453; GO:0045672; GO:0045892; GO:0045944; GO:0046330; GO:0046849; GO:0047485; GO:0048468; GO:0048471; GO:0048661; GO:0050852; GO:0051091; GO:0051092; GO:0051865; GO:0061630; GO:0070498; GO:0070534; GO:0070555; GO:0071222; GO:0071345; GO:0097400; GO:1901224; GO:1904996; GO:2000679"
"3191","Cluster_6906","Peve_00043672",-0.996921218382016,0.0499684699057156,0.953525644311219,159,-20.7,"2 17","859 882",17,"82.35%","82.35%","3UTR","P26618","Platelet-derived growth factor receptor alpha (PDGF-R-alpha) (PDGFR-alpha) (EC 2.7.10.1) (Alpha platelet-derived growth factor receptor) (Alpha-type platelet-derived growth factor receptor) (CD140 antigen-like family member A) (Platelet-derived growth factor alpha receptor) (CD antigen CD140a)","Mus musculus (Mouse)","adrenal gland development [GO:0030325]; anatomical structure morphogenesis [GO:0009653]; animal organ morphogenesis [GO:0009887]; cardiac myofibril assembly [GO:0055003]; cell chemotaxis [GO:0060326]; cell migration [GO:0016477]; cellular response to amino acid stimulus [GO:0071230]; cellular response to reactive oxygen species [GO:0034614]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digestive tract morphogenesis [GO:0048557]; estrogen metabolic process [GO:0008210]; extracellular matrix organization [GO:0030198]; face morphogenesis [GO:0060325]; female gonad development [GO:0008585]; hematopoietic progenitor cell differentiation [GO:0002244]; in utero embryonic development [GO:0001701]; Leydig cell differentiation [GO:0033327]; lung development [GO:0030324]; lung growth [GO:0060437]; luteinization [GO:0001553]; male genitalia development [GO:0030539]; metanephric glomerular capillary formation [GO:0072277]; negative regulation of platelet activation [GO:0010544]; odontogenesis of dentin-containing tooth [GO:0042475]; peptidyl-tyrosine phosphorylation [GO:0018108]; phosphatidylinositol-mediated signaling [GO:0048015]; platelet aggregation [GO:0070527]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; platelet-derived growth factor receptor-alpha signaling pathway [GO:0035790]; positive regulation of branching involved in lung morphogenesis [GO:0061047]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway [GO:0038091]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of kinase activity [GO:0033674]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phospholipase C activity [GO:0010863]; protein autophosphorylation [GO:0046777]; regulation of chemotaxis [GO:0050920]; regulation of mesenchymal stem cell differentiation [GO:2000739]; retina vasculature development in camera-type eye [GO:0061298]; roof of mouth development [GO:0060021]; signal transduction involved in regulation of gene expression [GO:0023019]; skeletal system morphogenesis [GO:0048705]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; white fat cell differentiation [GO:0050872]; wound healing [GO:0042060]","GO:0001553; GO:0001701; GO:0002244; GO:0004672; GO:0004714; GO:0005018; GO:0005021; GO:0005161; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005886; GO:0005902; GO:0005929; GO:0007169; GO:0007204; GO:0008210; GO:0008284; GO:0008585; GO:0009653; GO:0009887; GO:0009897; GO:0009986; GO:0010544; GO:0010863; GO:0016477; GO:0018108; GO:0019838; GO:0023019; GO:0030054; GO:0030198; GO:0030324; GO:0030325; GO:0030335; GO:0030424; GO:0030539; GO:0032991; GO:0033327; GO:0033674; GO:0034614; GO:0035790; GO:0038085; GO:0038091; GO:0042060; GO:0042475; GO:0042803; GO:0043235; GO:0043548; GO:0043552; GO:0046777; GO:0048008; GO:0048015; GO:0048146; GO:0048407; GO:0048557; GO:0048701; GO:0048705; GO:0050731; GO:0050872; GO:0050920; GO:0055003; GO:0060021; GO:0060325; GO:0060326; GO:0060437; GO:0061047; GO:0061298; GO:0062063; GO:0070374; GO:0070527; GO:0071230; GO:0072277; GO:2000739"
"3201","Cluster_15726","Peve_00034555",0.999999835926399,0.000364682128698326,0.201157207099209,171,-20.04,"2 20","598 619",18,"83.33%","83.33%","3UTR","P10079","Fibropellin-1 (Epidermal growth factor-related protein 1) (Fibropellin-I) (SpEGF I) (UEGF-1)","Strongylocentrotus purpuratus (Purple sea urchin)","","GO:0005509; GO:0005615; GO:0009374; GO:0031410; GO:0032579"
"3237","Cluster_589","Peve_00045100",-0.998993624634128,0.0285635082887394,0.903929377050813,159,-20.33,"2 21","24 46",20,"70.00%","80.00%","3UTR",NA,NA,NA,NA,NA
"3248","Cluster_13502","Peve_00024638",0.997844556977271,0.0418062711782387,0.909359886114279,163,-20.88,"2 21","204 227",21,"71.43%","80.95%","3UTR",NA,NA,NA,NA,NA
"3250","Cluster_15890","Peve_00027583",-0.999998513833777,0.00109756150847525,0.276171237895402,166,-22.27,"2 21","702 726",22,"77.27%","81.82%","3UTR",NA,NA,NA,NA,NA
"3257","Cluster_1167","Peve_00024588",0.99826145042459,0.037544956087,0.909359886114279,147,-21.7,"2 12","469 490",10,"90.00%","90.00%","3UTR","O60268","Uncharacterized protein KIAA0513","Homo sapiens (Human)","","GO:0005737"
"3276","Cluster_4629","Peve_00000905",0.997835542257382,0.0418936347438744,0.909769090275153,155,-24.56,"2 12","903 924",10,"100.00%","100.00%","3UTR",NA,NA,NA,NA,NA
"3291","Cluster_9149","Peve_00032177",1,9.48637384723993e-09,6.86838308108347e-06,156,-22.28,"2 18","853 876",18,"77.78%","77.78%","3UTR",NA,NA,NA,NA,NA
"3328","Cluster_9149","Peve_00043019",-0.998042064423258,0.0398442086073031,0.909359886114279,162,-24.46,"2 15","294 315",13,"84.62%","100.00%","3UTR",NA,NA,NA,NA,NA
"3338","Cluster_2787","Peve_00015503",0.998952984103862,0.0291346401596183,0.903929377050813,146,-21.22,"2 16","123 146",16,"75.00%","75.00%","3UTR",NA,NA,NA,NA,NA
"3346","Cluster_589","Peve_00009459",-0.996976921072009,0.0495141506171131,0.951254322422111,160,-23.47,"2 19","358 378",17,"76.47%","88.24%","3UTR",NA,NA,NA,NA,NA
"3361","Cluster_6904","Peve_00039844",0.999999795128444,0.000407507833291957,0.220203561024059,155,-23.05,"2 21","24 48",22,"63.64%","77.27%","3UTR","O04469","Enoyl-CoA delta isomerase 1, peroxisomal (EC 5.3.3.8) (Delta(3),Delta(2)-enoyl CoA isomerase 1) (AtECI1)","Arabidopsis thaliana (Mouse-ear cress)","fatty acid beta-oxidation [GO:0006635]; fatty acid catabolic process [GO:0009062]","GO:0004165; GO:0005777; GO:0006635; GO:0009062"
"3367","Cluster_16738","Peve_00010457",0.999924418203837,0.00782720053096207,0.573710369894872,166,-23.26,"2 21","323 343",19,"73.68%","89.47%","3UTR","Q80T79","CUB and sushi domain-containing protein 3 (CUB and sushi multiple domains protein 3)","Mus musculus (Mouse)","negative regulation of complement activation, classical pathway [GO:0045959]; regulation of dendrite development [GO:0050773]","GO:0005615; GO:0005886; GO:0045959; GO:0050773"
"3375","Cluster_8887","Peve_00003756",-0.999888656727405,0.00950016485251684,0.60604832750937,154,-21.23,"2 20","549 570",19,"68.42%","78.95%","3UTR",NA,NA,NA,NA,NA
"3385","Cluster_5563","Peve_00000470",0.998070534296603,0.0395533713646997,0.909359886114279,161,-21.83,"2 20","946 970",20,"75.00%","85.00%","3UTR","A7RR04","Elongation factor G, mitochondrial (EF-Gmt) (Elongation factor G 1, mitochondrial) (mEF-G 1) (Elongation factor G1)","Nematostella vectensis (Starlet sea anemone)","mitochondrial translational elongation [GO:0070125]","GO:0003746; GO:0003924; GO:0005525; GO:0005739; GO:0070125"
"3388","Cluster_11134","Peve_00000107",0.999846092086893,0.0111694339890098,0.652903054366067,153,-21.65,"2 15","117 139",14,"78.57%","92.86%","3UTR","Q6PE54","Probable ATP-dependent RNA helicase DHX40 (EC 3.6.4.13) (DEAH box protein 40)","Mus musculus (Mouse)","","GO:0003723; GO:0003724; GO:0005524; GO:0016887"
"3416","Cluster_6904","Peve_00002367",-0.998173851896017,0.0384794833063825,0.909359886114279,164,-23.3,"2 21","643 664",19,"73.68%","78.95%","3UTR",NA,NA,NA,NA,NA
"3426","Cluster_7658","Peve_00008040",-0.999314839069881,0.0235676465242015,0.851706337230628,170,-20.56,"2 21","920 943",21,"80.95%","85.71%","3UTR","P33610","DNA primase large subunit (DNA primase 58 kDa subunit) (p58)","Mus musculus (Mouse)","DNA replication initiation [GO:0006270]; DNA replication, synthesis of RNA primer [GO:0006269]; positive regulation of DNA primase activity [GO:1903934]","GO:0003677; GO:0005658; GO:0006269; GO:0006270; GO:0046872; GO:0051539; GO:0071667; GO:1903934"
"3429","Cluster_796","Peve_00003541",0.998317429681288,0.036935386301087,0.909359886114279,163,-24.23,"2 21","376 398",20,"75.00%","80.00%","3UTR","Q6TEK8","Vitamin K epoxide reductase complex subunit 1-like protein 1 (VKORC1-like protein 1) (EC 1.17.4.4)","Takifugu rubripes (Japanese pufferfish) (Fugu rubripes)","vitamin K metabolic process [GO:0042373]","GO:0005789; GO:0042373; GO:0047057; GO:0048038"
"3449","Cluster_15726","Peve_00001450",0.999108109553157,0.0268895268710568,0.889863763909286,158,-20.61,"2 21","969 993",22,"72.73%","77.27%","3UTR",NA,NA,NA,NA,NA
"3472","Cluster_15726","Peve_00033678",0.999904013014523,0.0088207349235263,0.583683194376181,168,-20.13,"2 18","144 166",17,"88.24%","88.24%","3UTR","Q61425","Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial (HCDH) (EC 1.1.1.35) (Medium and short-chain L-3-hydroxyacyl-coenzyme A dehydrogenase) (Short-chain 3-hydroxyacyl-CoA dehydrogenase)","Mus musculus (Mouse)","fatty acid beta-oxidation [GO:0006635]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of insulin secretion [GO:0050796]; response to activity [GO:0014823]; response to insulin [GO:0032868]; response to xenobiotic stimulus [GO:0009410]","GO:0003857; GO:0005654; GO:0005737; GO:0005739; GO:0005743; GO:0005759; GO:0006635; GO:0009410; GO:0014823; GO:0032868; GO:0042802; GO:0046676; GO:0050796; GO:0070403; GO:0120162"
"3475","Cluster_9149","Peve_00041933",1,0,0,143,-21.67,"2 16","888 909",14,"71.43%","71.43%","3UTR",NA,NA,NA,NA,NA
"3486","Cluster_796","Peve_00032232",0.998122772067377,0.0390140994983106,0.909359886114279,155,-21.08,"2 12","941 962",10,"100.00%","100.00%","3UTR","Q5R5R4","RUN and FYVE domain-containing protein 2","Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)","","GO:0005634; GO:0046872"
"3516","Cluster_4735","Peve_00026202",0.99999940598563,0.000693894776195108,0.239778920002343,159,-23.8,"2 21","946 968",20,"70.00%","80.00%","3UTR",NA,NA,NA,NA,NA
"3532","Cluster_4629","Peve_00036582",0.998776265532991,0.0314980026586388,0.903929377050813,163,-24.32,"2 16","77 98",14,"85.71%","92.86%","3UTR","P30975","Tachykinin-like peptides receptor 99D (Tachykinin-like receptor at 99D) (dTKR)","Drosophila melanogaster (Fruit fly)","detection of chemical stimulus involved in sensory perception of smell [GO:0050911]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of synaptic transmission [GO:0050805]; neuropeptide signaling pathway [GO:0007218]; olfactory behavior [GO:0042048]; positive regulation of sensory perception of pain [GO:1904058]; tachykinin receptor signaling pathway [GO:0007217]","GO:0004995; GO:0005886; GO:0007186; GO:0007217; GO:0007218; GO:0008188; GO:0016020; GO:0042048; GO:0050805; GO:0050911; GO:1904058"
"3534","Cluster_9149","Peve_00031673",0.999232747668771,0.0249397445505303,0.86745289293403,148,-20.42,"2 18","477 499",17,"64.71%","82.35%","3UTR","P38062","Methionine aminopeptidase 2 (MAP 2) (MetAP 2) (EC 3.4.11.18) (Initiation factor 2-associated 67 kDa glycoprotein) (p67) (p67eIF2) (Peptidase M)","Rattus norvegicus (Rat)","N-terminal protein amino acid modification [GO:0031365]; peptidyl-methionine modification [GO:0018206]; protein initiator methionine removal involved in protein maturation [GO:0035551]; protein processing [GO:0016485]","GO:0004177; GO:0005737; GO:0008235; GO:0016485; GO:0018206; GO:0031365; GO:0035551; GO:0046872; GO:0070006"
"3593","Cluster_4735","Peve_00018929",0.999041921949982,0.0278695685926089,0.899642249848007,163,-20.67,"2 17","84 106",16,"87.50%","87.50%","3UTR",NA,NA,NA,NA,NA
"3606","Cluster_7855","Peve_00044261",-0.999136681236325,0.0264552555081203,0.885091958128636,176,-20.97,"2 21","648 669",19,"84.21%","84.21%","3UTR",NA,NA,NA,NA,NA
"3614","Cluster_1140","Peve_00000108",-0.998781804329405,0.0314266250831325,0.903929377050813,175,-20.39,"2 21","2909 2932",21,"80.95%","85.71%","CDS","Q6P4S8","Integrator complex subunit 1 (Int1)","Mus musculus (Mouse)","blastocyst growth [GO:0001832]; inner cell mass cell proliferation [GO:0001833]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; snRNA processing [GO:0016180]; U2 snRNA 3'-end processing [GO:0034474]","GO:0001832; GO:0001833; GO:0005634; GO:0016180; GO:0031965; GO:0032039; GO:0034474; GO:0043066; GO:0043154"
"3624","Cluster_1140","Peve_00011435",-0.998365252615658,0.0364065585365617,0.909359886114279,180,-22.69,"2 21","440 461",19,"84.21%","89.47%","CDS","P48733","Uromodulin (Tamm-Horsfall urinary glycoprotein) (THP) [Cleaved into: Uromodulin, secreted form]","Bos taurus (Bovine)","antibacterial innate immune response [GO:0140367]; defense response to Gram-negative bacterium [GO:0050829]","GO:0000922; GO:0005201; GO:0005509; GO:0005576; GO:0005929; GO:0016020; GO:0016323; GO:0016324; GO:0031012; GO:0050829; GO:0060170; GO:0140367"
"3635","Cluster_1140","Peve_00017311",-0.999023311227815,0.0281389943499374,0.902057778093395,173,-21.7,"2 18","1926 1947",16,"87.50%","93.75%","CDS","O43345","Zinc finger protein 208 (Zinc finger protein 91-like)","Homo sapiens (Human)","regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0008270"
"3660","Cluster_1140","Peve_00033721",-0.999771409683522,0.0136123249702019,0.714231839928071,175,-20.41,"2 21","16799 16822",21,"76.19%","90.48%","CDS","O00339","Matrilin-2","Homo sapiens (Human)","extracellular matrix organization [GO:0030198]","GO:0005201; GO:0005509; GO:0005576; GO:0030198; GO:0031012; GO:0062023; GO:0120216"
"3678","Cluster_1167","Peve_00000226",0.999909726776791,0.00855416971793389,0.573710369894872,147,-21.83,"2 17","25698 25722",18,"72.22%","72.22%","CDS","Q9JIS1","Regulating synaptic membrane exocytosis protein 2 (Rab-3-interacting molecule 2) (RIM 2)","Rattus norvegicus (Rat)","adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; calcium-ion regulated exocytosis [GO:0017156]; cell differentiation [GO:0030154]; establishment of localization in cell [GO:0051649]; exocytosis [GO:0006887]; insulin secretion [GO:0030073]; intracellular protein transport [GO:0006886]; maintenance of presynaptic active zone structure [GO:0048790]; neurotransmitter secretion [GO:0007269]; positive regulation of dendrite extension [GO:1903861]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of gene expression [GO:0010628]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; positive regulation of synaptic transmission [GO:0050806]; regulation of calcium-dependent activation of synaptic vesicle fusion [GO:0150037]; regulation of exocytosis [GO:0017157]; regulation of membrane potential [GO:0042391]; regulation of synaptic plasticity [GO:0048167]; spontaneous neurotransmitter secretion [GO:0061669]; synaptic vesicle docking [GO:0016081]; synaptic vesicle priming [GO:0016082]","GO:0006886; GO:0006887; GO:0007188; GO:0007269; GO:0010628; GO:0016081; GO:0016082; GO:0017156; GO:0017157; GO:0019904; GO:0030073; GO:0030154; GO:0030674; GO:0031267; GO:0032991; GO:0042391; GO:0042734; GO:0042995; GO:0044325; GO:0044877; GO:0045202; GO:0046872; GO:0048167; GO:0048788; GO:0048790; GO:0048791; GO:0050806; GO:0051649; GO:0060077; GO:0061669; GO:0097151; GO:0098684; GO:0098831; GO:0098882; GO:0098978; GO:0098982; GO:0140677; GO:0150037; GO:1903861; GO:2000463"
"3687","Cluster_1167","Peve_00000536",0.999910457964593,0.0085194555748794,0.573710369894872,155,-24.9,"2 21","16316 16341",23,"65.22%","73.91%","CDS","Q96D71","RalBP1-associated Eps domain-containing protein 1 (RalBP1-interacting protein 1)","Homo sapiens (Human)","endocytosis [GO:0006897]; endosomal transport [GO:0016197]","GO:0005509; GO:0005829; GO:0005886; GO:0005905; GO:0006897; GO:0016197; GO:0017124"
"3695","Cluster_1167","Peve_00000776",0.998287142619543,0.0372664249833469,0.909359886114279,145,-20.33,"2 16","309 333",17,"76.47%","76.47%","CDS",NA,NA,NA,NA,NA
"3696","Cluster_1167","Peve_00000776",0.998287142619543,0.0372664249833469,0.909359886114279,145,-20.33,"2 16","4189 4213",17,"76.47%","76.47%","CDS",NA,NA,NA,NA,NA
"3717","Cluster_1167","Peve_00001544",0.999909726776791,0.00855416971793915,0.573710369894872,154,-23.08,"2 21","3282 3302",19,"63.16%","84.21%","CDS","O35474","EGF-like repeat and discoidin I-like domain-containing protein 3 (Developmentally-regulated endothelial cell locus 1 protein) (Integrin-binding protein DEL1)","Mus musculus (Mouse)","cell adhesion [GO:0007155]; positive regulation of cell-substrate adhesion [GO:0010811]","GO:0005509; GO:0005576; GO:0007155; GO:0010811"
"3719","Cluster_1167","Peve_00001636",0.999909726776791,0.00855416971793915,0.573710369894872,145,-23.57,"2 21","3989 4014",23,"69.57%","69.57%","CDS",NA,NA,NA,NA,NA
"3721","Cluster_1167","Peve_00001859",0.999909726776791,0.00855416971793915,0.573710369894872,150,-20.48,"2 19","14629 14648",17,"76.47%","82.35%","CDS","Q90WN7","Synaptonemal complex protein 2-like (SCP-2-like) (145 kDa nucleolar protein)","Xenopus laevis (African clawed frog)","","GO:0000775; GO:0005730"
"3731","Cluster_1167","Peve_00002111",0.999909726776791,0.00855416971793389,0.573710369894872,143,-22.64,"2 12","6428 6449",10,"80.00%","90.00%","CDS","Q498D6","Fibroblast growth factor receptor 4 (FGFR-4) (EC 2.7.10.1) (CD antigen CD334)","Rattus norvegicus (Rat)","alveolar secondary septum development [GO:0061144]; cell migration [GO:0016477]; cholesterol homeostasis [GO:0042632]; fibroblast growth factor receptor signaling pathway [GO:0008543]; glucose homeostasis [GO:0042593]; lung development [GO:0030324]; negative regulation of fibroblast growth factor production [GO:0090272]; negative regulation of gene expression [GO:0010629]; organ induction [GO:0001759]; peptidyl-tyrosine phosphorylation [GO:0018108]; phosphate ion homeostasis [GO:0055062]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of kinase activity [GO:0033674]; positive regulation of parathyroid hormone secretion [GO:2000830]; positive regulation of proteolysis [GO:0045862]; protein autophosphorylation [GO:0046777]; regulation of bile acid biosynthetic process [GO:0070857]; regulation of extracellular matrix disassembly [GO:0010715]; regulation of lipid metabolic process [GO:0019216]; regulation of phosphate transport [GO:0010966]; regulation of phosphorus metabolic process [GO:0051174]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vitamin D3 metabolic process [GO:0070640]","GO:0001759; GO:0004714; GO:0005007; GO:0005524; GO:0005768; GO:0005783; GO:0005794; GO:0005886; GO:0005911; GO:0007169; GO:0008201; GO:0008284; GO:0008543; GO:0010628; GO:0010629; GO:0010715; GO:0010966; GO:0016477; GO:0017134; GO:0018108; GO:0019216; GO:0030133; GO:0030324; GO:0033674; GO:0042593; GO:0042632; GO:0043085; GO:0043235; GO:0045862; GO:0046777; GO:0051174; GO:0055062; GO:0061144; GO:0070374; GO:0070640; GO:0070857; GO:0090272; GO:2000573; GO:2000830"
"3732","Cluster_1167","Peve_00002130",0.999909726776791,0.00855416971793389,0.573710369894872,156,-24.16,"2 20","18683 18702",18,"72.22%","83.33%","CDS","Q20191","Zinc metalloproteinase nas-13 (EC 3.4.24.-) (Nematode astacin 13)","Caenorhabditis elegans","proteolysis [GO:0006508]","GO:0004222; GO:0005576; GO:0006508; GO:0008270"
"3742","Cluster_1167","Peve_00002245",0.999909726776791,0.00855416971793915,0.573710369894872,144,-20.32,"2 21","15594 15618",23,"69.57%","69.57%","CDS",NA,NA,NA,NA,NA
"3745","Cluster_1167","Peve_00001844",0.999712456515832,0.0152671261208546,0.747661024355386,147,-22.24,"2 21","2285 2308",21,"61.90%","71.43%","CDS","P35559","Insulin-degrading enzyme (EC 3.4.24.56) (Insulin protease) (Insulinase) (Insulysin)","Rattus norvegicus (Rat)","amyloid-beta clearance [GO:0097242]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; amyloid-beta metabolic process [GO:0050435]; antigen processing and presentation of endogenous peptide antigen via MHC class I [GO:0019885]; bradykinin catabolic process [GO:0010815]; determination of adult lifespan [GO:0008340]; hormone catabolic process [GO:0042447]; insulin catabolic process [GO:1901143]; insulin metabolic process [GO:1901142]; insulin receptor recycling [GO:0038020]; negative regulation of proteolysis [GO:0045861]; peptide catabolic process [GO:0043171]; positive regulation of protein binding [GO:0032092]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; regulation of aerobic respiration [GO:1903715]; response to oxidative stress [GO:0006979]; ubiquitin recycling [GO:0010992]","GO:0001540; GO:0004175; GO:0004222; GO:0005524; GO:0005615; GO:0005634; GO:0005737; GO:0005739; GO:0005777; GO:0005782; GO:0005829; GO:0006508; GO:0006979; GO:0008233; GO:0008270; GO:0008340; GO:0009897; GO:0009986; GO:0010815; GO:0010992; GO:0016323; GO:0016887; GO:0017046; GO:0019885; GO:0030163; GO:0031597; GO:0031626; GO:0031904; GO:0032092; GO:0038020; GO:0042277; GO:0042447; GO:0042802; GO:0042803; GO:0043171; GO:0043559; GO:0044877; GO:0045861; GO:0050435; GO:0051603; GO:0070062; GO:0097242; GO:0140036; GO:0150094; GO:1901142; GO:1901143; GO:1903715"
"3772","Cluster_1167","Peve_00003099",0.998614570448091,0.0335148667827687,0.909359886114279,156,-24.94,"2 21","22156 22177",19,"63.16%","78.95%","CDS","P35546","Proto-oncogene tyrosine-protein kinase receptor Ret (EC 2.7.10.1) (Proto-oncogene c-Ret) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment]","Mus musculus (Mouse)","activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; anatomical structure morphogenesis [GO:0009653]; cellular response to retinoic acid [GO:0071300]; embryonic epithelial tube formation [GO:0001838]; enteric nervous system development [GO:0048484]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; innervation [GO:0060384]; MAPK cascade [GO:0000165]; membrane protein proteolysis [GO:0033619]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; neuron cell-cell adhesion [GO:0007158]; neuron differentiation [GO:0030182]; neuron maturation [GO:0042551]; Peyer's patch morphogenesis [GO:0061146]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell migration [GO:0030335]; positive regulation of cell size [GO:0045793]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of gene expression [GO:0010628]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of metanephric glomerulus development [GO:0072300]; positive regulation of neuron maturation [GO:0014042]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; positive regulation of protein kinase B signaling [GO:0051897]; regulation of axonogenesis [GO:0050770]; regulation of cell adhesion [GO:0030155]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; retina development in camera-type eye [GO:0060041]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; ureter maturation [GO:0035799]; ureteric bud development [GO:0001657]","GO:0000165; GO:0001657; GO:0001755; GO:0001838; GO:0004714; GO:0005509; GO:0005524; GO:0005769; GO:0005886; GO:0006919; GO:0007156; GO:0007158; GO:0007169; GO:0007399; GO:0009410; GO:0009653; GO:0010008; GO:0010628; GO:0010976; GO:0014042; GO:0030155; GO:0030182; GO:0030335; GO:0030424; GO:0030425; GO:0033141; GO:0033619; GO:0033630; GO:0033674; GO:0035799; GO:0035860; GO:0042551; GO:0043025; GO:0043235; GO:0043410; GO:0045121; GO:0045793; GO:0045893; GO:0048265; GO:0048484; GO:0050770; GO:0051897; GO:0060041; GO:0060384; GO:0061146; GO:0071300; GO:0072300; GO:0098797; GO:2001241"
"3783","Cluster_1167","Peve_00003388",0.999335236615113,0.0232141468595536,0.847368488701098,150,-23.47,"2 15","5196 5217",13,"76.92%","84.62%","CDS",NA,NA,NA,NA,NA
"3784","Cluster_1167","Peve_00003388",0.999335236615113,0.0232141468595536,0.847368488701098,154,-26.19,"2 21","728 748",19,"68.42%","78.95%","CDS",NA,NA,NA,NA,NA
"3803","Cluster_1167","Peve_00003793",0.999909726776791,0.00855416971793915,0.573710369894872,165,-25.62,"2 20","1942 1962",18,"77.78%","88.89%","CDS","Q96KE9","BTB/POZ domain-containing protein 6 (Lens BTB domain protein)","Homo sapiens (Human)","neurogenesis [GO:0022008]","GO:0005829; GO:0022008"
"3816","Cluster_1167","Peve_00004232",0.999909726776791,0.00855416971793915,0.573710369894872,146,-22.27,"2 20","1398 1421",20,"65.00%","70.00%","CDS","Q8BG58","Transmembrane prolyl 4-hydroxylase (P4H-TM) (EC 1.14.11.29) (Hypoxia-inducible factor prolyl hydroxylase 4) (HIF-PH4) (HIF-prolyl hydroxylase 4) (HPH-4)","Mus musculus (Mouse)","peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; regulation of erythrocyte differentiation [GO:0045646]","GO:0004656; GO:0005506; GO:0005509; GO:0005783; GO:0005789; GO:0016706; GO:0018401; GO:0031418; GO:0045646"
"3822","Cluster_1167","Peve_00004514",0.999306288894562,0.0237142587257691,0.852510803297052,152,-21.93,"2 17","7785 7806",15,"73.33%","80.00%","CDS","Q12830","Nucleosome-remodeling factor subunit BPTF (Bromodomain and PHD finger-containing transcription factor) (Fetal Alz-50 clone 1 protein) (Fetal Alzheimer antigen)","Homo sapiens (Human)","anterior/posterior pattern specification [GO:0009952]; brain development [GO:0007420]; chromatin remodeling [GO:0006338]; embryonic placenta development [GO:0001892]; endoderm development [GO:0007492]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000122; GO:0000785; GO:0000978; GO:0001892; GO:0005634; GO:0005654; GO:0005737; GO:0006338; GO:0006355; GO:0006357; GO:0007420; GO:0007492; GO:0009952; GO:0016589; GO:0035064; GO:0043565; GO:0045944; GO:0046872; GO:0070062; GO:1904949"
"3851","Cluster_1167","Peve_00005112",0.999914846341146,0.00830806449585902,0.573710369894872,141,-22.16,"2 14","7167 7188",12,"75.00%","75.00%","CDS",NA,NA,NA,NA,NA
"3854","Cluster_1167","Peve_00004764",0.999909726776791,0.00855416971794441,0.573710369894872,159,-25.08,"2 21","8716 8738",20,"70.00%","80.00%","CDS","O43854","EGF-like repeat and discoidin I-like domain-containing protein 3 (Developmentally-regulated endothelial cell locus 1 protein) (Integrin-binding protein DEL1)","Homo sapiens (Human)","cell adhesion [GO:0007155]; positive regulation of cell-substrate adhesion [GO:0010811]","GO:0005178; GO:0005509; GO:0007155; GO:0010811; GO:0062023; GO:0070062; GO:1903561"
"3855","Cluster_1167","Peve_00005214",0.999909726776791,0.00855416971792863,0.573710369894872,152,-22.04,"2 19","1775 1795",17,"76.47%","76.47%","CDS","P21804","Fibroblast growth factor receptor 1 (FGFR-1) (bFGF-R-1) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1) (Tyrosine kinase receptor CEK1)","Gallus gallus (Chicken)","epicardial cell to mesenchymal cell transition [GO:0003347]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of phospholipase C activity [GO:0010863]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]","GO:0003347; GO:0004714; GO:0005007; GO:0005524; GO:0005634; GO:0005829; GO:0005886; GO:0007169; GO:0008201; GO:0008284; GO:0010863; GO:0017134; GO:0018108; GO:0031410; GO:0033674; GO:0043235; GO:0043406; GO:0045597; GO:0045893"
"3856","Cluster_1167","Peve_00005214",0.999909726776791,0.00855416971792863,0.573710369894872,156,-25.71,"2 19","2214 2241",23,"73.91%","73.91%","CDS","P21804","Fibroblast growth factor receptor 1 (FGFR-1) (bFGF-R-1) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1) (Tyrosine kinase receptor CEK1)","Gallus gallus (Chicken)","epicardial cell to mesenchymal cell transition [GO:0003347]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of phospholipase C activity [GO:0010863]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]","GO:0003347; GO:0004714; GO:0005007; GO:0005524; GO:0005634; GO:0005829; GO:0005886; GO:0007169; GO:0008201; GO:0008284; GO:0010863; GO:0017134; GO:0018108; GO:0031410; GO:0033674; GO:0043235; GO:0043406; GO:0045597; GO:0045893"
"3870","Cluster_1167","Peve_00005762",0.998589476055448,0.033817104073598,0.909359886114279,147,-20.66,"2 20","55833 55852",18,"72.22%","77.78%","CDS","A1L3F5","C-Maf-inducing protein (c-Mip)","Xenopus laevis (African clawed frog)","","GO:0005634; GO:0005737"
"3876","Cluster_1167","Peve_00005941",0.999909726776791,0.00855416971793915,0.573710369894872,152,-23.21,"2 13","41063 41084",11,"90.91%","90.91%","CDS",NA,NA,NA,NA,NA
"3877","Cluster_1167","Peve_00005937",0.998112144659499,0.0391244120935113,0.909359886114279,150,-22.13,"2 19","11775 11796",17,"70.59%","70.59%","CDS","Q9Y253","DNA polymerase eta (EC 2.7.7.7) (RAD30 homolog A) (Xeroderma pigmentosum variant type protein)","Homo sapiens (Human)","cellular response to UV-C [GO:0071494]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA synthesis involved in DNA repair [GO:0000731]; error-free translesion synthesis [GO:0070987]; error-prone translesion synthesis [GO:0042276]; pyrimidine dimer repair [GO:0006290]; regulation of DNA repair [GO:0006282]; response to radiation [GO:0009314]; response to UV-C [GO:0010225]","GO:0000731; GO:0003684; GO:0003887; GO:0005634; GO:0005654; GO:0005657; GO:0005829; GO:0006260; GO:0006281; GO:0006282; GO:0006290; GO:0009314; GO:0010225; GO:0035861; GO:0042276; GO:0046872; GO:0070987; GO:0071494"
"3878","Cluster_1167","Peve_00005937",0.998112144659499,0.0391244120935113,0.909359886114279,151,-26.36,"2 21","8314 8332",19,"73.68%","78.95%","CDS","Q9Y253","DNA polymerase eta (EC 2.7.7.7) (RAD30 homolog A) (Xeroderma pigmentosum variant type protein)","Homo sapiens (Human)","cellular response to UV-C [GO:0071494]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA synthesis involved in DNA repair [GO:0000731]; error-free translesion synthesis [GO:0070987]; error-prone translesion synthesis [GO:0042276]; pyrimidine dimer repair [GO:0006290]; regulation of DNA repair [GO:0006282]; response to radiation [GO:0009314]; response to UV-C [GO:0010225]","GO:0000731; GO:0003684; GO:0003887; GO:0005634; GO:0005654; GO:0005657; GO:0005829; GO:0006260; GO:0006281; GO:0006282; GO:0006290; GO:0009314; GO:0010225; GO:0035861; GO:0042276; GO:0046872; GO:0070987; GO:0071494"
"3886","Cluster_1167","Peve_00006147",0.998797149089736,0.031228028253816,0.903929377050813,140,-24.54,"2 9","8551 8572",7,"100.00%","100.00%","CDS","Q2KIH4","Ribosome biogenesis regulatory protein homolog","Bos taurus (Bovine)","endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; mitotic metaphase plate congression [GO:0007080]; protein localization to nucleolus [GO:1902570]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosomal large subunit assembly [GO:0000027]; ribosomal large subunit biogenesis [GO:0042273]; ribosomal large subunit export from nucleus [GO:0000055]","GO:0000027; GO:0000055; GO:0000447; GO:0000794; GO:0005730; GO:0007080; GO:0008097; GO:0030687; GO:0042273; GO:1901796; GO:1902570"
"3891","Cluster_1167","Peve_00006405",0.998249339248832,0.0376755410016539,0.909359886114279,143,-20.62,"2 15","9801 9820",13,"76.92%","84.62%","CDS",NA,NA,NA,NA,NA
"3908","Cluster_1167","Peve_00006734",0.997186132942251,0.0477692913024595,0.94460944882157,151,-24.15,"2 12","17771 17792",10,"90.00%","100.00%","CDS",NA,NA,NA,NA,NA
"3927","Cluster_1167","Peve_00007130",0.998360755174564,0.0364566178277266,0.909359886114279,140,-20.94,"2 9","432 453",7,"100.00%","100.00%","CDS","Q9Y2H9","Microtubule-associated serine/threonine-protein kinase 1 (EC 2.7.11.1) (Syntrophin-associated serine/threonine-protein kinase)","Homo sapiens (Human)","brain development [GO:0007420]; cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]","GO:0000287; GO:0004674; GO:0005524; GO:0005737; GO:0005856; GO:0005886; GO:0006468; GO:0007010; GO:0007420; GO:0008017; GO:0018105; GO:0030424; GO:0030425; GO:0035556; GO:0043005; GO:0043025; GO:0106310"
"3940","Cluster_1167","Peve_00007364",0.998367533584612,0.036381143649436,0.909359886114279,153,-24.31,"2 15","21935 21957",14,"85.71%","85.71%","CDS","P84039","Ectonucleotide pyrophosphatase/phosphodiesterase family member 5 (E-NPP 5) (NPP-5) (EC 3.1.-.-)","Rattus norvegicus (Rat)","cell communication [GO:0007154]","GO:0000210; GO:0005886; GO:0007154; GO:0008270; GO:0016020"
"3951","Cluster_1167","Peve_00007688",0.99996576416501,0.0052678915078678,0.551398425649056,150,-25.62,"2 19","212 233",17,"64.71%","76.47%","CDS",NA,NA,NA,NA,NA
"3968","Cluster_1167","Peve_00007969",0.999363808240768,0.0227097402921709,0.840566722266011,158,-24.51,"2 21","1933 1956",21,"71.43%","80.95%","CDS","P46023","G-protein coupled receptor GRL101","Lymnaea stagnalis (Great pond snail) (Helix stagnalis)","","GO:0004930; GO:0005886"
"3980","Cluster_1167","Peve_00008195",0.999909726776791,0.00855416971793389,0.573710369894872,146,-20.57,"2 16","8765 8788",16,"75.00%","75.00%","CDS",NA,NA,NA,NA,NA
"3981","Cluster_1167","Peve_00008266",0.999909726776791,0.00855416971793915,0.573710369894872,150,-25.93,"2 21","1551 1571",19,"68.42%","73.68%","CDS",NA,NA,NA,NA,NA
"3982","Cluster_1167","Peve_00008387",0.999946883222669,0.0065616475953019,0.573710369894872,147,-22.99,"2 20","493 511",18,"72.22%","72.22%","CDS","P35384","Extracellular calcium-sensing receptor (CaSR) (Parathyroid cell calcium-sensing receptor) (BoPCaR1) (PCaR1)","Bos taurus (Bovine)","calcium ion import [GO:0070509]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; detection of calcium ion [GO:0005513]; G protein-coupled receptor signaling pathway [GO:0007186]; JNK cascade [GO:0007254]; ossification [GO:0001503]; positive regulation of ATP-dependent activity [GO:0032781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; regulation of calcium ion transport [GO:0051924]; vasodilation [GO:0042311]","GO:0001503; GO:0004930; GO:0005509; GO:0005513; GO:0005886; GO:0006816; GO:0006874; GO:0007186; GO:0007254; GO:0008284; GO:0010628; GO:0016597; GO:0032781; GO:0042311; GO:0042803; GO:0043679; GO:0051924; GO:0070509"
"3996","Cluster_1167","Peve_00008820",0.998248244852637,0.0376873187172547,0.909359886114279,144,-23.14,"2 21","43794 43815",19,"57.89%","68.42%","CDS","Q969X6","U3 small nucleolar RNA-associated protein 4 homolog (Cirhin) (UTP4 small subunit processome component)","Homo sapiens (Human)","maturation of SSU-rRNA [GO:0030490]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; regulation of DNA-templated transcription [GO:0006355]","GO:0000462; GO:0001650; GO:0003723; GO:0005654; GO:0005694; GO:0005730; GO:0006355; GO:0030490; GO:0030686; GO:0032040; GO:0034455"
"3997","Cluster_1167","Peve_00008998",-0.997353015680191,0.0463304639479773,0.937216290033208,150,-21.16,"2 11","6106 6127",9,"100.00%","100.00%","CDS",NA,NA,NA,NA,NA
"4002","Cluster_1167","Peve_00009220",0.999909726776791,0.00855416971793915,0.573710369894872,143,-20.44,"2 21","2547 2569",20,"60.00%","70.00%","CDS",NA,NA,NA,NA,NA
"4003","Cluster_1167","Peve_00009226",0.99883535025456,0.0307280462571865,0.903929377050813,142,-22.87,"2 17","1297 1325",22,"68.18%","68.18%","CDS",NA,NA,NA,NA,NA
"4005","Cluster_1167","Peve_00009248",0.998360346309731,0.0364611653409239,0.909359886114279,152,-24.01,"2 20","669 688",18,"72.22%","77.78%","CDS","O15439","ATP-binding cassette sub-family C member 4 (EC 7.6.2.-) (EC 7.6.2.2) (EC 7.6.2.3) (MRP/cMOAT-related ABC transporter) (Multi-specific organic anion transporter B) (MOAT-B) (Multidrug resistance-associated protein 4)","Homo sapiens (Human)","bile acid and bile salt transport [GO:0015721]; cAMP transport [GO:0070730]; cilium assembly [GO:0060271]; export across plasma membrane [GO:0140115]; leukotriene transport [GO:0071716]; platelet degranulation [GO:0002576]; prostaglandin secretion [GO:0032310]; prostaglandin transport [GO:0015732]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; urate transport [GO:0015747]; xenobiotic metabolic process [GO:0006805]; xenobiotic transmembrane transport [GO:0006855]","GO:0001409; GO:0002576; GO:0005524; GO:0005730; GO:0005794; GO:0005886; GO:0006805; GO:0006855; GO:0008559; GO:0015132; GO:0015143; GO:0015216; GO:0015431; GO:0015432; GO:0015562; GO:0015721; GO:0015732; GO:0015747; GO:0016020; GO:0016323; GO:0016324; GO:0016404; GO:0016887; GO:0031088; GO:0032310; GO:0034634; GO:0042626; GO:0042910; GO:0043225; GO:0055085; GO:0060271; GO:0070730; GO:0071716; GO:0098591; GO:0140115; GO:0140359; GO:0150104"
"4014","Cluster_1167","Peve_00008800",0.997722603479927,0.04297312169955,0.916725852445521,153,-24.83,"2 19","10857 10880",19,"68.42%","78.95%","CDS","Q7Z333","Probable helicase senataxin (EC 3.6.4.-) (Amyotrophic lateral sclerosis 4 protein) (SEN1 homolog) (Senataxin)","Homo sapiens (Human)","cell differentiation [GO:0030154]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to oxidative stress [GO:0034599]; cellular response to retinoic acid [GO:0071300]; circadian rhythm [GO:0007623]; DNA recombination [GO:0006310]; DNA-templated transcription termination [GO:0006353]; double-strand break repair [GO:0006302]; fibroblast growth factor receptor signaling pathway [GO:0008543]; MAPK cascade [GO:0000165]; mRNA splice site selection [GO:0006376]; negative regulation of apoptotic process [GO:0043066]; nervous system development [GO:0007399]; positive regulation of DNA-templated transcription initiation [GO:2000144]; positive regulation of neuron projection development [GO:0010976]; positive regulation of RNA splicing [GO:0033120]; positive regulation of termination of DNA-templated transcription [GO:0060566]; positive regulation of termination of RNA polymerase II transcription, poly(A)-coupled [GO:2000806]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein kinase B signaling [GO:0043491]; RNA processing [GO:0006396]; spermatogenesis [GO:0007283]; termination of RNA polymerase II transcription [GO:0006369]","GO:0000165; GO:0000228; GO:0000781; GO:0001147; GO:0003677; GO:0003678; GO:0003723; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006302; GO:0006310; GO:0006353; GO:0006369; GO:0006376; GO:0006396; GO:0006974; GO:0007283; GO:0007399; GO:0007623; GO:0008543; GO:0010976; GO:0016604; GO:0016787; GO:0030154; GO:0030424; GO:0030426; GO:0033120; GO:0034599; GO:0042802; GO:0043066; GO:0043491; GO:0044344; GO:0045171; GO:0045944; GO:0060566; GO:0070301; GO:0071300; GO:2000144; GO:2000806"
"4015","Cluster_1167","Peve_00008800",0.997722603479927,0.04297312169955,0.916725852445521,158,-25.88,"2 17","16894 16914",15,"86.67%","86.67%","CDS","Q7Z333","Probable helicase senataxin (EC 3.6.4.-) (Amyotrophic lateral sclerosis 4 protein) (SEN1 homolog) (Senataxin)","Homo sapiens (Human)","cell differentiation [GO:0030154]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to oxidative stress [GO:0034599]; cellular response to retinoic acid [GO:0071300]; circadian rhythm [GO:0007623]; DNA recombination [GO:0006310]; DNA-templated transcription termination [GO:0006353]; double-strand break repair [GO:0006302]; fibroblast growth factor receptor signaling pathway [GO:0008543]; MAPK cascade [GO:0000165]; mRNA splice site selection [GO:0006376]; negative regulation of apoptotic process [GO:0043066]; nervous system development [GO:0007399]; positive regulation of DNA-templated transcription initiation [GO:2000144]; positive regulation of neuron projection development [GO:0010976]; positive regulation of RNA splicing [GO:0033120]; positive regulation of termination of DNA-templated transcription [GO:0060566]; positive regulation of termination of RNA polymerase II transcription, poly(A)-coupled [GO:2000806]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein kinase B signaling [GO:0043491]; RNA processing [GO:0006396]; spermatogenesis [GO:0007283]; termination of RNA polymerase II transcription [GO:0006369]","GO:0000165; GO:0000228; GO:0000781; GO:0001147; GO:0003677; GO:0003678; GO:0003723; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006302; GO:0006310; GO:0006353; GO:0006369; GO:0006376; GO:0006396; GO:0006974; GO:0007283; GO:0007399; GO:0007623; GO:0008543; GO:0010976; GO:0016604; GO:0016787; GO:0030154; GO:0030424; GO:0030426; GO:0033120; GO:0034599; GO:0042802; GO:0043066; GO:0043491; GO:0044344; GO:0045171; GO:0045944; GO:0060566; GO:0070301; GO:0071300; GO:2000144; GO:2000806"
"4018","Cluster_1167","Peve_00008801",0.999909726776791,0.00855416971793915,0.573710369894872,153,-24.83,"2 19","934 957",19,"68.42%","78.95%","CDS",NA,NA,NA,NA,NA
"4034","Cluster_1167","Peve_00009822",0.999955273448146,0.00602115002709614,0.573710369894872,150,-25.12,"2 21","136 156",19,"68.42%","73.68%","CDS",NA,NA,NA,NA,NA
"4037","Cluster_1167","Peve_00009873",0.999959878657719,0.00570274956330863,0.561781303084973,144,-23.48,"2 15","5838 5858",13,"76.92%","84.62%","CDS","Q9H8V3","Protein ECT2 (Epithelial cell-transforming sequence 2 oncogene)","Homo sapiens (Human)","activation of GTPase activity [GO:0090630]; activation of protein kinase activity [GO:0032147]; bicellular tight junction assembly [GO:0070830]; cell differentiation [GO:0030154]; cell morphogenesis [GO:0000902]; cellular response to calcium ion [GO:0071277]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to ionizing radiation [GO:0071479]; intracellular signal transduction [GO:0035556]; mitotic cytokinesis [GO:0000281]; nervous system development [GO:0007399]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cytokinesis [GO:0032467]; positive regulation of GTPase activity [GO:0043547]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of protein import into nucleus [GO:0042307]; protein homooligomerization [GO:0051260]; protein transport [GO:0015031]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of cytokinesis, actomyosin contractile ring assembly [GO:2000431]; regulation of protein kinase activity [GO:0045859]; regulation of small GTPase mediated signal transduction [GO:0051056]","GO:0000281; GO:0000902; GO:0005085; GO:0005096; GO:0005634; GO:0005654; GO:0005737; GO:0005815; GO:0005829; GO:0005911; GO:0005923; GO:0005938; GO:0007399; GO:0015031; GO:0016604; GO:0030154; GO:0030496; GO:0031267; GO:0032147; GO:0032154; GO:0032467; GO:0035556; GO:0042307; GO:0042803; GO:0043065; GO:0043123; GO:0043547; GO:0045666; GO:0045859; GO:0051056; GO:0051260; GO:0051988; GO:0070301; GO:0070830; GO:0071277; GO:0071479; GO:0072686; GO:0090630; GO:0097149; GO:2000431"
"4039","Cluster_1167","Peve_00009911",0.99887693469296,0.0301743747691789,0.903929377050813,150,-21.22,"2 16","2548 2570",15,"73.33%","86.67%","CDS","F6Z5C0","Ubiquitin carboxyl-terminal hydrolase 15 (EC 3.4.19.12) (Deubiquitinating enzyme 15) (Ubiquitin thioesterase 15) (Ubiquitin-specific-processing protease 15)","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","BMP signaling pathway [GO:0030509]; histone H2B conserved C-terminal lysine deubiquitination [GO:0035616]; monoubiquitinated protein deubiquitination [GO:0035520]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; protein deubiquitination [GO:0016579]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0004197; GO:0004843; GO:0005634; GO:0005737; GO:0006511; GO:0007179; GO:0016579; GO:0030509; GO:0035520; GO:0035616; GO:0060389"
"4049","Cluster_1167","Peve_00010154",0.999910964622944,0.00849531807985483,0.573710369894872,142,-20.58,"2 11","20439 20460",9,"88.89%","88.89%","CDS","A0A0R4IBK5","E3 ubiquitin-protein ligase rnf213-alpha (EC 2.3.2.27) (EC 3.6.4.-) (E3 ubiquitin-lipopolysaccharide ligase rnf213-alpha) (EC 2.3.2.-) (Mysterin-A) (Mysterin-alpha) (RING finger protein 213-A) (RING finger protein 213-alpha)","Danio rerio (Zebrafish) (Brachydanio rerio)","blood circulation [GO:0008015]; defense response to bacterium [GO:0042742]; immune system process [GO:0002376]; lipid droplet formation [GO:0140042]; lipid ubiquitination [GO:0120323]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; protein K63-linked ubiquitination [GO:0070534]; regulation of lipid metabolic process [GO:0019216]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]; xenophagy [GO:0098792]","GO:0002040; GO:0002376; GO:0004842; GO:0005524; GO:0005730; GO:0005811; GO:0005829; GO:0006511; GO:0008015; GO:0016887; GO:0019216; GO:0042742; GO:0046872; GO:0061630; GO:0070534; GO:0098792; GO:0120323; GO:0140042; GO:2000051"
"4060","Cluster_1167","Peve_00010305",0.999909726776791,0.00855416971793389,0.573710369894872,176,-27.48,"2 21","1565 1586",19,"78.95%","89.47%","CDS",NA,NA,NA,NA,NA
"4061","Cluster_1167","Peve_00010307",0.999909726776791,0.00855416971793915,0.573710369894872,176,-27.48,"2 21","1565 1586",19,"78.95%","89.47%","CDS",NA,NA,NA,NA,NA
"4062","Cluster_1167","Peve_00010322",0.999909726776791,0.00855416971794441,0.573710369894872,149,-20.84,"2 20","257 277",18,"72.22%","72.22%","CDS","F1PZV2","Major facilitator superfamily domain-containing protein 12","Canis lupus familiaris (Dog) (Canis familiaris)","carbohydrate transport [GO:0008643]; cysteine transmembrane transport [GO:1903712]; melanin biosynthetic process [GO:0042438]; organic substance transport [GO:0071702]; pigment metabolic process involved in pigmentation [GO:0043474]; regulation of melanin biosynthetic process [GO:0048021]","GO:0005764; GO:0005765; GO:0005886; GO:0008643; GO:0015293; GO:0033162; GO:0033229; GO:0042438; GO:0043474; GO:0048021; GO:0071702; GO:1903712"
"4075","Cluster_1167","Peve_00010717",0.999909726776791,0.00855416971793915,0.573710369894872,142,-21.85,"2 11","5807 5828",9,"88.89%","88.89%","CDS","P07314","Glutathione hydrolase 1 proenzyme (EC 3.4.19.13) (Gamma-glutamyltransferase 1) (Gamma-glutamyltranspeptidase 1) (GGT 1) (EC 2.3.2.2) (Leukotriene-C4 hydrolase) (EC 3.4.19.14) (CD antigen CD224) [Cleaved into: Glutathione hydrolase 1 heavy chain; Glutathione hydrolase 1 light chain]","Rattus norvegicus (Rat)","aging [GO:0007568]; amino acid metabolic process [GO:0006520]; cellular response to oxidative stress [GO:0034599]; cysteine biosynthetic process [GO:0019344]; fatty acid metabolic process [GO:0006631]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; glutathione catabolic process [GO:0006751]; hepatoblast differentiation [GO:0061017]; hepatocyte differentiation [GO:0070365]; leukotriene D4 biosynthetic process [GO:1901750]; leukotriene metabolic process [GO:0006691]; liver regeneration [GO:0097421]; peptide modification [GO:0031179]; proteolysis [GO:0006508]; regulation of immune system process [GO:0002682]; regulation of inflammatory response [GO:0050727]; response to alcohol [GO:0097305]; response to estradiol [GO:0032355]; response to lipopolysaccharide [GO:0032496]; response to tumor necrosis factor [GO:0034612]; spermatogenesis [GO:0007283]; zymogen activation [GO:0031638]","GO:0000048; GO:0002682; GO:0002951; GO:0005615; GO:0005886; GO:0006508; GO:0006520; GO:0006536; GO:0006631; GO:0006691; GO:0006750; GO:0006751; GO:0007283; GO:0007568; GO:0016755; GO:0019344; GO:0031179; GO:0031638; GO:0031982; GO:0032355; GO:0032496; GO:0034599; GO:0034612; GO:0036374; GO:0050727; GO:0061017; GO:0070365; GO:0097305; GO:0097421; GO:0102953; GO:0103068; GO:1901750"
"4076","Cluster_1167","Peve_00010778",0.999909726776791,0.00855416971793915,0.573710369894872,146,-20.65,"2 21","10393 10411",19,"73.68%","78.95%","CDS","Q4V9Y5","Cysteine-rich secretory protein LCCL domain-containing 2","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","","GO:0005576"
"4089","Cluster_1167","Peve_00011363",0.999909726776791,0.00855416971793915,0.573710369894872,145,-20.49,"2 10","6629 6650",8,"100.00%","100.00%","CDS","Q96CG8","Collagen triple helix repeat-containing protein 1","Homo sapiens (Human)","cell migration [GO:0016477]; cochlea morphogenesis [GO:0090103]; establishment of planar polarity involved in neural tube closure [GO:0090177]; inner ear receptor cell stereocilium organization [GO:0060122]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; ossification involved in bone remodeling [GO:0043932]; osteoblast differentiation [GO:0001649]; osteoblast proliferation [GO:0033687]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of protein binding [GO:0032092]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]","GO:0001649; GO:0005109; GO:0005576; GO:0005581; GO:0005615; GO:0016477; GO:0016528; GO:0017147; GO:0032092; GO:0033687; GO:0033690; GO:0043932; GO:0045669; GO:0060071; GO:0060122; GO:0062023; GO:0090090; GO:0090103; GO:0090177"
"4094","Cluster_1167","Peve_00011528",0.999909726776791,0.00855416971793389,0.573710369894872,148,-21.52,"2 21","11134 11153",19,"73.68%","73.68%","CDS","Q6V4S5","Protein sidekick-2","Mus musculus (Mouse)","camera-type eye photoreceptor cell differentiation [GO:0060219]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416]","GO:0005886; GO:0007156; GO:0007416; GO:0010842; GO:0045202; GO:0060219"
"4095","Cluster_1167","Peve_00011528",0.999909726776791,0.00855416971793389,0.573710369894872,154,-22.48,"2 21","7917 7941",22,"72.73%","72.73%","CDS","Q6V4S5","Protein sidekick-2","Mus musculus (Mouse)","camera-type eye photoreceptor cell differentiation [GO:0060219]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416]","GO:0005886; GO:0007156; GO:0007416; GO:0010842; GO:0045202; GO:0060219"
"4103","Cluster_1167","Peve_00011810",0.997092796096673,0.0485554673589907,0.947538901194076,142,-21.38,"2 11","27625 27646",9,"88.89%","88.89%","CDS","F1MA98","Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein)","Rattus norvegicus (Rat)","cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; mitotic spindle assembly checkpoint signaling [GO:0007094]; mRNA export from nucleus [GO:0006406]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin formation [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; regulation of protein localization [GO:0032880]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404]","GO:0000122; GO:0000776; GO:0003682; GO:0003729; GO:0005634; GO:0005635; GO:0005643; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006406; GO:0006606; GO:0006611; GO:0006999; GO:0007094; GO:0010965; GO:0015631; GO:0017056; GO:0019898; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0032880; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070840; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673"
"4104","Cluster_1167","Peve_00011810",0.997092796096673,0.0485554673589907,0.947538901194076,147,-22.92,"2 12","25947 25968",10,"90.00%","90.00%","CDS","F1MA98","Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein)","Rattus norvegicus (Rat)","cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; mitotic spindle assembly checkpoint signaling [GO:0007094]; mRNA export from nucleus [GO:0006406]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin formation [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; regulation of protein localization [GO:0032880]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404]","GO:0000122; GO:0000776; GO:0003682; GO:0003729; GO:0005634; GO:0005635; GO:0005643; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006406; GO:0006606; GO:0006611; GO:0006999; GO:0007094; GO:0010965; GO:0015631; GO:0017056; GO:0019898; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0032880; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070840; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673"
"4105","Cluster_1167","Peve_00011810",0.997092796096673,0.0485554673589907,0.947538901194076,150,-21.99,"2 11","37785 37806",9,"100.00%","100.00%","CDS","F1MA98","Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein)","Rattus norvegicus (Rat)","cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; mitotic spindle assembly checkpoint signaling [GO:0007094]; mRNA export from nucleus [GO:0006406]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin formation [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; regulation of protein localization [GO:0032880]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404]","GO:0000122; GO:0000776; GO:0003682; GO:0003729; GO:0005634; GO:0005635; GO:0005643; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006406; GO:0006606; GO:0006611; GO:0006999; GO:0007094; GO:0010965; GO:0015631; GO:0017056; GO:0019898; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0032880; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070840; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673"
"4110","Cluster_1167","Peve_00011946",0.999909726776791,0.00855416971793915,0.573710369894872,142,-24.37,"2 21","6951 6976",23,"65.22%","65.22%","CDS",NA,NA,NA,NA,NA
"4120","Cluster_1167","Peve_00012138",0.998405703354998,0.0359531878007655,0.909359886114279,147,-24.68,"2 12","1303 1324",10,"90.00%","90.00%","CDS","F4KGU4","ATP-dependent RNA helicase DEAH12, chloroplastic (EC 3.6.4.13)","Arabidopsis thaliana (Mouse-ear cress)","","GO:0003723; GO:0003724; GO:0005524; GO:0009507; GO:0016740; GO:0016887; GO:0046872; GO:0140096"
"4121","Cluster_1167","Peve_00012138",0.998405703354998,0.0359531878007655,0.909359886114279,149,-22.57,"2 20","6975 7000",22,"68.18%","72.73%","CDS","F4KGU4","ATP-dependent RNA helicase DEAH12, chloroplastic (EC 3.6.4.13)","Arabidopsis thaliana (Mouse-ear cress)","","GO:0003723; GO:0003724; GO:0005524; GO:0009507; GO:0016740; GO:0016887; GO:0046872; GO:0140096"
"4122","Cluster_1167","Peve_00012115",0.999910871663019,0.00849975187831585,0.573710369894872,150,-20.65,"2 20","2452 2474",19,"63.16%","78.95%","CDS","A5PJW8",NA,NA,NA,NA
"4135","Cluster_1167","Peve_00012576",0.999650459187876,0.0168328137218846,0.778099913711208,152,-22.53,"2 21","17929 17950",19,"63.16%","73.68%","CDS","Q9QYY8","Spastin (EC 5.6.1.1)","Mus musculus (Mouse)","anterograde axonal transport [GO:0008089]; axonal transport of mitochondrion [GO:0019896]; axonogenesis [GO:0007409]; cytokinetic process [GO:0032506]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exit from mitosis [GO:0010458]; membrane fission [GO:0090148]; metabolic process [GO:0008152]; microtubule bundle formation [GO:0001578]; microtubule severing [GO:0051013]; mitotic cytokinesis [GO:0000281]; mitotic spindle disassembly [GO:0051228]; nuclear membrane reassembly [GO:0031468]; positive regulation of cytokinesis [GO:0032467]; positive regulation of microtubule depolymerization [GO:0031117]; protein hexamerization [GO:0034214]; protein homooligomerization [GO:0051260]","GO:0000281; GO:0000922; GO:0001578; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005783; GO:0005789; GO:0005811; GO:0005813; GO:0005829; GO:0005874; GO:0006888; GO:0007409; GO:0008017; GO:0008089; GO:0008152; GO:0008568; GO:0010458; GO:0015630; GO:0016853; GO:0016887; GO:0019896; GO:0030424; GO:0030496; GO:0031117; GO:0031410; GO:0031468; GO:0031965; GO:0032467; GO:0032506; GO:0034214; GO:0043014; GO:0048471; GO:0048487; GO:0051013; GO:0051228; GO:0051260; GO:0071782; GO:0090148; GO:1904115"
"4139","Cluster_1167","Peve_00012763",0.997216635484962,0.0475095534720038,0.943238620332273,151,-21.35,"2 12","9219 9240",10,"90.00%","100.00%","CDS",NA,NA,NA,NA,NA
"4149","Cluster_1167","Peve_00013085",0.999909726776791,0.00855416971793915,0.573710369894872,153,-22.38,"2 21","8369 8388",19,"73.68%","73.68%","CDS","Q7TN88","Polycystic kidney disease protein 1-like 2 (PC1-like 2 protein) (Polycystin-1L2)","Mus musculus (Mouse)","detection of mechanical stimulus [GO:0050982]","GO:0001965; GO:0005262; GO:0005509; GO:0016020; GO:0030246; GO:0050982"
"4159","Cluster_1167","Peve_00013573",0.999909726776791,0.00855416971793915,0.573710369894872,144,-20.7,"2 21","7606 7627",19,"57.89%","68.42%","CDS","B8VIU6","Uncharacterized skeletal organic matrix protein 5 (Uncharacterized SOMP-5)","Acropora millepora (Staghorn coral) (Heteropora millepora)","","GO:0005576"
"4172","Cluster_1167","Peve_00014007",0.999909726776791,0.00855416971793389,0.573710369894872,151,-24.38,"2 12","3520 3541",10,"90.00%","100.00%","CDS","Q5EAW4","Protein MCM10 homolog","Xenopus laevis (African clawed frog)","cellular response to DNA damage stimulus [GO:0006974]; DNA replication initiation [GO:0006270]","GO:0003690; GO:0003697; GO:0005634; GO:0006270; GO:0006974; GO:0046872"
"4215","Cluster_1167","Peve_00015040",0.999909726776791,0.00855416971793389,0.573710369894872,157,-25.18,"2 21","3322 3348",24,"75.00%","75.00%","CDS",NA,NA,NA,NA,NA
"4236","Cluster_1167","Peve_00015570",0.998135332124585,0.0388833229901565,0.909359886114279,145,-20.42,"2 19","7365 7387",18,"66.67%","72.22%","CDS","G3I6Z6","Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)]","Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus)","angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355]","GO:0000139; GO:0001525; GO:0005509; GO:0005634; GO:0005796; GO:0005912; GO:0006355; GO:0016324; GO:0030154; GO:0038023; GO:0050793; GO:0060271; GO:0061314"
"4255","Cluster_1167","Peve_00016081",0.998472782168961,0.0351885118974169,0.909359886114279,152,-21.19,"2 20","47450 47471",19,"68.42%","84.21%","CDS",NA,NA,NA,NA,NA
"4261","Cluster_1167","Peve_00016266",0.997218255892448,0.04749571558219,0.943092358689762,147,-21.22,"2 21","2320 2342",20,"65.00%","70.00%","CDS","Q5VT52","Regulation of nuclear pre-mRNA domain-containing protein 2","Homo sapiens (Human)","mRNA 3'-end processing [GO:0031124]","GO:0000993; GO:0005654; GO:0016591; GO:0031124"
"4262","Cluster_1167","Peve_00016327",0.999909726776791,0.00855416971793915,0.573710369894872,143,-23.86,"2 20","3532 3554",21,"66.67%","71.43%","CDS","Q96AY4","Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio)","Homo sapiens (Human)","cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0000922; GO:0005737; GO:0005815; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301"
"4263","Cluster_1167","Peve_00016327",0.999909726776791,0.00855416971793915,0.573710369894872,143,-23.86,"2 20","825 847",21,"66.67%","71.43%","CDS","Q96AY4","Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio)","Homo sapiens (Human)","cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0000922; GO:0005737; GO:0005815; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301"
"4264","Cluster_1167","Peve_00016317",0.999592690559685,0.018170718522517,0.782669382293497,152,-23.19,"2 13","13890 13911",11,"90.91%","90.91%","CDS","F8W2M8","Tripeptidyl-peptidase 1 (TPP-1) (EC 3.4.14.9) (Tripeptidyl aminopeptidase) (Tripeptidyl-peptidase I) (TPP-I)","Danio rerio (Zebrafish) (Brachydanio rerio)","central nervous system development [GO:0007417]; locomotory behavior [GO:0007626]; neurogenesis [GO:0022008]; proteolysis [GO:0006508]","GO:0004175; GO:0004252; GO:0005764; GO:0006508; GO:0007417; GO:0007626; GO:0008240; GO:0022008; GO:0046872"
"4271","Cluster_1167","Peve_00016655",0.999909726776791,0.00855416971793915,0.573710369894872,147,-20.36,"2 20","10152 10173",18,"66.67%","66.67%","CDS","Q7TQ69","Transmembrane channel-like protein 3","Mus musculus (Mouse)","","GO:0005886; GO:0008381"
"4284","Cluster_1167","Peve_00017013",0.999909726776791,0.00855416971793389,0.573710369894872,144,-22.28,"2 13","3299 3320",11,"81.82%","81.82%","CDS",NA,NA,NA,NA,NA
"4302","Cluster_1167","Peve_00017537",0.99996273202871,0.00549622300675805,0.551398425649056,155,-21.34,"2 16","6556 6577",14,"78.57%","85.71%","CDS","Q13118","Krueppel-like factor 10 (EGR-alpha) (Transforming growth factor-beta-inducible early growth response protein 1) (TGFB-inducible early growth response protein 1) (TIEG-1)","Homo sapiens (Human)","bone mineralization [GO:0030282]; cell-cell signaling [GO:0007267]; cellular response to starvation [GO:0009267]; circadian rhythm [GO:0007623]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of circadian rhythm [GO:0042752]; regulation of transcription by RNA polymerase II [GO:0006357]; somatic stem cell population maintenance [GO:0035019]","GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001046; GO:0001228; GO:0003700; GO:0005634; GO:0006357; GO:0007267; GO:0007623; GO:0008285; GO:0009267; GO:0030282; GO:0035019; GO:0042752; GO:0045672; GO:0045892; GO:0045944; GO:0046872; GO:1990837"
"4303","Cluster_1167","Peve_00017537",0.99996273202871,0.00549622300675805,0.551398425649056,155,-21.34,"2 16","7507 7528",14,"78.57%","85.71%","CDS","Q13118","Krueppel-like factor 10 (EGR-alpha) (Transforming growth factor-beta-inducible early growth response protein 1) (TGFB-inducible early growth response protein 1) (TIEG-1)","Homo sapiens (Human)","bone mineralization [GO:0030282]; cell-cell signaling [GO:0007267]; cellular response to starvation [GO:0009267]; circadian rhythm [GO:0007623]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of circadian rhythm [GO:0042752]; regulation of transcription by RNA polymerase II [GO:0006357]; somatic stem cell population maintenance [GO:0035019]","GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001046; GO:0001228; GO:0003700; GO:0005634; GO:0006357; GO:0007267; GO:0007623; GO:0008285; GO:0009267; GO:0030282; GO:0035019; GO:0042752; GO:0045672; GO:0045892; GO:0045944; GO:0046872; GO:1990837"
"4305","Cluster_1167","Peve_00017626",0.999909726776791,0.00855416971793915,0.573710369894872,154,-22.16,"2 19","7281 7302",17,"70.59%","76.47%","CDS","Q7TQP6","Serine/threonine-protein kinase TNNI3K (EC 2.7.11.1) (Cardiac ankyrin repeat kinase) (TNNI3-interacting kinase)","Rattus norvegicus (Rat)","bundle of His cell to Purkinje myocyte communication [GO:0086069]; protein phosphorylation [GO:0006468]; regulation of cardiac conduction [GO:1903779]; regulation of cardiac muscle contraction [GO:0055117]; regulation of heart rate [GO:0002027]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0002027; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0006357; GO:0006468; GO:0008022; GO:0031013; GO:0046872; GO:0055117; GO:0061629; GO:0086069; GO:0106310; GO:1903779"
"4314","Cluster_1167","Peve_00017815",0.999624036298081,0.0174574853769298,0.782669382293497,160,-23.96,"2 19","1656 1676",17,"76.47%","88.24%","CDS","O35111","Potassium channel subfamily K member 3 (Acid-sensitive potassium channel protein TASK-1) (Cardiac two pore background K(+) channel) (TWIK-related acid-sensitive K(+) channel 1) (Two pore potassium channel KT3.1) (Two pore K(+) channel KT3.1) (cTBAK-1)","Mus musculus (Mouse)","brain development [GO:0007420]; cellular response to hypoxia [GO:0071456]; cellular response to zinc ion [GO:0071294]; cochlea development [GO:0090102]; ion transmembrane transport [GO:0034220]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; positive regulation of voltage-gated potassium channel activity [GO:1903818]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of resting membrane potential [GO:0060075]; response to xenobiotic stimulus [GO:0009410]; stabilization of membrane potential [GO:0030322]","GO:0005216; GO:0005252; GO:0005886; GO:0006813; GO:0007420; GO:0008022; GO:0009410; GO:0015271; GO:0022841; GO:0030322; GO:0034220; GO:0044548; GO:0051481; GO:0060075; GO:0071294; GO:0071456; GO:0071805; GO:0090102; GO:1903818"
"4324","Cluster_1167","Peve_00018050",0.999909726776791,0.00855416971793389,0.573710369894872,174,-26.85,"2 21","5382 5402",19,"84.21%","89.47%","CDS",NA,NA,NA,NA,NA
"4331","Cluster_1167","Peve_00018084",0.999796415038106,0.0128462194457193,0.696479349653946,142,-21.56,"2 11","7593 7614",9,"88.89%","88.89%","CDS","Q5I0I5","U6 snRNA phosphodiesterase 1 (3'-5' RNA exonuclease USB1) (EC 4.6.1.-)","Rattus norvegicus (Rat)","RNA splicing [GO:0008380]; snRNA 3'-end processing [GO:0034472]; U6 snRNA 3'-end processing [GO:0034477]","GO:0000175; GO:0005634; GO:0005654; GO:0008380; GO:0016829; GO:0034472; GO:0034477; GO:0045171; GO:1990838"
"4337","Cluster_1167","Peve_00018512",0.999909726776791,0.00855416971793389,0.573710369894872,147,-24.92,"2 21","3123 3145",20,"65.00%","70.00%","CDS",NA,NA,NA,NA,NA
"4340","Cluster_1167","Peve_00018567",0.999909726776791,0.00855416971793915,0.573710369894872,149,-21.88,"2 14","1584 1605",12,"75.00%","91.67%","CDS",NA,NA,NA,NA,NA
"4368","Cluster_1167","Peve_00019043",0.999909726776791,0.00855416971793915,0.573710369894872,148,-21.04,"2 21","1411 1429",19,"68.42%","73.68%","CDS",NA,NA,NA,NA,NA
"4371","Cluster_1167","Peve_00019304",0.999909726776791,0.00855416971793915,0.573710369894872,152,-23.69,"2 13","19920 19941",11,"90.91%","90.91%","CDS",NA,NA,NA,NA,NA
"4372","Cluster_1167","Peve_00019304",0.999909726776791,0.00855416971793915,0.573710369894872,154,-21.17,"2 19","18500 18521",17,"70.59%","76.47%","CDS",NA,NA,NA,NA,NA
"4373","Cluster_1167","Peve_00019304",0.999909726776791,0.00855416971793915,0.573710369894872,159,-24.7,"2 20","16534 16554",19,"78.95%","84.21%","CDS",NA,NA,NA,NA,NA
"4375","Cluster_1167","Peve_00019413",0.997277672715347,0.0469855010262438,0.940151481590584,150,-22.03,"2 20","8513 8535",19,"68.42%","73.68%","CDS","Q6DFB7","Centrosomal protein POC5 (Protein of centriole 5)","Xenopus laevis (African clawed frog)","cell cycle [GO:0007049]","GO:0005737; GO:0005814; GO:0007049"
"4381","Cluster_1167","Peve_00019614",0.999909726776791,0.00855416971794441,0.573710369894872,154,-22.16,"2 19","21890 21911",17,"70.59%","76.47%","CDS","Q5GIG6","Serine/threonine-protein kinase TNNI3K (EC 2.7.11.1) (Cardiac ankyrin repeat kinase) (TNNI3-interacting kinase)","Mus musculus (Mouse)","bundle of His cell to Purkinje myocyte communication [GO:0086069]; protein phosphorylation [GO:0006468]; regulation of cardiac conduction [GO:1903779]; regulation of cardiac muscle contraction [GO:0055117]; regulation of heart rate [GO:0002027]","GO:0002027; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0008022; GO:0031013; GO:0046872; GO:0055117; GO:0086069; GO:0106310; GO:1903779"
"4386","Cluster_1167","Peve_00019725",0.998585738294794,0.033861891113506,0.909359886114279,152,-23.21,"2 13","5437 5458",11,"90.91%","90.91%","CDS","Q9NV70","Exocyst complex component 1 (Exocyst complex component Sec3)","Homo sapiens (Human)","defense response to virus [GO:0051607]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; membrane fission [GO:0090148]; mitotic cytokinesis [GO:0000281]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of protein secretion [GO:0050714]; protein transport [GO:0015031]; regulation of macroautophagy [GO:0016241]; vesicle docking involved in exocytosis [GO:0006904]; vesicle tethering involved in exocytosis [GO:0090522]","GO:0000145; GO:0000281; GO:0005546; GO:0005737; GO:0005829; GO:0005886; GO:0006887; GO:0006893; GO:0006904; GO:0015031; GO:0016020; GO:0016241; GO:0048015; GO:0048471; GO:0050714; GO:0051607; GO:0090148; GO:0090522; GO:0090543; GO:0098592"
"4391","Cluster_1167","Peve_00020003",0.999909726776791,0.00855416971794441,0.573710369894872,156,-23.86,"2 18","4141 4165",19,"73.68%","78.95%","CDS","Q5HZP1","Ribonuclease H2 subunit B (RNase H2 subunit B) (Ribonuclease HI subunit B)","Xenopus laevis (African clawed frog)","RNA catabolic process [GO:0006401]","GO:0005634; GO:0006401; GO:0032299"
"4395","Cluster_1167","Peve_00020149",0.99989178672184,0.00936567997820576,0.602207777435852,142,-20.6,"2 11","1212 1233",9,"88.89%","88.89%","CDS","Q09596","Probable glutathione S-transferase 5 (EC 2.5.1.18) (GST class-sigma)","Caenorhabditis elegans","glutathione metabolic process [GO:0006749]; innate immune response [GO:0045087]","GO:0004364; GO:0006749; GO:0045087"
"4396","Cluster_1167","Peve_00020151",0.999909726776791,0.00855416971793915,0.573710369894872,145,-23.56,"2 21","2151 2179",26,"65.38%","69.23%","CDS","Q09596","Probable glutathione S-transferase 5 (EC 2.5.1.18) (GST class-sigma)","Caenorhabditis elegans","glutathione metabolic process [GO:0006749]; innate immune response [GO:0045087]","GO:0004364; GO:0006749; GO:0045087"
"4398","Cluster_1167","Peve_00020080",0.999909726776791,0.00855416971793389,0.573710369894872,146,-23.49,"2 21","6446 6471",23,"60.87%","73.91%","CDS",NA,NA,NA,NA,NA
"4400","Cluster_1167","Peve_00013358",0.999909726776791,0.00855416971793915,0.573710369894872,147,-20.85,"2 17","2104 2126",16,"75.00%","75.00%","CDS","P07911","Uromodulin (Tamm-Horsfall urinary glycoprotein) (THP) [Cleaved into: Uromodulin, secreted form]","Homo sapiens (Human)","antibacterial innate immune response [GO:0140367]; apoptotic signaling pathway [GO:0097190]; autophagy [GO:0006914]; cellular calcium ion homeostasis [GO:0006874]; cellular chloride ion homeostasis [GO:0030644]; cellular defense response [GO:0006968]; cellular phosphate ion homeostasis [GO:0030643]; cellular response to unfolded protein [GO:0034620]; cellular sodium ion homeostasis [GO:0006883]; chaperone-mediated protein folding [GO:0061077]; citric acid secretion [GO:0046720]; collecting duct development [GO:0072044]; connective tissue replacement [GO:0097709]; creatinine homeostasis [GO:0097273]; defense response to Gram-negative bacterium [GO:0050829]; endoplasmic reticulum organization [GO:0007029]; glomerular filtration [GO:0003094]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; inflammatory response [GO:0006954]; juxtaglomerular apparatus development [GO:0072051]; leukocyte cell-cell adhesion [GO:0007159]; lipid metabolic process [GO:0006629]; metanephric ascending thin limb development [GO:0072218]; metanephric distal convoluted tubule development [GO:0072221]; metanephric thick ascending limb development [GO:0072233]; micturition [GO:0060073]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell population proliferation [GO:0008285]; neutrophil migration [GO:1990266]; organ or tissue specific immune response [GO:0002251]; peptidyl-threonine phosphorylation [GO:0018107]; potassium ion homeostasis [GO:0055075]; protein localization to vacuole [GO:0072665]; protein transport into plasma membrane raft [GO:0044861]; regulation of blood pressure [GO:0008217]; regulation of protein transport [GO:0051223]; regulation of urine volume [GO:0035809]; renal sodium ion absorption [GO:0070294]; renal urate salt excretion [GO:0097744]; renal water homeostasis [GO:0003091]; response to lipopolysaccharide [GO:0032496]; response to water deprivation [GO:0009414]; response to xenobiotic stimulus [GO:0009410]; RNA splicing [GO:0008380]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; ubiquitin-dependent ERAD pathway [GO:0030433]; urate transport [GO:0015747]; urea transmembrane transport [GO:0071918]","GO:0000922; GO:0002251; GO:0003091; GO:0003094; GO:0005201; GO:0005509; GO:0005615; GO:0005783; GO:0005796; GO:0005929; GO:0006629; GO:0006874; GO:0006883; GO:0006914; GO:0006954; GO:0006968; GO:0007029; GO:0007157; GO:0007159; GO:0008217; GO:0008285; GO:0008380; GO:0009410; GO:0009414; GO:0009986; GO:0015747; GO:0016020; GO:0016323; GO:0016324; GO:0018107; GO:0019864; GO:0019898; GO:0030433; GO:0030643; GO:0030644; GO:0032496; GO:0033209; GO:0033555; GO:0034620; GO:0035809; GO:0044861; GO:0046720; GO:0050829; GO:0051223; GO:0055075; GO:0060073; GO:0060170; GO:0061077; GO:0070062; GO:0070294; GO:0071918; GO:0072044; GO:0072051; GO:0072218; GO:0072221; GO:0072233; GO:0072665; GO:0097190; GO:0097273; GO:0097709; GO:0097744; GO:0140367; GO:1990266"
"4401","Cluster_1167","Peve_00020266",0.999582569792977,0.0183951005418645,0.782669382293497,141,-20.76,"2 12","6532 6552",10,"90.00%","90.00%","CDS","Q8TCJ2","Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3B (Oligosaccharyl transferase subunit STT3B) (STT3-B) (EC 2.4.99.18) (Source of immunodominant MHC-associated peptides homolog)","Homo sapiens (Human)","co-translational protein modification [GO:0043686]; glycoprotein catabolic process [GO:0006516]; post-translational protein modification [GO:0043687]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; response to unfolded protein [GO:0006986]; ubiquitin-dependent ERAD pathway [GO:0030433]","GO:0004579; GO:0005783; GO:0005789; GO:0006487; GO:0006516; GO:0006986; GO:0008250; GO:0016020; GO:0018279; GO:0030433; GO:0032991; GO:0034998; GO:0043686; GO:0043687; GO:0046872"
"4402","Cluster_1167","Peve_00020314",0.999909726776791,0.00855416971793389,0.573710369894872,140,-23,"2 9","781 802",7,"100.00%","100.00%","CDS","P05099","Cartilage matrix protein (Matrilin-1)","Gallus gallus (Chicken)","extracellular matrix organization [GO:0030198]","GO:0005509; GO:0005576; GO:0030198"
"4423","Cluster_1167","Peve_00020723",0.999909726776791,0.00855416971794441,0.573710369894872,145,-20.42,"2 19","4394 4416",18,"66.67%","72.22%","CDS","P35546","Proto-oncogene tyrosine-protein kinase receptor Ret (EC 2.7.10.1) (Proto-oncogene c-Ret) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment]","Mus musculus (Mouse)","activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; anatomical structure morphogenesis [GO:0009653]; cellular response to retinoic acid [GO:0071300]; embryonic epithelial tube formation [GO:0001838]; enteric nervous system development [GO:0048484]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; innervation [GO:0060384]; MAPK cascade [GO:0000165]; membrane protein proteolysis [GO:0033619]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; neuron cell-cell adhesion [GO:0007158]; neuron differentiation [GO:0030182]; neuron maturation [GO:0042551]; Peyer's patch morphogenesis [GO:0061146]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell migration [GO:0030335]; positive regulation of cell size [GO:0045793]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of gene expression [GO:0010628]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of metanephric glomerulus development [GO:0072300]; positive regulation of neuron maturation [GO:0014042]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; positive regulation of protein kinase B signaling [GO:0051897]; regulation of axonogenesis [GO:0050770]; regulation of cell adhesion [GO:0030155]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; retina development in camera-type eye [GO:0060041]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; ureter maturation [GO:0035799]; ureteric bud development [GO:0001657]","GO:0000165; GO:0001657; GO:0001755; GO:0001838; GO:0004714; GO:0005509; GO:0005524; GO:0005769; GO:0005886; GO:0006919; GO:0007156; GO:0007158; GO:0007169; GO:0007399; GO:0009410; GO:0009653; GO:0010008; GO:0010628; GO:0010976; GO:0014042; GO:0030155; GO:0030182; GO:0030335; GO:0030424; GO:0030425; GO:0033141; GO:0033619; GO:0033630; GO:0033674; GO:0035799; GO:0035860; GO:0042551; GO:0043025; GO:0043235; GO:0043410; GO:0045121; GO:0045793; GO:0045893; GO:0048265; GO:0048484; GO:0050770; GO:0051897; GO:0060041; GO:0060384; GO:0061146; GO:0071300; GO:0072300; GO:0098797; GO:2001241"
"4433","Cluster_1167","Peve_00020864",0.999909726776791,0.00855416971793915,0.573710369894872,150,-20.1,"2 16","1489 1512",16,"75.00%","81.25%","CDS",NA,NA,NA,NA,NA
"4442","Cluster_1167","Peve_00020874",0.999909726776791,0.00855416971793915,0.573710369894872,145,-21.21,"2 10","27661 27682",8,"100.00%","100.00%","CDS","Q5VU97","VWFA and cache domain-containing protein 1 (Cache domain-containing protein 1)","Homo sapiens (Human)","","GO:0005245; GO:0005891"
"4450","Cluster_1167","Peve_00021597",0.999909726776791,0.00855416971793915,0.573710369894872,164,-27.14,"2 21","6330 6349",19,"84.21%","84.21%","CDS",NA,NA,NA,NA,NA
"4454","Cluster_1167","Peve_00021762",0.999909726776791,0.00855416971793915,0.573710369894872,148,-20.91,"2 21","8046 8065",19,"68.42%","78.95%","CDS",NA,NA,NA,NA,NA
"4457","Cluster_1167","Peve_00021789",0.999909726776791,0.00855416971793389,0.573710369894872,141,-21.54,"2 12","7110 7130",10,"90.00%","90.00%","CDS",NA,NA,NA,NA,NA
"4458","Cluster_1167","Peve_00021789",0.999909726776791,0.00855416971793389,0.573710369894872,146,-24.06,"2 16","7658 7683",18,"66.67%","77.78%","CDS",NA,NA,NA,NA,NA
"4473","Cluster_1167","Peve_00021681",0.999909726776791,0.00855416971794441,0.573710369894872,150,-21.33,"2 18","217 236",16,"75.00%","81.25%","CDS",NA,NA,NA,NA,NA
"4480","Cluster_1167","Peve_00022627",0.999909726776791,0.00855416971793389,0.573710369894872,151,-22.89,"2 21","8324 8341",19,"68.42%","78.95%","CDS",NA,NA,NA,NA,NA
"4485","Cluster_1167","Peve_00022730",0.999983602976637,0.00364567728204132,0.528605282212205,146,-20.73,"2 11","113 134",9,"88.89%","100.00%","CDS",NA,NA,NA,NA,NA
"4486","Cluster_1167","Peve_00022785",0.999909726776791,0.00855416971793915,0.573710369894872,155,-23.63,"2 20","7079 7100",18,"72.22%","72.22%","CDS","O88322","Nidogen-2 (NID-2) (Entactin-2)","Mus musculus (Mouse)","cell-matrix adhesion [GO:0007160]","GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005886; GO:0007160; GO:0009986; GO:0031012; GO:0062023"
"4487","Cluster_1167","Peve_00022766",0.999975210971309,0.00448255650740406,0.54328949385489,145,-20.14,"2 10","6290 6311",8,"100.00%","100.00%","CDS",NA,NA,NA,NA,NA
"4494","Cluster_1167","Peve_00022891",0.999909726776791,0.00855416971793389,0.573710369894872,152,-20.8,"2 13","2238 2259",11,"90.91%","90.91%","CDS","Q9H0J9","Protein mono-ADP-ribosyltransferase PARP12 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 12) (ARTD12) (Poly [ADP-ribose] polymerase 12) (PARP-12) (Zinc finger CCCH domain-containing protein 1)","Homo sapiens (Human)","protein auto-ADP-ribosylation [GO:0070213]","GO:0003723; GO:0003950; GO:0005634; GO:0016779; GO:0046872; GO:0070213; GO:0140803; GO:1990404"
"4496","Cluster_1167","Peve_00022620",0.998032919587633,0.0399371798823631,0.909359886114279,142,-20.4,"2 11","32234 32255",9,"88.89%","88.89%","CDS","O75899","Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20)","Homo sapiens (Human)","adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932]","GO:0004888; GO:0004965; GO:0005737; GO:0005886; GO:0007186; GO:0007193; GO:0007194; GO:0007214; GO:0007268; GO:0038039; GO:0043005; GO:0045211; GO:0046982; GO:0051932; GO:0150099; GO:1902710; GO:1902712"
"4497","Cluster_1167","Peve_00022981",0.99978346420904,0.013248533344867,0.706187587087588,145,-20.43,"2 10","25811 25832",8,"100.00%","100.00%","CDS","Q9CR50","RING finger and CHY zinc finger domain-containing protein 1 (EC 2.3.2.27) (Androgen receptor N-terminal-interacting protein) (CH-rich-interacting match with PLAG1) (E3 ubiquitin-protein ligase Pirh2) (RING-type E3 ubiquitin transferase RCHY1) (Zinc finger protein 363)","Mus musculus (Mouse)","positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0000151; GO:0002039; GO:0005102; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006511; GO:0008270; GO:0016567; GO:0016607; GO:0031398; GO:0032436; GO:0042803; GO:0043231; GO:0051865; GO:0061630"
"4500","Cluster_1167","Peve_00022568",0.998769483347398,0.0315851840875417,0.903929377050813,149,-21.19,"2 14","197 218",12,"83.33%","83.33%","CDS",NA,NA,NA,NA,NA
"4505","Cluster_1167","Peve_00023166",0.999909726776791,0.00855416971793915,0.573710369894872,141,-21.38,"2 21","1356 1381",24,"62.50%","66.67%","CDS",NA,NA,NA,NA,NA
"4506","Cluster_1167","Peve_00023116",-0.998588079170744,0.0338338489230548,0.909359886114279,149,-20.2,"2 20","7521 7541",18,"72.22%","72.22%","CDS",NA,NA,NA,NA,NA
"4513","Cluster_1167","Peve_00023477",0.998446023409574,0.0354955257496804,0.909359886114279,147,-24.41,"2 20","37735 37756",18,"61.11%","72.22%","CDS","P12111","Collagen alpha-3(VI) chain","Homo sapiens (Human)","cell adhesion [GO:0007155]; muscle organ development [GO:0007517]; negative regulation of peptidase activity [GO:0010466]","GO:0004867; GO:0005576; GO:0005589; GO:0005615; GO:0005788; GO:0007155; GO:0007517; GO:0010466; GO:0030020; GO:0031012; GO:0042383; GO:0062023; GO:0070062; GO:1903561"
"4525","Cluster_1167","Peve_00023804",0.998790745170331,0.0313110628689443,0.903929377050813,148,-20.54,"2 21","10821 10842",19,"63.16%","68.42%","CDS","A7RRG3","Protein AKTIP homolog (Fused toes protein homolog)","Nematostella vectensis (Starlet sea anemone)","",""
"4529","Cluster_1167","Peve_00023820",0.998240206991165,0.0377737084885981,0.909359886114279,156,-22.04,"2 18","22197 22219",17,"76.47%","82.35%","CDS","O60645","Exocyst complex component 3 (Exocyst complex component Sec6)","Homo sapiens (Human)","exocyst localization [GO:0051601]; exocytosis [GO:0006887]; membrane fission [GO:0090148]; mitotic cytokinesis [GO:0000281]; protein transport [GO:0015031]; vesicle docking involved in exocytosis [GO:0006904]; vesicle tethering involved in exocytosis [GO:0090522]","GO:0000145; GO:0000149; GO:0000281; GO:0005794; GO:0005829; GO:0006887; GO:0006904; GO:0015031; GO:0030426; GO:0030496; GO:0030667; GO:0042734; GO:0045296; GO:0048471; GO:0051601; GO:0090148; GO:0090522"
"4545","Cluster_1167","Peve_00024385",0.999909726776791,0.00855416971793389,0.573710369894872,150,-21.4,"2 11","1576 1597",9,"100.00%","100.00%","CDS","Q14517","Protocadherin Fat 1 (Cadherin family member 7) (Cadherin-related tumor suppressor homolog) (Protein fat homolog) [Cleaved into: Protocadherin Fat 1, nuclear form]","Homo sapiens (Human)","actin filament organization [GO:0007015]; anatomical structure morphogenesis [GO:0009653]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; cell-cell signaling [GO:0007267]; epithelial cell morphogenesis [GO:0003382]; establishment of epithelial cell apical/basal polarity involved in camera-type eye morphogenesis [GO:0003412]; establishment or maintenance of cell polarity [GO:0007163]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; lens development in camera-type eye [GO:0002088]","GO:0002088; GO:0003382; GO:0003412; GO:0005509; GO:0005634; GO:0005886; GO:0005911; GO:0005925; GO:0007015; GO:0007155; GO:0007156; GO:0007163; GO:0007267; GO:0009653; GO:0016324; GO:0016477; GO:0030027; GO:0030175; GO:0048471; GO:0070062; GO:0098609"
"4558","Cluster_1167","Peve_00024781",0.999745454039197,0.0143643982890296,0.730880670957694,151,-20.65,"2 20","25900 25919",18,"77.78%","77.78%","CDS","P07207","Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein]","Drosophila melanogaster (Fruit fly)","actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222]","GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048"
"4565","Cluster_1167","Peve_00024625",0.999909726776791,0.00855416971792863,0.573710369894872,156,-22.04,"2 18","6312 6334",17,"76.47%","82.35%","CDS",NA,NA,NA,NA,NA
"4576","Cluster_1167","Peve_00025704",0.999909726776791,0.00855416971793389,0.573710369894872,154,-24.01,"2 20","532 554",19,"73.68%","73.68%","CDS",NA,NA,NA,NA,NA
"4593","Cluster_1167","Peve_00026246",0.999909726776791,0.00855416971794441,0.573710369894872,153,-20.67,"2 20","174 194",18,"72.22%","77.78%","CDS",NA,NA,NA,NA,NA
"4596","Cluster_1167","Peve_00025931",0.998327332486837,0.0368265034677488,0.909359886114279,148,-21.14,"2 18","33892 33917",20,"65.00%","75.00%","CDS",NA,NA,NA,NA,NA
"4597","Cluster_1167","Peve_00025932",0.99877228270283,0.0315492290189202,0.903929377050813,145,-26.39,"2 10","46407 46428",8,"100.00%","100.00%","CDS",NA,NA,NA,NA,NA
"4601","Cluster_1167","Peve_00026446",0.998556066248906,0.0342153531038022,0.909359886114279,151,-20.11,"2 21","1839 1861",20,"65.00%","75.00%","CDS","P53708","Integrin alpha-8 [Cleaved into: Integrin alpha-8 heavy chain; Integrin alpha-8 light chain]","Homo sapiens (Human)","brain development [GO:0007420]; cell adhesion mediated by integrin [GO:0033627]; cell projection organization [GO:0030030]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; establishment of protein localization [GO:0045184]; extracellular matrix organization [GO:0030198]; inner ear morphogenesis [GO:0042472]; integrin-mediated signaling pathway [GO:0007229]; kidney development [GO:0001822]; memory [GO:0007613]; mesodermal cell differentiation [GO:0048333]; metanephros development [GO:0001656]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; smooth muscle cell differentiation [GO:0051145]; smooth muscle tissue development [GO:0048745]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]","GO:0001656; GO:0001822; GO:0005178; GO:0005783; GO:0005886; GO:0005925; GO:0007160; GO:0007179; GO:0007229; GO:0007420; GO:0007613; GO:0008305; GO:0009897; GO:0009986; GO:0030030; GO:0030198; GO:0030511; GO:0032591; GO:0033627; GO:0034446; GO:0034678; GO:0042472; GO:0043204; GO:0045177; GO:0045184; GO:0045944; GO:0046872; GO:0048333; GO:0048745; GO:0051145; GO:0098609; GO:0098839; GO:0098978"
"4602","Cluster_1167","Peve_00022430",0.999909726776791,0.00855416971793915,0.573710369894872,142,-24.37,"2 21","6500 6525",23,"65.22%","65.22%","CDS","P42893","Endothelin-converting enzyme 1 (ECE-1) (EC 3.4.24.71)","Rattus norvegicus (Rat)","apoptotic process [GO:0006915]; axonogenesis involved in innervation [GO:0060385]; blood vessel diameter maintenance [GO:0097746]; bradykinin catabolic process [GO:0010815]; calcitonin catabolic process [GO:0010816]; ear development [GO:0043583]; embryonic digit morphogenesis [GO:0042733]; embryonic heart tube development [GO:0035050]; endothelin maturation [GO:0034959]; gene expression [GO:0010467]; heart development [GO:0007507]; hormone catabolic process [GO:0042447]; neuron projection development [GO:0031175]; peptide hormone processing [GO:0016486]; pharyngeal system development [GO:0060037]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; positive regulation of receptor recycling [GO:0001921]; protein processing [GO:0016485]; regulation of blood pressure [GO:0008217]; regulation of ERK1 and ERK2 cascade [GO:0070372]; response to cadmium ion [GO:0046686]; response to hypoxia [GO:0001666]; response to muscle stretch [GO:0035994]; response to xenobiotic stimulus [GO:0009410]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; substance P catabolic process [GO:0010814]; sympathetic neuron axon guidance [GO:0097492]","GO:0001666; GO:0001921; GO:0004175; GO:0004222; GO:0005768; GO:0005769; GO:0005886; GO:0006915; GO:0007507; GO:0008217; GO:0008270; GO:0009410; GO:0009897; GO:0010467; GO:0010613; GO:0010814; GO:0010815; GO:0010816; GO:0016020; GO:0016485; GO:0016486; GO:0030141; GO:0031175; GO:0031410; GO:0031982; GO:0033093; GO:0034959; GO:0035050; GO:0035994; GO:0042447; GO:0042733; GO:0042802; GO:0042803; GO:0043583; GO:0043950; GO:0045745; GO:0046686; GO:0048471; GO:0060037; GO:0060385; GO:0070372; GO:0097492; GO:0097746; GO:1902287"
"4603","Cluster_1167","Peve_00022430",0.999909726776791,0.00855416971793915,0.573710369894872,142,-24.37,"2 21","6779 6804",23,"65.22%","65.22%","CDS","P42893","Endothelin-converting enzyme 1 (ECE-1) (EC 3.4.24.71)","Rattus norvegicus (Rat)","apoptotic process [GO:0006915]; axonogenesis involved in innervation [GO:0060385]; blood vessel diameter maintenance [GO:0097746]; bradykinin catabolic process [GO:0010815]; calcitonin catabolic process [GO:0010816]; ear development [GO:0043583]; embryonic digit morphogenesis [GO:0042733]; embryonic heart tube development [GO:0035050]; endothelin maturation [GO:0034959]; gene expression [GO:0010467]; heart development [GO:0007507]; hormone catabolic process [GO:0042447]; neuron projection development [GO:0031175]; peptide hormone processing [GO:0016486]; pharyngeal system development [GO:0060037]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; positive regulation of receptor recycling [GO:0001921]; protein processing [GO:0016485]; regulation of blood pressure [GO:0008217]; regulation of ERK1 and ERK2 cascade [GO:0070372]; response to cadmium ion [GO:0046686]; response to hypoxia [GO:0001666]; response to muscle stretch [GO:0035994]; response to xenobiotic stimulus [GO:0009410]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; substance P catabolic process [GO:0010814]; sympathetic neuron axon guidance [GO:0097492]","GO:0001666; GO:0001921; GO:0004175; GO:0004222; GO:0005768; GO:0005769; GO:0005886; GO:0006915; GO:0007507; GO:0008217; GO:0008270; GO:0009410; GO:0009897; GO:0010467; GO:0010613; GO:0010814; GO:0010815; GO:0010816; GO:0016020; GO:0016485; GO:0016486; GO:0030141; GO:0031175; GO:0031410; GO:0031982; GO:0033093; GO:0034959; GO:0035050; GO:0035994; GO:0042447; GO:0042733; GO:0042802; GO:0042803; GO:0043583; GO:0043950; GO:0045745; GO:0046686; GO:0048471; GO:0060037; GO:0060385; GO:0070372; GO:0097492; GO:0097746; GO:1902287"
"4604","Cluster_1167","Peve_00022430",0.999909726776791,0.00855416971793915,0.573710369894872,147,-21.27,"2 21","29922 29945",21,"61.90%","71.43%","CDS","P42893","Endothelin-converting enzyme 1 (ECE-1) (EC 3.4.24.71)","Rattus norvegicus (Rat)","apoptotic process [GO:0006915]; axonogenesis involved in innervation [GO:0060385]; blood vessel diameter maintenance [GO:0097746]; bradykinin catabolic process [GO:0010815]; calcitonin catabolic process [GO:0010816]; ear development [GO:0043583]; embryonic digit morphogenesis [GO:0042733]; embryonic heart tube development [GO:0035050]; endothelin maturation [GO:0034959]; gene expression [GO:0010467]; heart development [GO:0007507]; hormone catabolic process [GO:0042447]; neuron projection development [GO:0031175]; peptide hormone processing [GO:0016486]; pharyngeal system development [GO:0060037]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; positive regulation of receptor recycling [GO:0001921]; protein processing [GO:0016485]; regulation of blood pressure [GO:0008217]; regulation of ERK1 and ERK2 cascade [GO:0070372]; response to cadmium ion [GO:0046686]; response to hypoxia [GO:0001666]; response to muscle stretch [GO:0035994]; response to xenobiotic stimulus [GO:0009410]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; substance P catabolic process [GO:0010814]; sympathetic neuron axon guidance [GO:0097492]","GO:0001666; GO:0001921; GO:0004175; GO:0004222; GO:0005768; GO:0005769; GO:0005886; GO:0006915; GO:0007507; GO:0008217; GO:0008270; GO:0009410; GO:0009897; GO:0010467; GO:0010613; GO:0010814; GO:0010815; GO:0010816; GO:0016020; GO:0016485; GO:0016486; GO:0030141; GO:0031175; GO:0031410; GO:0031982; GO:0033093; GO:0034959; GO:0035050; GO:0035994; GO:0042447; GO:0042733; GO:0042802; GO:0042803; GO:0043583; GO:0043950; GO:0045745; GO:0046686; GO:0048471; GO:0060037; GO:0060385; GO:0070372; GO:0097492; GO:0097746; GO:1902287"
"4625","Cluster_1167","Peve_00027017",0.999999471445474,0.000654545796278981,0.239778920002343,152,-21.38,"2 21","3165 3185",20,"75.00%","75.00%","CDS","P29146","PC3-like endoprotease variant A (EC 3.4.21.-) (SPC3)","Hydra vulgaris (Hydra) (Hydra attenuata)","proteolysis [GO:0006508]","GO:0004252; GO:0006508"
"4632","Cluster_1167","Peve_00027087",0.999856934029782,0.0107688287544455,0.644120398105949,153,-21.5,"2 21","945 966",20,"75.00%","75.00%","CDS","P67963","Casein kinase I isoform alpha (CKI-alpha) (EC 2.7.11.1) (CK1)","Xenopus laevis (African clawed frog)","cell cycle [GO:0007049]; cell division [GO:0051301]; intermediate filament cytoskeleton organization [GO:0045104]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; protein phosphorylation [GO:0006468]; Wnt signaling pathway [GO:0016055]","GO:0000776; GO:0004674; GO:0005524; GO:0005737; GO:0005819; GO:0006468; GO:0007049; GO:0016055; GO:0016607; GO:0036064; GO:0045104; GO:0051301; GO:0106310; GO:1900226"
"4642","Cluster_1167","Peve_00027409",0.998789595503491,0.0313259464152717,0.903929377050813,155,-27.2,"2 21","103 121",19,"78.95%","78.95%","CDS",NA,NA,NA,NA,NA
"4657","Cluster_1167","Peve_00027965",0.999909726776791,0.00855416971793389,0.573710369894872,155,-26.06,"2 21","2690 2716",24,"66.67%","70.83%","CDS","Q96AY4","Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio)","Homo sapiens (Human)","cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0000922; GO:0005737; GO:0005815; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301"
"4664","Cluster_1167","Peve_00028079",0.999909726776791,0.00855416971794441,0.573710369894872,145,-20.42,"2 19","1550 1572",18,"66.67%","72.22%","CDS","Q9JME2","Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4S-1) (C4ST-1) (C4ST1)","Mus musculus (Mouse)","apoptotic process [GO:0006915]; carbohydrate biosynthetic process [GO:0016051]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate metabolic process [GO:0030204]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585]; transforming growth factor beta receptor signaling pathway [GO:0007179]","GO:0000139; GO:0001537; GO:0001701; GO:0002063; GO:0006915; GO:0007179; GO:0007585; GO:0008146; GO:0009791; GO:0016051; GO:0030166; GO:0030204; GO:0030206; GO:0030326; GO:0030512; GO:0033037; GO:0036342; GO:0042127; GO:0042733; GO:0043066; GO:0047756; GO:0048589; GO:0048703; GO:0048704; GO:0050659; GO:0051216"
"4671","Cluster_1167","Peve_00028300",0.999909726776791,0.00855416971793915,0.573710369894872,167,-29.83,"2 17","3185 3207",16,"87.50%","93.75%","CDS","B8V7Q1","Protocadherin-like protein","Acropora millepora (Staghorn coral) (Heteropora millepora)","homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]","GO:0005509; GO:0005886; GO:0007156"
"4673","Cluster_1167","Peve_00028337",-0.998451755265533,0.0354299855648368,0.909359886114279,156,-21.35,"2 21","22 43",19,"63.16%","78.95%","CDS",NA,NA,NA,NA,NA
"4677","Cluster_1167","Peve_00028477",0.999909726776791,0.00855416971793915,0.573710369894872,141,-23.25,"2 20","1158 1183",22,"63.64%","68.18%","CDS",NA,NA,NA,NA,NA
"4697","Cluster_1167","Peve_00028884",0.999909726776791,0.00855416971793915,0.573710369894872,155,-21.11,"2 21","6460 6482",20,"70.00%","75.00%","CDS","Q91287","Fibroblast growth factor receptor 3 (FGFR-3) (EC 2.7.10.1) (PFR3)","Pleurodeles waltl (Iberian ribbed newt)","apoptotic process [GO:0006915]; positive regulation of cell population proliferation [GO:0008284]","GO:0005007; GO:0005524; GO:0005886; GO:0006915; GO:0008284"
"4708","Cluster_1167","Peve_00029395",0.99850383281095,0.0348288670077051,0.909359886114279,149,-20.73,"2 14","8480 8501",12,"83.33%","83.33%","CDS","Q14541","Hepatocyte nuclear factor 4-gamma (HNF-4-gamma) (Nuclear receptor subfamily 2 group A member 2)","Homo sapiens (Human)","anatomical structure development [GO:0048856]; cell differentiation [GO:0030154]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0003700; GO:0004879; GO:0005654; GO:0005829; GO:0006357; GO:0008270; GO:0030154; GO:0045171; GO:0045944; GO:0048856; GO:0072686"
"4719","Cluster_1167","Peve_00029695",0.999614767519651,0.0176713818866947,0.782669382293497,140,-21.39,"2 9","3188 3209",7,"100.00%","100.00%","CDS","P97739","Endothelin-converting enzyme 1 (ECE-1) (EC 3.4.24.71)","Cavia porcellus (Guinea pig)","proteolysis [GO:0006508]","GO:0004222; GO:0005886; GO:0006508; GO:0046872"
"4723","Cluster_1167","Peve_00029859",0.99913900379337,0.0264196405908856,0.885091958128636,140,-21.2,"2 9","4011 4032",7,"100.00%","100.00%","CDS",NA,NA,NA,NA,NA
"4731","Cluster_1167","Peve_00030203",0.99985976849378,0.0106616149938441,0.641117160078398,142,-21.95,"2 11","12508 12529",9,"88.89%","88.89%","CDS","Q9NZJ4","Sacsin (DnaJ homolog subfamily C member 29) (DNAJC29)","Homo sapiens (Human)","negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457]","GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0030424; GO:0030425; GO:0030544; GO:0042802; GO:0051087; GO:0070628; GO:0070852; GO:0090084"
"4742","Cluster_1167","Peve_00030425",0.999405152548207,0.0219593486528571,0.830690932108223,143,-21.56,"2 20","10608 10631",21,"71.43%","71.43%","CDS","Q8IZN3","Palmitoyltransferase ZDHHC14 (EC 2.3.1.225) (DHHC domain-containing cysteine-rich protein 14) (DHHC-14) (NEW1 domain-containing protein) (NEW1CP) (Zinc finger DHHC domain-containing protein 14)","Homo sapiens (Human)","peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]","GO:0005783; GO:0005789; GO:0005794; GO:0006612; GO:0016409; GO:0018230; GO:0018345; GO:0019706; GO:0032580"
"4752","Cluster_1167","Peve_00030753",0.999964126437774,0.00539241950765597,0.551398425649056,140,-20.96,"2 9","1553 1574",7,"100.00%","100.00%","CDS",NA,NA,NA,NA,NA
"4754","Cluster_1167","Peve_00030801",0.999909726776791,0.00855416971793915,0.573710369894872,158,-27.26,"2 17","13675 13699",18,"83.33%","83.33%","CDS","Q12955","Ankyrin-3 (ANK-3) (Ankyrin-G)","Homo sapiens (Human)","axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; establishment of protein localization [GO:0045184]; Golgi to plasma membrane protein transport [GO:0043001]; magnesium ion homeostasis [GO:0010960]; maintenance of protein location in plasma membrane [GO:0072660]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; plasma membrane organization [GO:0007009]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transport [GO:0043266]; signal transduction [GO:0007165]","GO:0000281; GO:0005200; GO:0005764; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0007009; GO:0007165; GO:0007409; GO:0007528; GO:0008092; GO:0008093; GO:0009925; GO:0009986; GO:0010628; GO:0010650; GO:0010765; GO:0010960; GO:0014704; GO:0014731; GO:0016323; GO:0016328; GO:0016529; GO:0019228; GO:0030018; GO:0030315; GO:0030425; GO:0030507; GO:0030674; GO:0031594; GO:0033268; GO:0034112; GO:0042383; GO:0043001; GO:0043005; GO:0043034; GO:0043194; GO:0043266; GO:0044325; GO:0045184; GO:0045211; GO:0045296; GO:0045838; GO:0071286; GO:0071709; GO:0072659; GO:0072660; GO:0090314; GO:0099612; GO:1900827; GO:1902260; GO:2000651; GO:2001259"
"4761","Cluster_1167","Peve_00031172",0.999909726776791,0.00855416971793915,0.573710369894872,160,-20.83,"2 21","15880 15901",19,"68.42%","78.95%","CDS","Q9UMZ3","Phosphatidylinositol phosphatase PTPRQ (EC 3.1.3.-) (Receptor-type tyrosine-protein phosphatase Q) (PTP-RQ) (R-PTP-Q) (EC 3.1.3.48)","Homo sapiens (Human)","peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; regulation of fat cell differentiation [GO:0045598]","GO:0004725; GO:0016020; GO:0043235; GO:0045598; GO:1990264"
"4762","Cluster_1167","Peve_00031172",0.999909726776791,0.00855416971793915,0.573710369894872,164,-24.22,"2 21","10289 10310",19,"73.68%","78.95%","CDS","Q9UMZ3","Phosphatidylinositol phosphatase PTPRQ (EC 3.1.3.-) (Receptor-type tyrosine-protein phosphatase Q) (PTP-RQ) (R-PTP-Q) (EC 3.1.3.48)","Homo sapiens (Human)","peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; regulation of fat cell differentiation [GO:0045598]","GO:0004725; GO:0016020; GO:0043235; GO:0045598; GO:1990264"
"4765","Cluster_1167","Peve_00031233",0.999909726776791,0.00855416971793915,0.573710369894872,146,-23.49,"2 21","8891 8914",21,"66.67%","71.43%","CDS",NA,NA,NA,NA,NA
"4768","Cluster_1167","Peve_00031346",0.999285062109625,0.0240743824704661,0.856569794819485,148,-20.36,"2 21","5047 5068",21,"71.43%","71.43%","CDS","Q5ZJQ8","Ubiquitin-associated domain-containing protein 2 (UBA domain-containing protein 2) (Phosphoglycerate dehydrogenase-like protein 1)","Gallus gallus (Chicken)","negative regulation of canonical Wnt signaling pathway [GO:0090090]; Wnt signaling pathway [GO:0016055]","GO:0005789; GO:0016055; GO:0090090"
"4775","Cluster_1167","Peve_00031679",0.999909726776791,0.00855416971793389,0.573710369894872,141,-23.52,"2 20","8133 8160",24,"62.50%","66.67%","CDS",NA,NA,NA,NA,NA
"4787","Cluster_1167","Peve_00032175",0.999909726776791,0.00855416971793915,0.573710369894872,142,-24.4,"2 20","1133 1155",19,"63.16%","68.42%","CDS","P0C5E4","Phosphatidylinositol phosphatase PTPRQ (EC 3.1.3.-) (Receptor-type tyrosine-protein phosphatase Q) (PTP-RQ) (R-PTP-Q) (EC 3.1.3.48)","Mus musculus (Mouse)","detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; inner ear morphogenesis [GO:0042472]; neuromuscular process controlling balance [GO:0050885]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; regulation of fat cell differentiation [GO:0045598]; vestibular receptor cell morphogenesis [GO:0060116]","GO:0002244; GO:0004725; GO:0016020; GO:0032421; GO:0042472; GO:0043235; GO:0045598; GO:0050885; GO:0050910; GO:0060116; GO:1990264"
"4789","Cluster_1167","Peve_00032218",0.999909726776791,0.00855416971793389,0.573710369894872,155,-28.79,"2 21","622 648",24,"66.67%","70.83%","CDS",NA,NA,NA,NA,NA
"4795","Cluster_1167","Peve_00032379",0.999829145067882,0.0117683361362963,0.669104173589419,146,-20.32,"2 17","1406 1426",15,"73.33%","80.00%","CDS",NA,NA,NA,NA,NA
"4806","Cluster_1167","Peve_00032614",0.999989663831242,0.00289451157471858,0.458622503733527,145,-25.3,"2 15","17228 17250",14,"78.57%","78.57%","CDS",NA,NA,NA,NA,NA
"4813","Cluster_1167","Peve_00032739",0.999970447939082,0.00489429426099903,0.551398425649056,146,-24.29,"2 20","2375 2398",20,"65.00%","70.00%","CDS",NA,NA,NA,NA,NA
"4839","Cluster_1167","Peve_00033656",0.999008853972955,0.0283465246073945,0.903124690393816,146,-22.05,"2 12","3616 3638",11,"90.91%","90.91%","CDS","Q9ERG2","Striatin-3 (Cell cycle autoantigen SG2NA) (S/G2 antigen)","Mus musculus (Mouse)","negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to estradiol [GO:0032355]","GO:0000122; GO:0005516; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005886; GO:0030425; GO:0031267; GO:0032355; GO:0032991; GO:0033147; GO:0043025; GO:0044877; GO:0045892; GO:0045944; GO:0051721; GO:0070016; GO:0090443"
"4843","Cluster_1167","Peve_00033720",0.999143976900459,0.0263432193593904,0.884162272141201,147,-21.21,"2 21","12639 12657",19,"73.68%","73.68%","CDS",NA,NA,NA,NA,NA
"4844","Cluster_1167","Peve_00033720",0.999143976900459,0.0263432193593904,0.884162272141201,153,-22.27,"2 18","15592 15613",16,"75.00%","75.00%","CDS",NA,NA,NA,NA,NA
"4846","Cluster_1167","Peve_00033774",0.999909726776791,0.00855416971793389,0.573710369894872,140,-23,"2 9","817 838",7,"100.00%","100.00%","CDS","P05099","Cartilage matrix protein (Matrilin-1)","Gallus gallus (Chicken)","extracellular matrix organization [GO:0030198]","GO:0005509; GO:0005576; GO:0030198"
"4847","Cluster_1167","Peve_00033616",-0.999269695346556,0.0243317636324826,0.85991842743963,149,-22.74,"2 21","2645 2664",19,"68.42%","73.68%","CDS","Q7KZ85","Transcription elongation factor SPT6 (hSPT6) (Histone chaperone suppressor of Ty6) (Tat-cotransactivator 2 protein) (Tat-CT2 protein)","Homo sapiens (Human)","blastocyst formation [GO:0001825]; mRNA processing [GO:0006397]; mRNA transcription by RNA polymerase II [GO:0042789]; mRNA transport [GO:0051028]; nucleosome organization [GO:0034728]; positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; regulation of isotype switching [GO:0045191]; regulation of mRNA export from nucleus [GO:0010793]; regulation of mRNA processing [GO:0050684]; regulation of muscle cell differentiation [GO:0051147]; RNA splicing [GO:0008380]; transcription elongation by RNA polymerase II promoter [GO:0006368]; transcription elongation-coupled chromatin remodeling [GO:0140673]","GO:0001825; GO:0003677; GO:0003723; GO:0005654; GO:0006368; GO:0006397; GO:0008023; GO:0008380; GO:0010793; GO:0031491; GO:0032968; GO:0034728; GO:0042393; GO:0042789; GO:0045191; GO:0050684; GO:0051028; GO:0051147; GO:0140673"
"4853","Cluster_1167","Peve_00033968",0.999657786824062,0.0166554307882447,0.775337211553618,147,-21.44,"2 19","3557 3576",17,"70.59%","76.47%","CDS","Q0P678","Zinc finger CCCH domain-containing protein 18 (Nuclear protein NHN1)","Mus musculus (Mouse)","RNA destabilization [GO:0050779]","GO:0016607; GO:0030674; GO:0032991; GO:0046872; GO:0050779; GO:0140262; GO:1990904"
"4866","Cluster_1167","Peve_00034282",0.998864167162046,0.0303454405378906,0.903929377050813,146,-22.07,"2 11","5 26",9,"88.89%","100.00%","CDS",NA,NA,NA,NA,NA
"4867","Cluster_1167","Peve_00034282",0.998864167162046,0.0303454405378906,0.903929377050813,153,-22.32,"2 14","1201 1222",12,"83.33%","91.67%","CDS",NA,NA,NA,NA,NA
"4872","Cluster_1167","Peve_00034349",0.999909726776791,0.00855416971793389,0.573710369894872,148,-20.4,"2 13","27 48",11,"81.82%","90.91%","CDS","Q9CR50","RING finger and CHY zinc finger domain-containing protein 1 (EC 2.3.2.27) (Androgen receptor N-terminal-interacting protein) (CH-rich-interacting match with PLAG1) (E3 ubiquitin-protein ligase Pirh2) (RING-type E3 ubiquitin transferase RCHY1) (Zinc finger protein 363)","Mus musculus (Mouse)","positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0000151; GO:0002039; GO:0005102; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006511; GO:0008270; GO:0016567; GO:0016607; GO:0031398; GO:0032436; GO:0042803; GO:0043231; GO:0051865; GO:0061630"
"4885","Cluster_1167","Peve_00034622",0.997048940457244,0.0489205090104163,0.949250660792813,149,-22.1,"2 15","2769 2791",14,"78.57%","85.71%","CDS","O00339","Matrilin-2","Homo sapiens (Human)","extracellular matrix organization [GO:0030198]","GO:0005201; GO:0005509; GO:0005576; GO:0030198; GO:0031012; GO:0062023; GO:0120216"
"4923","Cluster_1167","Peve_00035933",0.998897096463031,0.0299022459316688,0.903929377050813,151,-20.1,"2 21","1432 1455",21,"61.90%","76.19%","CDS",NA,NA,NA,NA,NA
"4937","Cluster_1167","Peve_00036241",0.999909726776791,0.00855416971793915,0.573710369894872,150,-21,"2 21","17697 17723",24,"62.50%","75.00%","CDS","A0A0R4IBK5","E3 ubiquitin-protein ligase rnf213-alpha (EC 2.3.2.27) (EC 3.6.4.-) (E3 ubiquitin-lipopolysaccharide ligase rnf213-alpha) (EC 2.3.2.-) (Mysterin-A) (Mysterin-alpha) (RING finger protein 213-A) (RING finger protein 213-alpha)","Danio rerio (Zebrafish) (Brachydanio rerio)","blood circulation [GO:0008015]; defense response to bacterium [GO:0042742]; immune system process [GO:0002376]; lipid droplet formation [GO:0140042]; lipid ubiquitination [GO:0120323]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; protein K63-linked ubiquitination [GO:0070534]; regulation of lipid metabolic process [GO:0019216]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]; xenophagy [GO:0098792]","GO:0002040; GO:0002376; GO:0004842; GO:0005524; GO:0005730; GO:0005811; GO:0005829; GO:0006511; GO:0008015; GO:0016887; GO:0019216; GO:0042742; GO:0046872; GO:0061630; GO:0070534; GO:0098792; GO:0120323; GO:0140042; GO:2000051"
"4947","Cluster_1167","Peve_00036304",0.998004045644015,0.0402293194706296,0.909359886114279,145,-22.64,"2 10","34659 34680",8,"100.00%","100.00%","CDS","Q5PQN1","Probable E3 ubiquitin-protein ligase HERC4 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 4) (HECT-type E3 ubiquitin transferase HERC4)","Rattus norvegicus (Rat)","cell differentiation [GO:0030154]; negative regulation of smoothened signaling pathway [GO:0045879]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0001650; GO:0005737; GO:0005829; GO:0006511; GO:0007283; GO:0016567; GO:0030154; GO:0045879; GO:0061630"
"4948","Cluster_1167","Peve_00036304",0.998004045644015,0.0402293194706296,0.909359886114279,160,-21.03,"2 17","3987 4008",15,"80.00%","86.67%","CDS","Q5PQN1","Probable E3 ubiquitin-protein ligase HERC4 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 4) (HECT-type E3 ubiquitin transferase HERC4)","Rattus norvegicus (Rat)","cell differentiation [GO:0030154]; negative regulation of smoothened signaling pathway [GO:0045879]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0001650; GO:0005737; GO:0005829; GO:0006511; GO:0007283; GO:0016567; GO:0030154; GO:0045879; GO:0061630"
"4955","Cluster_1167","Peve_00036499",0.999960220513847,0.00567840213011246,0.560635076887081,147,-22.07,"2 12","13365 13386",10,"90.00%","90.00%","CDS","O00571","ATP-dependent RNA helicase DDX3X (EC 3.6.4.13) (CAP-Rf) (DEAD box protein 3, X-chromosomal) (DEAD box, X isoform) (DBX) (Helicase-like protein 2) (HLP2)","Homo sapiens (Human)","cell differentiation [GO:0030154]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to osmotic stress [GO:0071470]; cellular response to virus [GO:0098586]; chromosome segregation [GO:0007059]; cytosolic ribosome assembly [GO:0042256]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; gamete generation [GO:0007276]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway [GO:0097193]; lipid homeostasis [GO:0055088]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of translation [GO:0017148]; positive regulation of apoptotic process [GO:0043065]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell growth [GO:0030307]; positive regulation of chemokine (C-C motif) ligand 5 production [GO:0071651]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of protein acetylation [GO:1901985]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of protein K63-linked ubiquitination [GO:1902523]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of toll-like receptor 7 signaling pathway [GO:0034157]; positive regulation of toll-like receptor 8 signaling pathway [GO:0034161]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation [GO:0045727]; positive regulation of translation in response to endoplasmic reticulum stress [GO:0036493]; positive regulation of translational initiation [GO:0045948]; positive regulation of viral genome replication [GO:0045070]; primary miRNA processing [GO:0031053]; protein localization to cytoplasmic stress granule [GO:1903608]; response to virus [GO:0009615]; RNA secondary structure unwinding [GO:0010501]; stress granule assembly [GO:0034063]; translational initiation [GO:0006413]; Wnt signaling pathway [GO:0016055]","GO:0003677; GO:0003678; GO:0003723; GO:0003724; GO:0003729; GO:0003924; GO:0005524; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0006413; GO:0007059; GO:0007276; GO:0008134; GO:0008143; GO:0008190; GO:0008625; GO:0009615; GO:0010494; GO:0010501; GO:0010628; GO:0016055; GO:0016887; GO:0017111; GO:0017148; GO:0030027; GO:0030154; GO:0030307; GO:0030308; GO:0031053; GO:0031252; GO:0031333; GO:0031369; GO:0031954; GO:0032727; GO:0032728; GO:0033592; GO:0034063; GO:0034157; GO:0034161; GO:0034774; GO:0035556; GO:0035613; GO:0036493; GO:0042256; GO:0043015; GO:0043024; GO:0043065; GO:0043066; GO:0043154; GO:0043186; GO:0043273; GO:0043280; GO:0043539; GO:0045070; GO:0045087; GO:0045296; GO:0045727; GO:0045944; GO:0045948; GO:0048027; GO:0055088; GO:0070062; GO:0070878; GO:0071243; GO:0071470; GO:0071651; GO:0071902; GO:0072559; GO:0090263; GO:0097193; GO:0098586; GO:1900087; GO:1900227; GO:1901223; GO:1901224; GO:1901985; GO:1902042; GO:1902523; GO:1903608; GO:1904813; GO:2001243"
"4956","Cluster_1167","Peve_00036508",0.999909726776791,0.00855416971793915,0.573710369894872,155,-21.68,"2 17","6066 6088",16,"81.25%","81.25%","CDS","Q8VI56","Low-density lipoprotein receptor-related protein 4 (LRP-4) (LDLR dan)","Mus musculus (Mouse)","amyloid-beta clearance by cellular catabolic process [GO:0150094]; anatomical structure development [GO:0048856]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; endocytosis [GO:0006897]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; protein localization [GO:0008104]; proximal/distal pattern formation [GO:0009954]; receptor clustering [GO:0043113]; regulation of protein phosphorylation [GO:0001932]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055]","GO:0001822; GO:0001932; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0008104; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0016055; GO:0030279; GO:0030326; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0043113; GO:0044853; GO:0048699; GO:0048813; GO:0048856; GO:0050731; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150094; GO:1901631; GO:1904395"
"4957","Cluster_1167","Peve_00036508",0.999909726776791,0.00855416971793915,0.573710369894872,164,-25.05,"2 21","23785 23806",19,"68.42%","84.21%","CDS","Q8VI56","Low-density lipoprotein receptor-related protein 4 (LRP-4) (LDLR dan)","Mus musculus (Mouse)","amyloid-beta clearance by cellular catabolic process [GO:0150094]; anatomical structure development [GO:0048856]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; endocytosis [GO:0006897]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; protein localization [GO:0008104]; proximal/distal pattern formation [GO:0009954]; receptor clustering [GO:0043113]; regulation of protein phosphorylation [GO:0001932]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055]","GO:0001822; GO:0001932; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0008104; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0016055; GO:0030279; GO:0030326; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0043113; GO:0044853; GO:0048699; GO:0048813; GO:0048856; GO:0050731; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150094; GO:1901631; GO:1904395"
"4967","Cluster_1167","Peve_00036717",0.998121717950127,0.0390250551586088,0.909359886114279,159,-22.63,"2 21","9865 9887",20,"65.00%","85.00%","CDS","Q9NU19","TBC1 domain family member 22B","Homo sapiens (Human)","activation of GTPase activity [GO:0090630]","GO:0005096; GO:0071889; GO:0090630"
"4970","Cluster_1167","Peve_00036708",0.999952936172769,0.00617647154077515,0.573710369894872,152,-26.99,"2 14","193 215",13,"84.62%","92.31%","CDS","O60290","Zinc finger protein 862","Homo sapiens (Human)","regulation of DNA-templated transcription [GO:0006355]","GO:0005634; GO:0006355; GO:0046872; GO:0046983"
"4978","Cluster_1167","Peve_00037063",0.999909726776791,0.00855416971793389,0.573710369894872,164,-24.03,"2 21","918 939",19,"68.42%","84.21%","CDS","Q96AY4","Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio)","Homo sapiens (Human)","cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0000922; GO:0005737; GO:0005815; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301"
"4980","Cluster_1167","Peve_00037070",0.999984983127836,0.00348887497095565,0.515443117995556,145,-22.68,"2 15","841 863",14,"78.57%","78.57%","CDS","Q9I9H8","Apoptotic protease-activating factor 1 (APAF-1)","Danio rerio (Zebrafish) (Brachydanio rerio)","anatomical structure development [GO:0048856]; apoptotic signaling pathway [GO:0097190]; regulation of apoptotic process [GO:0042981]","GO:0005524; GO:0042981; GO:0043293; GO:0043531; GO:0048856; GO:0097190"
"4983","Cluster_1167","Peve_00037343",0.999909726776791,0.00855416971793915,0.573710369894872,141,-20.76,"2 12","4528 4548",10,"90.00%","90.00%","CDS",NA,NA,NA,NA,NA
"5009","Cluster_1167","Peve_00038067",0.999909726776791,0.00855416971793915,0.573710369894872,147,-23.48,"2 14","248 268",12,"83.33%","91.67%","CDS",NA,NA,NA,NA,NA
"5010","Cluster_1167","Peve_00038130",0.999956604133176,0.00593090373786624,0.572821453072688,145,-21.94,"2 10","3214 3235",8,"100.00%","100.00%","CDS","A2RT67","DENN domain-containing protein 3","Mus musculus (Mouse)","endosome to lysosome transport [GO:0008333]; protein catabolic process [GO:0030163]; regulation of Rab protein signal transduction [GO:0032483]","GO:0005085; GO:0008333; GO:0030163; GO:0031410; GO:0032483"
"5013","Cluster_1167","Peve_00038230",0.999909726776791,0.00855416971793389,0.573710369894872,150,-21.33,"2 21","13038 13058",19,"63.16%","78.95%","CDS","A6QLU6","Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133)","Bos taurus (Bovine)","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]","GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189"
"5020","Cluster_1167","Peve_00038393",0.997587196470693,0.0442327011798084,0.92530164628749,141,-21.29,"2 14","30 51",12,"75.00%","75.00%","CDS","O60293","Zinc finger C3H1 domain-containing protein (Coiled-coil domain-containing protein 131) (Proline/serine-rich coiled-coil protein 2)","Homo sapiens (Human)","RNA processing [GO:0006396]","GO:0000178; GO:0005615; GO:0005634; GO:0006396; GO:0046872"
"5025","Cluster_1167","Peve_00038539",0.999588655116799,0.0182605165534585,0.782669382293497,151,-22.76,"2 12","54 75",10,"90.00%","100.00%","CDS","Q8BX90","Fibronectin type-III domain-containing protein 3A","Mus musculus (Mouse)","cell-cell adhesion [GO:0098609]; fertilization [GO:0009566]; Sertoli cell development [GO:0060009]; spermatid development [GO:0007286]","GO:0000139; GO:0001669; GO:0005737; GO:0005794; GO:0005829; GO:0007286; GO:0009566; GO:0012506; GO:0016020; GO:0031410; GO:0043231; GO:0060009; GO:0098609"
"5038","Cluster_1167","Peve_00038834",0.997317155093029,0.0466433836153534,0.93897035826855,160,-24.21,"2 21","218 237",19,"78.95%","84.21%","CDS","B3EWZ6","MAM and LDL-receptor class A domain-containing protein 2 (Skeletal organic matrix MAM and LDL-receptor 2) (SOM MAM and LDL-receptor 2)","Acropora millepora (Staghorn coral) (Heteropora millepora)","","GO:0005576; GO:0016020"
"5059","Cluster_1167","Peve_00039250",0.99997853118278,0.00417157404869491,0.54328949385489,155,-21.41,"2 20","24627 24649",20,"80.00%","80.00%","CDS","Q38SD2","Leucine-rich repeat serine/threonine-protein kinase 1 (EC 2.7.11.1)","Homo sapiens (Human)","bone resorption [GO:0045453]; intracellular signal transduction [GO:0035556]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732]; osteoclast development [GO:0036035]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; signal transduction [GO:0007165]","GO:0004674; GO:0004722; GO:0005524; GO:0005525; GO:0005737; GO:0005739; GO:0005829; GO:0007165; GO:0018108; GO:0035556; GO:0036035; GO:0042802; GO:0043231; GO:0045453; GO:0046872; GO:0050731; GO:0050732; GO:0090263; GO:0106310; GO:1902533"
"5060","Cluster_1167","Peve_00036985",0.997756794620378,0.0426491968770769,0.914386765051354,144,-20.8,"2 16","1040 1059",14,"78.57%","78.57%","CDS",NA,NA,NA,NA,NA
"5075","Cluster_1167","Peve_00039811",0.997173310350041,0.0478780594352554,0.945312205299076,152,-23.71,"2 21","33046 33065",19,"73.68%","78.95%","CDS","Q4TU93","C-type mannose receptor 2 (Endocytic receptor 180) (Macrophage mannose receptor 2) (CD antigen CD280)","Rattus norvegicus (Rat)","collagen catabolic process [GO:0030574]; endocytosis [GO:0006897]","GO:0005518; GO:0005886; GO:0006897; GO:0030246; GO:0030574; GO:0038023"
"5086","Cluster_1167","Peve_00040359",0.999909726776791,0.00855416971793915,0.573710369894872,163,-23.61,"2 16","5494 5515",14,"85.71%","92.86%","CDS",NA,NA,NA,NA,NA
"5094","Cluster_1167","Peve_00040588",0.999909726776791,0.00855416971793915,0.573710369894872,145,-20.61,"2 10","8978 8999",8,"100.00%","100.00%","CDS","Q9DGB6","Toll-like receptor 2 type-2","Gallus gallus (Chicken)","detection of bacterial lipoprotein [GO:0042494]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; toll-like receptor signaling pathway [GO:0002224]","GO:0002224; GO:0004888; GO:0005886; GO:0006954; GO:0038023; GO:0042494; GO:0042497; GO:0045087; GO:0050135; GO:0061809"
"5097","Cluster_1167","Peve_00039535",0.998015074605896,0.0401179818688438,0.909359886114279,147,-20.62,"2 21","112189 112214",23,"65.22%","65.22%","CDS","P46023","G-protein coupled receptor GRL101","Lymnaea stagnalis (Great pond snail) (Helix stagnalis)","","GO:0004930; GO:0005886"
"5106","Cluster_1167","Peve_00040932",0.999909726776791,0.00855416971793389,0.573710369894872,151,-27.59,"2 14","7799 7819",12,"91.67%","91.67%","CDS",NA,NA,NA,NA,NA
"5107","Cluster_1167","Peve_00040948",0.999909726776791,0.00855416971793915,0.573710369894872,152,-20.23,"2 21","2076 2097",19,"63.16%","73.68%","CDS",NA,NA,NA,NA,NA
"5126","Cluster_1167","Peve_00041569",0.999301819989969,0.0237905288947379,0.853813685085773,154,-21.37,"2 21","3121 3141",19,"73.68%","73.68%","CDS",NA,NA,NA,NA,NA
"5127","Cluster_1167","Peve_00041482",0.999815936547399,0.0122147776163142,0.681122687635093,145,-21.61,"2 10","906 927",8,"100.00%","100.00%","CDS","Q9Z1K5","E3 ubiquitin-protein ligase ARIH1 (EC 2.3.2.31) (Protein ariadne-1 homolog) (ARI-1) (RING-type E3 ubiquitin transferase ARIH1) (UbcH7-binding protein) (UbcM4-interacting protein 77) (Ubiquitin-conjugating enzyme E2-binding protein 1)","Mus musculus (Mouse)","positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0000151; GO:0000209; GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0006511; GO:0008270; GO:0015030; GO:0016567; GO:0016604; GO:0019005; GO:0031462; GO:0031463; GO:0031464; GO:0031624; GO:0031625; GO:0032436; GO:0061630; GO:0097413"
"5154","Cluster_1167","Peve_00042755",0.999992038326394,0.00254037361647819,0.422009192811724,147,-20.54,"2 12","17174 17195",10,"90.00%","90.00%","CDS",NA,NA,NA,NA,NA
"5185","Cluster_1167","Peve_00043299",0.99767924235131,0.0433804490039369,0.91918014323027,154,-20.53,"2 21","14087 14107",19,"68.42%","78.95%","CDS","O75152","Zinc finger CCCH domain-containing protein 11A","Homo sapiens (Human)","poly(A)+ mRNA export from nucleus [GO:0016973]","GO:0003723; GO:0003729; GO:0005654; GO:0016973; GO:0046872"
"5186","Cluster_1167","Peve_00043299",0.99767924235131,0.0433804490039369,0.91918014323027,158,-24.71,"2 21","14114 14134",19,"63.16%","89.47%","CDS","O75152","Zinc finger CCCH domain-containing protein 11A","Homo sapiens (Human)","poly(A)+ mRNA export from nucleus [GO:0016973]","GO:0003723; GO:0003729; GO:0005654; GO:0016973; GO:0046872"
"5193","Cluster_1167","Peve_00043814",0.999909726776791,0.00855416971793915,0.573710369894872,151,-21.47,"2 21","8761 8784",21,"66.67%","71.43%","CDS",NA,NA,NA,NA,NA
"5194","Cluster_1167","Peve_00043809",0.999909726776791,0.00855416971793389,0.573710369894872,151,-21.47,"2 21","3528 3551",21,"66.67%","71.43%","CDS",NA,NA,NA,NA,NA
"5196","Cluster_1167","Peve_00043856",0.99891562964676,0.0296498971347644,0.903929377050813,153,-25.99,"2 21","810 833",22,"68.18%","77.27%","CDS",NA,NA,NA,NA,NA
"5201","Cluster_1167","Peve_00044041",0.999909726776791,0.00855416971793915,0.573710369894872,157,-22.8,"2 19","1086 1108",18,"72.22%","83.33%","CDS","Q19269","Zinc metalloproteinase nas-14 (EC 3.4.24.-) (Nematode astacin 14)","Caenorhabditis elegans","proteolysis [GO:0006508]","GO:0004222; GO:0005576; GO:0006508; GO:0008270"
"5230","Cluster_1167","Peve_00044798",0.999909726776791,0.00855416971793389,0.573710369894872,153,-20.1,"2 21","11807 11826",19,"68.42%","78.95%","CDS",NA,NA,NA,NA,NA
"5234","Cluster_1167","Peve_00044833",0.998564982655492,0.034109522881364,0.909359886114279,142,-23.91,"2 11","20373 20394",9,"88.89%","88.89%","CDS","Q9QXV3","Inhibitor of growth protein 1","Mus musculus (Mouse)","cell cycle [GO:0007049]; negative regulation of cell migration [GO:0030336]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of stem cell population maintenance [GO:1902459]; protein import into nucleus [GO:0006606]; regulation of cell death [GO:0010941]; regulation of DNA-templated transcription [GO:0006355]","GO:0000122; GO:0005634; GO:0006355; GO:0006606; GO:0007049; GO:0010941; GO:0016580; GO:0030336; GO:0030512; GO:0035064; GO:0045893; GO:0046872; GO:1902455; GO:1902459"
"5243","Cluster_1167","Peve_00044993",0.999909726776791,0.00855416971793915,0.573710369894872,146,-24.46,"2 20","1385 1407",19,"68.42%","68.42%","CDS","Q5XXP2","Melanopsin (Opsin-4)","Phodopus sungorus (Striped hairy-footed hamster) (Djungarian hamster)","hyaloid vascular plexus regression [GO:1990384]; optokinetic behavior [GO:0007634]; phototransduction [GO:0007602]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; visual perception [GO:0007601]","GO:0005502; GO:0005886; GO:0007601; GO:0007602; GO:0007634; GO:0008020; GO:0016020; GO:0030424; GO:0030425; GO:0042752; GO:0043204; GO:0048511; GO:1990384"
"5246","Cluster_1167","Peve_00045011",0.999909726776791,0.00855416971793389,0.573710369894872,147,-22.81,"2 21","75 97",20,"65.00%","70.00%","CDS",NA,NA,NA,NA,NA
"5249","Cluster_1167","Peve_00045068",0.996947347218333,0.0497558748086694,0.952281411175107,152,-23.21,"2 13","58494 58515",11,"90.91%","90.91%","CDS","Q96RW7","Hemicentin-1 (Fibulin-6) (FIBL-6)","Homo sapiens (Human)","actin filament reorganization [GO:0090527]; basement membrane organization [GO:0071711]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601]","GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005912; GO:0005927; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0032154; GO:0051301; GO:0062023; GO:0070062; GO:0071711; GO:0090527"
"5252","Cluster_1167","Peve_00043653",0.999909726776791,0.00855416971793389,0.573710369894872,152,-23.21,"2 13","35454 35475",11,"90.91%","90.91%","CDS","D2IYS2","Tyrosine-protein kinase receptor torso (EC 2.7.10.1)","Bombyx mori (Silk moth)","","GO:0004714; GO:0005524; GO:0005886; GO:0046872"
"5254","Cluster_1167","Peve_00045262",0.999140395172539,0.0263982816855058,0.884795287459298,156,-22.04,"2 18","12923 12945",17,"76.47%","82.35%","CDS","O60841","Eukaryotic translation initiation factor 5B (eIF-5B) (EC 3.6.5.3) (Translation initiation factor IF-2)","Homo sapiens (Human)","regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]","GO:0003723; GO:0003743; GO:0003924; GO:0005525; GO:0005737; GO:0005739; GO:0005829; GO:0006413; GO:0006446; GO:0045202; GO:0046872"
"5256","Cluster_1167","Peve_00045265",0.998095362879249,0.03929797736504,0.909359886114279,160,-23.56,"2 18","2666 2688",17,"82.35%","82.35%","CDS","O08759","Ubiquitin-protein ligase E3A (EC 2.3.2.26) (HECT-type ubiquitin transferase E3A) (Oncogenic protein-associated protein E6-AP)","Mus musculus (Mouse)","androgen receptor signaling pathway [GO:0030521]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; locomotory exploration behavior [GO:0035641]; modulation of chemical synaptic transmission [GO:0050804]; motor learning [GO:0061743]; negative regulation of dendritic spine morphogenesis [GO:0061002]; ovarian follicle development [GO:0001541]; positive regulation of Golgi lumen acidification [GO:1905528]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progesterone receptor signaling pathway [GO:0050847]; prostate gland growth [GO:0060736]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; regulation of ubiquitin-dependent protein catabolic process [GO:2000058]; response to cocaine [GO:0042220]; response to hydrogen peroxide [GO:0042542]; response to progesterone [GO:0032570]; rhythmic process [GO:0048511]; sperm entry [GO:0035037]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0000209; GO:0000502; GO:0001541; GO:0003713; GO:0004842; GO:0005634; GO:0005829; GO:0006511; GO:0014068; GO:0016567; GO:0030521; GO:0031398; GO:0032570; GO:0035037; GO:0035641; GO:0042220; GO:0042542; GO:0042752; GO:0045944; GO:0046872; GO:0048511; GO:0050804; GO:0050847; GO:0051865; GO:0060736; GO:0061002; GO:0061630; GO:0061743; GO:0070936; GO:0098978; GO:1905528; GO:1990416; GO:2000058"
"5257","Cluster_1167","Peve_00045265",0.998095362879249,0.03929797736504,0.909359886114279,160,-23.56,"2 18","3513 3535",17,"82.35%","82.35%","CDS","O08759","Ubiquitin-protein ligase E3A (EC 2.3.2.26) (HECT-type ubiquitin transferase E3A) (Oncogenic protein-associated protein E6-AP)","Mus musculus (Mouse)","androgen receptor signaling pathway [GO:0030521]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; locomotory exploration behavior [GO:0035641]; modulation of chemical synaptic transmission [GO:0050804]; motor learning [GO:0061743]; negative regulation of dendritic spine morphogenesis [GO:0061002]; ovarian follicle development [GO:0001541]; positive regulation of Golgi lumen acidification [GO:1905528]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progesterone receptor signaling pathway [GO:0050847]; prostate gland growth [GO:0060736]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; regulation of ubiquitin-dependent protein catabolic process [GO:2000058]; response to cocaine [GO:0042220]; response to hydrogen peroxide [GO:0042542]; response to progesterone [GO:0032570]; rhythmic process [GO:0048511]; sperm entry [GO:0035037]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0000209; GO:0000502; GO:0001541; GO:0003713; GO:0004842; GO:0005634; GO:0005829; GO:0006511; GO:0014068; GO:0016567; GO:0030521; GO:0031398; GO:0032570; GO:0035037; GO:0035641; GO:0042220; GO:0042542; GO:0042752; GO:0045944; GO:0046872; GO:0048511; GO:0050804; GO:0050847; GO:0051865; GO:0060736; GO:0061002; GO:0061630; GO:0061743; GO:0070936; GO:0098978; GO:1905528; GO:1990416; GO:2000058"
"5281","Cluster_2787","Peve_00000573",0.997993695501655,0.0403335252007132,0.909359886114279,158,-20.72,"2 20","1030 1053",20,"70.00%","80.00%","CDS","P05423","DNA-directed RNA polymerase III subunit RPC4 (RNA polymerase III subunit C4) (DNA-directed RNA polymerase III subunit D) (Protein BN51) (RNA polymerase III 47 kDa subunit) (RPC53 homolog)","Homo sapiens (Human)","defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]; transcription by RNA polymerase III [GO:0006383]","GO:0003677; GO:0003682; GO:0005654; GO:0005666; GO:0005829; GO:0006383; GO:0032728; GO:0045087; GO:0045089; GO:0051607"
"5295","Cluster_2787","Peve_00000718",0.99999406092141,0.00219409219147524,0.380586526074297,163,-24.91,"2 16","31183 31204",14,"78.57%","100.00%","CDS","Q8IWZ3","Ankyrin repeat and KH domain-containing protein 1 (HIV-1 Vpr-binding ankyrin repeat protein) (Multiple ankyrin repeats single KH domain) (hMASK)","Homo sapiens (Human)","innate immune response [GO:0045087]","GO:0003723; GO:0005737; GO:0045087"
"5299","Cluster_2787","Peve_00000701",0.999443593359727,0.0212378921988233,0.822386609072632,156,-21.16,"2 17","5057 5078",15,"73.33%","86.67%","CDS","Q58CQ9","Pantetheinase (EC 3.5.1.92) (Pantetheine hydrolase) (Vascular non-inflammatory molecule 1) (Vanin-1)","Bos taurus (Bovine)","pantothenate metabolic process [GO:0015939]","GO:0005886; GO:0015939; GO:0017159"
"5322","Cluster_2787","Peve_00001089",-0.997451283642094,0.0454619602813742,0.933015587291977,159,-21.83,"2 21","12485 12508",21,"66.67%","80.95%","CDS","A6QPF8","Transmembrane protein 120B","Bos taurus (Bovine)","fat cell differentiation [GO:0045444]; protein heterooligomerization [GO:0051291]","GO:0005637; GO:0016020; GO:0045444; GO:0051291"
"5345","Cluster_2787","Peve_00001408",0.99783352309857,0.0419131779151554,0.909938612156291,151,-24.17,"2 21","879 901",20,"65.00%","75.00%","CDS",NA,NA,NA,NA,NA
"5358","Cluster_2787","Peve_00001522",0.999999453445442,0.000665597835339763,0.239778920002343,178,-27.06,"2 21","235 255",19,"89.47%","89.47%","CDS","Q92035","Acetylcholinesterase (BfAChE) (EC 3.1.1.7)","Bungarus fasciatus (Banded krait) (Pseudoboa fasciata)","acetylcholine catabolic process in synaptic cleft [GO:0001507]","GO:0001507; GO:0003990; GO:0005886; GO:0043083; GO:0045202; GO:0090729"
"5364","Cluster_2787","Peve_00001631",0.997124687493112,0.0482882830107525,0.946238709759689,165,-26.47,"2 21","7381 7403",21,"76.19%","85.71%","CDS","Q8R5B6","SPRY domain-containing SOCS box protein 4 (SSB-4)","Mus musculus (Mouse)","intracellular signal transduction [GO:0035556]; positive regulation of protein polyubiquitination [GO:1902916]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0005829; GO:0006511; GO:0016567; GO:0019005; GO:0035556; GO:0042752; GO:0043161; GO:0048511; GO:1902916; GO:1990756"
"5372","Cluster_2787","Peve_00001931",0.99785995039932,0.0416566673105075,0.909359886114279,164,-20.27,"2 21","1939 1960",19,"73.68%","78.95%","CDS","O95477","Phospholipid-transporting ATPase ABCA1 (EC 7.6.2.1) (ATP-binding cassette sub-family A member 1) (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) (Cholesterol efflux regulatory protein)","Homo sapiens (Human)","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to retinoic acid [GO:0071300]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; endosomal transport [GO:0016197]; export across plasma membrane [GO:0140115]; G protein-coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; intracellular cholesterol transport [GO:0032367]; lipid transport [GO:0006869]; lysosome organization [GO:0007040]; negative regulation of cholesterol storage [GO:0010887]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; peptide secretion [GO:0002790]; phagocytosis, engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; platelet dense granule organization [GO:0060155]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of high-density lipoprotein particle assembly [GO:0090108]; protein lipidation [GO:0006497]; protein secretion [GO:0009306]; protein transmembrane transport [GO:0071806]; regulation of Cdc42 protein signal transduction [GO:0032489]; regulation of high-density lipoprotein particle assembly [GO:0090107]; response to laminar fluid shear stress [GO:0034616]; reverse cholesterol transport [GO:0043691]; signal release [GO:0023061]","GO:0002790; GO:0005102; GO:0005319; GO:0005524; GO:0005548; GO:0005768; GO:0005789; GO:0005794; GO:0005886; GO:0006497; GO:0006869; GO:0006911; GO:0007040; GO:0007186; GO:0007189; GO:0008203; GO:0008320; GO:0009306; GO:0009897; GO:0010745; GO:0010875; GO:0010887; GO:0015485; GO:0016197; GO:0016887; GO:0019905; GO:0023061; GO:0030139; GO:0031210; GO:0031267; GO:0032367; GO:0032489; GO:0033344; GO:0033700; GO:0034185; GO:0034186; GO:0034188; GO:0034380; GO:0034616; GO:0042626; GO:0042632; GO:0043231; GO:0043691; GO:0045121; GO:0045332; GO:0045335; GO:0046623; GO:0048471; GO:0051117; GO:0055091; GO:0060155; GO:0071222; GO:0071300; GO:0071404; GO:0071806; GO:0090107; GO:0090108; GO:0090554; GO:0090556; GO:0097708; GO:0120020; GO:0140115; GO:0140328; GO:0140359"
"5373","Cluster_2787","Peve_00001847",0.99919831613102,0.0254932797372286,0.874128698371413,151,-21.63,"2 21","3099 3124",23,"56.52%","78.26%","CDS","Q5F4A9","ADP-ribosylation factor-like protein 6-interacting protein 4 (ARL-6-interacting protein 4) (Aip-4)","Gallus gallus (Chicken)","mRNA processing [GO:0006397]; RNA splicing [GO:0008380]","GO:0005730; GO:0006397; GO:0008380; GO:0016607"
"5374","Cluster_2787","Peve_00001847",0.99919831613102,0.0254932797372286,0.874128698371413,157,-20.8,"2 14","2483 2504",12,"83.33%","100.00%","CDS","Q5F4A9","ADP-ribosylation factor-like protein 6-interacting protein 4 (ARL-6-interacting protein 4) (Aip-4)","Gallus gallus (Chicken)","mRNA processing [GO:0006397]; RNA splicing [GO:0008380]","GO:0005730; GO:0006397; GO:0008380; GO:0016607"
"5394","Cluster_2787","Peve_00002221",0.999980672456975,0.00395807614315678,0.54328949385489,156,-23.56,"2 13","10369 10390",11,"90.91%","100.00%","CDS","Q96LJ7","Dehydrogenase/reductase SDR family member 1 (EC 1.1.1.-) (Short chain dehydrogenase/reductase family 19C member 1) (Protein SDR19C1)","Homo sapiens (Human)","","GO:0004090; GO:0005783; GO:0016616; GO:0047045"
"5395","Cluster_2787","Peve_00002221",0.999980672456975,0.00395807614315678,0.54328949385489,156,-23.56,"2 13","6843 6864",11,"90.91%","100.00%","CDS","Q96LJ7","Dehydrogenase/reductase SDR family member 1 (EC 1.1.1.-) (Short chain dehydrogenase/reductase family 19C member 1) (Protein SDR19C1)","Homo sapiens (Human)","","GO:0004090; GO:0005783; GO:0016616; GO:0047045"
"5402","Cluster_2787","Peve_00001819",0.999817636668151,0.0121582335095889,0.679854262991557,153,-22.66,"2 21","12836 12860",22,"68.18%","81.82%","CDS","Q8R151","NFX1-type zinc finger-containing protein 1","Mus musculus (Mouse)","activation of innate immune response [GO:0002218]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of viral genome replication [GO:0045071]; RNA-mediated heterochromatin formation [GO:0031048]","GO:0002218; GO:0003723; GO:0004386; GO:0005741; GO:0008270; GO:0010494; GO:0031048; GO:0031380; GO:0042742; GO:0045071; GO:0045087; GO:0051607"
"5406","Cluster_2787","Peve_00002287",-0.999983802832915,0.00362339130752193,0.526496923485016,154,-20.56,"2 20","2439 2462",20,"65.00%","80.00%","CDS","A0A250YGJ5","NAD-dependent protein deacylase sirtuin-6 (EC 2.3.1.-) (NAD-dependent protein deacetylase sirtuin-6) (EC 2.3.1.286) (Protein mono-ADP-ribosyltransferase sirtuin-6) (EC 2.4.2.-)","Castor canadensis (American beaver)","cardiac muscle cell differentiation [GO:0055007]; circadian regulation of gene expression [GO:0032922]; determination of adult lifespan [GO:0008340]; double-strand break repair [GO:0006302]; ketone biosynthetic process [GO:0042181]; negative regulation of gluconeogenesis [GO:0045721]; negative regulation of glycolytic process [GO:0045820]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation by RNA polymerase II [GO:0034244]; negative regulation of transposition [GO:0010529]; pericentric heterochromatin formation [GO:0031508]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of insulin secretion [GO:0032024]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein localization to chromatin [GO:0120187]; positive regulation of stem cell differentiation [GO:2000738]; protein delipidation [GO:0051697]; protein destabilization [GO:0031648]; regulation of circadian rhythm [GO:0042752]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of lipid catabolic process [GO:0050994]; regulation of lipid metabolic process [GO:0019216]","GO:0000122; GO:0000781; GO:0000785; GO:0003684; GO:0003723; GO:0005634; GO:0005783; GO:0006302; GO:0008340; GO:0010529; GO:0010569; GO:0016779; GO:0019216; GO:0031490; GO:0031491; GO:0031508; GO:0031648; GO:0032024; GO:0032922; GO:0034244; GO:0034979; GO:0042181; GO:0042308; GO:0042752; GO:0042803; GO:0045600; GO:0045721; GO:0045820; GO:0046827; GO:0046872; GO:0046969; GO:0050994; GO:0051697; GO:0055007; GO:0070403; GO:0097372; GO:0106274; GO:0120162; GO:0120187; GO:0140612; GO:0140765; GO:0140773; GO:0140774; GO:1904841; GO:2000738; GO:2000781"
"5408","Cluster_2787","Peve_00002349",0.999743054310315,0.0144319524323624,0.731793424490305,151,-20.24,"2 13","227 249",12,"91.67%","91.67%","CDS","G8HTB6","ZP domain-containing protein","Acropora millepora (Staghorn coral) (Heteropora millepora)","","GO:0016020"
"5436","Cluster_2787","Peve_00002952",0.99978090846462,0.0133264922094828,0.707558044122782,161,-21.69,"2 21","5145 5167",21,"76.19%","80.95%","CDS",NA,NA,NA,NA,NA
"5451","Cluster_2787","Peve_00003173",0.999661999574085,0.0165525907644587,0.773765786956118,158,-23.19,"2 21","12651 12677",24,"70.83%","75.00%","CDS","Q9W770","Spondin-1 (F-spondin)","Gallus gallus (Chicken)","cell adhesion [GO:0007155]","GO:0005576; GO:0007155; GO:0031012; GO:0046872"
"5465","Cluster_2787","Peve_00003392",0.997354196901045,0.0463201207098193,0.937163514946439,158,-20.41,"2 19","8481 8502",17,"70.59%","82.35%","CDS","Q9Y3Q0","N-acetylated-alpha-linked acidic dipeptidase 2 (EC 3.4.17.21) (Glutamate carboxypeptidase III) (GCPIII) (N-acetylated-alpha-linked acidic dipeptidase II) (NAALADase II)","Homo sapiens (Human)","proteolysis [GO:0006508]","GO:0004180; GO:0004181; GO:0005886; GO:0006508; GO:0008236; GO:0008239; GO:0016020; GO:0016805; GO:0046872"
"5466","Cluster_2787","Peve_00003392",0.997354196901045,0.0463201207098193,0.937163514946439,158,-22.3,"2 17","4206 4226",15,"80.00%","93.33%","CDS","Q9Y3Q0","N-acetylated-alpha-linked acidic dipeptidase 2 (EC 3.4.17.21) (Glutamate carboxypeptidase III) (GCPIII) (N-acetylated-alpha-linked acidic dipeptidase II) (NAALADase II)","Homo sapiens (Human)","proteolysis [GO:0006508]","GO:0004180; GO:0004181; GO:0005886; GO:0006508; GO:0008236; GO:0008239; GO:0016020; GO:0016805; GO:0046872"
"5474","Cluster_2787","Peve_00003545",0.99717621236632,0.0478534645739355,0.945121679218986,147,-20.91,"2 16","21634 21655",14,"71.43%","78.57%","CDS","Q9Y4D8","Probable E3 ubiquitin-protein ligase HECTD4 (EC 2.3.2.26) (HECT domain-containing protein 4) (HECT-type E3 ubiquitin transferase HECTD4)","Homo sapiens (Human)","glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]","GO:0004842; GO:0006006; GO:0016020; GO:0042593"
"5482","Cluster_2787","Peve_00003302",0.999980135670977,0.00401266394534835,0.54328949385489,146,-21.64,"2 21","24166 24192",24,"58.33%","75.00%","CDS","Q7TSG1","Centrosomal protein of 120 kDa (Cep120) (Coiled-coil domain-containing protein 100)","Mus musculus (Mouse)","astral microtubule organization [GO:0030953]; cell population proliferation [GO:0008283]; centrosome cycle [GO:0007098]; cerebral cortex development [GO:0021987]; interkinetic nuclear migration [GO:0022027]; microtubule cytoskeleton organization [GO:0000226]; neurogenesis [GO:0022008]; positive regulation of centriole elongation [GO:1903724]; positive regulation of centrosome duplication [GO:0010825]; positive regulation of cilium assembly [GO:0045724]; positive regulation of establishment of protein localization [GO:1904951]; regulation of microtubule-based process [GO:0032886]; regulation of protein localization [GO:0032880]","GO:0000226; GO:0005737; GO:0005813; GO:0005814; GO:0007098; GO:0008022; GO:0008283; GO:0010825; GO:0021987; GO:0022008; GO:0022027; GO:0030953; GO:0032880; GO:0032886; GO:0045724; GO:1903724; GO:1904951"
"5486","Cluster_2787","Peve_00003305",0.999819424207648,0.0120984969926468,0.678179842102661,155,-20.25,"2 21","6958 6980",20,"65.00%","80.00%","CDS","Q3UZD5","Putative histone-lysine N-methyltransferase PRDM6 (EC 2.1.1.361) (PR domain zinc finger protein 6) (PR domain-containing protein 6) (PR domain-containing protein in smooth muscle)","Mus musculus (Mouse)","chromatin organization [GO:0006325]; histone methylation [GO:0016571]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of smooth muscle cell differentiation [GO:0051151]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurogenesis [GO:0022008]; regulation of gene expression [GO:0010468]","GO:0000122; GO:0005634; GO:0006325; GO:0010468; GO:0016571; GO:0022008; GO:0042802; GO:0045892; GO:0046872; GO:0051151; GO:0140944"
"5493","Cluster_2787","Peve_00003898",0.998457229830989,0.0353672740541857,0.909359886114279,154,-20.51,"2 21","16953 16973",19,"68.42%","78.95%","CDS","Q07889","Son of sevenless homolog 1 (SOS-1)","Homo sapiens (Human)","axon guidance [GO:0007411]; B cell homeostasis [GO:0001782]; B cell receptor signaling pathway [GO:0050853]; blood vessel morphogenesis [GO:0048514]; cardiac atrium morphogenesis [GO:0003209]; cytokine-mediated signaling pathway [GO:0019221]; epidermal growth factor receptor signaling pathway [GO:0007173]; eyelid development in camera-type eye [GO:0061029]; Fc-epsilon receptor signaling pathway [GO:0038095]; fibroblast growth factor receptor signaling pathway [GO:0008543]; hair follicle development [GO:0001942]; heart trabecula morphogenesis [GO:0061384]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; leukocyte migration [GO:0050900]; midbrain morphogenesis [GO:1904693]; multicellular organism growth [GO:0035264]; neurotrophin TRK receptor signaling pathway [GO:0048011]; pericardium morphogenesis [GO:0003344]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of GTPase activity [GO:0043547]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; Ras protein signal transduction [GO:0007265]; regulation of cell population proliferation [GO:0042127]; regulation of MAP kinase activity [GO:0043405]; regulation of pro-B cell differentiation [GO:2000973]; regulation of T cell differentiation in thymus [GO:0033081]; regulation of T cell proliferation [GO:0042129]; regulation of transcription by RNA polymerase II [GO:0006357]; roof of mouth development [GO:0060021]; signal transduction [GO:0007165]; vitellogenesis [GO:0007296]","GO:0001782; GO:0001942; GO:0003209; GO:0003344; GO:0005085; GO:0005096; GO:0005737; GO:0005829; GO:0005886; GO:0006357; GO:0007165; GO:0007173; GO:0007265; GO:0007296; GO:0007411; GO:0008286; GO:0008543; GO:0014069; GO:0017124; GO:0019221; GO:0033081; GO:0035264; GO:0038095; GO:0042127; GO:0042129; GO:0043025; GO:0043405; GO:0043539; GO:0043547; GO:0045742; GO:0046982; GO:0048009; GO:0048011; GO:0048514; GO:0050853; GO:0050900; GO:0051057; GO:0060021; GO:0061029; GO:0061384; GO:1904693; GO:1905360; GO:2000973"
"5502","Cluster_2787","Peve_00004069",0.998859776055425,0.0304040525129495,0.903929377050813,162,-20.74,"2 21","633 653",19,"73.68%","84.21%","CDS","Q6P4Z2","Collagen alpha-1(II) chain (Alpha-1 type II collagen)","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","","GO:0005201; GO:0005576; GO:0005581; GO:0046872"
"5531","Cluster_2787","Peve_00004523",0.999999085687885,0.000860879549426188,0.239778920002343,152,-20.7,"2 13","12685 12706",11,"90.91%","90.91%","CDS","Q32LU7","Pentatricopeptide repeat domain-containing protein 3, mitochondrial","Danio rerio (Zebrafish) (Brachydanio rerio)","mitochondrial translation [GO:0032543]; regulation of translation [GO:0006417]","GO:0005739; GO:0005840; GO:0006417; GO:0019843; GO:0032543; GO:0043024; GO:1990904"
"5532","Cluster_2787","Peve_00004523",0.999999085687885,0.000860879549426188,0.239778920002343,161,-23.17,"2 19","7942 7965",19,"73.68%","84.21%","CDS","Q32LU7","Pentatricopeptide repeat domain-containing protein 3, mitochondrial","Danio rerio (Zebrafish) (Brachydanio rerio)","mitochondrial translation [GO:0032543]; regulation of translation [GO:0006417]","GO:0005739; GO:0005840; GO:0006417; GO:0019843; GO:0032543; GO:0043024; GO:1990904"
"5533","Cluster_2787","Peve_00004566",-0.999636187928725,0.017173026532108,0.782669382293497,161,-21.69,"2 21","22 44",21,"76.19%","80.95%","CDS",NA,NA,NA,NA,NA
"5549","Cluster_2787","Peve_00004847",0.99704225336107,0.048975931865785,0.949444666171571,156,-21.66,"2 21","5421 5440",19,"73.68%","84.21%","CDS","Q49B93","Sodium-coupled monocarboxylate transporter 2 (Electroneutral sodium monocarboxylate cotransporter) (Low-affinity sodium-lactate cotransporter) (Solute carrier family 5 member 12)","Mus musculus (Mouse)","sodium ion transport [GO:0006814]","GO:0005654; GO:0005886; GO:0006814; GO:0015129; GO:0015293; GO:0016324"
"5550","Cluster_2787","Peve_00004847",0.99704225336107,0.048975931865785,0.949444666171571,159,-28.37,"2 20","6127 6146",18,"77.78%","88.89%","CDS","Q49B93","Sodium-coupled monocarboxylate transporter 2 (Electroneutral sodium monocarboxylate cotransporter) (Low-affinity sodium-lactate cotransporter) (Solute carrier family 5 member 12)","Mus musculus (Mouse)","sodium ion transport [GO:0006814]","GO:0005654; GO:0005886; GO:0006814; GO:0015129; GO:0015293; GO:0016324"
"5560","Cluster_2787","Peve_00004912",0.999805909005942,0.0125430986396607,0.689535303834238,162,-21.14,"2 21","3062 3082",19,"78.95%","78.95%","CDS","Q7JQD3","Gelsolin-like protein 1 (Actin-modulator) (EWAM) (EWAM-P1)","Lumbricus terrestris (Common earthworm)","actin filament capping [GO:0051693]; actin filament fragmentation [GO:0030043]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actin nucleation [GO:0045010]","GO:0003779; GO:0005509; GO:0005737; GO:0005856; GO:0030041; GO:0030043; GO:0045010; GO:0051014; GO:0051015; GO:0051693"
"5627","Cluster_2787","Peve_00006122",-0.999839845331302,0.0113938558027464,0.658361276125779,164,-20.25,"2 17","3410 3431",15,"80.00%","93.33%","CDS","Q9NU22","Midasin (Dynein-related AAA-ATPase MDN1) (MIDAS-containing protein)","Homo sapiens (Human)","ribosomal large subunit assembly [GO:0000027]; ribosomal large subunit export from nucleus [GO:0000055]","GO:0000027; GO:0000055; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0016020; GO:0016887; GO:0030687; GO:0045111"
"5647","Cluster_2787","Peve_00006481",0.999312796815682,0.0236027483638687,0.851916223620059,151,-22.72,"2 21","11378 11403",23,"65.22%","69.57%","CDS","P35384","Extracellular calcium-sensing receptor (CaSR) (Parathyroid cell calcium-sensing receptor) (BoPCaR1) (PCaR1)","Bos taurus (Bovine)","calcium ion import [GO:0070509]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; detection of calcium ion [GO:0005513]; G protein-coupled receptor signaling pathway [GO:0007186]; JNK cascade [GO:0007254]; ossification [GO:0001503]; positive regulation of ATP-dependent activity [GO:0032781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; regulation of calcium ion transport [GO:0051924]; vasodilation [GO:0042311]","GO:0001503; GO:0004930; GO:0005509; GO:0005513; GO:0005886; GO:0006816; GO:0006874; GO:0007186; GO:0007254; GO:0008284; GO:0010628; GO:0016597; GO:0032781; GO:0042311; GO:0042803; GO:0043679; GO:0051924; GO:0070509"
"5656","Cluster_2787","Peve_00006231",0.999963027291266,0.00547440714279664,0.551398425649056,159,-22.18,"2 21","12453 12475",20,"70.00%","80.00%","CDS","Q96JH7","Deubiquitinating protein VCPIP1 (EC 3.4.19.12) (Valosin-containing protein p97/p47 complex-interacting protein 1) (Valosin-containing protein p97/p47 complex-interacting protein p135) (VCP/p47 complex-interacting 135-kDa protein)","Homo sapiens (Human)","cellular response to DNA damage stimulus [GO:0006974]; endoplasmic reticulum membrane fusion [GO:0016320]; Golgi reassembly [GO:0090168]; mitotic cell cycle [GO:0000278]; protein deubiquitination [GO:0016579]; protein K11-linked deubiquitination [GO:0035871]; protein K48-linked deubiquitination [GO:0071108]; protein ubiquitination [GO:0016567]; protein-DNA covalent cross-linking repair [GO:0106300]; regulation of protein localization to chromatin [GO:1905634]","GO:0000278; GO:0004843; GO:0005634; GO:0005737; GO:0005788; GO:0005795; GO:0006974; GO:0016320; GO:0016567; GO:0016579; GO:0035871; GO:0071108; GO:0090168; GO:0106300; GO:1905634"
"5657","Cluster_2787","Peve_00006231",0.999963027291266,0.00547440714279664,0.551398425649056,173,-32.92,"2 21","13214 13233",19,"84.21%","89.47%","CDS","Q96JH7","Deubiquitinating protein VCPIP1 (EC 3.4.19.12) (Valosin-containing protein p97/p47 complex-interacting protein 1) (Valosin-containing protein p97/p47 complex-interacting protein p135) (VCP/p47 complex-interacting 135-kDa protein)","Homo sapiens (Human)","cellular response to DNA damage stimulus [GO:0006974]; endoplasmic reticulum membrane fusion [GO:0016320]; Golgi reassembly [GO:0090168]; mitotic cell cycle [GO:0000278]; protein deubiquitination [GO:0016579]; protein K11-linked deubiquitination [GO:0035871]; protein K48-linked deubiquitination [GO:0071108]; protein ubiquitination [GO:0016567]; protein-DNA covalent cross-linking repair [GO:0106300]; regulation of protein localization to chromatin [GO:1905634]","GO:0000278; GO:0004843; GO:0005634; GO:0005737; GO:0005788; GO:0005795; GO:0006974; GO:0016320; GO:0016567; GO:0016579; GO:0035871; GO:0071108; GO:0090168; GO:0106300; GO:1905634"
"5659","Cluster_2787","Peve_00006612",0.999741217032286,0.0144834602394057,0.732628394312895,160,-20.68,"2 20","7660 7679",18,"77.78%","83.33%","CDS","P12955","Xaa-Pro dipeptidase (X-Pro dipeptidase) (EC 3.4.13.9) (Imidodipeptidase) (Peptidase D) (Proline dipeptidase) (Prolidase)","Homo sapiens (Human)","amino acid metabolic process [GO:0006520]; collagen catabolic process [GO:0030574]; proteolysis [GO:0006508]","GO:0004181; GO:0006508; GO:0006520; GO:0008233; GO:0030145; GO:0030574; GO:0070006; GO:0070062; GO:0102009"
"5683","Cluster_2787","Peve_00007009",-0.999797200270235,0.012821420582154,0.69597202795206,162,-24.39,"2 21","1637 1657",19,"73.68%","84.21%","CDS",NA,NA,NA,NA,NA
"5687","Cluster_2787","Peve_00007030",0.999928416611485,0.00761734871801782,0.573710369894872,160,-20.78,"2 21","27768 27789",19,"68.42%","78.95%","CDS","Q3UQ28","Peroxidasin homolog (EC 1.11.2.-) [Cleaved into: PXDN active fragment]","Mus musculus (Mouse)","angiogenesis [GO:0001525]; basement membrane assembly [GO:0070831]; basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; eye development [GO:0001654]; hydrogen peroxide catabolic process [GO:0042744]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; response to oxidative stress [GO:0006979]","GO:0001525; GO:0001654; GO:0004601; GO:0005201; GO:0005604; GO:0005615; GO:0005783; GO:0006979; GO:0007155; GO:0009986; GO:0016684; GO:0020037; GO:0030198; GO:0030199; GO:0031012; GO:0042744; GO:0043237; GO:0046872; GO:0051260; GO:0062023; GO:0070207; GO:0070831; GO:0071711; GO:0140825"
"5732","Cluster_2787","Peve_00007851",0.999117725600671,0.0267441559078376,0.888278112420496,157,-20.71,"2 20","15670 15690",18,"72.22%","83.33%","CDS","O95071","E3 ubiquitin-protein ligase UBR5 (EC 2.3.2.26) (E3 ubiquitin-protein ligase, HECT domain-containing 1) (HECT-type E3 ubiquitin transferase UBR5) (Hyperplastic discs protein homolog) (hHYD) (Progestin-induced protein)","Homo sapiens (Human)","cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; DNA repair-dependent chromatin remodeling [GO:0140861]; negative regulation of double-strand break repair [GO:2000780]; negative regulation of histone H2A K63-linked ubiquitination [GO:1901315]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of gene expression [GO:0010628]; positive regulation of protein import into nucleus [GO:0042307]; progesterone receptor signaling pathway [GO:0050847]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; regulation of double-strand break repair [GO:2000779]","GO:0000209; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006281; GO:0006974; GO:0008270; GO:0010628; GO:0016020; GO:0032991; GO:0034450; GO:0042307; GO:0043130; GO:0048471; GO:0050847; GO:0061630; GO:0070936; GO:0090263; GO:0140861; GO:1901315; GO:2000779; GO:2000780"
"5781","Cluster_2787","Peve_00008684",0.99769821407441,0.0432027035935973,0.918140469626035,160,-23.38,"2 18","79 102",18,"77.78%","83.33%","CDS",NA,NA,NA,NA,NA
"5809","Cluster_2787","Peve_00009375",0.999957006613217,0.0059033360413808,0.571521101410101,158,-22.37,"2 21","6905 6925",19,"68.42%","84.21%","CDS","Q9UKP5","A disintegrin and metalloproteinase with thrombospondin motifs 6 (ADAM-TS 6) (ADAM-TS6) (ADAMTS-6) (EC 3.4.24.-)","Homo sapiens (Human)","aorta development [GO:0035904]; cardiac septum development [GO:0003279]; coronary vasculature development [GO:0060976]; extracellular matrix organization [GO:0030198]; kidney development [GO:0001822]; proteolysis [GO:0006508]","GO:0001822; GO:0003279; GO:0004222; GO:0005576; GO:0006508; GO:0008237; GO:0030198; GO:0031012; GO:0035904; GO:0046872; GO:0060976"
"5815","Cluster_2787","Peve_00009466",0.999047644234391,0.0277862028185553,0.899096636156394,147,-20.51,"2 21","14171 14193",20,"65.00%","70.00%","CDS","P27590","Uromodulin (Tamm-Horsfall urinary glycoprotein) (THP) [Cleaved into: Uromodulin, secreted form]","Rattus norvegicus (Rat)","antibacterial innate immune response [GO:0140367]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; autophagy [GO:0006914]; calcium ion homeostasis [GO:0055074]; cellular calcium ion homeostasis [GO:0006874]; cellular chloride ion homeostasis [GO:0030644]; cellular phosphate ion homeostasis [GO:0030643]; cellular response to unfolded protein [GO:0034620]; cellular sodium ion homeostasis [GO:0006883]; chaperone-mediated protein folding [GO:0061077]; chemical homeostasis [GO:0048878]; chloride ion homeostasis [GO:0055064]; citric acid secretion [GO:0046720]; collecting duct development [GO:0072044]; connective tissue replacement [GO:0097709]; creatinine homeostasis [GO:0097273]; defense response to Gram-negative bacterium [GO:0050829]; endoplasmic reticulum organization [GO:0007029]; gene expression [GO:0010467]; glomerular filtration [GO:0003094]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; inflammatory response [GO:0006954]; ion homeostasis [GO:0050801]; juxtaglomerular apparatus development [GO:0072051]; kidney development [GO:0001822]; leukocyte cell-cell adhesion [GO:0007159]; lipid metabolic process [GO:0006629]; loop of Henle development [GO:0072070]; metanephric ascending thin limb development [GO:0072218]; metanephric distal convoluted tubule development [GO:0072221]; metanephric thick ascending limb development [GO:0072233]; micturition [GO:0060073]; multicellular organismal homeostasis [GO:0048871]; multicellular organismal response to stress [GO:0033555]; neutrophil migration [GO:1990266]; organ or tissue specific immune response [GO:0002251]; peptidyl-threonine phosphorylation [GO:0018107]; phosphate ion homeostasis [GO:0055062]; potassium ion homeostasis [GO:0055075]; protein localization to vacuole [GO:0072665]; protein phosphorylation [GO:0006468]; protein transport into plasma membrane raft [GO:0044861]; regulation of blood pressure [GO:0008217]; regulation of protein transport [GO:0051223]; regulation of urine volume [GO:0035809]; renal sodium ion absorption [GO:0070294]; renal urate salt excretion [GO:0097744]; renal water homeostasis [GO:0003091]; response to endoplasmic reticulum stress [GO:0034976]; response to lipopolysaccharide [GO:0032496]; response to organic substance [GO:0010033]; response to unfolded protein [GO:0006986]; response to water deprivation [GO:0009414]; response to xenobiotic stimulus [GO:0009410]; RNA splicing [GO:0008380]; sodium ion homeostasis [GO:0055078]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; ubiquitin-dependent ERAD pathway [GO:0030433]; urate transport [GO:0015747]; urea transmembrane transport [GO:0071918]; water homeostasis [GO:0030104]","GO:0000922; GO:0001822; GO:0002251; GO:0003091; GO:0003094; GO:0005201; GO:0005509; GO:0005615; GO:0005783; GO:0005794; GO:0005886; GO:0005929; GO:0006468; GO:0006629; GO:0006874; GO:0006883; GO:0006914; GO:0006915; GO:0006954; GO:0006986; GO:0007029; GO:0007157; GO:0007159; GO:0008217; GO:0008380; GO:0009410; GO:0009414; GO:0009986; GO:0010033; GO:0010467; GO:0015747; GO:0016020; GO:0016323; GO:0016324; GO:0018107; GO:0019864; GO:0030104; GO:0030433; GO:0030643; GO:0030644; GO:0031410; GO:0032496; GO:0033209; GO:0033555; GO:0034620; GO:0034976; GO:0035809; GO:0044861; GO:0045121; GO:0045177; GO:0046720; GO:0048871; GO:0048878; GO:0050801; GO:0050829; GO:0051223; GO:0055062; GO:0055064; GO:0055074; GO:0055075; GO:0055078; GO:0060073; GO:0060170; GO:0061077; GO:0070294; GO:0071918; GO:0072044; GO:0072051; GO:0072070; GO:0072218; GO:0072221; GO:0072233; GO:0072665; GO:0097190; GO:0097273; GO:0097709; GO:0097744; GO:0140367; GO:1990266"
"5816","Cluster_2787","Peve_00009466",0.999047644234391,0.0277862028185553,0.899096636156394,155,-21.18,"2 21","1996 2019",21,"61.90%","80.95%","CDS","P27590","Uromodulin (Tamm-Horsfall urinary glycoprotein) (THP) [Cleaved into: Uromodulin, secreted form]","Rattus norvegicus (Rat)","antibacterial innate immune response [GO:0140367]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; autophagy [GO:0006914]; calcium ion homeostasis [GO:0055074]; cellular calcium ion homeostasis [GO:0006874]; cellular chloride ion homeostasis [GO:0030644]; cellular phosphate ion homeostasis [GO:0030643]; cellular response to unfolded protein [GO:0034620]; cellular sodium ion homeostasis [GO:0006883]; chaperone-mediated protein folding [GO:0061077]; chemical homeostasis [GO:0048878]; chloride ion homeostasis [GO:0055064]; citric acid secretion [GO:0046720]; collecting duct development [GO:0072044]; connective tissue replacement [GO:0097709]; creatinine homeostasis [GO:0097273]; defense response to Gram-negative bacterium [GO:0050829]; endoplasmic reticulum organization [GO:0007029]; gene expression [GO:0010467]; glomerular filtration [GO:0003094]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; inflammatory response [GO:0006954]; ion homeostasis [GO:0050801]; juxtaglomerular apparatus development [GO:0072051]; kidney development [GO:0001822]; leukocyte cell-cell adhesion [GO:0007159]; lipid metabolic process [GO:0006629]; loop of Henle development [GO:0072070]; metanephric ascending thin limb development [GO:0072218]; metanephric distal convoluted tubule development [GO:0072221]; metanephric thick ascending limb development [GO:0072233]; micturition [GO:0060073]; multicellular organismal homeostasis [GO:0048871]; multicellular organismal response to stress [GO:0033555]; neutrophil migration [GO:1990266]; organ or tissue specific immune response [GO:0002251]; peptidyl-threonine phosphorylation [GO:0018107]; phosphate ion homeostasis [GO:0055062]; potassium ion homeostasis [GO:0055075]; protein localization to vacuole [GO:0072665]; protein phosphorylation [GO:0006468]; protein transport into plasma membrane raft [GO:0044861]; regulation of blood pressure [GO:0008217]; regulation of protein transport [GO:0051223]; regulation of urine volume [GO:0035809]; renal sodium ion absorption [GO:0070294]; renal urate salt excretion [GO:0097744]; renal water homeostasis [GO:0003091]; response to endoplasmic reticulum stress [GO:0034976]; response to lipopolysaccharide [GO:0032496]; response to organic substance [GO:0010033]; response to unfolded protein [GO:0006986]; response to water deprivation [GO:0009414]; response to xenobiotic stimulus [GO:0009410]; RNA splicing [GO:0008380]; sodium ion homeostasis [GO:0055078]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; ubiquitin-dependent ERAD pathway [GO:0030433]; urate transport [GO:0015747]; urea transmembrane transport [GO:0071918]; water homeostasis [GO:0030104]","GO:0000922; GO:0001822; GO:0002251; GO:0003091; GO:0003094; GO:0005201; GO:0005509; GO:0005615; GO:0005783; GO:0005794; GO:0005886; GO:0005929; GO:0006468; GO:0006629; GO:0006874; GO:0006883; GO:0006914; GO:0006915; GO:0006954; GO:0006986; GO:0007029; GO:0007157; GO:0007159; GO:0008217; GO:0008380; GO:0009410; GO:0009414; GO:0009986; GO:0010033; GO:0010467; GO:0015747; GO:0016020; GO:0016323; GO:0016324; GO:0018107; GO:0019864; GO:0030104; GO:0030433; GO:0030643; GO:0030644; GO:0031410; GO:0032496; GO:0033209; GO:0033555; GO:0034620; GO:0034976; GO:0035809; GO:0044861; GO:0045121; GO:0045177; GO:0046720; GO:0048871; GO:0048878; GO:0050801; GO:0050829; GO:0051223; GO:0055062; GO:0055064; GO:0055074; GO:0055075; GO:0055078; GO:0060073; GO:0060170; GO:0061077; GO:0070294; GO:0071918; GO:0072044; GO:0072051; GO:0072070; GO:0072218; GO:0072221; GO:0072233; GO:0072665; GO:0097190; GO:0097273; GO:0097709; GO:0097744; GO:0140367; GO:1990266"
"5819","Cluster_2787","Peve_00009505",0.99959671207991,0.0180807867542241,0.782669382293497,153,-20.41,"2 21","225 246",20,"75.00%","75.00%","CDS",NA,NA,NA,NA,NA
"5844","Cluster_2787","Peve_00010166",-0.999698083700696,0.015644054775235,0.755800904783597,172,-23.08,"2 21","368 389",19,"78.95%","84.21%","CDS",NA,NA,NA,NA,NA
"5859","Cluster_2787","Peve_00010342",0.999671024295392,0.0163301036180213,0.769967254188809,155,-20.43,"2 20","1175 1194",18,"77.78%","83.33%","CDS",NA,NA,NA,NA,NA
"5866","Cluster_2787","Peve_00010422",0.996936931004056,0.0498407339402141,0.952955683251839,162,-26.88,"2 20","6311 6333",19,"78.95%","78.95%","CDS","Q92485","Acid sphingomyelinase-like phosphodiesterase 3b (ASM-like phosphodiesterase 3b) (EC 3.1.4.-)","Homo sapiens (Human)","inflammatory response [GO:0006954]; innate immune response [GO:0045087]; membrane lipid catabolic process [GO:0046466]; negative regulation of inflammatory response [GO:0050728]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; sphingomyelin catabolic process [GO:0006685]","GO:0004767; GO:0005615; GO:0005886; GO:0006685; GO:0006954; GO:0008081; GO:0008270; GO:0016798; GO:0034122; GO:0045087; GO:0046466; GO:0050728; GO:0070062"
"5885","Cluster_2787","Peve_00010591",0.997238292841101,0.0473242711265986,0.9423456331619,154,-20.23,"2 16","2126 2148",15,"80.00%","86.67%","CDS",NA,NA,NA,NA,NA
"5892","Cluster_2787","Peve_00010733",0.999101148305045,0.0269942756006821,0.890996391779975,156,-22.6,"2 13","8181 8202",11,"90.91%","100.00%","CDS",NA,NA,NA,NA,NA
"5922","Cluster_2787","Peve_00011328",0.999984105773436,0.00358934658638763,0.524379672321757,158,-21.35,"2 20","10015 10037",19,"68.42%","84.21%","CDS","O80668","Amino acid transporter AVT1A (AtAvt1A)","Arabidopsis thaliana (Mouse-ear cress)","amino acid transmembrane transport [GO:0003333]","GO:0000325; GO:0003333; GO:0015171; GO:0016020"
"5980","Cluster_2787","Peve_00011078",0.998382772633742,0.0362108907750523,0.909359886114279,155,-22.05,"2 21","2236 2259",21,"66.67%","76.19%","CDS",NA,NA,NA,NA,NA
"5982","Cluster_2787","Peve_00012083",0.999040187210008,0.0278947921741052,0.899751445246142,163,-20.7,"2 21","12301 12324",21,"76.19%","76.19%","CDS","Q5ZKE7","UMP-CMP kinase (EC 2.7.4.14) (Deoxycytidylate kinase) (CK) (dCMP kinase) (Nucleoside-diphosphate kinase) (EC 2.7.4.6) (Uridine monophosphate/cytidine monophosphate kinase) (UMP/CMP kinase) (UMP/CMPK)","Gallus gallus (Chicken)","'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; CDP biosynthetic process [GO:0046705]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142]; UDP biosynthetic process [GO:0006225]","GO:0004127; GO:0004550; GO:0005524; GO:0005634; GO:0005737; GO:0006165; GO:0006207; GO:0006225; GO:0009142; GO:0033862; GO:0036430; GO:0036431; GO:0046705"
"5990","Cluster_2787","Peve_00012139",0.999990517292289,0.00277243674471523,0.446313889056449,162,-23.16,"2 20","10904 10927",20,"75.00%","80.00%","CDS","Q9D4H1","Exocyst complex component 2 (Exocyst complex component Sec5)","Mus musculus (Mouse)","exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; membrane fission [GO:0090148]; mitotic cytokinesis [GO:0000281]; positive regulation of exocytosis [GO:0045921]; protein transport [GO:0015031]; regulation of entry of bacterium into host cell [GO:2000535]; vesicle docking involved in exocytosis [GO:0006904]; vesicle tethering involved in exocytosis [GO:0090522]","GO:0000145; GO:0000281; GO:0005886; GO:0006887; GO:0006893; GO:0006904; GO:0015031; GO:0019901; GO:0031267; GO:0045921; GO:0047485; GO:0090148; GO:0090522; GO:0090543; GO:2000535"
"6026","Cluster_2787","Peve_00012279",0.999525998637372,0.0196020761520992,0.798903643537049,157,-21.16,"2 19","8636 8659",19,"73.68%","78.95%","CDS","Q5U3U0","Phytanoyl-CoA dioxygenase domain-containing protein 1 (Protein PHYHD1) (EC 1.14.11.-)","Danio rerio (Zebrafish) (Brachydanio rerio)","","GO:0046872; GO:0051213"
"6035","Cluster_2787","Peve_00012780",0.999514551705761,0.019837373988273,0.802441025798643,157,-21.64,"2 21","27893 27915",21,"71.43%","80.95%","CDS","P20735","Glutathione hydrolase 1 proenzyme (EC 3.4.19.13) (Gamma-glutamyltransferase 1) (Gamma-glutamyltranspeptidase 1) (GGT 1) (EC 2.3.2.2) (Leukotriene-C4 hydrolase) (EC 3.4.19.14) (CD antigen CD224) [Cleaved into: Glutathione hydrolase 1 heavy chain; Glutathione hydrolase 1 light chain]","Sus scrofa (Pig)","glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; glutathione catabolic process [GO:0006751]; zymogen activation [GO:0031638]","GO:0002951; GO:0005886; GO:0006536; GO:0006750; GO:0006751; GO:0031638; GO:0036374; GO:0102953; GO:0103068"
"6074","Cluster_2787","Peve_00013818",0.999999565158952,0.000593690915329897,0.239778920002343,155,-22.06,"2 21","366 390",22,"68.18%","72.73%","CDS","Q07536","Methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial (MMSDH) (Malonate-semialdehyde dehydrogenase [acylating]) (EC 1.2.1.18) (EC 1.2.1.27) (Aldehyde dehydrogenase family 6 member A1)","Bos taurus (Bovine)","thymine catabolic process [GO:0006210]; thymine metabolic process [GO:0019859]; valine catabolic process [GO:0006574]; valine metabolic process [GO:0006573]","GO:0000062; GO:0004491; GO:0005739; GO:0006210; GO:0006573; GO:0006574; GO:0018478; GO:0019859; GO:0102662"
"6185","Cluster_2787","Peve_00015572",0.999927947314274,0.00764227770951619,0.573710369894872,160,-20.15,"2 20","2924 2945",19,"78.95%","84.21%","CDS","P07207","Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein]","Drosophila melanogaster (Fruit fly)","actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222]","GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048"
"6188","Cluster_2787","Peve_00015583",0.997965012193854,0.0406209150714785,0.909359886114279,152,-21.32,"2 21","1572 1593",19,"63.16%","73.68%","CDS","P80467","Alcohol dehydrogenase class-3 (EC 1.1.1.1) (Alcohol dehydrogenase class-III) (Glutathione-dependent formaldehyde dehydrogenase) (FALDH) (FDH) (GSH-FDH) (EC 1.1.1.-) (S-(hydroxymethyl)glutathione dehydrogenase) (EC 1.1.1.284)","Saara hardwickii (Indian spiny-tailed lizard) (Uromastyx hardwickii)","ethanol oxidation [GO:0006069]","GO:0004022; GO:0005737; GO:0006069; GO:0008270; GO:0106321; GO:0106322"
"6239","Cluster_2787","Peve_00016648",0.999756154929201,0.014059210607724,0.724772403897406,164,-23.36,"2 17","8555 8576",15,"73.33%","100.00%","CDS","Q4KMD3","U11/U12 small nuclear ribonucleoprotein 35 kDa protein (U11/U12 snRNP 35 kDa protein) (U1 snRNP-binding protein homolog)","Danio rerio (Zebrafish) (Brachydanio rerio)","mRNA splicing, via spliceosome [GO:0000398]","GO:0000398; GO:0003729; GO:0005689; GO:0017069"
"6240","Cluster_2787","Peve_00016648",0.999756154929201,0.014059210607724,0.724772403897406,168,-27.59,"2 21","571 592",19,"68.42%","89.47%","CDS","Q4KMD3","U11/U12 small nuclear ribonucleoprotein 35 kDa protein (U11/U12 snRNP 35 kDa protein) (U1 snRNP-binding protein homolog)","Danio rerio (Zebrafish) (Brachydanio rerio)","mRNA splicing, via spliceosome [GO:0000398]","GO:0000398; GO:0003729; GO:0005689; GO:0017069"
"6252","Cluster_2787","Peve_00016980",-0.999963153550721,0.00546505171493988,0.551398425649056,151,-20.3,"2 21","3861 3884",21,"66.67%","71.43%","CDS",NA,NA,NA,NA,NA
"6308","Cluster_2787","Peve_00018009",0.999938989744559,0.00703232203684336,0.573710369894872,157,-20.88,"2 21","21473 21498",23,"69.57%","82.61%","CDS","Q8R1A4","Dedicator of cytokinesis protein 7 (Protein moonlight)","Mus musculus (Mouse)","activation of GTPase activity [GO:0090630]; axonogenesis [GO:0007409]; establishment of neuroblast polarity [GO:0045200]; hematopoietic progenitor cell differentiation [GO:0002244]; interkinetic nuclear migration [GO:0022027]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of cold-induced thermogenesis [GO:0120163]; neuron projection development [GO:0031175]; pigmentation [GO:0043473]; positive regulation of GTPase activity [GO:0043547]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; postsynaptic specialization assembly [GO:0098698]; regulation of neurogenesis [GO:0050767]; small GTPase mediated signal transduction [GO:0007264]","GO:0000226; GO:0002244; GO:0005085; GO:0007264; GO:0007409; GO:0008180; GO:0022027; GO:0030424; GO:0031175; GO:0031267; GO:0031594; GO:0033138; GO:0043473; GO:0043547; GO:0045200; GO:0050767; GO:0090630; GO:0098698; GO:0120163; GO:1904754"
"6342","Cluster_2787","Peve_00018683",-0.999977403674274,0.00427971502873518,0.54328949385489,165,-25.05,"2 18","4651 4672",16,"75.00%","93.75%","CDS","O89112","Glutathione S-transferase LANCL1 (EC 2.5.1.18) (40 kDa erythrocyte membrane protein) (p40) (LanC-like protein 1)","Mus musculus (Mouse)","carbohydrate metabolic process [GO:0005975]; peptide modification [GO:0031179]; regulation of neuron apoptotic process [GO:0043523]; regulation of oxidative stress-induced neuron death [GO:1903203]","GO:0004364; GO:0005737; GO:0005886; GO:0005975; GO:0008270; GO:0017124; GO:0031179; GO:0043295; GO:0043523; GO:0050750; GO:1903203"
"6343","Cluster_2787","Peve_00018721",-0.999787569512439,0.0131223383688255,0.703047117306653,161,-22.62,"2 21","20462 20483",20,"80.00%","80.00%","CDS","Q9PVW8","Rhamnose-binding lectin (RBL) (Roe lectin) (SAL)","Silurus asotus (Amur catfish) (Parasilurus asotus)","","GO:0005576; GO:0030246"
"6353","Cluster_2787","Peve_00018749",0.998587521356217,0.0338405332897438,0.909359886114279,142,-20.21,"2 21","1256 1281",23,"60.87%","69.57%","CDS","Q8BQH6","CUB domain-containing protein 2","Mus musculus (Mouse)","","GO:0005576"
"6367","Cluster_2787","Peve_00018891",0.99879347004041,0.0312757585322912,0.903929377050813,161,-25.21,"2 21","15037 15056",19,"68.42%","89.47%","CDS","Q5T4S7","E3 ubiquitin-protein ligase UBR4 (EC 2.3.2.27) (600 kDa retinoblastoma protein-associated factor) (N-recognin-4) (RING-type E3 ubiquitin transferase UBR4) (Retinoblastoma-associated factor of 600 kDa) (RBAF600) (p600) (Zinc finger UBR1-type protein 1)","Homo sapiens (Human)","ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0004842; GO:0005516; GO:0005654; GO:0005813; GO:0005829; GO:0005886; GO:0006511; GO:0008270; GO:0016020; GO:0035579; GO:0061630; GO:0070821; GO:0101003"
"6385","Cluster_2787","Peve_00019318",0.997831174284316,0.0419359003350525,0.910046115299369,156,-24.05,"2 21","15342 15361",19,"73.68%","84.21%","CDS","P51029","Protein Wnt-8b","Danio rerio (Zebrafish) (Brachydanio rerio)","canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; commissural neuron axon guidance [GO:0071679]; embryonic pattern specification [GO:0009880]; eye development [GO:0001654]; eye field cell fate commitment involved in camera-type eye formation [GO:0060898]; forebrain development [GO:0030900]; forebrain neuron differentiation [GO:0021879]; hypothalamus development [GO:0021854]; negative regulation of anterior neural cell fate commitment of the neural plate by Wnt signaling pathway [GO:0022002]; neuron differentiation [GO:0030182]; otic placode formation [GO:0043049]; sensory epithelium regeneration [GO:0070654]","GO:0001654; GO:0005109; GO:0005125; GO:0005615; GO:0009880; GO:0021854; GO:0021879; GO:0022002; GO:0030182; GO:0030900; GO:0043049; GO:0045165; GO:0060070; GO:0060898; GO:0070654; GO:0071679"
"6386","Cluster_2787","Peve_00019345",0.998480857242945,0.0350953363827291,0.909359886114279,154,-27.29,"2 21","18691 18719",26,"69.23%","69.23%","CDS","Q80T32","Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133) (G-protein coupled receptor PGR25)","Mus musculus (Mouse)","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; neurogenesis [GO:0022008]","GO:0004930; GO:0005654; GO:0005886; GO:0007166; GO:0007186; GO:0007189; GO:0022008"
"6434","Cluster_2787","Peve_00020132",0.999414316705503,0.0217895237502879,0.829230308546931,148,-20.9,"2 21","8579 8598",19,"73.68%","73.68%","CDS",NA,NA,NA,NA,NA
"6449","Cluster_2787","Peve_00020418",0.997336126674048,0.0464780994944581,0.938116783996528,157,-20.05,"2 19","15955 15978",19,"68.42%","84.21%","CDS","O43426","Synaptojanin-1 (EC 3.1.3.36) (Synaptic inositol 1,4,5-trisphosphate 5-phosphatase 1)","Homo sapiens (Human)","brain development [GO:0007420]; inositol phosphate dephosphorylation [GO:0046855]; inositol phosphate metabolic process [GO:0043647]; learning [GO:0007612]; membrane organization [GO:0061024]; neurotransmitter transport [GO:0006836]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; phosphatidylinositol metabolic process [GO:0046488]; positive regulation of endosome organization [GO:1904980]; positive regulation of gliogenesis [GO:0014015]; positive regulation of receptor-mediated endocytosis [GO:0048260]; response to cytokine [GO:0034097]; response to retinoic acid [GO:0032526]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle priming [GO:0016082]; synaptic vesicle transport [GO:0048489]; synaptic vesicle uncoating [GO:0016191]","GO:0003723; GO:0004438; GO:0004439; GO:0005829; GO:0005874; GO:0006661; GO:0006836; GO:0007420; GO:0007612; GO:0008022; GO:0012506; GO:0014015; GO:0016082; GO:0016191; GO:0017124; GO:0030117; GO:0030132; GO:0032526; GO:0034097; GO:0034595; GO:0034596; GO:0043195; GO:0043647; GO:0043812; GO:0043813; GO:0044877; GO:0046488; GO:0046855; GO:0046856; GO:0048260; GO:0048471; GO:0048488; GO:0048489; GO:0052629; GO:0052658; GO:0061024; GO:0097060; GO:0098688; GO:0098793; GO:1904980; GO:1990175"
"6450","Cluster_2787","Peve_00020418",0.997336126674048,0.0464780994944581,0.938116783996528,163,-21.28,"2 21","11255 11278",21,"76.19%","76.19%","CDS","O43426","Synaptojanin-1 (EC 3.1.3.36) (Synaptic inositol 1,4,5-trisphosphate 5-phosphatase 1)","Homo sapiens (Human)","brain development [GO:0007420]; inositol phosphate dephosphorylation [GO:0046855]; inositol phosphate metabolic process [GO:0043647]; learning [GO:0007612]; membrane organization [GO:0061024]; neurotransmitter transport [GO:0006836]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; phosphatidylinositol metabolic process [GO:0046488]; positive regulation of endosome organization [GO:1904980]; positive regulation of gliogenesis [GO:0014015]; positive regulation of receptor-mediated endocytosis [GO:0048260]; response to cytokine [GO:0034097]; response to retinoic acid [GO:0032526]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle priming [GO:0016082]; synaptic vesicle transport [GO:0048489]; synaptic vesicle uncoating [GO:0016191]","GO:0003723; GO:0004438; GO:0004439; GO:0005829; GO:0005874; GO:0006661; GO:0006836; GO:0007420; GO:0007612; GO:0008022; GO:0012506; GO:0014015; GO:0016082; GO:0016191; GO:0017124; GO:0030117; GO:0030132; GO:0032526; GO:0034097; GO:0034595; GO:0034596; GO:0043195; GO:0043647; GO:0043812; GO:0043813; GO:0044877; GO:0046488; GO:0046855; GO:0046856; GO:0048260; GO:0048471; GO:0048488; GO:0048489; GO:0052629; GO:0052658; GO:0061024; GO:0097060; GO:0098688; GO:0098793; GO:1904980; GO:1990175"
"6472","Cluster_2787","Peve_00020792",0.999488779325587,0.0203571899357057,0.810097073649321,165,-21,"2 19","1751 1773",18,"77.78%","88.89%","CDS",NA,NA,NA,NA,NA
"6499","Cluster_2787","Peve_00021264",0.999955012057579,0.00603871890632299,0.573710369894872,148,-20.21,"2 13","5306 5327",11,"81.82%","90.91%","CDS","O15050","TPR and ankyrin repeat-containing protein 1 (Lupus brain antigen 1 homolog)","Homo sapiens (Human)","",""
"6513","Cluster_2787","Peve_00021477",0.999886728835656,0.0095820603692022,0.60909012362496,153,-21.29,"2 15","11361 11383",14,"78.57%","92.86%","CDS","P0DTA4","Propionyl-CoA carboxylase alpha chain, mitochondrial (PCCase subunit alpha) (EC 6.4.1.3) (Propanoyl-CoA:carbon dioxide ligase subunit alpha)","Sus scrofa (Pig)","short-chain fatty acid catabolic process [GO:0019626]","GO:0004658; GO:0005524; GO:0005759; GO:0019626; GO:0046872"
"6518","Cluster_2787","Peve_00021504",0.999979738168967,0.00405261361177111,0.54328949385489,158,-23.68,"2 20","21026 21050",21,"66.67%","80.95%","CDS","Q5VZB9","Doublesex- and mab-3-related transcription factor A1","Homo sapiens (Human)","germ cell development [GO:0007281]; male mating behavior [GO:0060179]; ovarian follicle development [GO:0001541]; regulation of transcription by RNA polymerase II [GO:0006357]; sex differentiation [GO:0007548]","GO:0000785; GO:0000978; GO:0000981; GO:0001541; GO:0005634; GO:0006357; GO:0007281; GO:0007548; GO:0042802; GO:0046872; GO:0060179; GO:1990837"
"6524","Cluster_2787","Peve_00021731",0.999642017056776,0.017034886514364,0.781515462136098,146,-20.6,"2 21","19080 19100",19,"63.16%","73.68%","CDS",NA,NA,NA,NA,NA
"6525","Cluster_2787","Peve_00021731",0.999642017056776,0.017034886514364,0.781515462136098,162,-20.6,"2 21","15374 15398",22,"72.73%","81.82%","CDS",NA,NA,NA,NA,NA
"6544","Cluster_2787","Peve_00022001",0.999999203932145,0.000803285991715918,0.239778920002343,166,-21.51,"2 20","6225 6247",19,"78.95%","84.21%","CDS",NA,NA,NA,NA,NA
"6570","Cluster_2787","Peve_00022290",0.999737413073421,0.0145895257421886,0.734459231692133,167,-23.05,"2 21","1769 1791",20,"80.00%","80.00%","CDS","Q9C6W5","ABC transporter G family member 14 (ABC transporter ABCG.14) (AtABCG14) (Protein INSENSITIVE TO TEMPERATURE 211) (White-brown complex homolog protein 14) (AtWBC14)","Arabidopsis thaliana (Mouse-ear cress)","cotyledon vascular tissue pattern formation [GO:0010588]; cytokinin transport [GO:0010184]; cytokinin-activated signaling pathway [GO:0009736]; defense response to bacterium [GO:0042742]; export across plasma membrane [GO:0140115]; export from cell [GO:0140352]; response to hydrogen peroxide [GO:0042542]; stem vascular tissue pattern formation [GO:0010222]; transmembrane transport [GO:0055085]","GO:0005524; GO:0005886; GO:0009736; GO:0010184; GO:0010222; GO:0010588; GO:0015562; GO:0016020; GO:0016887; GO:0042542; GO:0042626; GO:0042742; GO:0055085; GO:0140115; GO:0140352; GO:0140359"
"6591","Cluster_2787","Peve_00022876",0.999985553864935,0.00342193281993488,0.509926549795741,155,-22.26,"2 21","6986 7008",20,"65.00%","80.00%","CDS","Q9JHU4","Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)","Mus musculus (Mouse)","cell division [GO:0051301]; cilium movement [GO:0003341]; cytoplasmic microtubule organization [GO:0031122]; establishment of spindle localization [GO:0051293]; microtubule-based movement [GO:0007018]; minus-end-directed vesicle transport along microtubule [GO:0072382]; mitotic cell cycle [GO:0000278]; nuclear migration [GO:0007097]; P-body assembly [GO:0033962]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of intracellular transport [GO:0032388]; positive regulation of spindle assembly [GO:1905832]; regulation of metaphase plate congression [GO:0090235]; regulation of mitotic spindle organization [GO:0060236]; retrograde axonal transport [GO:0008090]; stress granule assembly [GO:0034063]","GO:0000278; GO:0002177; GO:0003341; GO:0005524; GO:0005635; GO:0005737; GO:0005813; GO:0005868; GO:0005874; GO:0005881; GO:0005938; GO:0007018; GO:0007097; GO:0008090; GO:0008569; GO:0030175; GO:0030286; GO:0030424; GO:0031122; GO:0032388; GO:0033962; GO:0034063; GO:0043025; GO:0045505; GO:0051293; GO:0051301; GO:0051959; GO:0060236; GO:0072382; GO:0090235; GO:0120162; GO:1904115; GO:1905832"
"6592","Cluster_2787","Peve_00022876",0.999985553864935,0.00342193281993488,0.509926549795741,156,-20.59,"2 19","11319 11339",17,"76.47%","82.35%","CDS","Q9JHU4","Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)","Mus musculus (Mouse)","cell division [GO:0051301]; cilium movement [GO:0003341]; cytoplasmic microtubule organization [GO:0031122]; establishment of spindle localization [GO:0051293]; microtubule-based movement [GO:0007018]; minus-end-directed vesicle transport along microtubule [GO:0072382]; mitotic cell cycle [GO:0000278]; nuclear migration [GO:0007097]; P-body assembly [GO:0033962]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of intracellular transport [GO:0032388]; positive regulation of spindle assembly [GO:1905832]; regulation of metaphase plate congression [GO:0090235]; regulation of mitotic spindle organization [GO:0060236]; retrograde axonal transport [GO:0008090]; stress granule assembly [GO:0034063]","GO:0000278; GO:0002177; GO:0003341; GO:0005524; GO:0005635; GO:0005737; GO:0005813; GO:0005868; GO:0005874; GO:0005881; GO:0005938; GO:0007018; GO:0007097; GO:0008090; GO:0008569; GO:0030175; GO:0030286; GO:0030424; GO:0031122; GO:0032388; GO:0033962; GO:0034063; GO:0043025; GO:0045505; GO:0051293; GO:0051301; GO:0051959; GO:0060236; GO:0072382; GO:0090235; GO:0120162; GO:1904115; GO:1905832"
"6675","Cluster_2787","Peve_00024262",0.999974516288872,0.00454493189547208,0.54328949385489,150,-21.95,"2 21","8721 8746",23,"65.22%","73.91%","CDS","Q32P51","Heterogeneous nuclear ribonucleoprotein A1-like 2 (hnRNP A1-like 2) (hnRNP core protein A1-like 2)","Homo sapiens (Human)","mRNA splicing, via spliceosome [GO:0000398]; mRNA transport [GO:0051028]","GO:0000398; GO:0003730; GO:0005737; GO:0051028; GO:0071013"
"6676","Cluster_2787","Peve_00024262",0.999974516288872,0.00454493189547208,0.54328949385489,158,-20.39,"2 21","7005 7028",21,"71.43%","80.95%","CDS","Q32P51","Heterogeneous nuclear ribonucleoprotein A1-like 2 (hnRNP A1-like 2) (hnRNP core protein A1-like 2)","Homo sapiens (Human)","mRNA splicing, via spliceosome [GO:0000398]; mRNA transport [GO:0051028]","GO:0000398; GO:0003730; GO:0005737; GO:0051028; GO:0071013"
"6695","Cluster_2787","Peve_00024536",0.99951468205366,0.019834710323715,0.802441025798643,163,-20.19,"2 21","702 724",20,"75.00%","80.00%","CDS","Q5R5L7","Arrestin domain-containing protein 3","Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)","","GO:0005764; GO:0005769; GO:0005886"
"6763","Cluster_2787","Peve_00025408",0.997403727712652,0.0458843143728729,0.934400033667991,154,-23.16,"2 21","4415 4435",19,"63.16%","84.21%","CDS","Q4VA61","Cell adhesion molecule DSCAML1 (Down syndrome cell adhesion molecule-like protein 1 homolog)","Mus musculus (Mouse)","axon guidance [GO:0007411]; brain development [GO:0007420]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; dendrite self-avoidance [GO:0070593]; embryonic skeletal system morphogenesis [GO:0048704]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell adhesion [GO:0007162]","GO:0005886; GO:0007156; GO:0007162; GO:0007411; GO:0007420; GO:0009986; GO:0016338; GO:0030424; GO:0042803; GO:0045202; GO:0048704; GO:0070593; GO:0098632"
"6785","Cluster_2787","Peve_00025813",-0.999374785885544,0.0225129360429094,0.83828463858421,156,-22.85,"2 19","6786 6809",19,"73.68%","84.21%","CDS","Q3UMR0","Ankyrin repeat domain-containing protein 27 (VPS9 domain-containing protein) (VPS9-ankyrin-repeat protein)","Mus musculus (Mouse)","early endosome to late endosome transport [GO:0045022]; endocytic recycling [GO:0032456]; endosome to melanosome transport [GO:0035646]; negative regulation of SNARE complex assembly [GO:0035544]; neuron projection morphogenesis [GO:0048812]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of neuron projection development [GO:0010976]; protein transport [GO:0015031]","GO:0000149; GO:0005085; GO:0005096; GO:0005764; GO:0005769; GO:0005770; GO:0005829; GO:0005886; GO:0010976; GO:0015031; GO:0030133; GO:0030659; GO:0031267; GO:0032456; GO:0035544; GO:0035646; GO:0042470; GO:0043005; GO:0043231; GO:0045022; GO:0048812; GO:0050775; GO:0097422"
"6833","Cluster_2787","Peve_00026574",0.999746939611819,0.0143224186683252,0.730004405541176,156,-23.56,"2 13","9642 9663",11,"90.91%","100.00%","CDS","Q99L04","Dehydrogenase/reductase SDR family member 1 (EC 1.1.1.-) (Short chain dehydrogenase/reductase family 19C member 1) (Protein SDR19C1)","Mus musculus (Mouse)","","GO:0004090; GO:0005739; GO:0005743; GO:0005783; GO:0016616; GO:0047045"
"6851","Cluster_2787","Peve_00026798",0.99891167795814,0.0297038832251294,0.903929377050813,154,-20.81,"2 21","14996 15016",19,"68.42%","78.95%","CDS","P41216","Long-chain-fatty-acid--CoA ligase 1 (EC 6.2.1.3) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain acyl-CoA synthetase 1) (LACS 1) (Phytanate--CoA ligase) (EC 6.2.1.24)","Mus musculus (Mouse)","adiponectin-activated signaling pathway [GO:0033211]; fatty acid metabolic process [GO:0006631]; fatty acid transport [GO:0015908]; lipid biosynthetic process [GO:0008610]; long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of long-chain fatty acid import across plasma membrane [GO:0010747]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; response to nutrient [GO:0007584]; response to oleic acid [GO:0034201]; response to organic cyclic compound [GO:0014070]; response to organic substance [GO:0010033]; triglyceride biosynthetic process [GO:0019432]; very long-chain fatty acid metabolic process [GO:0000038]; xenobiotic catabolic process [GO:0042178]","GO:0000038; GO:0001676; GO:0004467; GO:0005524; GO:0005739; GO:0005741; GO:0005778; GO:0005783; GO:0005789; GO:0005886; GO:0006631; GO:0007584; GO:0008610; GO:0010033; GO:0010747; GO:0014070; GO:0015908; GO:0016020; GO:0019432; GO:0033211; GO:0034201; GO:0035338; GO:0042178; GO:0044539; GO:0047676; GO:0050197; GO:0070251; GO:0071902; GO:0090434; GO:0120162"
"6852","Cluster_2787","Peve_00026798",0.99891167795814,0.0297038832251294,0.903929377050813,162,-22.73,"2 20","11147 11169",19,"78.95%","78.95%","CDS","P41216","Long-chain-fatty-acid--CoA ligase 1 (EC 6.2.1.3) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain acyl-CoA synthetase 1) (LACS 1) (Phytanate--CoA ligase) (EC 6.2.1.24)","Mus musculus (Mouse)","adiponectin-activated signaling pathway [GO:0033211]; fatty acid metabolic process [GO:0006631]; fatty acid transport [GO:0015908]; lipid biosynthetic process [GO:0008610]; long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of long-chain fatty acid import across plasma membrane [GO:0010747]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; response to nutrient [GO:0007584]; response to oleic acid [GO:0034201]; response to organic cyclic compound [GO:0014070]; response to organic substance [GO:0010033]; triglyceride biosynthetic process [GO:0019432]; very long-chain fatty acid metabolic process [GO:0000038]; xenobiotic catabolic process [GO:0042178]","GO:0000038; GO:0001676; GO:0004467; GO:0005524; GO:0005739; GO:0005741; GO:0005778; GO:0005783; GO:0005789; GO:0005886; GO:0006631; GO:0007584; GO:0008610; GO:0010033; GO:0010747; GO:0014070; GO:0015908; GO:0016020; GO:0019432; GO:0033211; GO:0034201; GO:0035338; GO:0042178; GO:0044539; GO:0047676; GO:0050197; GO:0070251; GO:0071902; GO:0090434; GO:0120162"
"6853","Cluster_2787","Peve_00026855",0.997509002164895,0.0449440276735495,0.930099826201662,147,-20.54,"2 18","1124 1148",19,"68.42%","78.95%","CDS","Q9UKP5","A disintegrin and metalloproteinase with thrombospondin motifs 6 (ADAM-TS 6) (ADAM-TS6) (ADAMTS-6) (EC 3.4.24.-)","Homo sapiens (Human)","aorta development [GO:0035904]; cardiac septum development [GO:0003279]; coronary vasculature development [GO:0060976]; extracellular matrix organization [GO:0030198]; kidney development [GO:0001822]; proteolysis [GO:0006508]","GO:0001822; GO:0003279; GO:0004222; GO:0005576; GO:0006508; GO:0008237; GO:0030198; GO:0031012; GO:0035904; GO:0046872; GO:0060976"
"6867","Cluster_2787","Peve_00027141",-0.998668319889808,0.0328581633481719,0.909359886114279,156,-24.31,"2 18","3959 3982",18,"72.22%","83.33%","CDS","Q95M17","Acidic mammalian chitinase (AMCase) (EC 3.2.1.14) (Chitin-binding protein b04) (CBPb04)","Bos taurus (Bovine)","apoptotic process [GO:0006915]; chitin catabolic process [GO:0006032]; immune system process [GO:0002376]; polysaccharide catabolic process [GO:0000272]; positive regulation of chemokine production [GO:0032722]; production of molecular mediator involved in inflammatory response [GO:0002532]","GO:0000272; GO:0002376; GO:0002532; GO:0004568; GO:0005615; GO:0005737; GO:0006032; GO:0006915; GO:0008061; GO:0032722"
"6868","Cluster_2787","Peve_00027141",-0.998668319889808,0.0328581633481719,0.909359886114279,156,-24.31,"2 18","5147 5170",18,"72.22%","83.33%","CDS","Q95M17","Acidic mammalian chitinase (AMCase) (EC 3.2.1.14) (Chitin-binding protein b04) (CBPb04)","Bos taurus (Bovine)","apoptotic process [GO:0006915]; chitin catabolic process [GO:0006032]; immune system process [GO:0002376]; polysaccharide catabolic process [GO:0000272]; positive regulation of chemokine production [GO:0032722]; production of molecular mediator involved in inflammatory response [GO:0002532]","GO:0000272; GO:0002376; GO:0002532; GO:0004568; GO:0005615; GO:0005737; GO:0006032; GO:0006915; GO:0008061; GO:0032722"
"6881","Cluster_2787","Peve_00027053",0.999963682861668,0.00542565587934728,0.551398425649056,147,-20.2,"2 21","1363 1388",23,"56.52%","73.91%","CDS","Q5ZK62","Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 2 (Centaurin-beta-2) (Cnt-b2)","Gallus gallus (Chicken)","cellular response to nerve growth factor stimulus [GO:1990090]; endocytic recycling [GO:0032456]","GO:0005096; GO:0010008; GO:0032456; GO:0046872; GO:1990090"
"6934","Cluster_2787","Peve_00028185",0.999599913721229,0.0180088686322114,0.782669382293497,160,-20.42,"2 21","9618 9639",19,"68.42%","78.95%","CDS","Q96AC1","Fermitin family homolog 2 (Kindlin-2) (Mitogen-inducible gene 2 protein) (MIG-2) (Pleckstrin homology domain-containing family C member 1) (PH domain-containing family C member 1)","Homo sapiens (Human)","adherens junction maintenance [GO:0034334]; cell adhesion [GO:0007155]; cell-matrix adhesion [GO:0007160]; focal adhesion assembly [GO:0048041]; integrin activation [GO:0033622]; integrin-mediated signaling pathway [GO:0007229]; limb development [GO:0060173]; negative regulation of cell death [GO:0060548]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of vascular permeability [GO:0043116]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of GTPase activity [GO:0043547]; positive regulation of integrin activation [GO:0033625]; positive regulation of mesenchymal stem cell proliferation [GO:1902462]; positive regulation of myosin light chain kinase activity [GO:0035505]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of wound healing, spreading of epidermal cells [GO:1903691]; protein localization to cell junction [GO:1902414]; protein localization to membrane [GO:0072657]; regulation of cell morphogenesis [GO:0022604]; regulation of cell shape [GO:0008360]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; Wnt signaling pathway [GO:0016055]","GO:0001725; GO:0003779; GO:0005178; GO:0005547; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0005912; GO:0005925; GO:0005938; GO:0007155; GO:0007160; GO:0007179; GO:0007229; GO:0008360; GO:0009986; GO:0010718; GO:0016055; GO:0019901; GO:0022604; GO:0030054; GO:0030055; GO:0030335; GO:0031234; GO:0031258; GO:0031674; GO:0033622; GO:0033625; GO:0034334; GO:0034446; GO:0034713; GO:0035505; GO:0043116; GO:0043547; GO:0045599; GO:0045669; GO:0046332; GO:0048041; GO:0051015; GO:0051496; GO:0051894; GO:0051897; GO:0060173; GO:0060548; GO:0070374; GO:0072657; GO:1900026; GO:1900182; GO:1902414; GO:1902462; GO:1903691"
"6961","Cluster_2787","Peve_00028650",0.999981475796067,0.00387494522615433,0.54328949385489,159,-20.14,"2 18","33453 33473",16,"81.25%","87.50%","CDS",NA,NA,NA,NA,NA
"7018","Cluster_2787","Peve_00029338",0.99719372066599,0.0477048115691659,0.944331453217319,151,-23.57,"2 21","5094 5116",20,"65.00%","75.00%","CDS","Q8WML3","Histone acetyltransferase KAT6B (EC 2.3.1.48) (MOZ, YBF2/SAS3, SAS2 and TIP60 protein 4) (MYST-4)","Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)","histone acetylation [GO:0016573]; negative regulation of DNA-templated transcription [GO:0045892]; nucleosome assembly [GO:0006334]; positive regulation of DNA-templated transcription [GO:0045893]","GO:0000786; GO:0003677; GO:0003713; GO:0004402; GO:0005634; GO:0006334; GO:0016573; GO:0045892; GO:0045893; GO:0046872; GO:0061733; GO:0070776"
"7062","Cluster_2787","Peve_00030641",0.998537133427223,0.0344389923541351,0.909359886114279,159,-24.59,"2 21","3698 3722",22,"68.18%","77.27%","CDS","O35593","26S proteasome non-ATPase regulatory subunit 14 (EC 3.4.19.-) (26S proteasome regulatory subunit RPN11) (MAD1)","Mus musculus (Mouse)","double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein K63-linked deubiquitination [GO:0070536]; regulation of proteasomal protein catabolic process [GO:0061136]; response to ethanol [GO:0045471]","GO:0000502; GO:0000724; GO:0004175; GO:0006303; GO:0008237; GO:0008541; GO:0016579; GO:0022624; GO:0031597; GO:0043161; GO:0045471; GO:0046872; GO:0061133; GO:0061136; GO:0070536; GO:0070628; GO:0140492"
"7068","Cluster_2787","Peve_00030841",0.997836013002892,0.0418890771515329,0.909699887923376,156,-22.96,"2 21","2047 2067",20,"75.00%","80.00%","CDS","A0A481NSZ4",NA,NA,NA,NA
"7081","Cluster_2787","Peve_00031195",0.99925323466706,0.0246044819355876,0.863533862391494,159,-24.51,"2 21","4598 4616",19,"78.95%","84.21%","CDS","Q8CDI7","Coiled-coil domain-containing protein 150","Mus musculus (Mouse)","",""
"7100","Cluster_2787","Peve_00031564",0.999359286033301,0.0227903191671166,0.841473937269332,165,-21.75,"2 20","880 900",18,"83.33%","83.33%","CDS",NA,NA,NA,NA,NA
"7107","Cluster_2787","Peve_00031465",0.997462783776488,0.0453592357210168,0.932422928166732,153,-20.78,"2 21","4511 4533",21,"71.43%","76.19%","CDS","Q9HAR2","Adhesion G protein-coupled receptor L3 (Calcium-independent alpha-latrotoxin receptor 3) (CIRL-3) (Latrophilin-3) (Lectomedin-3)","Homo sapiens (Human)","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; brain development [GO:0007420]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; G protein-coupled receptor signaling pathway [GO:0007186]; neuron migration [GO:0001764]; synapse assembly [GO:0007416]","GO:0001764; GO:0004930; GO:0005509; GO:0005886; GO:0005911; GO:0007166; GO:0007186; GO:0007189; GO:0007416; GO:0007420; GO:0016020; GO:0030246; GO:0030424; GO:0098742; GO:0098978"
"7112","Cluster_2787","Peve_00031473",0.999991589178695,0.00261104663249684,0.42960878103792,155,-21.41,"2 21","249 272",21,"66.67%","76.19%","CDS",NA,NA,NA,NA,NA
"7113","Cluster_2787","Peve_00031638",0.999978115201414,0.00421179466202015,0.54328949385489,162,-23.08,"2 21","12253 12273",19,"73.68%","84.21%","CDS",NA,NA,NA,NA,NA
"7117","Cluster_2787","Peve_00031656",0.998196352178269,0.0382416206805407,0.909359886114279,159,-20.18,"2 21","13854 13876",20,"70.00%","80.00%","CDS","P18907","Sodium/potassium-transporting ATPase subunit alpha-1 (Sodium pump subunit alpha-1) (EC 7.2.2.13) (Na(+)/K(+) ATPase alpha-1 subunit)","Equus caballus (Horse)","cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; potassium ion import across plasma membrane [GO:1990573]; proton transmembrane transport [GO:1902600]; regulation of sodium ion transport [GO:0002028]; sodium ion export across plasma membrane [GO:0036376]","GO:0002028; GO:0005391; GO:0005524; GO:0005886; GO:0005890; GO:0006883; GO:0016020; GO:0016323; GO:0016887; GO:0019829; GO:0030007; GO:0030424; GO:0036376; GO:0042383; GO:0042470; GO:0046872; GO:1902600; GO:1990573"
"7146","Cluster_2787","Peve_00032481",0.999978115201415,0.00421179466200947,0.54328949385489,166,-25.48,"2 21","3311 3331",19,"78.95%","84.21%","CDS",NA,NA,NA,NA,NA
"7147","Cluster_2787","Peve_00032506",-0.999036126103867,0.02795375278729,0.900066868667072,157,-21.83,"2 20","18029 18049",18,"66.67%","88.89%","CDS","Q8R4Y8","Rotatin","Mus musculus (Mouse)","centriole replication [GO:0007099]; centriole-centriole cohesion [GO:0010457]; ciliary basal body organization [GO:0032053]; determination of left/right symmetry [GO:0007368]","GO:0005737; GO:0005813; GO:0005814; GO:0007099; GO:0007368; GO:0010457; GO:0016020; GO:0032053; GO:0036064"
"7148","Cluster_2787","Peve_00032506",-0.999036126103867,0.02795375278729,0.900066868667072,161,-20.87,"2 18","15352 15373",16,"75.00%","87.50%","CDS","Q8R4Y8","Rotatin","Mus musculus (Mouse)","centriole replication [GO:0007099]; centriole-centriole cohesion [GO:0010457]; ciliary basal body organization [GO:0032053]; determination of left/right symmetry [GO:0007368]","GO:0005737; GO:0005813; GO:0005814; GO:0007099; GO:0007368; GO:0010457; GO:0016020; GO:0032053; GO:0036064"
"7149","Cluster_2787","Peve_00032517",0.999599545379435,0.0180171572637455,0.782669382293497,155,-20.07,"2 19","21584 21605",18,"77.78%","83.33%","CDS","B3EWZ6","MAM and LDL-receptor class A domain-containing protein 2 (Skeletal organic matrix MAM and LDL-receptor 2) (SOM MAM and LDL-receptor 2)","Acropora millepora (Staghorn coral) (Heteropora millepora)","","GO:0005576; GO:0016020"
"7164","Cluster_2787","Peve_00032682",0.999628088147808,0.0173631529557996,0.782669382293497,159,-21.87,"2 21","33923 33945",20,"70.00%","80.00%","CDS","O15381","Nuclear valosin-containing protein-like (NVLp) (Nuclear VCP-like protein)","Homo sapiens (Human)","positive regulation of protein binding [GO:0032092]; positive regulation of telomerase activity [GO:0051973]; regulation of protein localization to nucleolus [GO:1904749]; ribosomal large subunit biogenesis [GO:0042273]; ribosome biogenesis [GO:0042254]; rRNA processing [GO:0006364]","GO:0003723; GO:0005524; GO:0005634; GO:0005654; GO:0005697; GO:0005730; GO:0006364; GO:0016020; GO:0016887; GO:0032092; GO:0042254; GO:0042273; GO:0051973; GO:1904749; GO:1990275"
"7166","Cluster_2787","Peve_00032828",0.999988003727036,0.00311830595838265,0.481935248631868,145,-20.8,"2 21","4159 4180",20,"60.00%","80.00%","CDS","Q5ZKF6","7-methylguanosine phosphate-specific 5'-nucleotidase (7-methylguanosine nucleotidase) (EC 3.1.3.91) (Cytosolic 5'-nucleotidase 3B) (Cytosolic 5'-nucleotidase III-like protein) (cN-III-like protein) (EC 3.1.3.5) (N(7)-methylguanylate 5'-phosphatase)","Gallus gallus (Chicken)","nucleotide metabolic process [GO:0009117]","GO:0000166; GO:0000287; GO:0005737; GO:0009117; GO:0016787"
"7167","Cluster_2787","Peve_00032838",0.998122190167769,0.039020147682088,0.909359886114279,150,-20.67,"2 20","3873 3897",21,"57.14%","80.95%","CDS","Q0P410","S-adenosylmethionine sensor upstream of mTORC1 (Probable methyltransferase BMT2 homolog) (EC 2.1.1.-)","Danio rerio (Zebrafish) (Brachydanio rerio)","cellular response to amino acid starvation [GO:0034198]; methylation [GO:0032259]; negative regulation of TORC1 signaling [GO:1904262]","GO:0008168; GO:0032259; GO:0034198; GO:1904047; GO:1904262"
"7170","Cluster_2787","Peve_00032861",0.997807072719316,0.0421683523975289,0.911155492969778,180,-28.74,"2 21","2014 2035",19,"78.95%","94.74%","CDS","Q96DI7","U5 small nuclear ribonucleoprotein 40 kDa protein (U5 snRNP 40 kDa protein) (U5-40K) (38 kDa-splicing factor) (Prp8-binding protein) (hPRP8BP) (U5 snRNP-specific 40 kDa protein) (WD repeat-containing protein 57)","Homo sapiens (Human)","mRNA splicing, via spliceosome [GO:0000398]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]","GO:0000375; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005682; GO:0005732; GO:0005829; GO:0006396; GO:0008380; GO:0016607; GO:0046540; GO:0071007; GO:0071013"
"7179","Cluster_2787","Peve_00033060",0.9990684077698,0.0274815846094019,0.895349114009296,147,-20.35,"2 21","2289 2311",20,"65.00%","70.00%","CDS","Q9UKP5","A disintegrin and metalloproteinase with thrombospondin motifs 6 (ADAM-TS 6) (ADAM-TS6) (ADAMTS-6) (EC 3.4.24.-)","Homo sapiens (Human)","aorta development [GO:0035904]; cardiac septum development [GO:0003279]; coronary vasculature development [GO:0060976]; extracellular matrix organization [GO:0030198]; kidney development [GO:0001822]; proteolysis [GO:0006508]","GO:0001822; GO:0003279; GO:0004222; GO:0005576; GO:0006508; GO:0008237; GO:0030198; GO:0031012; GO:0035904; GO:0046872; GO:0060976"
"7187","Cluster_2787","Peve_00033299",0.998005749759204,0.0402121365010448,0.909359886114279,162,-20.45,"2 19","13349 13370",17,"70.59%","88.24%","CDS","Q9Y6R4","Mitogen-activated protein kinase kinase kinase 4 (EC 2.7.11.25) (MAP three kinase 1) (MAPK/ERK kinase kinase 4) (MEK kinase 4) (MEKK 4)","Homo sapiens (Human)","chorionic trophoblast cell differentiation [GO:0060718]; intracellular signal transduction [GO:0035556]; male germ-line sex determination [GO:0019100]; MAPK cascade [GO:0000165]; placenta development [GO:0001890]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein phosphorylation [GO:0006468]; regulation of gene expression [GO:0010468]; response to UV-C [GO:0010225]","GO:0000165; GO:0001890; GO:0004709; GO:0005524; GO:0005737; GO:0006468; GO:0010225; GO:0010468; GO:0019100; GO:0032212; GO:0035556; GO:0043507; GO:0046872; GO:0048471; GO:0051973; GO:0060718; GO:0106310; GO:1900745; GO:1904355"
"7223","Cluster_2787","Peve_00034184",-0.999828291583492,0.0117976939825935,0.669806564206444,163,-20.95,"2 17","1852 1875",17,"82.35%","88.24%","CDS","Q03720","Calcium-activated potassium channel slowpoke (dSlo) (BK channel) (Maxi K channel) (MaxiK)","Drosophila melanogaster (Fruit fly)","circadian behavior [GO:0048512]; circadian rhythm [GO:0007623]; male courtship behavior, veined wing generated song production [GO:0045433]; negative regulation of neuromuscular synaptic transmission [GO:1900074]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]; regulation of synaptic assembly at neuromuscular junction [GO:0008582]; response to xenobiotic stimulus [GO:0009410]","GO:0005244; GO:0005886; GO:0006813; GO:0007623; GO:0008582; GO:0009410; GO:0015269; GO:0016020; GO:0034765; GO:0043005; GO:0043025; GO:0045211; GO:0045433; GO:0048512; GO:0060072; GO:1900074"
"7231","Cluster_2787","Peve_00034279",-0.998798423387131,0.031211479105201,0.903929377050813,156,-20.47,"2 18","2773 2795",17,"70.59%","88.24%","CDS","Q5JTD7","Leucine-rich repeat-containing protein 73","Homo sapiens (Human)","",""
"7260","Cluster_2787","Peve_00034941",0.999365959883862,0.0226713007702915,0.840165031394075,150,-21.06,"2 11","50 71",9,"100.00%","100.00%","CDS",NA,NA,NA,NA,NA
"7282","Cluster_2787","Peve_00035307",0.999619556547579,0.0175611902362094,0.782669382293497,150,-21.46,"2 21","9461 9485",22,"63.64%","77.27%","CDS","P49614","Beta-hexosaminidase subunit beta (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit beta) (Hexosaminidase subunit B) (N-acetyl-beta-glucosaminidase subunit beta)","Felis catus (Cat) (Felis silvestris catus)","carbohydrate metabolic process [GO:0005975]; ganglioside catabolic process [GO:0006689]; glycosaminoglycan metabolic process [GO:0030203]; single fertilization [GO:0007338]","GO:0004563; GO:0005764; GO:0005975; GO:0006689; GO:0007338; GO:0016020; GO:0030203; GO:0060473; GO:0102148"
"7309","Cluster_2787","Peve_00035821",0.999361810020579,0.0227453807293251,0.841171820670076,157,-20.59,"2 19","17209 17231",18,"72.22%","83.33%","CDS","Q9VT28","Protein furry","Drosophila melanogaster (Fruit fly)","antennal morphogenesis [GO:0048800]; cell morphogenesis [GO:0000902]; chaeta morphogenesis [GO:0008407]; dendrite self-avoidance [GO:0070593]; imaginal disc-derived wing hair organization [GO:0035317]; imaginal disc-derived wing morphogenesis [GO:0007476]; microtubule sliding [GO:0051012]; negative regulation of neuron projection arborization [GO:0150013]; neuron projection development [GO:0031175]; non-sensory hair organization [GO:0035316]; oocyte morphogenesis [GO:0048601]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; regulation of dendrite development [GO:0050773]; regulation of dendrite morphogenesis [GO:0048814]; rhabdomere development [GO:0042052]","GO:0000902; GO:0005737; GO:0005938; GO:0007476; GO:0008407; GO:0030424; GO:0030425; GO:0030427; GO:0031175; GO:0035316; GO:0035317; GO:0042052; GO:0044297; GO:0045177; GO:0045860; GO:0045893; GO:0048601; GO:0048800; GO:0048814; GO:0050773; GO:0051012; GO:0070593; GO:0071902; GO:0150013"
"7310","Cluster_2787","Peve_00035821",0.999361810020579,0.0227453807293251,0.841171820670076,157,-20.59,"2 19","17584 17606",18,"72.22%","83.33%","CDS","Q9VT28","Protein furry","Drosophila melanogaster (Fruit fly)","antennal morphogenesis [GO:0048800]; cell morphogenesis [GO:0000902]; chaeta morphogenesis [GO:0008407]; dendrite self-avoidance [GO:0070593]; imaginal disc-derived wing hair organization [GO:0035317]; imaginal disc-derived wing morphogenesis [GO:0007476]; microtubule sliding [GO:0051012]; negative regulation of neuron projection arborization [GO:0150013]; neuron projection development [GO:0031175]; non-sensory hair organization [GO:0035316]; oocyte morphogenesis [GO:0048601]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; regulation of dendrite development [GO:0050773]; regulation of dendrite morphogenesis [GO:0048814]; rhabdomere development [GO:0042052]","GO:0000902; GO:0005737; GO:0005938; GO:0007476; GO:0008407; GO:0030424; GO:0030425; GO:0030427; GO:0031175; GO:0035316; GO:0035317; GO:0042052; GO:0044297; GO:0045177; GO:0045860; GO:0045893; GO:0048601; GO:0048800; GO:0048814; GO:0050773; GO:0051012; GO:0070593; GO:0071902; GO:0150013"
"7322","Cluster_2787","Peve_00035885",0.997398092984475,0.0459341006789982,0.934597365740041,156,-21.49,"2 15","7295 7315",13,"92.31%","92.31%","CDS","D3YXS5","Kinesin-like protein KIF28 (Kinesin family member 28) (Kinesin-like protein 6)","Mus musculus (Mouse)","microtubule-based movement [GO:0007018]; mitochondrion organization [GO:0007005]; organelle transport along microtubule [GO:0072384]","GO:0003777; GO:0005524; GO:0005871; GO:0005874; GO:0007005; GO:0007018; GO:0008017; GO:0016887; GO:0031966; GO:0072384"
"7344","Cluster_2787","Peve_00036426",-0.999557126167793,0.0189474670428339,0.788323450098016,158,-23.37,"2 21","2095 2118",21,"71.43%","80.95%","CDS",NA,NA,NA,NA,NA
"7350","Cluster_2787","Peve_00036514",0.99802220152848,0.0400458710105364,0.909359886114279,162,-21.63,"2 21","36348 36368",19,"68.42%","89.47%","CDS","Q9QYP1","Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7)","Rattus norvegicus (Rat)","amyloid-beta clearance by cellular catabolic process [GO:0150094]; anatomical structure development [GO:0048856]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; endocytosis [GO:0006897]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; protein localization [GO:0008104]; proximal/distal pattern formation [GO:0009954]; receptor clustering [GO:0043113]; regulation of protein phosphorylation [GO:0001932]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055]","GO:0001822; GO:0001932; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0008104; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0016055; GO:0030279; GO:0030326; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0043113; GO:0044853; GO:0048699; GO:0048813; GO:0048856; GO:0050731; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150094; GO:1901631; GO:1904395"
"7366","Cluster_2787","Peve_00036864",0.999926519877196,0.00771760802126556,0.573710369894872,159,-24.52,"2 21","7781 7804",21,"66.67%","80.95%","CDS","Q0E908","Hillarin (D-Hillarin) (D-hil)","Drosophila melanogaster (Fruit fly)","","GO:0005938; GO:0032154; GO:0046872"
"7386","Cluster_2787","Peve_00037061",-0.999649545771953,0.0168547943103946,0.778328904052462,152,-20.45,"2 21","3728 3749",19,"63.16%","73.68%","CDS","Q92820","Gamma-glutamyl hydrolase (EC 3.4.19.9) (Conjugase) (GH) (Gamma-Glu-X carboxypeptidase)","Homo sapiens (Human)","tetrahydrofolylpolyglutamate metabolic process [GO:0046900]","GO:0005576; GO:0005615; GO:0005634; GO:0005773; GO:0008238; GO:0008242; GO:0034722; GO:0035578; GO:0035580; GO:0042470; GO:0046900; GO:0070062; GO:1904724"
"7434","Cluster_2787","Peve_00036941",0.997625825176949,0.043877050934988,0.9223980576249,160,-22.17,"2 21","25975 25996",19,"63.16%","84.21%","CDS","Q8C9W3","A disintegrin and metalloproteinase with thrombospondin motifs 2 (ADAM-TS 2) (ADAM-TS2) (ADAMTS-2) (EC 3.4.24.14) (Procollagen I N-proteinase) (PC I-NP) (Procollagen I/II amino propeptide-processing enzyme) (Procollagen N-endopeptidase) (pNPI)","Mus musculus (Mouse)","collagen catabolic process [GO:0030574]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; lung development [GO:0030324]; protein processing [GO:0016485]; skin development [GO:0043588]; spermatogenesis [GO:0007283]","GO:0004222; GO:0005576; GO:0007283; GO:0008233; GO:0008270; GO:0016485; GO:0030198; GO:0030199; GO:0030324; GO:0030574; GO:0031012; GO:0043588; GO:0062023"
"7442","Cluster_2787","Peve_00038239",0.999697706867341,0.0156538151958382,0.756052270871415,159,-21.88,"2 21","44193 44215",20,"65.00%","85.00%","CDS","P26714","Gamma-aminobutyric acid receptor subunit beta (GABA(A) receptor)","Lymnaea stagnalis (Great pond snail) (Helix stagnalis)","","GO:0004890; GO:0005230; GO:0005254; GO:0034707; GO:0045211"
"7466","Cluster_2787","Peve_00038670",0.998301344116502,0.0371115693761464,0.909359886114279,170,-21.23,"2 21","14706 14726",19,"84.21%","84.21%","CDS","P14272","Plasma kallikrein (EC 3.4.21.34) (Fletcher factor) (Kininogenin) (Plasma prekallikrein) [Cleaved into: Plasma kallikrein heavy chain; Plasma kallikrein light chain]","Rattus norvegicus (Rat)","blood coagulation, intrinsic pathway [GO:0007597]; fibrinolysis [GO:0042730]; inflammatory response [GO:0006954]; liver regeneration [GO:0097421]; plasminogen activation [GO:0031639]; positive regulation of fibrinolysis [GO:0051919]; proteolysis [GO:0006508]; zymogen activation [GO:0031638]","GO:0004252; GO:0005615; GO:0006508; GO:0006954; GO:0007597; GO:0031638; GO:0031639; GO:0042730; GO:0051919; GO:0097421"
"7483","Cluster_2787","Peve_00038927",0.998051613088915,0.0397469000009701,0.909359886114279,150,-23.11,"2 21","4173 4193",19,"68.42%","73.68%","CDS","Q14832","Metabotropic glutamate receptor 3 (mGluR3)","Homo sapiens (Human)","chemical synaptic transmission [GO:0007268]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; gene expression [GO:0010467]; negative regulation of adenylate cyclase activity [GO:0007194]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; regulation of synaptic transmission, glutamatergic [GO:0051966]","GO:0001640; GO:0001641; GO:0004930; GO:0005246; GO:0005886; GO:0007194; GO:0007216; GO:0007268; GO:0008066; GO:0010467; GO:0014069; GO:0030424; GO:0042734; GO:0043197; GO:0045211; GO:0051966; GO:0097110; GO:0097449; GO:0098978; GO:0099170"
"7495","Cluster_2787","Peve_00039096",0.997430536559693,0.0456466991605926,0.933474458367638,147,-20.27,"2 21","11407 11430",21,"61.90%","71.43%","CDS","A4IIL4","BRO1 domain-containing protein BROX (BRO1 domain- and CAAX motif-containing protein)","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","","GO:0016020"
"7496","Cluster_2787","Peve_00039096",0.997430536559693,0.0456466991605926,0.933474458367638,156,-21.92,"2 19","10181 10205",20,"75.00%","80.00%","CDS","A4IIL4","BRO1 domain-containing protein BROX (BRO1 domain- and CAAX motif-containing protein)","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","","GO:0016020"
"7499","Cluster_2787","Peve_00039063",0.997105325686941,0.0484506705316052,0.946735628940312,161,-21.98,"2 18","3680 3701",16,"75.00%","87.50%","CDS","Q8K2J9","BTB/POZ domain-containing protein 6","Mus musculus (Mouse)","neurogenesis [GO:0022008]","GO:0005829; GO:0022008"
"7515","Cluster_2787","Peve_00039669",0.998598356942047,0.0337104520372765,0.909359886114279,157,-23.34,"2 21","7339 7360",20,"75.00%","80.00%","CDS","Q5XK92","Protein CIP2A homolog","Xenopus laevis (African clawed frog)","","GO:0005737; GO:0016020"
"7526","Cluster_2787","Peve_00039735",0.99963307893818,0.0172462517680552,0.782669382293497,154,-20.72,"2 19","3236 3257",17,"70.59%","76.47%","CDS","Q9Y2G3","Phospholipid-transporting ATPase IF (EC 7.6.2.1) (ATPase IR) (ATPase class VI type 11B) (P4-ATPase flippase complex alpha subunit ATP11B)","Homo sapiens (Human)","aminophospholipid transport [GO:0015917]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; phospholipid translocation [GO:0045332]","GO:0000287; GO:0005524; GO:0005637; GO:0005783; GO:0005802; GO:0005886; GO:0006811; GO:0015075; GO:0015917; GO:0016020; GO:0016887; GO:0031901; GO:0034220; GO:0035577; GO:0045332; GO:0055037; GO:0055038; GO:0090555; GO:0090556; GO:0140326; GO:1990531"
"7528","Cluster_2787","Peve_00039588",0.998194007213558,0.0382664795011216,0.909359886114279,154,-23.56,"2 21","20366 20389",21,"71.43%","76.19%","CDS",NA,NA,NA,NA,NA
"7543","Cluster_2787","Peve_00040141",0.999981133900363,0.00391054119681501,0.54328949385489,149,-23.52,"2 21","1792 1819",25,"68.00%","72.00%","CDS","Q8BWW4","La-related protein 4 (La ribonucleoprotein domain family member 4)","Mus musculus (Mouse)","cytoskeleton organization [GO:0007010]; positive regulation of translation [GO:0045727]; post-transcriptional regulation of gene expression [GO:0010608]; regulation of cell morphogenesis [GO:0022604]; translation [GO:0006412]","GO:0003723; GO:0003730; GO:0005829; GO:0005844; GO:0006412; GO:0007010; GO:0008143; GO:0010494; GO:0010608; GO:0022604; GO:0022627; GO:0045727"
"7562","Cluster_2787","Peve_00040544",0.999182752758358,0.0257395786957529,0.877090006169449,157,-20.96,"2 14","511 532",12,"83.33%","100.00%","CDS",NA,NA,NA,NA,NA
"7576","Cluster_2787","Peve_00040758",0.998547527735705,0.0343163924254722,0.909359886114279,160,-20.07,"2 21","2090 2112",21,"80.95%","80.95%","CDS","Q9VAU9","Zinc finger protein 330 homolog (Nucleolar autoantigen 36 homolog)","Drosophila melanogaster (Fruit fly)","larval lymph gland hemopoiesis [GO:0035167]","GO:0000775; GO:0005634; GO:0005730; GO:0008270; GO:0030496; GO:0035167"
"7599","Cluster_2787","Peve_00041010",0.997467141500268,0.045320249773458,0.932139733194064,152,-20.38,"2 18","3922 3944",17,"64.71%","88.24%","CDS",NA,NA,NA,NA,NA
"7610","Cluster_2787","Peve_00041134",0.999935504551868,0.00723039439541066,0.573710369894872,166,-26.05,"2 19","1420 1441",17,"76.47%","88.24%","CDS","B3EWZ9","Hephaestin-like protein (EC 1.-.-.-)","Acropora millepora (Staghorn coral) (Heteropora millepora)","copper ion transport [GO:0006825]","GO:0005507; GO:0005576; GO:0006825; GO:0016020; GO:0016491"
"7612","Cluster_2787","Peve_00041037",0.998942356327033,0.0292821589318241,0.903929377050813,150,-22.94,"2 21","7223 7249",24,"58.33%","79.17%","CDS","Q8BM14","Lipase member K (EC 3.1.1.-) (Lipase-like abhydrolase domain-containing protein 2)","Mus musculus (Mouse)","lipid catabolic process [GO:0016042]","GO:0005576; GO:0016042; GO:0016788; GO:0043231"
"7647","Cluster_2787","Peve_00041609",0.99948661934441,0.020400154311116,0.810097073649321,163,-23.12,"2 16","18149 18170",14,"85.71%","92.86%","CDS",NA,NA,NA,NA,NA
"7648","Cluster_2787","Peve_00041609",0.99948661934441,0.020400154311116,0.810097073649321,165,-25.08,"2 14","17708 17729",12,"100.00%","100.00%","CDS",NA,NA,NA,NA,NA
"7708","Cluster_2787","Peve_00042855",0.999964675100817,0.00535102358037463,0.551398425649056,154,-21.98,"2 21","2837 2861",22,"63.64%","81.82%","CDS","Q80TT2","BAI1-associated protein 3 (BAP3) (Brain-specific angiogenesis inhibitor I-associated protein 3) (Baiap3)","Mus musculus (Mouse)","dense core granule maturation [GO:1990502]; exocytosis [GO:0006887]; G protein-coupled receptor signaling pathway [GO:0007186]; modulation of chemical synaptic transmission [GO:0050804]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of neurotransmitter secretion [GO:0001956]; regulation of behavior [GO:0050795]; regulation of dense core granule exocytosis [GO:1905413]; regulation of synaptic transmission, GABAergic [GO:0032228]; retrograde transport, endosome to Golgi [GO:0042147]","GO:0000149; GO:0001956; GO:0005509; GO:0005543; GO:0005829; GO:0005886; GO:0006887; GO:0007186; GO:0019905; GO:0031902; GO:0032228; GO:0032588; GO:0035774; GO:0042147; GO:0050795; GO:0050804; GO:0055038; GO:0098793; GO:0098982; GO:0099503; GO:1905413; GO:1990502"
"7743","Cluster_2787","Peve_00043472",0.99728265353091,0.0469424791144549,0.939886156491908,155,-21.34,"2 21","10790 10808",19,"73.68%","84.21%","CDS","P50416","Carnitine O-palmitoyltransferase 1, liver isoform (CPT1-L) (EC 2.3.1.21) (Carnitine O-palmitoyltransferase I, liver isoform) (CPT I) (CPTI-L) (Carnitine palmitoyltransferase 1A)","Homo sapiens (Human)","carnitine metabolic process [GO:0009437]; carnitine shuttle [GO:0006853]; cellular response to fatty acid [GO:0071398]; eating behavior [GO:0042755]; epithelial cell differentiation [GO:0030855]; fatty acid beta-oxidation [GO:0006635]; fatty acid metabolic process [GO:0006631]; glucose metabolic process [GO:0006006]; liver regeneration [GO:0097421]; long-chain fatty acid metabolic process [GO:0001676]; positive regulation of fatty acid beta-oxidation [GO:0032000]; regulation of insulin secretion [GO:0050796]; regulation of lipid storage [GO:0010883]; response to alkaloid [GO:0043279]; response to antibiotic [GO:0046677]; response to ethanol [GO:0045471]; response to nutrient levels [GO:0031667]; response to organic cyclic compound [GO:0014070]; response to tetrachloromethane [GO:1904772]; response to xenobiotic stimulus [GO:0009410]; triglyceride metabolic process [GO:0006641]","GO:0001676; GO:0004095; GO:0005739; GO:0005741; GO:0006006; GO:0006631; GO:0006635; GO:0006641; GO:0006853; GO:0009410; GO:0009437; GO:0010883; GO:0014070; GO:0016020; GO:0030855; GO:0031667; GO:0032000; GO:0042755; GO:0042802; GO:0043279; GO:0045471; GO:0046677; GO:0050796; GO:0071398; GO:0097421; GO:1904772; GO:1990698"
"7774","Cluster_2787","Peve_00044098",0.998576798713468,0.0339687687471795,0.909359886114279,159,-24.5,"2 21","894 921",25,"68.00%","72.00%","CDS",NA,NA,NA,NA,NA
"7775","Cluster_2787","Peve_00044098",0.998576798713468,0.0339687687471795,0.909359886114279,163,-25.16,"2 21","8868 8891",21,"76.19%","76.19%","CDS",NA,NA,NA,NA,NA
"7831","Cluster_2787","Peve_00044958",0.999761494514925,0.0139044219501823,0.720993769905639,165,-20.08,"2 21","60845 60864",19,"78.95%","84.21%","CDS","P11532","Dystrophin","Homo sapiens (Human)","actin cytoskeleton organization [GO:0030036]; cardiac muscle cell action potential [GO:0086001]; cardiac muscle contraction [GO:0060048]; maintenance of blood-brain barrier [GO:0035633]; motile cilium assembly [GO:0044458]; muscle cell cellular homeostasis [GO:0046716]; muscle cell development [GO:0055001]; muscle organ development [GO:0007517]; negative regulation of peptidyl-cysteine S-nitrosylation [GO:1902083]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; neuron development [GO:0048666]; peptide biosynthetic process [GO:0043043]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of neuron projection development [GO:0010976]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; protein localization [GO:0008104]; protein-containing complex assembly [GO:0065003]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cellular response to growth factor stimulus [GO:0090287]; regulation of heart rate [GO:0002027]; regulation of muscle system process [GO:0090257]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; regulation of skeletal muscle contraction [GO:0014819]; regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion [GO:0014809]; regulation of voltage-gated calcium channel activity [GO:1901385]; response to muscle stretch [GO:0035994]; skeletal muscle tissue development [GO:0007519]","GO:0002027; GO:0002162; GO:0003779; GO:0005200; GO:0005634; GO:0005829; GO:0005856; GO:0005886; GO:0007517; GO:0007519; GO:0008104; GO:0008270; GO:0008307; GO:0009986; GO:0010880; GO:0010881; GO:0010976; GO:0014809; GO:0014819; GO:0016010; GO:0016013; GO:0017022; GO:0017166; GO:0030018; GO:0030036; GO:0030054; GO:0030055; GO:0030175; GO:0030864; GO:0031527; GO:0032991; GO:0033137; GO:0035633; GO:0035994; GO:0042383; GO:0042995; GO:0043034; GO:0043043; GO:0044306; GO:0044458; GO:0045121; GO:0045202; GO:0045211; GO:0045666; GO:0046716; GO:0048666; GO:0050998; GO:0051015; GO:0055001; GO:0060048; GO:0060314; GO:0065003; GO:0086001; GO:0090257; GO:0090287; GO:1901385; GO:1902083; GO:2000651"
"7845","Cluster_2787","Peve_00045103",0.998442124139319,0.035540042458098,0.909359886114279,145,-21.42,"2 21","5163 5189",24,"62.50%","75.00%","CDS","P61972","Nuclear transport factor 2 (NTF-2)","Rattus norvegicus (Rat)","mRNA transport [GO:0051028]; negative regulation of vascular endothelial growth factor production [GO:1904046]; nucleocytoplasmic transport [GO:0006913]; positive regulation of protein import into nucleus [GO:0042307]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; protein localization to nuclear pore [GO:0090204]","GO:0005637; GO:0005640; GO:0005654; GO:0005829; GO:0006606; GO:0006611; GO:0006913; GO:0017056; GO:0031267; GO:0031965; GO:0042307; GO:0042802; GO:0044613; GO:0051028; GO:0061608; GO:0090204; GO:1904046"
"7876","Cluster_2854","Peve_00000772",0.999952919799256,0.0061775458534996,0.573710369894872,156,-22.12,"2 20","20005 20032",24,"75.00%","75.00%","CDS","D2IYS2","Tyrosine-protein kinase receptor torso (EC 2.7.10.1)","Bombyx mori (Silk moth)","","GO:0004714; GO:0005524; GO:0005886; GO:0046872"
"7898","Cluster_2854","Peve_00001436",0.998208024584781,0.0381176413484374,0.909359886114279,172,-20.31,"2 21","5552 5573",19,"78.95%","84.21%","CDS","P01026","Complement C3 [Cleaved into: Complement C3 beta chain; C3-beta-c (C3bc) (Neutrophil chemotactic factor-2) (ENCF-2); Complement C3 alpha chain; C3a anaphylatoxin (Neutrophil chemotactic factor-1) (ENCF-1); Acylation stimulating protein (ASP) (C3adesArg); Complement C3b alpha' chain; Complement C3c alpha' chain fragment 1; Complement C3dg fragment; Complement C3g fragment; Complement C3d fragment; Complement C3f fragment; Complement C3c alpha' chain fragment 2]","Rattus norvegicus (Rat)","amyloid-beta clearance [GO:0097242]; blood coagulation [GO:0007596]; cell surface receptor signaling pathway involved in cell-cell signaling [GO:1905114]; chemotaxis [GO:0006935]; complement activation [GO:0006956]; complement activation, alternative pathway [GO:0006957]; complement activation, classical pathway [GO:0006958]; complement-dependent cytotoxicity [GO:0097278]; complement-mediated synapse pruning [GO:0150062]; fatty acid metabolic process [GO:0006631]; inflammatory response [GO:0006954]; neuron remodeling [GO:0016322]; opsonization [GO:0008228]; oviduct epithelium development [GO:0035846]; positive regulation of activation of membrane attack complex [GO:0001970]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic cell clearance [GO:2000427]; positive regulation of developmental growth [GO:0048639]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; positive regulation of glucose transmembrane transport [GO:0010828]; positive regulation of lipid storage [GO:0010884]; positive regulation of opsonization [GO:1903028]; positive regulation of phagocytosis [GO:0050766]; positive regulation of phagocytosis, engulfment [GO:0060100]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of type IIa hypersensitivity [GO:0001798]; positive regulation of vascular endothelial growth factor production [GO:0010575]; proteolysis [GO:0006508]; regulation of complement activation [GO:0030449]; regulation of complement activation, alternative pathway [GO:0030451]; regulation of triglyceride biosynthetic process [GO:0010866]; response to bacterium [GO:0009617]; response to estradiol [GO:0032355]; response to estrogen [GO:0043627]; response to glucocorticoid [GO:0051384]; response to magnesium ion [GO:0032026]; response to progesterone [GO:0032570]; response to xenobiotic stimulus [GO:0009410]; retina development in camera-type eye [GO:0060041]; tolerance induction [GO:0002507]; vascular associated smooth muscle cell differentiation [GO:0035886]; vertebrate eye-specific patterning [GO:0150064]","GO:0001798; GO:0001934; GO:0001970; GO:0002507; GO:0004866; GO:0005576; GO:0005615; GO:0005886; GO:0006508; GO:0006631; GO:0006935; GO:0006954; GO:0006956; GO:0006957; GO:0006958; GO:0007596; GO:0008228; GO:0008289; GO:0009410; GO:0009617; GO:0009986; GO:0010575; GO:0010828; GO:0010866; GO:0010884; GO:0016322; GO:0030449; GO:0030451; GO:0031715; GO:0032026; GO:0032355; GO:0032570; GO:0032991; GO:0035846; GO:0035886; GO:0043627; GO:0045745; GO:0045766; GO:0048260; GO:0048639; GO:0050766; GO:0051384; GO:0060041; GO:0060100; GO:0070374; GO:0097242; GO:0097278; GO:0150062; GO:0150064; GO:1903028; GO:1905114; GO:1905370; GO:2000427"
"7899","Cluster_2854","Peve_00001435",-0.99830812163304,0.0370374381818108,0.909359886114279,168,-20.4,"2 21","30687 30708",19,"78.95%","78.95%","CDS",NA,NA,NA,NA,NA
"7933","Cluster_2854","Peve_00002593",-0.999856496315378,0.0107852903355044,0.6446111333421,164,-22.24,"2 21","3152 3173",19,"68.42%","84.21%","CDS","O74212","Acyl-lipid (8-3)-desaturase (EC 1.14.19.30) (Delta(5) fatty acid desaturase) (Delta-5 fatty acid desaturase)","Mortierella alpina (Oleaginous fungus) (Mortierella renispora)","fatty acid biosynthetic process [GO:0006633]","GO:0006633; GO:0016020; GO:0020037; GO:0046872; GO:0102866"
"7954","Cluster_2854","Peve_00003572",-0.999998761813949,0.00100181635887822,0.257580124662609,171,-26.19,"2 20","20700 20721",18,"72.22%","94.44%","CDS","Q5F361","TBC domain-containing protein kinase-like protein","Gallus gallus (Chicken)","activation of GTPase activity [GO:0090630]; protein phosphorylation [GO:0006468]","GO:0004672; GO:0005096; GO:0005524; GO:0005737; GO:0005819; GO:0006468; GO:0030496; GO:0090630"
"8012","Cluster_2854","Peve_00004802",-0.999895927074034,0.00918475909477155,0.595915595777701,154,-25.08,"2 20","27314 27340",23,"65.22%","73.91%","CDS","A0A8J1M587",NA,NA,NA,NA
"8013","Cluster_2854","Peve_00004802",-0.999895927074034,0.00918475909477155,0.595915595777701,165,-20.59,"2 20","23635 23658",20,"80.00%","85.00%","CDS","A0A8J1M587",NA,NA,NA,NA
"8071","Cluster_2854","Peve_00006544",0.999868704185365,0.0103163320854201,0.630000794609239,155,-21.95,"2 21","19985 20003",19,"73.68%","84.21%","CDS","Q9ZQ31","Serine/threonine-protein kinase STY13 (EC 2.7.11.1) (AtSTYPK) (Serine/threonine/tyrosine-protein kinase 13)","Arabidopsis thaliana (Mouse-ear cress)","protein phosphorylation [GO:0006468]; regulation of embryonic development [GO:0045995]; seed oilbody biogenesis [GO:0010344]; signal transduction [GO:0007165]","GO:0004672; GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005737; GO:0006468; GO:0007165; GO:0010344; GO:0045995; GO:0106310"
"8078","Cluster_2854","Peve_00006587",0.9994271673678,0.0215491294262711,0.825526415921874,162,-20.16,"2 21","68414 68434",19,"78.95%","78.95%","CDS","A2A8L5","Receptor-type tyrosine-protein phosphatase F (EC 3.1.3.48) (Leukocyte common antigen related) (LAR)","Mus musculus (Mouse)","cell migration [GO:0016477]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell projection organization [GO:0031345]; negative regulation of cytokine-mediated signaling pathway [GO:0001960]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of neurotrophin TRK receptor signaling pathway [GO:0051387]; negative regulation of receptor binding [GO:1900121]; nervous system development [GO:0007399]; neuron projection regeneration [GO:0031102]; peptidyl-tyrosine dephosphorylation [GO:0035335]; positive regulation of apoptotic process [GO:0043065]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of neuron apoptotic process [GO:0043525]; protein dephosphorylation [GO:0006470]; regulation of axon regeneration [GO:0048679]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175]; regulation of synapse structure or activity [GO:0050803]; synaptic membrane adhesion [GO:0099560]","GO:0001960; GO:0004721; GO:0004725; GO:0005001; GO:0005158; GO:0005768; GO:0005886; GO:0006470; GO:0007156; GO:0007399; GO:0008201; GO:0008285; GO:0010975; GO:0016020; GO:0016477; GO:0030426; GO:0030971; GO:0031102; GO:0031345; GO:0035335; GO:0035373; GO:0042059; GO:0042301; GO:0043005; GO:0043025; GO:0043065; GO:0043231; GO:0043525; GO:0044877; GO:0046627; GO:0048679; GO:0050775; GO:0050803; GO:0050839; GO:0051387; GO:0060076; GO:0098839; GO:0099175; GO:0099560; GO:1900121"
"8117","Cluster_2854","Peve_00007756",0.999962448044095,0.00551712420276166,0.551398425649056,160,-20.13,"2 17","9966 9987",15,"73.33%","93.33%","CDS",NA,NA,NA,NA,NA
"8118","Cluster_2854","Peve_00007756",0.999962448044095,0.00551712420276166,0.551398425649056,163,-21.08,"2 16","2883 2904",14,"85.71%","92.86%","CDS",NA,NA,NA,NA,NA
"8119","Cluster_2854","Peve_00007756",0.999962448044095,0.00551712420276166,0.551398425649056,163,-21.08,"2 16","5654 5675",14,"85.71%","92.86%","CDS",NA,NA,NA,NA,NA
"8166","Cluster_2854","Peve_00009508",0.998612130404786,0.0335443741149563,0.909359886114279,157,-22.74,"2 20","7343 7371",25,"72.00%","72.00%","CDS","P83111","Serine beta-lactamase-like protein LACTB, mitochondrial (EC 3.4.-.-)","Homo sapiens (Human)","lipid metabolic process [GO:0006629]; proteolysis [GO:0006508]; regulation of lipid metabolic process [GO:0019216]","GO:0005739; GO:0005829; GO:0006508; GO:0006629; GO:0008233; GO:0019216; GO:0042802"
"8196","Cluster_2854","Peve_00010511",0.999962448044095,0.00551712420276981,0.551398425649056,154,-20.1,"2 16","4284 4306",15,"80.00%","86.67%","CDS",NA,NA,NA,NA,NA
"8210","Cluster_2854","Peve_00010711",0.999962448044095,0.00551712420277797,0.551398425649056,162,-22.25,"2 16","2117 2139",15,"86.67%","93.33%","CDS",NA,NA,NA,NA,NA
"8235","Cluster_2854","Peve_00011724",0.999962448044095,0.00551712420276166,0.551398425649056,171,-20.09,"2 21","497 519",20,"75.00%","90.00%","CDS",NA,NA,NA,NA,NA
"8406","Cluster_2854","Peve_00015124",0.999962448044095,0.00551712420276166,0.551398425649056,149,-20.71,"2 19","9785 9808",19,"63.16%","78.95%","CDS",NA,NA,NA,NA,NA
"8451","Cluster_2854","Peve_00013445",0.999666874556682,0.0164327814720114,0.771576210959321,171,-20.48,"2 20","15909 15930",18,"83.33%","83.33%","CDS","B3DJT0","Squamous cell carcinoma antigen recognized by T-cells 3 (SART-3)","Danio rerio (Zebrafish) (Brachydanio rerio)","exocrine pancreas development [GO:0031017]; lymphocyte differentiation [GO:0030098]; mRNA splicing, via spliceosome [GO:0000398]; nucleosome assembly [GO:0006334]; positive regulation of histone deubiquitination [GO:1903586]; spliceosomal complex assembly [GO:0000245]; spliceosomal snRNP assembly [GO:0000387]; thymus development [GO:0048538]","GO:0000245; GO:0000387; GO:0000398; GO:0005634; GO:0005654; GO:0005737; GO:0006334; GO:0015030; GO:0016607; GO:0017070; GO:0030098; GO:0031017; GO:0042393; GO:0048538; GO:0061574; GO:1903586"
"8473","Cluster_2854","Peve_00016793",0.998844137775377,0.0306118796323651,0.903929377050813,166,-23.09,"2 15","2611 2632",13,"92.31%","100.00%","CDS",NA,NA,NA,NA,NA
"8474","Cluster_2854","Peve_00016793",0.998844137775377,0.0306118796323651,0.903929377050813,166,-23.09,"2 15","3294 3315",13,"92.31%","100.00%","CDS",NA,NA,NA,NA,NA
"8477","Cluster_2854","Peve_00016830",0.997788949392921,0.0423423068696936,0.91245824116165,163,-20.47,"2 21","7573 7595",20,"70.00%","85.00%","CDS","O94923","D-glucuronyl C5-epimerase (EC 5.1.3.17) (Heparan sulfate C5-epimerase) (Hsepi) (Heparin/heparan sulfate:glucuronic acid C5-epimerase) (Heparosan-N-sulfate-glucuronate 5-epimerase)","Homo sapiens (Human)","heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparin biosynthetic process [GO:0030210]","GO:0000139; GO:0005509; GO:0005794; GO:0015012; GO:0016857; GO:0030210; GO:0042803; GO:0047464"
"8490","Cluster_2854","Peve_00017150",-0.999275446346948,0.0242357588178883,0.858622359634376,152,-20.69,"2 20","23994 24015",19,"68.42%","84.21%","CDS","Q9UI17","Dimethylglycine dehydrogenase, mitochondrial (EC 1.5.8.4) (ME2GLYDH)","Homo sapiens (Human)","amino-acid betaine catabolic process [GO:0006579]; choline catabolic process [GO:0042426]; choline metabolic process [GO:0019695]","GO:0003723; GO:0005737; GO:0005739; GO:0005759; GO:0006579; GO:0009055; GO:0016491; GO:0019695; GO:0042426; GO:0047865"
"8491","Cluster_2854","Peve_00017150",-0.999275446346948,0.0242357588178883,0.858622359634376,152,-20.69,"2 20","26508 26529",19,"68.42%","84.21%","CDS","Q9UI17","Dimethylglycine dehydrogenase, mitochondrial (EC 1.5.8.4) (ME2GLYDH)","Homo sapiens (Human)","amino-acid betaine catabolic process [GO:0006579]; choline catabolic process [GO:0042426]; choline metabolic process [GO:0019695]","GO:0003723; GO:0005737; GO:0005739; GO:0005759; GO:0006579; GO:0009055; GO:0016491; GO:0019695; GO:0042426; GO:0047865"
"8518","Cluster_2854","Peve_00017979",0.999962448044095,0.00551712420276166,0.551398425649056,175,-20.64,"2 20","982 1003",18,"83.33%","88.89%","CDS",NA,NA,NA,NA,NA
"8521","Cluster_2854","Peve_00018147",-0.999981086743335,0.00391542548647461,0.54328949385489,175,-27.24,"2 21","6571 6593",20,"80.00%","90.00%","CDS",NA,NA,NA,NA,NA
"8590","Cluster_2854","Peve_00020543",0.998432065435628,0.0356546230703885,0.909359886114279,153,-20.11,"2 15","12294 12316",14,"85.71%","85.71%","CDS","Q8IWY4","Signal peptide, CUB and EGF-like domain-containing protein 1","Homo sapiens (Human)","adult heart development [GO:0007512]; blood coagulation [GO:0007596]; endothelial cell differentiation [GO:0045446]; inflammatory response [GO:0006954]; positive regulation of smoothened signaling pathway [GO:0045880]; post-embryonic development [GO:0009791]; signal transduction [GO:0007165]","GO:0005509; GO:0005615; GO:0005886; GO:0006954; GO:0007165; GO:0007512; GO:0007596; GO:0009791; GO:0009897; GO:0009986; GO:0042802; GO:0045446; GO:0045880"
"8610","Cluster_2854","Peve_00021417",-0.999791289095414,0.0130069432315257,0.700541156620554,171,-20.38,"2 20","7907 7928",18,"83.33%","83.33%","CDS",NA,NA,NA,NA,NA
"8639","Cluster_2854","Peve_00022083",0.999962448044095,0.00551712420276166,0.551398425649056,151,-20.79,"2 21","4803 4826",21,"61.90%","76.19%","CDS","Q5DU56","Protein NLRC3","Mus musculus (Mouse)","I-kappaB kinase/NF-kappaB signaling [GO:0007249]; intracellular signal transduction [GO:0035556]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of interferon-alpha production [GO:0032687]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of tumor necrosis factor production [GO:0032720]; regulation of protein ubiquitination [GO:0031396]; response to lipopolysaccharide [GO:0032496]; T cell activation [GO:0042110]","GO:0005524; GO:0005737; GO:0005829; GO:0007249; GO:0014067; GO:0031396; GO:0032088; GO:0032496; GO:0032687; GO:0032688; GO:0032691; GO:0032695; GO:0032715; GO:0032720; GO:0034451; GO:0035556; GO:0036312; GO:0042110; GO:0043124; GO:0043231; GO:0045824; GO:0048147; GO:0048471; GO:0050680; GO:0050728; GO:1900016; GO:1900226; GO:1901223"
"8646","Cluster_2854","Peve_00022183",-0.999945152530085,0.00666769007808603,0.573710369894872,148,-21.98,"2 20","289 313",22,"63.64%","77.27%","CDS","Q8BP00","IQ calmodulin-binding motif-containing protein 1","Mus musculus (Mouse)","cilium assembly [GO:0060271]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]","GO:0001750; GO:0005516; GO:0005654; GO:0005737; GO:0005813; GO:0005929; GO:0015630; GO:0019899; GO:0032391; GO:0045171; GO:0045494; GO:0048496; GO:0060271; GO:0072686"
"8654","Cluster_2854","Peve_00022723",-0.999968633848047,0.00504227905314111,0.551398425649056,151,-20.1,"2 13","20410 20432",12,"91.67%","91.67%","CDS","B3EWY9","Mucin-like protein","Acropora millepora (Staghorn coral) (Heteropora millepora)","cell-matrix adhesion [GO:0007160]","GO:0005509; GO:0007160; GO:0016020"
"8657","Cluster_2854","Peve_00022773",0.999962448044095,0.00551712420276166,0.551398425649056,170,-24.15,"2 20","594 616",19,"84.21%","84.21%","CDS","Q8VCK5","Kelch-like protein 20 (Kelch-like ECT2-interacting protein)","Mus musculus (Mouse)","Golgi to endosome transport [GO:0006895]; negative regulation of apoptotic process [GO:0043066]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K33-linked ubiquitination [GO:1990390]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]","GO:0003779; GO:0004842; GO:0005737; GO:0005794; GO:0005802; GO:0005829; GO:0006895; GO:0015031; GO:0016567; GO:0016605; GO:0019964; GO:0030424; GO:0030425; GO:0031463; GO:0043066; GO:0043161; GO:0048471; GO:1990390"
"8658","Cluster_2854","Peve_00022762",-0.999347892022002,0.0229920915957954,0.844186414712407,145,-20.62,"2 19","618 643",21,"61.90%","71.43%","CDS","O42819","Ras-related protein SEC4","Candida glabrata (Yeast) (Torulopsis glabrata)","ascospore-type prospore assembly [GO:0031321]; autophagy [GO:0006914]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; membrane addition at site of cytokinesis [GO:0007107]; protein transport [GO:0015031]; vesicle fusion [GO:0006906]","GO:0000131; GO:0003924; GO:0005525; GO:0005886; GO:0006887; GO:0006893; GO:0006906; GO:0006914; GO:0007107; GO:0015031; GO:0030658; GO:0031321; GO:0043332; GO:0062040"
"8688","Cluster_2854","Peve_00023189",-0.99980197200197,0.0126696782625539,0.692490720386583,167,-20.06,"2 20","2807 2828",18,"72.22%","88.89%","CDS","P31400","V-type proton ATPase catalytic subunit A (V-ATPase subunit A) (EC 7.1.2.2) (V-ATPase 69 kDa subunit) (Vacuolar proton pump subunit alpha)","Manduca sexta (Tobacco hawkmoth) (Tobacco hornworm)","","GO:0005524; GO:0033180; GO:0046933; GO:0046961"
"8742","Cluster_2854","Peve_00024330",0.998712895978614,0.0323034224717031,0.909137857332831,154,-20.42,"2 20","5946 5969",20,"65.00%","80.00%","CDS","Q7SY48","HEAT repeat-containing protein 1 (Protein BAP28)","Danio rerio (Zebrafish) (Brachydanio rerio)","maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; negative regulation of apoptotic process [GO:0043066]; positive regulation of transcription by RNA polymerase I [GO:0045943]; regulation of RNA stability [GO:0043487]","GO:0000462; GO:0030515; GO:0030686; GO:0032040; GO:0034455; GO:0043066; GO:0043487; GO:0045943"
"8743","Cluster_2854","Peve_00024330",0.998712895978614,0.0323034224717031,0.909137857332831,154,-20.42,"2 20","6063 6086",20,"65.00%","80.00%","CDS","Q7SY48","HEAT repeat-containing protein 1 (Protein BAP28)","Danio rerio (Zebrafish) (Brachydanio rerio)","maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; negative regulation of apoptotic process [GO:0043066]; positive regulation of transcription by RNA polymerase I [GO:0045943]; regulation of RNA stability [GO:0043487]","GO:0000462; GO:0030515; GO:0030686; GO:0032040; GO:0034455; GO:0043066; GO:0043487; GO:0045943"
"8744","Cluster_2854","Peve_00024330",0.998712895978614,0.0323034224717031,0.909137857332831,154,-20.42,"2 20","6296 6319",20,"65.00%","80.00%","CDS","Q7SY48","HEAT repeat-containing protein 1 (Protein BAP28)","Danio rerio (Zebrafish) (Brachydanio rerio)","maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; negative regulation of apoptotic process [GO:0043066]; positive regulation of transcription by RNA polymerase I [GO:0045943]; regulation of RNA stability [GO:0043487]","GO:0000462; GO:0030515; GO:0030686; GO:0032040; GO:0034455; GO:0043066; GO:0043487; GO:0045943"
"8745","Cluster_2854","Peve_00024330",0.998712895978614,0.0323034224717031,0.909137857332831,154,-20.42,"2 20","6374 6397",20,"65.00%","80.00%","CDS","Q7SY48","HEAT repeat-containing protein 1 (Protein BAP28)","Danio rerio (Zebrafish) (Brachydanio rerio)","maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; negative regulation of apoptotic process [GO:0043066]; positive regulation of transcription by RNA polymerase I [GO:0045943]; regulation of RNA stability [GO:0043487]","GO:0000462; GO:0030515; GO:0030686; GO:0032040; GO:0034455; GO:0043066; GO:0043487; GO:0045943"
"8746","Cluster_2854","Peve_00024330",0.998712895978614,0.0323034224717031,0.909137857332831,154,-20.42,"2 20","6413 6436",20,"65.00%","80.00%","CDS","Q7SY48","HEAT repeat-containing protein 1 (Protein BAP28)","Danio rerio (Zebrafish) (Brachydanio rerio)","maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; negative regulation of apoptotic process [GO:0043066]; positive regulation of transcription by RNA polymerase I [GO:0045943]; regulation of RNA stability [GO:0043487]","GO:0000462; GO:0030515; GO:0030686; GO:0032040; GO:0034455; GO:0043066; GO:0043487; GO:0045943"
"8747","Cluster_2854","Peve_00024330",0.998712895978614,0.0323034224717031,0.909137857332831,154,-20.42,"2 20","6686 6709",20,"65.00%","80.00%","CDS","Q7SY48","HEAT repeat-containing protein 1 (Protein BAP28)","Danio rerio (Zebrafish) (Brachydanio rerio)","maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; negative regulation of apoptotic process [GO:0043066]; positive regulation of transcription by RNA polymerase I [GO:0045943]; regulation of RNA stability [GO:0043487]","GO:0000462; GO:0030515; GO:0030686; GO:0032040; GO:0034455; GO:0043066; GO:0043487; GO:0045943"
"8748","Cluster_2854","Peve_00024330",0.998712895978614,0.0323034224717031,0.909137857332831,154,-20.42,"2 20","6803 6826",20,"65.00%","80.00%","CDS","Q7SY48","HEAT repeat-containing protein 1 (Protein BAP28)","Danio rerio (Zebrafish) (Brachydanio rerio)","maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; negative regulation of apoptotic process [GO:0043066]; positive regulation of transcription by RNA polymerase I [GO:0045943]; regulation of RNA stability [GO:0043487]","GO:0000462; GO:0030515; GO:0030686; GO:0032040; GO:0034455; GO:0043066; GO:0043487; GO:0045943"
"8749","Cluster_2854","Peve_00024330",0.998712895978614,0.0323034224717031,0.909137857332831,154,-20.42,"2 20","6881 6904",20,"65.00%","80.00%","CDS","Q7SY48","HEAT repeat-containing protein 1 (Protein BAP28)","Danio rerio (Zebrafish) (Brachydanio rerio)","maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; negative regulation of apoptotic process [GO:0043066]; positive regulation of transcription by RNA polymerase I [GO:0045943]; regulation of RNA stability [GO:0043487]","GO:0000462; GO:0030515; GO:0030686; GO:0032040; GO:0034455; GO:0043066; GO:0043487; GO:0045943"
"8750","Cluster_2854","Peve_00024330",0.998712895978614,0.0323034224717031,0.909137857332831,154,-20.75,"2 20","8206 8229",20,"65.00%","80.00%","CDS","Q7SY48","HEAT repeat-containing protein 1 (Protein BAP28)","Danio rerio (Zebrafish) (Brachydanio rerio)","maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; negative regulation of apoptotic process [GO:0043066]; positive regulation of transcription by RNA polymerase I [GO:0045943]; regulation of RNA stability [GO:0043487]","GO:0000462; GO:0030515; GO:0030686; GO:0032040; GO:0034455; GO:0043066; GO:0043487; GO:0045943"
"8755","Cluster_2854","Peve_00024485",-0.998027654256883,0.0399906121196841,0.909359886114279,160,-22.15,"2 18","6743 6765",17,"76.47%","88.24%","CDS","D3UW23","Glutamyl aminopeptidase (EAP) (EC 3.4.11.7) (Aminopeptidase A) (AP-A) (Rhiminopeptidase A)","Bitis rhinoceros (West African gaboon viper) (Vipera rhinoceros)","proteolysis [GO:0006508]","GO:0004177; GO:0005886; GO:0006508; GO:0008237; GO:0008270"
"8757","Cluster_2854","Peve_00024575",-0.997453644368208,0.045440892085478,0.933005102504876,169,-22.42,"2 19","637 660",19,"78.95%","89.47%","CDS","Q9CQL5","39S ribosomal protein L18, mitochondrial (L18mt) (MRP-L18)","Mus musculus (Mouse)","mitochondrial translation [GO:0032543]; rRNA import into mitochondrion [GO:0035928]","GO:0003735; GO:0005739; GO:0005743; GO:0005762; GO:0008097; GO:0032543; GO:0035928"
"8813","Cluster_2854","Peve_00026671",-0.997785330464857,0.0423769572915879,0.912802604012796,163,-21.21,"2 16","7935 7956",14,"85.71%","92.86%","CDS","Q90891","Dual specificity mitogen-activated protein kinase kinase 2 (MAP kinase kinase 2) (MAPKK 2) (EC 2.7.12.2) (ERK activator kinase 2) (MAPK/ERK kinase 2) (MEK2)","Gallus gallus (Chicken)","","GO:0004674; GO:0004708; GO:0004713; GO:0005524; GO:0106310"
"8814","Cluster_2854","Peve_00026728",-0.9999999977338,4.28592208061732e-05,0.0278278797948653,166,-24.15,"2 21","55853 55876",21,"80.95%","80.95%","CDS","O93484","Collagen alpha-2(I) chain (Alpha-2 type I collagen)","Oncorhynchus mykiss (Rainbow trout) (Salmo gairdneri)","","GO:0005201; GO:0005576; GO:0005581; GO:0046872"
"8815","Cluster_2854","Peve_00026513",-0.998903304384371,0.0298179562466768,0.903929377050813,171,-20.48,"2 20","37459 37480",18,"83.33%","83.33%","CDS","Q6ITT3","Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase C (EC 2.4.1.145) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase IVc) (GnT-IVc) (N-acetylglucosaminyltransferase IVc) (UDP-N-acetylglucosamine: alpha-1,3-D-mannoside beta-1,4-N-acetylglucosaminyltransferase IVc)","Sus scrofa (Pig)","protein N-linked glycosylation [GO:0006487]","GO:0000139; GO:0006487; GO:0008375; GO:0008454; GO:0046872"
"8819","Cluster_2854","Peve_00026894",-0.997426651890488,0.0456812066416228,0.933493920659362,159,-20.37,"2 21","28249 28273",22,"68.18%","77.27%","CDS","Q6YHK3","CD109 antigen (150 kDa TGF-beta-1-binding protein) (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 7) (Platelet-specific Gov antigen) (p180) (r150) (CD antigen CD109)","Homo sapiens (Human)","hair follicle development [GO:0001942]; keratinocyte proliferation [GO:0043616]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of peptidase activity [GO:0010466]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of stem cell proliferation [GO:2000647]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of wound healing [GO:0061045]; osteoclast fusion [GO:0072675]; protein phosphorylation [GO:0006468]; regulation of keratinocyte differentiation [GO:0045616]; stem cell proliferation [GO:0072089]","GO:0001933; GO:0001942; GO:0004867; GO:0005576; GO:0005615; GO:0005829; GO:0005886; GO:0006468; GO:0009986; GO:0010466; GO:0010839; GO:0030512; GO:0031092; GO:0043616; GO:0045616; GO:0050431; GO:0061045; GO:0072089; GO:0072675; GO:2000647"
"8821","Cluster_2854","Peve_00026871",-0.999966636237709,0.00520036512853229,0.551398425649056,159,-22.36,"2 21","7148 7172",22,"63.64%","81.82%","CDS","P63079","Gamma-aminobutyric acid receptor subunit beta-3 (GABA(A) receptor subunit beta-3)","Rattus norvegicus (Rat)","brain development [GO:0007420]; cellular response to histamine [GO:0071420]; cellular response to zinc ion [GO:0071294]; cerebellum development [GO:0021549]; chemical synaptic transmission [GO:0007268]; chemical synaptic transmission, postsynaptic [GO:0099565]; chloride transmembrane transport [GO:1902476]; circadian sleep/wake cycle, REM sleep [GO:0042747]; cochlea development [GO:0090102]; exploration behavior [GO:0035640]; gamma-aminobutyric acid signaling pathway [GO:0007214]; hard palate development [GO:0060022]; inhibitory postsynaptic potential [GO:0060080]; inhibitory synapse assembly [GO:1904862]; inner ear receptor cell development [GO:0060119]; innervation [GO:0060384]; ion transmembrane transport [GO:0034220]; learning [GO:0007612]; memory [GO:0007613]; motor behavior [GO:0061744]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron death [GO:1901215]; nervous system development [GO:0007399]; nervous system process [GO:0050877]; neuron development [GO:0048666]; regulation of membrane potential [GO:0042391]; regulation of neuron apoptotic process [GO:0043523]; regulation of postsynaptic membrane potential [GO:0060078]; reproductive behavior [GO:0019098]; response to anesthetic [GO:0072347]; response to xenobiotic stimulus [GO:0009410]; roof of mouth development [GO:0060021]; sensory perception of sound [GO:0007605]; signal transduction [GO:0007165]; social behavior [GO:0035176]; synaptic transmission, GABAergic [GO:0051932]","GO:0004890; GO:0005216; GO:0005231; GO:0005254; GO:0005886; GO:0007165; GO:0007214; GO:0007268; GO:0007399; GO:0007420; GO:0007605; GO:0007612; GO:0007613; GO:0009410; GO:0009986; GO:0019098; GO:0021549; GO:0022851; GO:0030594; GO:0030659; GO:0034220; GO:0034707; GO:0035176; GO:0035612; GO:0035640; GO:0042391; GO:0042747; GO:0042802; GO:0043005; GO:0043195; GO:0043523; GO:0043524; GO:0045202; GO:0045211; GO:0048666; GO:0050877; GO:0051932; GO:0060021; GO:0060022; GO:0060077; GO:0060078; GO:0060080; GO:0060119; GO:0060384; GO:0061744; GO:0071294; GO:0071420; GO:0072347; GO:0090102; GO:0098982; GO:0099565; GO:0099634; GO:1901215; GO:1902476; GO:1902711; GO:1904315; GO:1904862"
"8855","Cluster_2854","Peve_00027870",0.998125484911018,0.0389858902094067,0.909359886114279,167,-20.98,"2 20","1188 1209",18,"77.78%","83.33%","CDS",NA,NA,NA,NA,NA
"8895","Cluster_2854","Peve_00028991",-0.999364508377098,0.0226972393627853,0.840410910355847,151,-21.41,"2 21","9365 9392",25,"64.00%","68.00%","CDS",NA,NA,NA,NA,NA
"8970","Cluster_2854","Peve_00030679",0.999962448044095,0.00551712420277797,0.551398425649056,169,-20.83,"2 18","2504 2525",16,"81.25%","93.75%","CDS",NA,NA,NA,NA,NA
"8983","Cluster_2854","Peve_00031287",0.999982172170468,0.00380141253449467,0.542240609525931,157,-20.08,"2 21","2468 2487",19,"73.68%","78.95%","CDS","Q5W041","Armadillo repeat-containing protein 3 (Beta-catenin-like protein) (Cancer/testis antigen 81) (CT81) (KU-CT-1)","Homo sapiens (Human)","","GO:0070062"
"9014","Cluster_2854","Peve_00032011",0.999962448044095,0.00551712420276981,0.551398425649056,171,-27.89,"2 20","5649 5670",18,"83.33%","83.33%","CDS",NA,NA,NA,NA,NA
"9022","Cluster_2854","Peve_00032395",-0.998857649878391,0.0304323919424018,0.903929377050813,159,-22.43,"2 21","7647 7669",20,"70.00%","80.00%","CDS","Q7TN88","Polycystic kidney disease protein 1-like 2 (PC1-like 2 protein) (Polycystin-1L2)","Mus musculus (Mouse)","detection of mechanical stimulus [GO:0050982]","GO:0001965; GO:0005262; GO:0005509; GO:0016020; GO:0030246; GO:0050982"
"9023","Cluster_2854","Peve_00032395",-0.998857649878391,0.0304323919424018,0.903929377050813,159,-22.43,"2 21","7909 7931",20,"70.00%","80.00%","CDS","Q7TN88","Polycystic kidney disease protein 1-like 2 (PC1-like 2 protein) (Polycystin-1L2)","Mus musculus (Mouse)","detection of mechanical stimulus [GO:0050982]","GO:0001965; GO:0005262; GO:0005509; GO:0016020; GO:0030246; GO:0050982"
"9030","Cluster_2854","Peve_00032523",0.999962448044095,0.00551712420276166,0.551398425649056,152,-22.87,"2 13","5152 5173",11,"81.82%","100.00%","CDS",NA,NA,NA,NA,NA
"9094","Cluster_2854","Peve_00034406",0.997281121151485,0.0469557192682797,0.939935945786585,156,-20.02,"2 21","71492 71513",19,"68.42%","73.68%","CDS","O88488","Phosphatidylinositol phosphatase PTPRQ (EC 3.1.3.-) (Protein-tyrosine phosphatase receptor-type expressed by glomerular mesangial cells protein 1) (rPTP-GMC1) (Receptor-type tyrosine-protein phosphatase Q) (PTP-RQ) (R-PTP-Q) (EC 3.1.3.48)","Rattus norvegicus (Rat)","detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; inner ear morphogenesis [GO:0042472]; neuromuscular process controlling balance [GO:0050885]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; regulation of fat cell differentiation [GO:0045598]; vestibular receptor cell morphogenesis [GO:0060116]","GO:0002244; GO:0004725; GO:0005886; GO:0032421; GO:0042472; GO:0043235; GO:0045598; GO:0050885; GO:0050910; GO:0060116; GO:1990264"
"9101","Cluster_2854","Peve_00034569",0.999603958340296,0.0179176022280377,0.782669382293497,155,-23.11,"2 12","1449 1470",10,"100.00%","100.00%","CDS",NA,NA,NA,NA,NA
"9140","Cluster_2854","Peve_00035451",-0.999371623109792,0.022569813346519,0.839052039044429,172,-21.82,"2 21","7855 7876",19,"73.68%","89.47%","CDS","Q7Z6B0","Coiled-coil domain-containing protein 91 (GGA-binding partner) (p56 accessory protein)","Homo sapiens (Human)","Golgi to lysosome transport [GO:0090160]; protein transport [GO:0015031]","GO:0005654; GO:0005794; GO:0005802; GO:0005829; GO:0015031; GO:0016020; GO:0090160"
"9156","Cluster_2854","Peve_00035967",0.999999046646997,0.000879067096608153,0.239778920002343,162,-23.51,"2 20","5095 5117",19,"68.42%","89.47%","CDS","O88488","Phosphatidylinositol phosphatase PTPRQ (EC 3.1.3.-) (Protein-tyrosine phosphatase receptor-type expressed by glomerular mesangial cells protein 1) (rPTP-GMC1) (Receptor-type tyrosine-protein phosphatase Q) (PTP-RQ) (R-PTP-Q) (EC 3.1.3.48)","Rattus norvegicus (Rat)","detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; inner ear morphogenesis [GO:0042472]; neuromuscular process controlling balance [GO:0050885]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; regulation of fat cell differentiation [GO:0045598]; vestibular receptor cell morphogenesis [GO:0060116]","GO:0002244; GO:0004725; GO:0005886; GO:0032421; GO:0042472; GO:0043235; GO:0045598; GO:0050885; GO:0050910; GO:0060116; GO:1990264"
"9201","Cluster_2854","Peve_00037185",-0.999042445184161,0.0278619561486011,0.899642249848007,183,-28.51,"2 20","1458 1479",18,"88.89%","94.44%","CDS","P41565","Isocitrate dehydrogenase [NAD] subunit gamma 1, mitochondrial (Isocitric dehydrogenase subunit gamma) (NAD(+)-specific ICDH subunit gamma)","Rattus norvegicus (Rat)","2-oxoglutarate metabolic process [GO:0006103]; isocitrate metabolic process [GO:0006102]; NADH metabolic process [GO:0006734]; negative regulation of growth [GO:0045926]; tricarboxylic acid cycle [GO:0006099]","GO:0000287; GO:0004449; GO:0005524; GO:0005739; GO:0005962; GO:0006099; GO:0006102; GO:0006103; GO:0006734; GO:0045926; GO:0051287"
"9202","Cluster_2854","Peve_00037231",0.99967338084874,0.016271506544801,0.768900380839141,171,-23.73,"2 20","1366 1387",18,"77.78%","88.89%","CDS",NA,NA,NA,NA,NA
"9214","Cluster_2854","Peve_00037537",0.999962448044095,0.00551712420276166,0.551398425649056,159,-22.18,"2 21","21288 21312",22,"68.18%","77.27%","CDS","Q9H2X9","Solute carrier family 12 member 5 (Electroneutral potassium-chloride cotransporter 2) (K-Cl cotransporter 2) (hKCC2) (Neuronal K-Cl cotransporter)","Homo sapiens (Human)","cell volume homeostasis [GO:0006884]; cellular chloride ion homeostasis [GO:0030644]; cellular ion homeostasis [GO:0006873]; chemical synaptic transmission [GO:0007268]; chloride ion homeostasis [GO:0055064]; chloride transmembrane transport [GO:1902476]; dendritic spine development [GO:0060996]; hypotonic response [GO:0006971]; intracellular pH reduction [GO:0051452]; ion transport [GO:0006811]; learning [GO:0007612]; multicellular organism growth [GO:0035264]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573]; response to xenobiotic stimulus [GO:0009410]; thermosensory behavior [GO:0040040]","GO:0005886; GO:0006811; GO:0006873; GO:0006884; GO:0006971; GO:0007268; GO:0007612; GO:0008519; GO:0009410; GO:0015108; GO:0015379; GO:0016020; GO:0019901; GO:0030644; GO:0032590; GO:0035264; GO:0040040; GO:0043005; GO:0043025; GO:0043204; GO:0045202; GO:0051452; GO:0055064; GO:0055075; GO:0060996; GO:0071944; GO:1902476; GO:1990573"
"9226","Cluster_2854","Peve_00037049",-0.997894257144077,0.0413213048798677,0.909359886114279,184,-25.94,"2 21","7423 7444",19,"89.47%","89.47%","CDS",NA,NA,NA,NA,NA
"9227","Cluster_2854","Peve_00037939",0.999962448044095,0.00551712420276981,0.551398425649056,159,-20.51,"2 20","12628 12646",18,"77.78%","83.33%","CDS","P07949","Proto-oncogene tyrosine-protein kinase receptor Ret (EC 2.7.10.1) (Cadherin family member 12) (Proto-oncogene c-Ret) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment]","Homo sapiens (Human)","activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; axon guidance [GO:0007411]; cellular response to retinoic acid [GO:0071300]; embryonic epithelial tube formation [GO:0001838]; enteric nervous system development [GO:0048484]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; innervation [GO:0060384]; lymphocyte migration into lymphoid organs [GO:0097021]; MAPK cascade [GO:0000165]; membrane protein proteolysis [GO:0033619]; neural crest cell migration [GO:0001755]; neuron cell-cell adhesion [GO:0007158]; neuron maturation [GO:0042551]; Peyer's patch morphogenesis [GO:0061146]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell migration [GO:0030335]; positive regulation of cell size [GO:0045793]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of gene expression [GO:0010628]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of metanephric glomerulus development [GO:0072300]; positive regulation of neuron maturation [GO:0014042]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; positive regulation of protein kinase B signaling [GO:0051897]; posterior midgut development [GO:0007497]; protein phosphorylation [GO:0006468]; regulation of axonogenesis [GO:0050770]; regulation of cell adhesion [GO:0030155]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; retina development in camera-type eye [GO:0060041]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; ureter maturation [GO:0035799]; ureteric bud development [GO:0001657]","GO:0000165; GO:0001657; GO:0001755; GO:0001838; GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005769; GO:0005886; GO:0006468; GO:0006919; GO:0007156; GO:0007158; GO:0007165; GO:0007169; GO:0007411; GO:0007497; GO:0009410; GO:0010008; GO:0010628; GO:0010976; GO:0014042; GO:0030155; GO:0030335; GO:0030424; GO:0030425; GO:0033141; GO:0033619; GO:0033630; GO:0033674; GO:0035799; GO:0035860; GO:0038023; GO:0042551; GO:0043025; GO:0043235; GO:0043410; GO:0045121; GO:0045793; GO:0045893; GO:0048265; GO:0048484; GO:0050770; GO:0051897; GO:0060041; GO:0060384; GO:0061146; GO:0071300; GO:0072300; GO:0097021; GO:0098797; GO:2001241"
"9259","Cluster_2854","Peve_00038534",-0.998485426650187,0.0350425019077328,0.909359886114279,152,-20.14,"2 14","9013 9035",13,"84.62%","92.31%","CDS","Q14517","Protocadherin Fat 1 (Cadherin family member 7) (Cadherin-related tumor suppressor homolog) (Protein fat homolog) [Cleaved into: Protocadherin Fat 1, nuclear form]","Homo sapiens (Human)","actin filament organization [GO:0007015]; anatomical structure morphogenesis [GO:0009653]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; cell-cell signaling [GO:0007267]; epithelial cell morphogenesis [GO:0003382]; establishment of epithelial cell apical/basal polarity involved in camera-type eye morphogenesis [GO:0003412]; establishment or maintenance of cell polarity [GO:0007163]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; lens development in camera-type eye [GO:0002088]","GO:0002088; GO:0003382; GO:0003412; GO:0005509; GO:0005634; GO:0005886; GO:0005911; GO:0005925; GO:0007015; GO:0007155; GO:0007156; GO:0007163; GO:0007267; GO:0009653; GO:0016324; GO:0016477; GO:0030027; GO:0030175; GO:0048471; GO:0070062; GO:0098609"
"9354","Cluster_2854","Peve_00041797",0.999925407085804,0.0077758273230635,0.573710369894872,152,-20.39,"2 18","18365 18390",20,"70.00%","75.00%","CDS","Q8VHN7","Adhesion G-protein coupled receptor V1 (ADGRV1) (EC 3.4.-.-) (G-protein coupled receptor 98) (Monogenic audiogenic seizure susceptibility protein 1) (MASS1) (Neurepin) (Protein rueda) (Very large G-protein coupled receptor 1) (VLGR1) [Cleaved into: ADGRV1 subunit alpha; ADGRV1 subunit beta (VLGR1 subunit beta) (Vbeta)]","Mus musculus (Mouse)","cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cellular response to calcium ion [GO:0071277]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; inner ear development [GO:0048839]; inner ear receptor cell differentiation [GO:0060113]; inner ear receptor cell stereocilium organization [GO:0060122]; maintenance of animal organ identity [GO:0048496]; negative regulation of adenylate cyclase activity [GO:0007194]; nervous system development [GO:0007399]; nervous system process [GO:0050877]; photoreceptor cell maintenance [GO:0045494]; positive regulation of bone mineralization [GO:0030501]; positive regulation of protein kinase A signaling [GO:0010739]; positive regulation of protein kinase C signaling [GO:0090037]; regulation of protein stability [GO:0031647]; self proteolysis [GO:0097264]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601]","GO:0001917; GO:0001965; GO:0002141; GO:0002142; GO:0004930; GO:0005509; GO:0005576; GO:0005737; GO:0005886; GO:0007166; GO:0007194; GO:0007399; GO:0007601; GO:0007605; GO:0009986; GO:0010739; GO:0010855; GO:0016020; GO:0016787; GO:0017022; GO:0030501; GO:0031647; GO:0032391; GO:0032420; GO:0043235; GO:0045184; GO:0045202; GO:0045494; GO:0048471; GO:0048496; GO:0048839; GO:0050877; GO:0050910; GO:0050953; GO:0051649; GO:0060113; GO:0060122; GO:0060171; GO:0071277; GO:0090037; GO:0097264; GO:0098609; GO:1990075; GO:1990696"
"9365","Cluster_2854","Peve_00041884",0.999999550681443,0.00060349310788746,0.239778920002343,154,-20.86,"2 20","13010 13032",19,"68.42%","78.95%","CDS","P00735","Prothrombin (EC 3.4.21.5) (Coagulation factor II) [Cleaved into: Activation peptide fragment 1; Activation peptide fragment 2; Thrombin light chain; Thrombin heavy chain]","Bos taurus (Bovine)","acute-phase response [GO:0006953]; platelet activation [GO:0030168]; positive regulation of blood coagulation [GO:0030194]; protein polymerization [GO:0051258]; proteolysis [GO:0006508]","GO:0004252; GO:0005509; GO:0005615; GO:0006508; GO:0006953; GO:0030168; GO:0030194; GO:0051258; GO:0062023; GO:0070051"
"9383","Cluster_2854","Peve_00041682",-0.998485426650187,0.0350425019077328,0.909359886114279,161,-20.58,"2 20","1808 1828",18,"77.78%","83.33%","CDS","Q4UMH6","Putative ankyrin repeat protein RF_0381","Rickettsia felis (strain ATCC VR-1525 / URRWXCal2) (Rickettsia azadi)","guanosine tetraphosphate metabolic process [GO:0015969]","GO:0015969"
"9384","Cluster_2854","Peve_00041682",-0.998485426650187,0.0350425019077328,0.909359886114279,161,-20.58,"2 20","2003 2023",18,"77.78%","83.33%","CDS","Q4UMH6","Putative ankyrin repeat protein RF_0381","Rickettsia felis (strain ATCC VR-1525 / URRWXCal2) (Rickettsia azadi)","guanosine tetraphosphate metabolic process [GO:0015969]","GO:0015969"
"9411","Cluster_2854","Peve_00042929",-0.999607236533936,0.0178432877164636,0.782669382293497,165,-27.04,"2 21","31027 31048",20,"80.00%","85.00%","CDS","Q04467","Isocitrate dehydrogenase [NADP], mitochondrial (IDH) (EC 1.1.1.42) (ICD-M) (IDP) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase)","Bos taurus (Bovine)","2-oxoglutarate metabolic process [GO:0006103]; glyoxylate cycle [GO:0006097]; isocitrate metabolic process [GO:0006102]; NADP metabolic process [GO:0006739]; tricarboxylic acid cycle [GO:0006099]","GO:0000287; GO:0004450; GO:0005739; GO:0005743; GO:0005777; GO:0005829; GO:0006097; GO:0006099; GO:0006102; GO:0006103; GO:0006739; GO:0051287"
"9420","Cluster_2854","Peve_00043346",0.999962448044095,0.00551712420276166,0.551398425649056,167,-21.1,"2 20","378 399",18,"72.22%","88.89%","CDS","A0A2B4RNI3",NA,NA,NA,NA
"9424","Cluster_2854","Peve_00041707",0.999795898790508,0.0128624973090348,0.697089785965063,160,-20.44,"2 21","3833 3854",19,"68.42%","78.95%","CDS",NA,NA,NA,NA,NA
"9436","Cluster_2854","Peve_00043948",-0.999925689816771,0.00776107671533052,0.573710369894872,152,-20.69,"2 20","20578 20599",19,"68.42%","84.21%","CDS","Q6DRN3","Nucleolar complex protein 3 homolog (NOC3 protein homolog) (NOC3-like protein) (Nucleolar complex-associated protein 3-like protein)","Danio rerio (Zebrafish) (Brachydanio rerio)","DNA replication initiation [GO:0006270]; muscle organ development [GO:0007517]; regulation of lipid metabolic process [GO:0019216]","GO:0003682; GO:0005634; GO:0005730; GO:0006270; GO:0007517; GO:0019216"
"9462","Cluster_2854","Peve_00044389",0.999986498807432,0.00330812320175955,0.500095982000588,155,-20.93,"2 20","16743 16764",18,"61.11%","83.33%","CDS","Q5RHH4","Intraflagellar transport protein 172 homolog","Danio rerio (Zebrafish) (Brachydanio rerio)","cilium assembly [GO:0060271]; intraciliary transport [GO:0042073]; photoreceptor cell maintenance [GO:0045494]; pronephros development [GO:0048793]; regulation of TOR signaling [GO:0032006]; retina development in camera-type eye [GO:0060041]","GO:0005929; GO:0005930; GO:0030992; GO:0032006; GO:0036064; GO:0042073; GO:0045494; GO:0048793; GO:0060041; GO:0060271"
"9466","Cluster_2854","Peve_00044518",0.999901905632251,0.00891703984388479,0.586861520389792,171,-20.09,"2 21","4544 4566",20,"75.00%","90.00%","CDS","Q5ZLX5","Zinc finger Ran-binding domain-containing protein 2","Gallus gallus (Chicken)","RNA processing [GO:0006396]","GO:0001530; GO:0003723; GO:0005634; GO:0006396; GO:0046872"
"9471","Cluster_2854","Peve_00044684",0.999962448044095,0.00551712420276166,0.551398425649056,161,-21.25,"2 21","218 242",22,"77.27%","81.82%","CDS",NA,NA,NA,NA,NA
"9489","Cluster_2854","Peve_00045236",-0.999000731937584,0.0284624509847491,0.903848995020577,149,-20.36,"2 20","11151 11178",24,"66.67%","70.83%","CDS","Q7TMK9","Heterogeneous nuclear ribonucleoprotein Q (hnRNP Q) (Glycine- and tyrosine-rich RNA-binding protein) (GRY-RBP) (NS1-associated protein 1) (Synaptotagmin-binding, cytoplasmic RNA-interacting protein) (pp68)","Mus musculus (Mouse)","cellular response to type II interferon [GO:0071346]; CRD-mediated mRNA stabilization [GO:0070934]; mRNA modification [GO:0016556]; mRNA processing [GO:0006397]; negative regulation of mRNA modification [GO:0090367]; negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900152]; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000623]; negative regulation of translation [GO:0017148]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of DNA demethylation [GO:1901537]; positive regulation of translation [GO:0045727]; RNA splicing [GO:0008380]","GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005829; GO:0006397; GO:0008143; GO:0008380; GO:0016020; GO:0016556; GO:0017148; GO:0043025; GO:0045293; GO:0045727; GO:0048027; GO:0070934; GO:0070937; GO:0071013; GO:0071204; GO:0071346; GO:0090367; GO:0097452; GO:0106002; GO:1900152; GO:1901537; GO:1990635; GO:1990904; GO:2000623; GO:2000767"
"9490","Cluster_2854","Peve_00045254",-0.999992320114512,0.00249501275975525,0.416769192445762,150,-20.16,"2 21","518 541",21,"66.67%","76.19%","CDS",NA,NA,NA,NA,NA
"9495","Cluster_2882","Peve_00000242",-0.996940885947183,0.0498085306799997,0.952787398997432,157,-20.93,"2 20","4868 4892",21,"76.19%","76.19%","CDS","P53990","IST1 homolog (hIST1) (Charged multivesicular body protein 8) (CHMP8) (Putative MAPK-activating protein PM28)","Homo sapiens (Human)","abscission [GO:0009838]; cell division [GO:0051301]; collateral sprouting [GO:0048668]; cytoskeleton-dependent cytokinesis [GO:0061640]; ESCRT III complex disassembly [GO:1904903]; establishment of protein localization [GO:0045184]; multivesicular body assembly [GO:0036258]; positive regulation of collateral sprouting [GO:0048672]; positive regulation of proteolysis [GO:0045862]; protein localization [GO:0008104]; protein transport [GO:0015031]; viral capsid secondary envelopment [GO:0046745]; viral release from host cell [GO:0019076]","GO:0005576; GO:0005635; GO:0005793; GO:0005813; GO:0005829; GO:0008104; GO:0009838; GO:0015031; GO:0019076; GO:0019904; GO:0030496; GO:0035578; GO:0036258; GO:0042802; GO:0043231; GO:0044877; GO:0045184; GO:0045296; GO:0045862; GO:0046745; GO:0048668; GO:0048672; GO:0051301; GO:0061640; GO:0070062; GO:0090541; GO:0090543; GO:1904903"
"9496","Cluster_2882","Peve_00000242",-0.996940885947183,0.0498085306799997,0.952787398997432,173,-24.97,"2 20","5510 5530",18,"88.89%","88.89%","CDS","P53990","IST1 homolog (hIST1) (Charged multivesicular body protein 8) (CHMP8) (Putative MAPK-activating protein PM28)","Homo sapiens (Human)","abscission [GO:0009838]; cell division [GO:0051301]; collateral sprouting [GO:0048668]; cytoskeleton-dependent cytokinesis [GO:0061640]; ESCRT III complex disassembly [GO:1904903]; establishment of protein localization [GO:0045184]; multivesicular body assembly [GO:0036258]; positive regulation of collateral sprouting [GO:0048672]; positive regulation of proteolysis [GO:0045862]; protein localization [GO:0008104]; protein transport [GO:0015031]; viral capsid secondary envelopment [GO:0046745]; viral release from host cell [GO:0019076]","GO:0005576; GO:0005635; GO:0005793; GO:0005813; GO:0005829; GO:0008104; GO:0009838; GO:0015031; GO:0019076; GO:0019904; GO:0030496; GO:0035578; GO:0036258; GO:0042802; GO:0043231; GO:0044877; GO:0045184; GO:0045296; GO:0045862; GO:0046745; GO:0048668; GO:0048672; GO:0051301; GO:0061640; GO:0070062; GO:0090541; GO:0090543; GO:1904903"
"9531","Cluster_2882","Peve_00001230",-0.997937527792035,0.0408944004063604,0.909359886114279,153,-20.21,"2 21","2131 2153",21,"71.43%","76.19%","CDS","B3EWZ5","MAM and LDL-receptor class A domain-containing protein 1 (Skeletal organic matrix MAM and LDL-receptor 1) (SOM MAM and LDL-receptor 1)","Acropora millepora (Staghorn coral) (Heteropora millepora)","","GO:0005576; GO:0016020"
"9533","Cluster_2882","Peve_00001286",-0.999831516694319,0.0116863706387285,0.666814993313648,147,-25.6,"2 21","15837 15866",27,"59.26%","66.67%","CDS","Q5R5S4","26S proteasome non-ATPase regulatory subunit 1 (26S proteasome regulatory subunit RPN2) (26S proteasome regulatory subunit S1)","Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)","regulation of protein catabolic process [GO:0042176]","GO:0022624; GO:0030234; GO:0031625; GO:0042176"
"9534","Cluster_2882","Peve_00001286",-0.999831516694319,0.0116863706387285,0.666814993313648,155,-23.81,"2 21","10688 10711",21,"71.43%","71.43%","CDS","Q5R5S4","26S proteasome non-ATPase regulatory subunit 1 (26S proteasome regulatory subunit RPN2) (26S proteasome regulatory subunit S1)","Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)","regulation of protein catabolic process [GO:0042176]","GO:0022624; GO:0030234; GO:0031625; GO:0042176"
"9543","Cluster_2882","Peve_00001600",-0.999968762882795,0.00503189679255099,0.551398425649056,168,-21.93,"2 18","21250 21272",17,"88.24%","88.24%","CDS","Q5R826","CSC1-like protein 1 (Transmembrane protein 63A)","Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)","","GO:0003676; GO:0005227; GO:0005765; GO:0005886; GO:1990760"
"9544","Cluster_2882","Peve_00001600",-0.999968762882795,0.00503189679255099,0.551398425649056,168,-22.63,"2 18","14778 14800",17,"88.24%","88.24%","CDS","Q5R826","CSC1-like protein 1 (Transmembrane protein 63A)","Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)","","GO:0003676; GO:0005227; GO:0005765; GO:0005886; GO:1990760"
"9545","Cluster_2882","Peve_00001600",-0.999968762882795,0.00503189679255099,0.551398425649056,168,-22.63,"2 18","27706 27728",17,"88.24%","88.24%","CDS","Q5R826","CSC1-like protein 1 (Transmembrane protein 63A)","Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)","","GO:0003676; GO:0005227; GO:0005765; GO:0005886; GO:1990760"
"9563","Cluster_2882","Peve_00002096",-0.998926876388747,0.0294957090939906,0.903929377050813,145,-23.03,"2 19","28697 28722",21,"66.67%","66.67%","CDS","Q9JID6","Long-chain-fatty-acid--CoA ligase 1 (EC 6.2.1.3) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain acyl-CoA synthetase 1) (LACS 1) (Palmitoyl-CoA ligase) (Phytanate--CoA ligase) (EC 6.2.1.24)","Cavia porcellus (Guinea pig)","long-chain fatty acid metabolic process [GO:0001676]; very long-chain fatty acid metabolic process [GO:0000038]","GO:0000038; GO:0001676; GO:0004467; GO:0005524; GO:0005741; GO:0005778; GO:0005783; GO:0005789; GO:0047676; GO:0050197; GO:0070251"
"9569","Cluster_2882","Peve_00002350",-0.9974322416173,0.0456315449231137,0.93332862243605,161,-20.97,"2 14","6866 6887",12,"91.67%","100.00%","CDS","Q1L8F9","KICSTOR subunit 2","Danio rerio (Zebrafish) (Brachydanio rerio)","cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; negative regulation of TORC1 signaling [GO:1904262]; protein localization to lysosome [GO:0061462]","GO:0005765; GO:0034198; GO:0042149; GO:0061462; GO:0140007; GO:1904262"
"9597","Cluster_2882","Peve_00003586",-0.998590344098593,0.033806694422102,0.909359886114279,160,-20.54,"2 21","38432 38453",19,"68.42%","78.95%","CDS","Q8IY21","Probable ATP-dependent RNA helicase DDX60 (EC 3.6.4.13) (DEAD box protein 60)","Homo sapiens (Human)","defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; response to virus [GO:0009615]","GO:0003690; GO:0003724; GO:0003725; GO:0003727; GO:0005524; GO:0005737; GO:0005829; GO:0009615; GO:0016887; GO:0045087; GO:0045111; GO:0051607; GO:1900245; GO:1900246"
"9598","Cluster_2882","Peve_00003586",-0.998590344098593,0.033806694422102,0.909359886114279,160,-22.57,"2 21","31069 31090",19,"73.68%","73.68%","CDS","Q8IY21","Probable ATP-dependent RNA helicase DDX60 (EC 3.6.4.13) (DEAD box protein 60)","Homo sapiens (Human)","defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; response to virus [GO:0009615]","GO:0003690; GO:0003724; GO:0003725; GO:0003727; GO:0005524; GO:0005737; GO:0005829; GO:0009615; GO:0016887; GO:0045087; GO:0045111; GO:0051607; GO:1900245; GO:1900246"
"9633","Cluster_2882","Peve_00004622",-0.99854349113181,0.0343640557012432,0.909359886114279,170,-20.02,"2 21","5658 5681",21,"80.95%","85.71%","CDS","Q13415","Origin recognition complex subunit 1 (Replication control protein 1)","Homo sapiens (Human)","DNA replication initiation [GO:0006270]; mitotic DNA replication checkpoint signaling [GO:0033314]","GO:0000781; GO:0000808; GO:0003677; GO:0003682; GO:0003688; GO:0005524; GO:0005634; GO:0005654; GO:0005664; GO:0005829; GO:0006270; GO:0016887; GO:0033314; GO:0046872"
"9663","Cluster_2882","Peve_00006220",-0.998529572564813,0.0345278988141967,0.909359886114279,145,-22,"2 10","8905 8926",8,"100.00%","100.00%","CDS",NA,NA,NA,NA,NA
"9665","Cluster_2882","Peve_00006527",-0.999847649720536,0.0111127683729467,0.651110503314638,149,-21.12,"2 15","26696 26718",14,"78.57%","85.71%","CDS","Q9H251","Cadherin-23 (Otocadherin)","Homo sapiens (Human)","auditory receptor cell stereocilium organization [GO:0060088]; calcium ion transport [GO:0006816]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; equilibrioception [GO:0050957]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; locomotory behavior [GO:0007626]; photoreceptor cell maintenance [GO:0045494]; post-embryonic animal organ morphogenesis [GO:0048563]; regulation of cytosolic calcium ion concentration [GO:0051480]; response to stimulus [GO:0050896]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601]","GO:0001917; GO:0005509; GO:0005813; GO:0006816; GO:0007156; GO:0007601; GO:0007605; GO:0007626; GO:0016020; GO:0016339; GO:0016342; GO:0032420; GO:0032426; GO:0045296; GO:0045494; GO:0048563; GO:0050896; GO:0050953; GO:0050957; GO:0051480; GO:0060088; GO:0060091; GO:0098683; GO:0098684; GO:0098742"
"9676","Cluster_2882","Peve_00000005",-0.998189752804816,0.0383115390865436,0.909359886114279,147,-20.16,"2 13","2025 2048",13,"84.62%","84.62%","CDS","P52564","Dual specificity mitogen-activated protein kinase kinase 6 (MAP kinase kinase 6) (MAPKK 6) (EC 2.7.12.2) (MAPK/ERK kinase 6) (MEK 6) (Stress-activated protein kinase kinase 3) (SAPK kinase 3) (SAPKK-3) (SAPKK3)","Homo sapiens (Human)","apoptotic process [GO:0006915]; bone development [GO:0060348]; cardiac muscle contraction [GO:0060048]; cellular response to sorbitol [GO:0072709]; cellular senescence [GO:0090398]; MAPK cascade [GO:0000165]; negative regulation of cold-induced thermogenesis [GO:0120163]; nucleotide-binding oligomerization domain containing signaling pathway [GO:0070423]; osteoblast differentiation [GO:0001649]; ovulation cycle process [GO:0022602]; p38MAPK cascade [GO:0038066]; positive regulation of apoptotic process [GO:0043065]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of prostaglandin secretion [GO:0032308]; regulation of cell cycle [GO:0051726]; regulation of signal transduction by p53 class mediator [GO:1901796]; response to ischemia [GO:0002931]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165]; signal transduction in response to DNA damage [GO:0042770]; stress-activated MAPK cascade [GO:0051403]","GO:0000165; GO:0001649; GO:0002931; GO:0004674; GO:0004708; GO:0004713; GO:0005524; GO:0005654; GO:0005829; GO:0005856; GO:0006915; GO:0007165; GO:0009410; GO:0019211; GO:0019901; GO:0022602; GO:0032308; GO:0038066; GO:0042770; GO:0042802; GO:0043065; GO:0043406; GO:0043539; GO:0051403; GO:0051726; GO:0051770; GO:0060048; GO:0060348; GO:0070423; GO:0072709; GO:0090398; GO:0106310; GO:0120163; GO:0140537; GO:1901796"
"9678","Cluster_2882","Peve_00006896",-0.999754770568984,0.0140990643134194,0.725755651730332,157,-22.64,"2 14","5207 5228",12,"91.67%","91.67%","CDS","Q7ZWW7","Tetraspanin-31-B (Tspan-31-B) (Sarcoma-amplified sequence homolog B)","Xenopus laevis (African clawed frog)","","GO:0016020"
"9679","Cluster_2882","Peve_00006896",-0.999754770568984,0.0140990643134194,0.725755651730332,157,-22.64,"2 14","6793 6814",12,"91.67%","91.67%","CDS","Q7ZWW7","Tetraspanin-31-B (Tspan-31-B) (Sarcoma-amplified sequence homolog B)","Xenopus laevis (African clawed frog)","","GO:0016020"
"9702","Cluster_2882","Peve_00007645",-0.99711685553391,0.0483540352291861,0.946452802050405,154,-21.57,"2 20","5907 5932",22,"68.18%","72.73%","CDS","Q99M87","DnaJ homolog subfamily A member 3, mitochondrial (DnaJ protein Tid-1) (mTid-1) (Tumorous imaginal discs protein Tid56 homolog)","Mus musculus (Mouse)","activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation-induced cell death of T cells [GO:0006924]; apoptotic process [GO:0006915]; cellular senescence [GO:0090398]; mitochondrial DNA replication [GO:0006264]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of programmed cell death [GO:0043069]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of type II interferon-mediated signaling pathway [GO:0060336]; neuromuscular junction development [GO:0007528]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of T cell proliferation [GO:0042102]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to heat [GO:0009408]; response to type II interferon [GO:0034341]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; small GTPase mediated signal transduction [GO:0007264]; T cell differentiation in thymus [GO:0033077]","GO:0000122; GO:0005133; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0005884; GO:0005886; GO:0006264; GO:0006457; GO:0006469; GO:0006915; GO:0006919; GO:0006924; GO:0007005; GO:0007264; GO:0007528; GO:0008285; GO:0009408; GO:0019897; GO:0019901; GO:0030544; GO:0030695; GO:0030971; GO:0031398; GO:0031594; GO:0032088; GO:0033077; GO:0034341; GO:0042102; GO:0042645; GO:0043065; GO:0043066; GO:0043069; GO:0043124; GO:0043154; GO:0043231; GO:0044877; GO:0045211; GO:0046872; GO:0050821; GO:0051059; GO:0051082; GO:0060336; GO:0061629; GO:0071340; GO:0090398; GO:0106137; GO:0140297"
"9724","Cluster_2882","Peve_00008382",-0.999998674676404,0.00103646856226412,0.264577589483208,157,-21.77,"2 20","27767 27791",21,"71.43%","80.95%","CDS","A2A9C3","KICSTOR complex protein SZT2 (Seizure threshold 2 protein) (Transcript increased in glutamate resistance) (TIGR)","Mus musculus (Mouse)","cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; central nervous system development [GO:0007417]; corpus callosum morphogenesis [GO:0021540]; negative regulation of TORC1 signaling [GO:1904262]; pigmentation [GO:0043473]; post-embryonic development [GO:0009791]; protein localization to lysosome [GO:0061462]; regulation of superoxide dismutase activity [GO:1901668]; response to nutrient levels [GO:0031667]","GO:0005765; GO:0005777; GO:0007417; GO:0009791; GO:0021540; GO:0031667; GO:0034198; GO:0042149; GO:0043473; GO:0061462; GO:0061700; GO:0140007; GO:1901668; GO:1904262; GO:1990130"
"9760","Cluster_2882","Peve_00009585",-0.999810478284584,0.0123945701379348,0.685731608006455,152,-22.3,"2 21","18324 18345",19,"63.16%","73.68%","CDS","P0CI65","Nephrocystin-3","Danio rerio (Zebrafish) (Brachydanio rerio)","cilium assembly [GO:0060271]; convergent extension [GO:0060026]; determination of left/right symmetry [GO:0007368]; heart jogging [GO:0003146]; kidney development [GO:0001822]; Kupffer's vesicle development [GO:0070121]; left/right pattern formation [GO:0060972]; pronephros development [GO:0048793]; visual perception [GO:0007601]; Wnt signaling pathway [GO:0016055]","GO:0001822; GO:0003146; GO:0005929; GO:0007368; GO:0007601; GO:0016055; GO:0048793; GO:0060026; GO:0060271; GO:0060972; GO:0070121; GO:0097543; GO:0097546"
"9761","Cluster_2882","Peve_00009585",-0.999810478284584,0.0123945701379348,0.685731608006455,157,-21.9,"2 19","19588 19610",18,"77.78%","77.78%","CDS","P0CI65","Nephrocystin-3","Danio rerio (Zebrafish) (Brachydanio rerio)","cilium assembly [GO:0060271]; convergent extension [GO:0060026]; determination of left/right symmetry [GO:0007368]; heart jogging [GO:0003146]; kidney development [GO:0001822]; Kupffer's vesicle development [GO:0070121]; left/right pattern formation [GO:0060972]; pronephros development [GO:0048793]; visual perception [GO:0007601]; Wnt signaling pathway [GO:0016055]","GO:0001822; GO:0003146; GO:0005929; GO:0007368; GO:0007601; GO:0016055; GO:0048793; GO:0060026; GO:0060271; GO:0060972; GO:0070121; GO:0097543; GO:0097546"
"9775","Cluster_2882","Peve_00010241",-0.999280470349742,0.0241515780394229,0.857298733095813,158,-25.56,"2 16","10999 11021",15,"86.67%","86.67%","CDS","Q60598","Src substrate cortactin","Mus musculus (Mouse)","actin cytoskeleton reorganization [GO:0031532]; cell motility [GO:0048870]; dendritic spine maintenance [GO:0097062]; extrinsic apoptotic signaling pathway [GO:0097191]; focal adhesion assembly [GO:0048041]; intracellular protein transport [GO:0006886]; lamellipodium organization [GO:0097581]; modification of postsynaptic actin cytoskeleton [GO:0098885]; modification of postsynaptic structure [GO:0099010]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; neuron projection morphogenesis [GO:0048812]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of chemotaxis [GO:0050921]; positive regulation of smooth muscle contraction [GO:0045987]; receptor-mediated endocytosis [GO:0006898]; regulation of actin filament polymerization [GO:0030833]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of axon extension [GO:0030516]; regulation of cell projection assembly [GO:0060491]; substrate-dependent cell migration, cell extension [GO:0006930]","GO:0001726; GO:0002102; GO:0005522; GO:0005737; GO:0005783; GO:0005794; GO:0005829; GO:0005884; GO:0005886; GO:0005905; GO:0005925; GO:0005938; GO:0006886; GO:0006898; GO:0006930; GO:0008076; GO:0030027; GO:0030054; GO:0030426; GO:0030427; GO:0030516; GO:0030833; GO:0030838; GO:0030863; GO:0030864; GO:0031532; GO:0043197; GO:0043231; GO:0045987; GO:0048041; GO:0048812; GO:0048870; GO:0050921; GO:0051015; GO:0060491; GO:0070064; GO:0071933; GO:0097062; GO:0097191; GO:0097581; GO:0098794; GO:0098871; GO:0098885; GO:0098978; GO:0099010; GO:1903146; GO:1990023; GO:2001237"
"9808","Cluster_2882","Peve_00011277",-0.998762352756012,0.0316765855529158,0.903929377050813,163,-22.74,"2 21","21594 21617",21,"71.43%","80.95%","CDS","Q8IWV8","E3 ubiquitin-protein ligase UBR2 (EC 2.3.2.27) (N-recognin-2) (RING-type E3 ubiquitin transferase UBR2) (Ubiquitin-protein ligase E3-alpha-2) (Ubiquitin-protein ligase E3-alpha-II)","Homo sapiens (Human)","cellular response to leucine [GO:0071233]; heterochromatin formation [GO:0031507]; histone H2A ubiquitination [GO:0033522]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transposition [GO:0010529]; protein ubiquitination [GO:0016567]; reciprocal meiotic recombination [GO:0007131]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596]","GO:0000151; GO:0000785; GO:0005634; GO:0005737; GO:0005829; GO:0007131; GO:0007140; GO:0007141; GO:0007283; GO:0008270; GO:0010529; GO:0016567; GO:0031507; GO:0032007; GO:0033522; GO:0061630; GO:0070728; GO:0071233; GO:0071596"
"9859","Cluster_2882","Peve_00013068",0.997427621442327,0.0456725965588281,0.933493920659362,166,-23.01,"2 21","1380 1403",21,"76.19%","85.71%","CDS",NA,NA,NA,NA,NA
"9866","Cluster_2882","Peve_00013326",-0.997240786263881,0.0473028929719221,0.942326285748566,149,-23.64,"2 14","40830 40851",12,"83.33%","83.33%","CDS","D4G3R4","tRNA(Glu)-specific nuclease WapA (EC 3.1.-.-) (Cell wall-associated protein) (RNase WapA) (Toxin WapA)","Bacillus subtilis subsp. natto (strain BEST195)","tRNA catabolic process [GO:0016078]","GO:0004519; GO:0004549; GO:0005576; GO:0016078; GO:0090729"
"9867","Cluster_2882","Peve_00013326",-0.997240786263881,0.0473028929719221,0.942326285748566,168,-24.13,"2 21","26349 26370",19,"73.68%","84.21%","CDS","D4G3R4","tRNA(Glu)-specific nuclease WapA (EC 3.1.-.-) (Cell wall-associated protein) (RNase WapA) (Toxin WapA)","Bacillus subtilis subsp. natto (strain BEST195)","tRNA catabolic process [GO:0016078]","GO:0004519; GO:0004549; GO:0005576; GO:0016078; GO:0090729"
"9911","Cluster_2882","Peve_00015249",-0.999160764172372,0.0260835984901328,0.881322544431866,147,-22.68,"2 17","589 615",20,"70.00%","70.00%","CDS","Q6P5D8","Structural maintenance of chromosomes flexible hinge domain-containing protein 1 (SMC hinge domain-containing protein 1) (EC 3.6.1.-)","Mus musculus (Mouse)","chromosome organization [GO:0051276]; dosage compensation by inactivation of X chromosome [GO:0009048]; double-strand break repair [GO:0006302]; inactivation of X chromosome by heterochromatin formation [GO:0060820]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; nose development [GO:0043584]; positive regulation of DNA repair [GO:0045739]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]","GO:0000781; GO:0001740; GO:0003677; GO:0005524; GO:0006302; GO:0009048; GO:0016887; GO:0035861; GO:0042803; GO:0043584; GO:0045739; GO:0051276; GO:0060820; GO:2000042; GO:2001034"
"9929","Cluster_2882","Peve_00015953",-0.999740923544185,0.014491671178143,0.732730416382572,160,-21.56,"2 21","36607 36628",19,"68.42%","78.95%","CDS","Q99PF4","Cadherin-23 (Otocadherin)","Mus musculus (Mouse)","auditory receptor cell stereocilium organization [GO:0060088]; calcium ion transport [GO:0006816]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; equilibrioception [GO:0050957]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear development [GO:0048839]; inner ear morphogenesis [GO:0042472]; inner ear receptor cell stereocilium organization [GO:0060122]; locomotory behavior [GO:0007626]; photoreceptor cell maintenance [GO:0045494]; post-embryonic animal organ morphogenesis [GO:0048563]; regulation of cytosolic calcium ion concentration [GO:0051480]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]","GO:0001917; GO:0005509; GO:0005813; GO:0005886; GO:0006816; GO:0007155; GO:0007156; GO:0007605; GO:0007626; GO:0016339; GO:0016342; GO:0032420; GO:0032426; GO:0042472; GO:0042491; GO:0045177; GO:0045202; GO:0045296; GO:0045494; GO:0047485; GO:0048563; GO:0048839; GO:0050953; GO:0050957; GO:0051480; GO:0060088; GO:0060091; GO:0060122; GO:0098683; GO:0098684; GO:0098742"
"9988","Cluster_2882","Peve_00018009",-0.998541509666997,0.0343874282242607,0.909359886114279,164,-22.15,"2 17","21733 21754",15,"80.00%","93.33%","CDS","Q8R1A4","Dedicator of cytokinesis protein 7 (Protein moonlight)","Mus musculus (Mouse)","activation of GTPase activity [GO:0090630]; axonogenesis [GO:0007409]; establishment of neuroblast polarity [GO:0045200]; hematopoietic progenitor cell differentiation [GO:0002244]; interkinetic nuclear migration [GO:0022027]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of cold-induced thermogenesis [GO:0120163]; neuron projection development [GO:0031175]; pigmentation [GO:0043473]; positive regulation of GTPase activity [GO:0043547]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; postsynaptic specialization assembly [GO:0098698]; regulation of neurogenesis [GO:0050767]; small GTPase mediated signal transduction [GO:0007264]","GO:0000226; GO:0002244; GO:0005085; GO:0007264; GO:0007409; GO:0008180; GO:0022027; GO:0030424; GO:0031175; GO:0031267; GO:0031594; GO:0033138; GO:0043473; GO:0043547; GO:0045200; GO:0050767; GO:0090630; GO:0098698; GO:0120163; GO:1904754"
"9989","Cluster_2882","Peve_00018009",-0.998541509666997,0.0343874282242607,0.909359886114279,164,-22.59,"2 17","19663 19684",15,"80.00%","93.33%","CDS","Q8R1A4","Dedicator of cytokinesis protein 7 (Protein moonlight)","Mus musculus (Mouse)","activation of GTPase activity [GO:0090630]; axonogenesis [GO:0007409]; establishment of neuroblast polarity [GO:0045200]; hematopoietic progenitor cell differentiation [GO:0002244]; interkinetic nuclear migration [GO:0022027]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of cold-induced thermogenesis [GO:0120163]; neuron projection development [GO:0031175]; pigmentation [GO:0043473]; positive regulation of GTPase activity [GO:0043547]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; postsynaptic specialization assembly [GO:0098698]; regulation of neurogenesis [GO:0050767]; small GTPase mediated signal transduction [GO:0007264]","GO:0000226; GO:0002244; GO:0005085; GO:0007264; GO:0007409; GO:0008180; GO:0022027; GO:0030424; GO:0031175; GO:0031267; GO:0031594; GO:0033138; GO:0043473; GO:0043547; GO:0045200; GO:0050767; GO:0090630; GO:0098698; GO:0120163; GO:1904754"
"10008","Cluster_2882","Peve_00018891",-0.999873054198373,0.0101439917288081,0.625864793275983,164,-22,"2 19","34876 34901",21,"80.95%","80.95%","CDS","Q5T4S7","E3 ubiquitin-protein ligase UBR4 (EC 2.3.2.27) (600 kDa retinoblastoma protein-associated factor) (N-recognin-4) (RING-type E3 ubiquitin transferase UBR4) (Retinoblastoma-associated factor of 600 kDa) (RBAF600) (p600) (Zinc finger UBR1-type protein 1)","Homo sapiens (Human)","ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0004842; GO:0005516; GO:0005654; GO:0005813; GO:0005829; GO:0005886; GO:0006511; GO:0008270; GO:0016020; GO:0035579; GO:0061630; GO:0070821; GO:0101003"
"10012","Cluster_2882","Peve_00018941",-0.999999932848589,0.000233304273359623,0.13715989294074,158,-23.63,"2 21","8369 8389",19,"68.42%","84.21%","CDS","A3KP59","Ribosomal oxygenase 1 (Bifunctional lysine-specific demethylase and histidyl-hydroxylase NO66) (EC 1.14.11.-, EC 1.14.11.27) (Histone lysine demethylase NO66)","Danio rerio (Zebrafish) (Brachydanio rerio)","chromatin organization [GO:0006325]; histone H3-K36 demethylation [GO:0070544]; histone H3-K4 demethylation [GO:0034720]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of osteoblast differentiation [GO:0045668]","GO:0005506; GO:0005634; GO:0005654; GO:0005730; GO:0006325; GO:0016706; GO:0032453; GO:0034647; GO:0034720; GO:0036139; GO:0045668; GO:0045892; GO:0051864; GO:0070544; GO:0140457; GO:0140680"
"10047","Cluster_2882","Peve_00020567",0.998597279659724,0.0337234072578845,0.909359886114279,143,-21.94,"2 21","1974 1998",22,"63.64%","63.64%","CDS","Q81E85","DEAD-box ATP-dependent RNA helicase CshC (EC 3.6.4.13)","Bacillus cereus (strain ATCC 14579 / DSM 31 / CCUG 7414 / JCM 2152 / NBRC 15305 / NCIMB 9373 / NCTC 2599 / NRRL B-3711)","ribosomal large subunit assembly [GO:0000027]","GO:0000027; GO:0003723; GO:0003724; GO:0005524; GO:0005829; GO:0016887; GO:0033592"
"10056","Cluster_2882","Peve_00020859",-0.999908910369173,0.00859276408710134,0.575369165819932,162,-25.8,"2 21","17262 17287",23,"73.91%","78.26%","CDS","Q8CBC7",NA,NA,NA,NA
"10065","Cluster_2882","Peve_00020888",-0.999989002458213,0.00298568048308791,0.468149337940133,160,-20.35,"2 19","2427 2447",17,"82.35%","82.35%","CDS","Q8N264","Rho GTPase-activating protein 24 (Filamin-A-associated RhoGAP) (FilGAP) (RAC1- and CDC42-specific GTPase-activating protein of 72 kDa) (RC-GAP72) (Rho-type GTPase-activating protein 24) (RhoGAP of 73 kDa) (Sarcoma antigen NY-SAR-88) (p73RhoGAP)","Homo sapiens (Human)","activation of GTPase activity [GO:0090630]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; negative regulation of Rac protein signal transduction [GO:0035021]; negative regulation of ruffle assembly [GO:1900028]; signal transduction [GO:0007165]; wound healing, spreading of epidermal cells [GO:0035313]","GO:0001525; GO:0005096; GO:0005737; GO:0005856; GO:0005912; GO:0005925; GO:0007165; GO:0030154; GO:0035021; GO:0035313; GO:0042995; GO:0090630; GO:1900028"
"10081","Cluster_2882","Peve_00021878",-0.99780584165499,0.0421801912909202,0.911235497295089,163,-22.39,"2 21","31683 31705",20,"75.00%","80.00%","CDS","E9Q634","Unconventional myosin-Ie (Unconventional myosin 1E)","Mus musculus (Mouse)","actin filament organization [GO:0007015]; endocytosis [GO:0006897]; glomerular basement membrane development [GO:0032836]; glomerular filtration [GO:0003094]; hemopoiesis [GO:0030097]; in utero embryonic development [GO:0001701]; kidney development [GO:0001822]; nitrogen compound metabolic process [GO:0006807]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; podocyte development [GO:0072015]; post-embryonic hemopoiesis [GO:0035166]; vasculogenesis [GO:0001570]; vesicle transport along actin filament [GO:0030050]","GO:0000146; GO:0001570; GO:0001701; GO:0001822; GO:0003094; GO:0005516; GO:0005524; GO:0005737; GO:0005856; GO:0005886; GO:0005902; GO:0005903; GO:0005912; GO:0006807; GO:0006897; GO:0007015; GO:0015629; GO:0016459; GO:0016887; GO:0030050; GO:0030097; GO:0031982; GO:0032437; GO:0032836; GO:0032991; GO:0035091; GO:0035166; GO:0044877; GO:0045334; GO:0048008; GO:0051015; GO:0072015"
"10148","Cluster_2882","Peve_00024666",-0.997381924336928,0.0460766625438826,0.935575984585431,168,-23.03,"2 18","43508 43530",17,"88.24%","88.24%","CDS","B3DLH6","Myoferlin (Fer-1-like protein 3)","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","plasma membrane repair [GO:0001778]","GO:0001778; GO:0005543; GO:0005901; GO:0030659; GO:0031965; GO:0046872"
"10197","Cluster_2882","Peve_00026810",-0.999890968595625,0.0094010176895016,0.602954859488328,157,-22.73,"2 16","3429 3449",14,"85.71%","92.86%","CDS","P23359","Bone morphogenetic protein 7 (BMP-7) (Osteogenic protein 1) (OP-1)","Mus musculus (Mouse)","allantois development [GO:1905069]; ameloblast differentiation [GO:0036305]; anatomical structure formation involved in morphogenesis [GO:0048646]; animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; BMP signaling pathway [GO:0030509]; branching involved in salivary gland morphogenesis [GO:0060445]; branching morphogenesis of an epithelial tube [GO:0048754]; camera-type eye morphogenesis [GO:0048593]; cardiac muscle tissue development [GO:0048738]; cardiac septum morphogenesis [GO:0060411]; cartilage development [GO:0051216]; cell development [GO:0048468]; cell population proliferation [GO:0008283]; cellular response to BMP stimulus [GO:0071773]; chorio-allantoic fusion [GO:0060710]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic limb morphogenesis [GO:0030326]; embryonic pattern specification [GO:0009880]; embryonic skeletal joint morphogenesis [GO:0060272]; endocardial cushion formation [GO:0003272]; epithelial cell differentiation [GO:0030855]; eye development [GO:0001654]; heart trabecula morphogenesis [GO:0061384]; hindbrain development [GO:0030902]; kidney development [GO:0001822]; mesenchymal cell apoptotic process involved in nephron morphogenesis [GO:1901145]; mesenchymal cell differentiation [GO:0048762]; mesenchyme development [GO:0060485]; mesoderm formation [GO:0001707]; metanephric mesenchymal cell proliferation involved in metanephros development [GO:0072136]; metanephric mesenchyme morphogenesis [GO:0072133]; monocyte aggregation [GO:0070487]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell death [GO:0060548]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of glomerular mesangial cell proliferation [GO:0072125]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis [GO:0072040]; negative regulation of mitotic nuclear division [GO:0045839]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of phosphorylation [GO:0042326]; negative regulation of prostatic bud formation [GO:0060686]; nephrogenic mesenchyme morphogenesis [GO:0072134]; neural fold elevation formation [GO:0021502]; neuron projection morphogenesis [GO:0048812]; odontogenesis of dentin-containing tooth [GO:0042475]; ossification [GO:0001503]; pattern specification process [GO:0007389]; pericardium morphogenesis [GO:0003344]; pharyngeal system development [GO:0060037]; positive regulation of apoptotic process [GO:0043065]; positive regulation of bone mineralization [GO:0030501]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis [GO:1905312]; positive regulation of cell death [GO:0010942]; positive regulation of dendrite development [GO:1900006]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epithelial cell differentiation [GO:0030858]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of gene expression [GO:0010628]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of hyaluranon cable assembly [GO:1900106]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to nucleus [GO:0034504]; regulation of branching involved in prostate gland morphogenesis [GO:0060687]; regulation of pathway-restricted SMAD protein phosphorylation [GO:0060393]; regulation of phosphorylation [GO:0042325]; response to estradiol [GO:0032355]; response to peptide hormone [GO:0043434]; response to vitamin D [GO:0033280]; salivary gland morphogenesis [GO:0007435]; SMAD protein signal transduction [GO:0060395]; steroid hormone mediated signaling pathway [GO:0043401]; tube morphogenesis [GO:0035239]; ureteric bud development [GO:0001657]","GO:0001503; GO:0001654; GO:0001657; GO:0001707; GO:0001822; GO:0003272; GO:0003344; GO:0005125; GO:0005615; GO:0007389; GO:0007411; GO:0007435; GO:0008083; GO:0008201; GO:0008283; GO:0008285; GO:0009880; GO:0009887; GO:0010628; GO:0010718; GO:0010800; GO:0010862; GO:0010942; GO:0021502; GO:0030326; GO:0030501; GO:0030509; GO:0030855; GO:0030858; GO:0030902; GO:0031982; GO:0032355; GO:0033280; GO:0034116; GO:0034504; GO:0035239; GO:0036305; GO:0042325; GO:0042326; GO:0042475; GO:0043065; GO:0043401; GO:0043407; GO:0043434; GO:0045665; GO:0045666; GO:0045669; GO:0045746; GO:0045786; GO:0045839; GO:0045892; GO:0045893; GO:0045944; GO:0048468; GO:0048593; GO:0048596; GO:0048646; GO:0048738; GO:0048754; GO:0048762; GO:0048812; GO:0050768; GO:0051216; GO:0060037; GO:0060272; GO:0060391; GO:0060393; GO:0060395; GO:0060411; GO:0060445; GO:0060485; GO:0060548; GO:0060686; GO:0060687; GO:0060710; GO:0061384; GO:0062023; GO:0070487; GO:0070700; GO:0071773; GO:0072040; GO:0072125; GO:0072133; GO:0072134; GO:0072136; GO:0090336; GO:1900006; GO:1900106; GO:1901145; GO:1905069; GO:1905312"
"10225","Cluster_2882","Peve_00027615",-0.999570935117446,0.0186497122617979,0.78300471784633,174,-22.65,"2 21","2736 2756",19,"84.21%","89.47%","CDS","Q96RR1","Twinkle mtDNA helicase (EC 3.6.4.12) (Progressive external ophthalmoplegia 1 protein) (T7 gp4-like protein with intramitochondrial nucleoid localization) (T7-like mitochondrial DNA helicase) (Twinkle protein, mitochondrial)","Homo sapiens (Human)","cellular response to glucose stimulus [GO:0071333]; DNA unwinding involved in DNA replication [GO:0006268]; mitochondrial DNA replication [GO:0006264]; mitochondrial transcription [GO:0006390]; protein hexamerization [GO:0034214]","GO:0002020; GO:0003678; GO:0003697; GO:0005524; GO:0005739; GO:0005759; GO:0006264; GO:0006268; GO:0006390; GO:0016887; GO:0034214; GO:0042645; GO:0042802; GO:0043139; GO:0071333"
"10241","Cluster_2882","Peve_00028225",-0.99969815242718,0.0156422740231089,0.755785321447373,170,-20.69,"2 20","16502 16524",19,"84.21%","84.21%","CDS","Q9HAR2","Adhesion G protein-coupled receptor L3 (Calcium-independent alpha-latrotoxin receptor 3) (CIRL-3) (Latrophilin-3) (Lectomedin-3)","Homo sapiens (Human)","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; brain development [GO:0007420]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; G protein-coupled receptor signaling pathway [GO:0007186]; neuron migration [GO:0001764]; synapse assembly [GO:0007416]","GO:0001764; GO:0004930; GO:0005509; GO:0005886; GO:0005911; GO:0007166; GO:0007186; GO:0007189; GO:0007416; GO:0007420; GO:0016020; GO:0030246; GO:0030424; GO:0098742; GO:0098978"
"10251","Cluster_2882","Peve_00028552",-0.997639910543261,0.0437466503137105,0.921378164792108,141,-22.36,"2 21","2686 2717",29,"62.07%","65.52%","CDS",NA,NA,NA,NA,NA
"10302","Cluster_2882","Peve_00030448",-0.999991617818975,0.00260659730591339,0.429142730253057,170,-24.01,"2 20","2592 2614",19,"84.21%","84.21%","CDS","Q15700","Disks large homolog 2 (Channel-associated protein of synapse-110) (Chapsyn-110) (Postsynaptic density protein PSD-93)","Homo sapiens (Human)","anterograde axonal protein transport [GO:0099641]; cell-cell adhesion [GO:0098609]; cellular response to potassium ion [GO:0035865]; chemical synaptic transmission [GO:0007268]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; receptor clustering [GO:0043113]; receptor localization to synapse [GO:0097120]; retrograde axonal protein transport [GO:0099642]","GO:0004385; GO:0005829; GO:0005886; GO:0005912; GO:0007268; GO:0014069; GO:0016020; GO:0016323; GO:0019900; GO:0030054; GO:0031594; GO:0035865; GO:0043005; GO:0043113; GO:0043204; GO:0044224; GO:0045197; GO:0097120; GO:0098609; GO:0098839; GO:0099641; GO:0099642; GO:1904115"
"10314","Cluster_2882","Peve_00031203",-0.999642836282204,0.0170153824605288,0.78115066833064,154,-20.85,"2 15","10739 10760",13,"84.62%","84.62%","CDS","Q9DC53","Copine-8 (Copine VIII)","Mus musculus (Mouse)","cellular response to calcium ion [GO:0071277]","GO:0005544; GO:0005886; GO:0046872; GO:0071277"
"10325","Cluster_2882","Peve_00031656",-0.999987539024059,0.00317812958056457,0.486484762577909,148,-20.28,"2 15","9020 9040",13,"84.62%","84.62%","CDS","P18907","Sodium/potassium-transporting ATPase subunit alpha-1 (Sodium pump subunit alpha-1) (EC 7.2.2.13) (Na(+)/K(+) ATPase alpha-1 subunit)","Equus caballus (Horse)","cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; potassium ion import across plasma membrane [GO:1990573]; proton transmembrane transport [GO:1902600]; regulation of sodium ion transport [GO:0002028]; sodium ion export across plasma membrane [GO:0036376]","GO:0002028; GO:0005391; GO:0005524; GO:0005886; GO:0005890; GO:0006883; GO:0016020; GO:0016323; GO:0016887; GO:0019829; GO:0030007; GO:0030424; GO:0036376; GO:0042383; GO:0042470; GO:0046872; GO:1902600; GO:1990573"
"10336","Cluster_2882","Peve_00032212",-0.999999906350369,0.000275516847034453,0.158435603320091,151,-20.7,"2 18","7032 7052",16,"75.00%","81.25%","CDS","Q5ZMH1","Septin-2","Gallus gallus (Chicken)","cilium assembly [GO:0060271]; cytoskeleton-dependent cytokinesis [GO:0061640]; regulation of exocytosis [GO:0017157]; smoothened signaling pathway [GO:0007224]","GO:0003924; GO:0005525; GO:0005737; GO:0005819; GO:0005940; GO:0007224; GO:0008021; GO:0015630; GO:0017157; GO:0030496; GO:0031105; GO:0032153; GO:0032154; GO:0060090; GO:0060170; GO:0060271; GO:0061640"
"10349","Cluster_2882","Peve_00032842",-0.998941963827773,0.0292875927972194,0.903929377050813,169,-23.14,"2 20","1382 1402",18,"77.78%","94.44%","CDS","Q60803","TNF receptor-associated factor 3 (EC 2.3.2.27) (CD40 receptor-associated factor 1) (CRAF1) (CD40-binding protein) (CD40BP) (RING-type E3 ubiquitin transferase TRAF3)","Mus musculus (Mouse)","apoptotic process [GO:0006915]; innate immune response [GO:0045087]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of JNK cascade [GO:0046330]; protein K63-linked ubiquitination [GO:0070534]; regulation of apoptotic process [GO:0042981]; regulation of cytokine production [GO:0001817]; regulation of defense response to virus [GO:0050688]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of interferon-beta production [GO:0032648]; regulation of proteolysis [GO:0030162]; Toll signaling pathway [GO:0008063]; toll-like receptor signaling pathway [GO:0002224]; tumor necrosis factor-mediated signaling pathway [GO:0033209]","GO:0001817; GO:0002224; GO:0005164; GO:0005739; GO:0005768; GO:0006915; GO:0008063; GO:0008270; GO:0009898; GO:0016740; GO:0019901; GO:0019903; GO:0030162; GO:0031625; GO:0031996; GO:0032088; GO:0032648; GO:0033209; GO:0035631; GO:0042802; GO:0042981; GO:0043122; GO:0045087; GO:0046330; GO:0050688; GO:0070534"
"10390","Cluster_2882","Peve_00034689",-0.999903510444138,0.00884379702785195,0.584509800176466,140,-20.71,"2 9","8460 8481",7,"100.00%","100.00%","CDS","Q99042","D-amino-acid oxidase (DAAO) (DAMOX) (DAO) (EC 1.4.3.3)","Trigonopsis variabilis (Yeast)","D-amino acid metabolic process [GO:0046416]","GO:0003884; GO:0046416; GO:0071949"
"10391","Cluster_2882","Peve_00034689",-0.999903510444138,0.00884379702785195,0.584509800176466,152,-22.44,"2 19","985 1009",20,"75.00%","75.00%","CDS","Q99042","D-amino-acid oxidase (DAAO) (DAMOX) (DAO) (EC 1.4.3.3)","Trigonopsis variabilis (Yeast)","D-amino acid metabolic process [GO:0046416]","GO:0003884; GO:0046416; GO:0071949"
"10395","Cluster_2882","Peve_00034882",-0.998997016836603,0.0285153198965821,0.903929377050813,155,-20.95,"2 16","54061 54082",14,"78.57%","85.71%","CDS","B3EWZ3","Coadhesin","Acropora millepora (Staghorn coral) (Heteropora millepora)","","GO:0016020"
"10459","Cluster_2882","Peve_00037061",0.999255631731733,0.0245649559507044,0.862975589709272,142,-20.2,"2 21","1089 1116",25,"60.00%","68.00%","CDS","Q92820","Gamma-glutamyl hydrolase (EC 3.4.19.9) (Conjugase) (GH) (Gamma-Glu-X carboxypeptidase)","Homo sapiens (Human)","tetrahydrofolylpolyglutamate metabolic process [GO:0046900]","GO:0005576; GO:0005615; GO:0005634; GO:0005773; GO:0008238; GO:0008242; GO:0034722; GO:0035578; GO:0035580; GO:0042470; GO:0046900; GO:0070062; GO:1904724"
"10556","Cluster_2882","Peve_00040799",-0.99996501950937,0.00532487399178108,0.551398425649056,155,-22.05,"2 17","475 497",16,"75.00%","87.50%","CDS","O75970","Multiple PDZ domain protein (Multi-PDZ domain protein 1)","Homo sapiens (Human)","","GO:0005737; GO:0005923; GO:0008022; GO:0014069; GO:0016324; GO:0016327; GO:0030425"
"10557","Cluster_2882","Peve_00040799",-0.99996501950937,0.00532487399178108,0.551398425649056,155,-22.05,"2 17","9905 9927",16,"75.00%","87.50%","CDS","O75970","Multiple PDZ domain protein (Multi-PDZ domain protein 1)","Homo sapiens (Human)","","GO:0005737; GO:0005923; GO:0008022; GO:0014069; GO:0016324; GO:0016327; GO:0030425"
"10562","Cluster_2882","Peve_00041006",-0.998514567283615,0.0347036686074603,0.909359886114279,153,-21.7,"2 14","6653 6674",12,"83.33%","91.67%","CDS",NA,NA,NA,NA,NA
"10563","Cluster_2882","Peve_00041032",-0.999687299962528,0.0159210022998918,0.76221148641831,142,-20.86,"2 21","6869 6897",26,"61.54%","65.38%","CDS","Q9NZB2","Constitutive coactivator of PPAR-gamma-like protein 1 (Oxidative stress-associated Src activator) (Protein FAM120A)","Homo sapiens (Human)","","GO:0003723; GO:0005634; GO:0005829; GO:0005886; GO:0016020"
"10640","Cluster_2882","Peve_00043688",-0.997831704073983,0.0419307762257842,0.910014395738592,161,-22.53,"2 21","6531 6555",22,"72.73%","86.36%","CDS","Q6NXT4","Zinc transporter 6 (ZnT-6) (Solute carrier family 30 member 6)","Homo sapiens (Human)","cellular zinc ion homeostasis [GO:0006882]; insulin processing [GO:0030070]; regulation of zinc ion transport [GO:0071579]; zinc ion import into Golgi lumen [GO:1904257]; zinc ion import into organelle [GO:0062111]; zinc ion transmembrane transport [GO:0071577]; zinc ion transport [GO:0006829]","GO:0000139; GO:0005385; GO:0005794; GO:0006829; GO:0006882; GO:0015297; GO:0030070; GO:0032588; GO:0062111; GO:0071577; GO:0071579; GO:1904257"
"10641","Cluster_2882","Peve_00044203",0.998347468552471,0.0366041066840402,0.909359886114279,172,-21.28,"2 21","11847 11868",19,"78.95%","84.21%","CDS","P28749","Retinoblastoma-like protein 1 (107 kDa retinoblastoma-associated protein) (p107) (pRb1)","Homo sapiens (Human)","cell cycle [GO:0007049]; cell differentiation [GO:0030154]; chromatin organization [GO:0006325]; negative regulation of cellular senescence [GO:2000773]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of lipid kinase activity [GO:0043550]","GO:0000122; GO:0000785; GO:0000977; GO:0005654; GO:0005667; GO:0006325; GO:0007049; GO:0010629; GO:0030154; GO:0043550; GO:1990841; GO:2000134; GO:2000773"
"10653","Cluster_2882","Peve_00044546",-0.997859033802024,0.0416655904526033,0.909359886114279,167,-20.16,"2 21","11883 11906",21,"76.19%","80.95%","CDS","Q95LD9","Aryl hydrocarbon receptor (Ah receptor) (AhR)","Delphinapterus leucas (Beluga whale)","cAMP-mediated signaling [GO:0019933]; cell cycle [GO:0007049]; cellular response to 2,3,7,8-tetrachlorodibenzodioxine [GO:1904613]; cellular response to cAMP [GO:0071320]; cellular response to forskolin [GO:1904322]; circadian regulation of gene expression [GO:0032922]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of T cell mediated immune response to tumor cell [GO:0002841]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of adaptive immune response [GO:0002819]; regulation of B cell proliferation [GO:0030888]; response to toxic substance [GO:0009636]; response to xenobiotic stimulus [GO:0009410]","GO:0001094; GO:0001223; GO:0002819; GO:0002841; GO:0004879; GO:0005634; GO:0005737; GO:0005829; GO:0007049; GO:0009410; GO:0009636; GO:0017025; GO:0019933; GO:0030888; GO:0032922; GO:0034753; GO:0045892; GO:0045893; GO:0045944; GO:0046982; GO:0051879; GO:0060090; GO:0061629; GO:0070888; GO:0071320; GO:1904322; GO:1904613; GO:1990837"
"10718","Cluster_29","Peve_00003393",0.999030167120238,0.0280400431950666,0.900780957733848,161,-20.72,"2 20","2997 3017",18,"66.67%","94.44%","CDS",NA,NA,NA,NA,NA
"10730","Cluster_29","Peve_00004159",0.99948900137754,0.0203527679413273,0.810097073649321,155,-20.04,"2 20","2429 2450",18,"61.11%","83.33%","CDS",NA,NA,NA,NA,NA
"10765","Cluster_29","Peve_00006246",-0.997689878763426,0.0432808865951937,0.918486173374404,169,-22.58,"2 21","17104 17128",22,"81.82%","86.36%","CDS",NA,NA,NA,NA,NA
"10807","Cluster_29","Peve_00009613",0.997569389923622,0.0443956862719401,0.926596703746095,161,-20.96,"2 21","22089 22110",20,"75.00%","85.00%","CDS","P27694","Replication protein A 70 kDa DNA-binding subunit (RP-A p70) (Replication factor A protein 1) (RF-A protein 1) (Single-stranded DNA-binding protein) [Cleaved into: Replication protein A 70 kDa DNA-binding subunit, N-terminally processed]","Homo sapiens (Human)","base-excision repair [GO:0006284]; cellular response to DNA damage stimulus [GO:0006974]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA unwinding involved in DNA replication [GO:0006268]; DNA-templated DNA replication [GO:0006261]; double-strand break repair via homologous recombination [GO:0000724]; meiotic cell cycle [GO:0051321]; mismatch repair [GO:0006298]; nucleotide-excision repair [GO:0006289]; protein localization to chromosome [GO:0034502]; telomere maintenance [GO:0000723]; telomere maintenance via telomerase [GO:0007004]","GO:0000723; GO:0000724; GO:0000781; GO:0003684; GO:0003697; GO:0005634; GO:0005654; GO:0005662; GO:0006260; GO:0006261; GO:0006268; GO:0006281; GO:0006284; GO:0006289; GO:0006298; GO:0006310; GO:0006974; GO:0007004; GO:0016605; GO:0034502; GO:0043047; GO:0046872; GO:0051321; GO:0090734; GO:0098505"
"10846","Cluster_29","Peve_00012313",-0.997746845316925,0.0427437088338936,0.91504584599282,165,-20.56,"2 14","36526 36547",12,"100.00%","100.00%","CDS","Q4G0P3","Hydrocephalus-inducing protein homolog","Homo sapiens (Human)","axonemal central apparatus assembly [GO:1904158]; cilium movement [GO:0003341]; epithelial cell development [GO:0002064]; trachea development [GO:0060438]; ventricular system development [GO:0021591]","GO:0002064; GO:0003341; GO:0005930; GO:0021591; GO:0060438; GO:1904158; GO:1990716; GO:1990718"
"10847","Cluster_29","Peve_00012313",-0.997746845316925,0.0427437088338936,0.91504584599282,178,-23.22,"2 21","46170 46190",19,"84.21%","94.74%","CDS","Q4G0P3","Hydrocephalus-inducing protein homolog","Homo sapiens (Human)","axonemal central apparatus assembly [GO:1904158]; cilium movement [GO:0003341]; epithelial cell development [GO:0002064]; trachea development [GO:0060438]; ventricular system development [GO:0021591]","GO:0002064; GO:0003341; GO:0005930; GO:0021591; GO:0060438; GO:1904158; GO:1990716; GO:1990718"
"10854","Cluster_29","Peve_00012947",-0.998676166610317,0.0327611930500019,0.909359886114279,159,-22.31,"2 21","10070 10093",21,"71.43%","76.19%","CDS",NA,NA,NA,NA,NA
"10891","Cluster_29","Peve_00015560",-0.999741680546707,0.0144704829734696,0.73240086229425,157,-20.87,"2 19","3660 3685",21,"71.43%","76.19%","CDS","Q8NBS9","Thioredoxin domain-containing protein 5 (EC 1.8.4.-) (EC 5.3.4.1) (Endoplasmic reticulum resident protein 46) (ER protein 46) (ERp46) (Thioredoxin-like protein p46)","Homo sapiens (Human)","negative regulation of apoptotic process [GO:0043066]; protein folding [GO:0006457]","GO:0003756; GO:0005576; GO:0005783; GO:0005788; GO:0006457; GO:0015035; GO:0035578; GO:0043066; GO:0043202; GO:0070062"
"10972","Cluster_29","Peve_00022650",-0.998728025936349,0.0321129567027359,0.907232568269296,172,-21.47,"2 21","632 653",19,"73.68%","89.47%","CDS","B8VIW9","Fibronectin type III domain-containing protein (Neuroglian-like protein)","Acropora millepora (Staghorn coral) (Heteropora millepora)","","GO:0016020"
"11093","Cluster_29","Peve_00031470",0.998537239893341,0.0344377388061273,0.909359886114279,171,-22.59,"2 21","133 155",20,"75.00%","90.00%","CDS","Q8QHA5","DNA replication ATP-dependent helicase/nuclease DNA2 (DNA replication ATP-dependent helicase-like homolog) [Includes: DNA replication nuclease DNA2 (EC 3.1.-.-); DNA replication ATP-dependent helicase DNA2 (EC 3.6.4.12)]","Xenopus laevis (African clawed frog)","base-excision repair [GO:0006284]; DNA double-strand break processing [GO:0000729]; DNA replication [GO:0006260]; DNA replication checkpoint signaling [GO:0000076]; DNA replication, Okazaki fragment processing [GO:0033567]; DNA replication, removal of RNA primer [GO:0043137]; double-strand break repair via single-strand annealing [GO:0045002]; mitochondrial DNA replication [GO:0006264]; positive regulation of DNA replication [GO:0045740]","GO:0000076; GO:0000729; GO:0003677; GO:0003678; GO:0004518; GO:0005524; GO:0005634; GO:0005739; GO:0006260; GO:0006264; GO:0006284; GO:0016887; GO:0016890; GO:0017108; GO:0017116; GO:0033567; GO:0043137; GO:0043139; GO:0045002; GO:0045740; GO:0046872; GO:0051539"
"11111","Cluster_29","Peve_00032670",0.997330421307962,0.046527867385145,0.938457139308314,163,-20.88,"2 18","4092 4112",16,"81.25%","93.75%","CDS","P53041","Serine/threonine-protein phosphatase 5 (PP5) (EC 3.1.3.16) (Protein phosphatase T) (PP-T) (PPT)","Homo sapiens (Human)","DNA-templated transcription [GO:0006351]; double-strand break repair [GO:0006302]; MAPK cascade [GO:0000165]; mitotic cell cycle [GO:0000278]; peptidyl-serine dephosphorylation [GO:0070262]; peptidyl-threonine dephosphorylation [GO:0035970]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; protein dephosphorylation [GO:0006470]; response to arachidonic acid [GO:1904550]; response to lead ion [GO:0010288]; response to morphine [GO:0043278]","GO:0000165; GO:0000278; GO:0003723; GO:0004721; GO:0004722; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006302; GO:0006351; GO:0006470; GO:0008289; GO:0010288; GO:0016791; GO:0017018; GO:0032991; GO:0035970; GO:0042802; GO:0043123; GO:0043231; GO:0043278; GO:0043531; GO:0046872; GO:0048156; GO:0051879; GO:0060090; GO:0070262; GO:0101031; GO:1904550"
"11138","Cluster_29","Peve_00034473",-0.999931280904205,0.00746339326112324,0.573710369894872,161,-20.21,"2 20","6992 7012",18,"77.78%","83.33%","CDS","Q2TBV1","Replication factor C subunit 3 (Activator 1 38 kDa subunit) (A1 38 kDa subunit) (Activator 1 subunit 3) (Replication factor C 38 kDa subunit) (RF-C 38 kDa subunit) (RFC38)","Bos taurus (Bovine)","DNA repair [GO:0006281]; DNA-templated DNA replication [GO:0006261]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264]; response to organophosphorus [GO:0046683]","GO:0003677; GO:0003689; GO:0005634; GO:0005663; GO:0006261; GO:0006281; GO:0017116; GO:0031390; GO:0046683; GO:1900264"
"11160","Cluster_29","Peve_00036084",0.997252198201742,0.0472049257556936,0.941841739843215,148,-20.28,"2 13","7286 7307",11,"81.82%","90.91%","CDS","P41247","Patatin-like phospholipase domain-containing protein 4 (EC 3.1.1.3) (Calcium-independent phospholipase A2-eta) (iPLA2-eta) (EC 3.1.1.4) (Protein GS2)","Homo sapiens (Human)","lipid homeostasis [GO:0055088]; triglyceride catabolic process [GO:0019433]","GO:0004623; GO:0004806; GO:0005737; GO:0005739; GO:0005811; GO:0005829; GO:0016020; GO:0016411; GO:0019433; GO:0047376; GO:0050253; GO:0051264; GO:0051265; GO:0055088"
"11207","Cluster_29","Peve_00039612",0.998791189124848,0.0313053135571202,0.903929377050813,164,-20.73,"2 21","18980 19002",21,"80.95%","85.71%","CDS","Q5F364","Multidrug resistance-associated protein 1 (EC 7.6.2.2) (ATP-binding cassette sub-family C member 1) (Glutathione-S-conjugate-translocating ATPase ABCC1) (EC 7.6.2.3) (Leukotriene C(4) transporter) (LTC4 transporter)","Gallus gallus (Chicken)","glutathione transmembrane transport [GO:0034775]; lipid transport [GO:0006869]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]","GO:0005524; GO:0006869; GO:0008559; GO:0016020; GO:0016323; GO:0016887; GO:0034634; GO:0034775; GO:0042626; GO:0042908; GO:0055085"
"11228","Cluster_29","Peve_00041444",0.999173782819429,0.0258804687412055,0.878621033485623,151,-20.57,"2 21","1814 1837",21,"66.67%","71.43%","CDS",NA,NA,NA,NA,NA
"11303","Cluster_4079","Peve_00000079",-0.99896049267317,0.0290299659456012,0.903929377050813,144,-21.1,"2 14","12511 12533",13,"76.92%","84.62%","CDS","Q9UBX3","Mitochondrial dicarboxylate carrier (DIC) (Solute carrier family 25 member 10)","Homo sapiens (Human)","dicarboxylic acid transport [GO:0006835]; gluconeogenesis [GO:0006094]; ion transport [GO:0006811]; lipid transport [GO:0006869]; malate transmembrane transport [GO:0071423]; mitochondrial transport [GO:0006839]; oxaloacetate transport [GO:0015729]; phosphate ion transmembrane transport [GO:0035435]; succinate transmembrane transport [GO:0071422]; sulfate transport [GO:0008272]; sulfide oxidation, using sulfide:quinone oxidoreductase [GO:0070221]; thiosulfate transport [GO:0015709]","GO:0005310; GO:0005634; GO:0005654; GO:0005739; GO:0005743; GO:0006094; GO:0006811; GO:0006835; GO:0006839; GO:0006869; GO:0008272; GO:0015114; GO:0015116; GO:0015117; GO:0015131; GO:0015140; GO:0015141; GO:0015297; GO:0015709; GO:0015729; GO:0022857; GO:0035435; GO:0070221; GO:0071422; GO:0071423"
"11324","Cluster_4079","Peve_00003488",-0.999800775330523,0.0127079029286043,0.693540545915765,155,-20.15,"2 18","13273 13297",19,"73.68%","84.21%","CDS","Q9ULI1","NACHT and WD repeat domain-containing protein 2 (Leucine-rich repeat and WD repeat-containing protein KIAA1239)","Homo sapiens (Human)","",""
"11343","Cluster_4079","Peve_00004794",-0.997222211495177,0.0474619187732666,0.942888539658333,145,-21.25,"2 20","9909 9929",18,"61.11%","77.78%","CDS","P29476","Nitric oxide synthase, brain (EC 1.14.13.39) (BNOS) (Constitutive NOS) (NC-NOS) (NOS type I) (Neuronal NOS) (N-NOS) (nNOS) (Peptidyl-cysteine S-nitrosylase NOS1)","Rattus norvegicus (Rat)","aging [GO:0007568]; arginine catabolic process [GO:0006527]; behavioral response to cocaine [GO:0048148]; brain development [GO:0007420]; calcium ion transport [GO:0006816]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to growth factor stimulus [GO:0071363]; cellular response to mechanical stimulus [GO:0071260]; establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; female pregnancy [GO:0007565]; multicellular organismal response to stress [GO:0033555]; muscle contraction [GO:0006936]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood pressure [GO:0045776]; negative regulation of calcium ion transport [GO:0051926]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of heart contraction [GO:0045822]; negative regulation of hepatic stellate cell contraction [GO:0061875]; negative regulation of hydrolase activity [GO:0051346]; negative regulation of insulin secretion [GO:0046676]; negative regulation of iron ion transmembrane transport [GO:0034760]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of potassium ion transport [GO:0043267]; negative regulation of serotonin uptake [GO:0051612]; negative regulation of vasoconstriction [GO:0045906]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide mediated signal transduction [GO:0007263]; peptidyl-cysteine S-nitrosylation [GO:0018119]; positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process [GO:0140196]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of guanylate cyclase activity [GO:0031284]; positive regulation of histone acetylation [GO:0035066]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of neuron death [GO:1901216]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of sodium ion transmembrane transport [GO:1902307]; positive regulation of the force of heart contraction [GO:0098735]; positive regulation of transcription by RNA polymerase II [GO:0045944]; potassium ion transport [GO:0006813]; regulation of heart contraction [GO:0008016]; regulation of neurogenesis [GO:0050767]; regulation of postsynaptic membrane potential [GO:0060078]; regulation of sensory perception of pain [GO:0051930]; regulation of sodium ion transport [GO:0002028]; response to activity [GO:0014823]; response to estrogen [GO:0043627]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hormone [GO:0009725]; response to hypoxia [GO:0001666]; response to lead ion [GO:0010288]; response to lipopolysaccharide [GO:0032496]; response to nicotine [GO:0035094]; response to nitric oxide [GO:0071731]; response to nutrient levels [GO:0031667]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243]; response to peptide hormone [GO:0043434]; response to vitamin E [GO:0033197]; retrograde trans-synaptic signaling by nitric oxide [GO:0098924]; striated muscle contraction [GO:0006941]; synaptic signaling by nitric oxide [GO:0099163]; vasodilation [GO:0042311]; xenobiotic catabolic process [GO:0042178]","GO:0001666; GO:0001917; GO:0002028; GO:0004517; GO:0005516; GO:0005634; GO:0005737; GO:0005739; GO:0005741; GO:0005829; GO:0005856; GO:0005886; GO:0006527; GO:0006809; GO:0006813; GO:0006816; GO:0006936; GO:0006941; GO:0007263; GO:0007420; GO:0007565; GO:0007568; GO:0008016; GO:0008270; GO:0008285; GO:0009408; GO:0009725; GO:0010181; GO:0010243; GO:0010288; GO:0012506; GO:0014069; GO:0014070; GO:0014823; GO:0016020; GO:0016491; GO:0016529; GO:0017080; GO:0018119; GO:0019899; GO:0020037; GO:0030018; GO:0030141; GO:0030315; GO:0030425; GO:0031284; GO:0031667; GO:0031965; GO:0032496; GO:0032991; GO:0033017; GO:0033137; GO:0033138; GO:0033197; GO:0033555; GO:0034760; GO:0035066; GO:0035094; GO:0042178; GO:0042311; GO:0042383; GO:0042582; GO:0042802; GO:0043066; GO:0043197; GO:0043267; GO:0043434; GO:0043524; GO:0043627; GO:0044305; GO:0044325; GO:0045121; GO:0045184; GO:0045202; GO:0045471; GO:0045776; GO:0045822; GO:0045893; GO:0045906; GO:0045944; GO:0046676; GO:0046870; GO:0048148; GO:0048306; GO:0048471; GO:0050660; GO:0050661; GO:0050767; GO:0051117; GO:0051219; GO:0051346; GO:0051481; GO:0051612; GO:0051649; GO:0051926; GO:0051930; GO:0060078; GO:0061875; GO:0070402; GO:0071260; GO:0071363; GO:0071731; GO:0071872; GO:0071944; GO:0097110; GO:0098735; GO:0098924; GO:0098978; GO:0099091; GO:0099092; GO:0099163; GO:0140196; GO:1900273; GO:1901216; GO:1902307"
"11378","Cluster_4079","Peve_00006710",-0.999870677820193,0.0102384994051752,0.627878635187842,149,-20.06,"2 20","6617 6642",22,"63.64%","77.27%","CDS",NA,NA,NA,NA,NA
"11395","Cluster_4079","Peve_00007704",0.999470091301485,0.0207259680810419,0.814976186752212,166,-20.87,"2 21","1416 1436",19,"78.95%","84.21%","CDS","Q8CIV7","Transcription factor Ovo-like 2 (mOvo2) (Zinc finger OVO2) (Zinc finger protein 339) (Zinc finger protein mOVO)","Mus musculus (Mouse)","angiogenesis [GO:0001525]; cell population proliferation [GO:0008283]; cellular response to transforming growth factor beta stimulus [GO:0071560]; dorsal/ventral pattern formation [GO:0009953]; embryonic digestive tract morphogenesis [GO:0048557]; endocardium formation [GO:0060214]; epidermal cell differentiation [GO:0009913]; epidermis development [GO:0008544]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula formation [GO:0060347]; labyrinthine layer blood vessel development [GO:0060716]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of gene expression [GO:0010629]; negative regulation of keratinocyte differentiation [GO:0045617]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of stem cell proliferation [GO:2000647]; negative regulation of transcription by competitive promoter binding [GO:0010944]; neural crest cell migration [GO:0001755]; neural fold formation [GO:0001842]; positive regulation of gene expression [GO:0010628]; positive regulation of keratinocyte differentiation [GO:0045618]; regulation of cell cycle [GO:0051726]; regulation of keratinocyte proliferation [GO:0010837]; regulation of SMAD protein signal transduction [GO:0060390]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000976; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0001525; GO:0001755; GO:0001842; GO:0001947; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0006357; GO:0007507; GO:0008283; GO:0008285; GO:0008544; GO:0009913; GO:0009953; GO:0010628; GO:0010629; GO:0010719; GO:0010837; GO:0010944; GO:0045617; GO:0045618; GO:0045746; GO:0046872; GO:0048557; GO:0051726; GO:0060214; GO:0060347; GO:0060390; GO:0060716; GO:0071560; GO:1990837; GO:2000647"
"11401","Cluster_4079","Peve_00007872",-0.998303813951919,0.0370845719252309,0.909359886114279,178,-26.11,"2 19","5098 5119",17,"82.35%","100.00%","CDS","Q68F70","Integrator complex subunit 4 (Int4)","Xenopus laevis (African clawed frog)","","GO:0005634"
"11412","Cluster_4079","Peve_00008249",0.999637653688134,0.0171383953926177,0.782669382293497,143,-21.97,"2 21","28195 28222",25,"60.00%","64.00%","CDS","Q8AV57","Protein sidekick-2","Gallus gallus (Chicken)","camera-type eye photoreceptor cell differentiation [GO:0060219]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416]","GO:0005886; GO:0007156; GO:0007416; GO:0010842; GO:0042802; GO:0045202; GO:0060219"
"11478","Cluster_4079","Peve_00012577",0.999637962480495,0.0171310907052322,0.782669382293497,152,-21.35,"2 21","32 53",19,"63.16%","73.68%","CDS",NA,NA,NA,NA,NA
"11490","Cluster_4079","Peve_00013338",-0.99990357816145,0.00884069310177129,0.584362857011891,150,-20.36,"2 11","16791 16812",9,"100.00%","100.00%","CDS","Q96JG6","Syndetin (Coiled-coil domain-containing protein 132) (EARP/GARPII complex subunit VPS50)","Homo sapiens (Human)","endocytic recycling [GO:0032456]; protein transport [GO:0015031]","GO:0000149; GO:0015031; GO:0016020; GO:0032456; GO:0048471; GO:0055037; GO:0070062; GO:1990745"
"11501","Cluster_4079","Peve_00014208",-0.999976270387259,0.00438572407632336,0.54328949385489,170,-23.95,"2 20","3804 3826",19,"78.95%","89.47%","CDS","Q3UQ28","Peroxidasin homolog (EC 1.11.2.-) [Cleaved into: PXDN active fragment]","Mus musculus (Mouse)","angiogenesis [GO:0001525]; basement membrane assembly [GO:0070831]; basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; eye development [GO:0001654]; hydrogen peroxide catabolic process [GO:0042744]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; response to oxidative stress [GO:0006979]","GO:0001525; GO:0001654; GO:0004601; GO:0005201; GO:0005604; GO:0005615; GO:0005783; GO:0006979; GO:0007155; GO:0009986; GO:0016684; GO:0020037; GO:0030198; GO:0030199; GO:0031012; GO:0042744; GO:0043237; GO:0046872; GO:0051260; GO:0062023; GO:0070207; GO:0070831; GO:0071711; GO:0140825"
"11512","Cluster_4079","Peve_00014607",-0.999140905722226,0.0263904399617349,0.884795287459298,146,-21.21,"2 21","11519 11539",19,"63.16%","73.68%","CDS","Q8K370","Acyl-CoA dehydrogenase family member 10 (ACAD-10) (EC 1.3.99.-)","Mus musculus (Mouse)","fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]","GO:0003995; GO:0005737; GO:0005739; GO:0033539; GO:0050660"
"11557","Cluster_4079","Peve_00018051",-0.998721687740386,0.0321928830822343,0.907987904402525,148,-20.43,"2 20","8025 8044",18,"66.67%","77.78%","CDS","Q92072","DNA (cytosine-5)-methyltransferase 1 (Dnmt1) (EC 2.1.1.37) (DNA methyltransferase GgaI) (DNA MTase GgaI) (M.GgaI) (MCMT)","Gallus gallus (Chicken)","positive regulation of DNA methylation-dependent heterochromatin formation [GO:0090309]","GO:0003677; GO:0003886; GO:0005634; GO:0008270; GO:0090309; GO:1990841"
"11583","Cluster_4079","Peve_00020593",-0.999401709222497,0.0220228200533377,0.831702977566352,163,-23.36,"2 20","956 977",18,"72.22%","83.33%","CDS","Q53QZ3","Rho GTPase-activating protein 15 (ArhGAP15) (Rho-type GTPase-activating protein 15)","Homo sapiens (Human)","regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]","GO:0005096; GO:0005737; GO:0005829; GO:0007165; GO:0008360; GO:0016020; GO:0043087; GO:0051056"
"11599","Cluster_4079","Peve_00021480",-0.999949503052708,0.00639778307294428,0.573710369894872,150,-20.36,"2 11","3021 3042",9,"100.00%","100.00%","CDS","Q5PRC1","LHFPL tetraspan subfamily member 6 protein","Danio rerio (Zebrafish) (Brachydanio rerio)","","GO:0016020"
"11656","Cluster_4079","Peve_00022405",-0.999648379930316,0.0168828077485472,0.778762172672388,150,-20.84,"2 16","84119 84142",16,"68.75%","87.50%","CDS","Q80TQ5","Pleckstrin homology domain-containing family M member 2 (PH domain-containing family M member 2)","Mus musculus (Mouse)","autophagosome-lysosome fusion [GO:0061909]; Golgi organization [GO:0007030]; late endosome to lysosome transport [GO:1902774]; lysosome localization [GO:0032418]; natural killer cell mediated cytotoxicity [GO:0042267]; positive regulation of membrane tubulation [GO:1903527]; regulation of protein localization [GO:0032880]","GO:0005764; GO:0005765; GO:0007030; GO:0010008; GO:0019894; GO:0032418; GO:0032880; GO:0042267; GO:0044754; GO:0061909; GO:1902774; GO:1903527"
"11657","Cluster_4079","Peve_00022405",-0.999648379930316,0.0168828077485472,0.778762172672388,179,-23.85,"2 20","35301 35322",18,"88.89%","88.89%","CDS","Q80TQ5","Pleckstrin homology domain-containing family M member 2 (PH domain-containing family M member 2)","Mus musculus (Mouse)","autophagosome-lysosome fusion [GO:0061909]; Golgi organization [GO:0007030]; late endosome to lysosome transport [GO:1902774]; lysosome localization [GO:0032418]; natural killer cell mediated cytotoxicity [GO:0042267]; positive regulation of membrane tubulation [GO:1903527]; regulation of protein localization [GO:0032880]","GO:0005764; GO:0005765; GO:0007030; GO:0010008; GO:0019894; GO:0032418; GO:0032880; GO:0042267; GO:0044754; GO:0061909; GO:1902774; GO:1903527"
"11741","Cluster_4079","Peve_00029427",-0.999890925187699,0.00940288891868048,0.602964340913104,148,-20.23,"2 18","14132 14154",17,"64.71%","82.35%","CDS","P16157","Ankyrin-1 (ANK-1) (Ankyrin-R) (Erythrocyte ankyrin)","Homo sapiens (Human)","cytoskeleton organization [GO:0007010]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165]","GO:0005198; GO:0005200; GO:0005829; GO:0005856; GO:0005886; GO:0006887; GO:0006888; GO:0007010; GO:0007165; GO:0008093; GO:0009898; GO:0014731; GO:0016323; GO:0016529; GO:0019899; GO:0019903; GO:0030507; GO:0031430; GO:0043005; GO:0044325; GO:0045199; GO:0051117; GO:0072659"
"11806","Cluster_4079","Peve_00034064",0.999679374900727,0.0161215013418805,0.766332216045467,158,-21.05,"2 17","2275 2298",17,"82.35%","88.24%","CDS","Q9JLG8","Calpain-15 (EC 3.4.22.-) (Small optic lobes homolog)","Mus musculus (Mouse)","proteolysis [GO:0006508]","GO:0004198; GO:0005737; GO:0006508; GO:0046872"
"11840","Cluster_4079","Peve_00036216",-0.997122511412326,0.0483065609820818,0.946322577595136,160,-20.26,"2 20","3028 3052",21,"76.19%","85.71%","CDS","Q5VU97","VWFA and cache domain-containing protein 1 (Cache domain-containing protein 1)","Homo sapiens (Human)","","GO:0005245; GO:0005891"
"11858","Cluster_4079","Peve_00037268",-0.998526996122875,0.0345581424096249,0.909359886114279,176,-27.94,"2 21","3716 3737",19,"73.68%","94.74%","CDS","Q10751","Angiotensin-converting enzyme (ACE) (EC 3.4.15.1) (Dipeptidyl carboxypeptidase I) (Kininase II)","Gallus gallus (Chicken)","angiotensin maturation [GO:0002003]; bradykinin catabolic process [GO:0010815]; cell population proliferation [GO:0008283]; hormone catabolic process [GO:0042447]; hormone metabolic process [GO:0042445]; kidney development [GO:0001822]; positive regulation of systemic arterial blood pressure [GO:0003084]; primitive erythrocyte differentiation [GO:0060319]; regulation of blood pressure [GO:0008217]; regulation of synaptic plasticity [GO:0048167]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]; substance P catabolic process [GO:0010814]","GO:0001822; GO:0002003; GO:0003081; GO:0003084; GO:0004180; GO:0004222; GO:0005737; GO:0005886; GO:0008217; GO:0008237; GO:0008241; GO:0008270; GO:0008283; GO:0010814; GO:0010815; GO:0016020; GO:0031404; GO:0042445; GO:0042447; GO:0048167; GO:0060319; GO:0070573"
"11860","Cluster_4079","Peve_00037364",-0.998597154918296,0.0337249070566547,0.909359886114279,171,-22.4,"2 21","2639 2661",20,"75.00%","90.00%","CDS","Q01460","Di-N-acetylchitobiase (EC 3.2.1.-)","Rattus norvegicus (Rat)","chitin catabolic process [GO:0006032]; oligosaccharide catabolic process [GO:0009313]","GO:0004568; GO:0005764; GO:0006032; GO:0008061; GO:0009313; GO:0016798"
"11921","Cluster_4079","Peve_00039765",-0.997379354968361,0.0460992766018146,0.935872558354947,163,-20.09,"2 16","13778 13799",14,"85.71%","92.86%","CDS",NA,NA,NA,NA,NA
"11956","Cluster_4079","Peve_00041522",-0.999917309077773,0.0081870422438826,0.573710369894872,147,-20.94,"2 21","18731 18753",20,"60.00%","75.00%","CDS","O75581","Low-density lipoprotein receptor-related protein 6 (LRP-6)","Homo sapiens (Human)","canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in neural crest cell differentiation [GO:0044335]; canonical Wnt signaling pathway involved in regulation of cell proliferation [GO:0044340]; cell-cell adhesion [GO:0098609]; cellular response to cholesterol [GO:0071397]; chemical synaptic transmission [GO:0007268]; dopaminergic neuron differentiation [GO:0071542]; midbrain dopaminergic neuron differentiation [GO:1904948]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; neural crest cell differentiation [GO:0014033]; neural crest formation [GO:0014029]; positive regulation of cell cycle [GO:0045787]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to plasma membrane [GO:0072659]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; response to peptide hormone [GO:0043434]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904953]; Wnt signaling pathway involved in somitogenesis [GO:0090244]","GO:0001933; GO:0005041; GO:0005102; GO:0005109; GO:0005576; GO:0005783; GO:0005886; GO:0006469; GO:0007204; GO:0007268; GO:0009986; GO:0014029; GO:0014033; GO:0016055; GO:0017147; GO:0019210; GO:0019534; GO:0031410; GO:0031901; GO:0034392; GO:0042802; GO:0042803; GO:0042813; GO:0043025; GO:0043434; GO:0044335; GO:0044340; GO:0045121; GO:0045202; GO:0045787; GO:0045893; GO:0045944; GO:0051091; GO:0060070; GO:0071397; GO:0071542; GO:0071901; GO:0071936; GO:0072659; GO:0090118; GO:0090244; GO:0098609; GO:1904928; GO:1904948; GO:1904953; GO:1990851; GO:1990909"
"11958","Cluster_4079","Peve_00041469",-0.998917582509894,0.029623181749673,0.903929377050813,150,-21.58,"2 19","6753 6774",17,"64.71%","76.47%","CDS","Q4U2V3","Cytosolic carboxypeptidase 1 (EC 3.4.17.-) (EC 3.4.17.24) (ATP/GTP-binding protein 1) (Protein deglutamylase CCP1)","Danio rerio (Zebrafish) (Brachydanio rerio)","C-terminal protein deglutamylation [GO:0035609]; cerebellar Purkinje cell differentiation [GO:0021702]; chordate embryonic development [GO:0043009]; eye photoreceptor cell differentiation [GO:0001754]; mitochondrion organization [GO:0007005]; neuromuscular process [GO:0050905]; olfactory bulb development [GO:0021772]; protein side chain deglutamylation [GO:0035610]; proteolysis [GO:0006508]; T cell differentiation in thymus [GO:0033077]","GO:0001754; GO:0004181; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006508; GO:0007005; GO:0008270; GO:0015631; GO:0021702; GO:0021772; GO:0033077; GO:0035609; GO:0035610; GO:0043009; GO:0050905"
"11994","Cluster_4079","Peve_00043735",-0.997254902330616,0.0471816820647028,0.941693828213016,160,-21.51,"2 17","7640 7661",15,"80.00%","86.67%","CDS","Q96RW7","Hemicentin-1 (Fibulin-6) (FIBL-6)","Homo sapiens (Human)","actin filament reorganization [GO:0090527]; basement membrane organization [GO:0071711]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601]","GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005912; GO:0005927; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0032154; GO:0051301; GO:0062023; GO:0070062; GO:0071711; GO:0090527"
"12024","Cluster_4080","Peve_00000338",-0.999804588326262,0.0125857020309173,0.690230613076756,165,-22.19,"2 18","6900 6921",16,"81.25%","87.50%","CDS",NA,NA,NA,NA,NA
"12070","Cluster_4080","Peve_00002136",-0.999928334539756,0.00762171423750272,0.573710369894872,180,-25.28,"2 21","14363 14384",19,"73.68%","100.00%","CDS","Q6L9W6","Beta-1,4-N-acetylgalactosaminyltransferase 3 (B4GalNAcT3) (Beta4GalNAc-T3) (Beta4GalNAcT3) (EC 2.4.1.244) (Beta-1,4-N-acetylgalactosaminyltransferase III) (N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase 2) (NGalNAc-T2)","Homo sapiens (Human)","","GO:0005794; GO:0008376; GO:0032580; GO:0033842; GO:0043231"
"12086","Cluster_4080","Peve_00001724",0.998901289172471,0.0298453443927078,0.903929377050813,167,-20.2,"2 19","17347 17366",17,"88.24%","88.24%","CDS","Q9DBV3","Probable ATP-dependent RNA helicase DHX34 (EC 3.6.4.13) (DEAH box protein 34) (DExH-box helicase 34)","Mus musculus (Mouse)","negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000623]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of phosphorylation [GO:0042327]","GO:0000184; GO:0000956; GO:0003723; GO:0003724; GO:0005524; GO:0016887; GO:0042327; GO:0044877; GO:2000623"
"12089","Cluster_4080","Peve_00002773",0.997843062548644,0.0418207666049359,0.909453341483137,142,-20.39,"2 21","1951 1977",24,"62.50%","66.67%","CDS",NA,NA,NA,NA,NA
"12143","Cluster_4080","Peve_00005576",-0.999254790480881,0.0245788348473907,0.863232416698613,166,-21.05,"2 20","12079 12101",19,"73.68%","89.47%","CDS","P16086","Spectrin alpha chain, non-erythrocytic 1 (Alpha-II spectrin) (Fodrin alpha chain)","Rattus norvegicus (Rat)","actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; actin filament capping [GO:0051693]","GO:0005509; GO:0005516; GO:0005829; GO:0005886; GO:0005916; GO:0008091; GO:0016020; GO:0016328; GO:0019905; GO:0030018; GO:0030036; GO:0030054; GO:0030507; GO:0030863; GO:0030864; GO:0031532; GO:0032437; GO:0032991; GO:0033010; GO:0033270; GO:0042995; GO:0044877; GO:0051015; GO:0051693; GO:0098794; GO:0098978"
"12165","Cluster_4080","Peve_00006728",-0.999848093384746,0.0110965752378794,0.650674186418027,175,-22.05,"2 20","6156 6177",18,"83.33%","88.89%","CDS","Q9NYQ6","Cadherin EGF LAG seven-pass G-type receptor 1 (Cadherin family member 9) (Flamingo homolog 2) (hFmi2)","Homo sapiens (Human)","apical protein localization [GO:0045176]; cell-cell adhesion [GO:0098609]; central nervous system development [GO:0007417]; establishment of body hair planar orientation [GO:0048105]; establishment of planar polarity [GO:0001736]; establishment of planar polarity of embryonic epithelium [GO:0042249]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; lateral sprouting involved in lung morphogenesis [GO:0060490]; neural tube closure [GO:0001843]; neuron migration [GO:0001764]; orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis [GO:0060488]; planar dichotomous subdivision of terminal units involved in lung branching morphogenesis [GO:0060489]; protein localization involved in establishment of planar polarity [GO:0090251]; regulation of actin cytoskeleton organization [GO:0032956]; Rho protein signal transduction [GO:0007266]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]","GO:0001736; GO:0001764; GO:0001843; GO:0004930; GO:0005509; GO:0005654; GO:0005886; GO:0007156; GO:0007266; GO:0007417; GO:0016020; GO:0032956; GO:0042249; GO:0045176; GO:0048105; GO:0060071; GO:0060488; GO:0060489; GO:0060490; GO:0090251; GO:0098609"
"12180","Cluster_4080","Peve_00006196",0.998560855420922,0.0341585503936042,0.909359886114279,163,-20.13,"2 21","15131 15156",23,"73.91%","73.91%","CDS",NA,NA,NA,NA,NA
"12194","Cluster_4080","Peve_00007902",0.997270750279292,0.0470452285126639,0.940564386922415,159,-23.97,"2 21","521 542",21,"80.95%","80.95%","CDS","Q9Y6N5","Sulfide:quinone oxidoreductase, mitochondrial (SQOR) (EC 1.8.5.8) (Sulfide dehydrogenase-like) (Sulfide quinone oxidoreductase)","Homo sapiens (Human)","sulfide oxidation, using sulfide:quinone oxidoreductase [GO:0070221]","GO:0005739; GO:0005743; GO:0048038; GO:0070221; GO:0070224; GO:0071949; GO:0106436"
"12285","Cluster_4080","Peve_00012307",-0.999918356914133,0.00813500419649827,0.573710369894872,168,-23.1,"2 19","796 816",17,"88.24%","88.24%","CDS",NA,NA,NA,NA,NA
"12300","Cluster_4080","Peve_00012703",0.997227364175877,0.0474178580287118,0.942888539658333,162,-21.71,"2 21","82 108",24,"70.83%","79.17%","CDS","F1R345","ATP-dependent DNA helicase DDX11 (EC 3.6.4.12) (DEAD/H-box protein 11)","Danio rerio (Zebrafish) (Brachydanio rerio)","DNA duplex unwinding [GO:0032508]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; establishment of sister chromatid cohesion [GO:0034085]; nucleolar chromatin organization [GO:1990700]; regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901836]; rRNA transcription [GO:0009303]","GO:0000922; GO:0003677; GO:0003678; GO:0003723; GO:0005524; GO:0005634; GO:0005730; GO:0005737; GO:0005815; GO:0006260; GO:0006281; GO:0009303; GO:0016887; GO:0030496; GO:0032508; GO:0034085; GO:0046872; GO:0051539; GO:1901836; GO:1990700"
"12302","Cluster_4080","Peve_00012719",0.999429934477363,0.0214970141452558,0.825175158091499,158,-21.55,"2 21","2301 2319",19,"84.21%","84.21%","CDS","B6ELU0","tRNA-cytidine(32) 2-sulfurtransferase (EC 2.8.1.-) (Two-thiocytidine biosynthesis protein A) (tRNA 2-thiocytidine biosynthesis protein TtcA)","Aliivibrio salmonicida (strain LFI1238) (Vibrio salmonicida (strain LFI1238))","tRNA thio-modification [GO:0034227]","GO:0000049; GO:0000287; GO:0005524; GO:0005737; GO:0016783; GO:0034227; GO:0051539"
"12342","Cluster_4080","Peve_00013409",-0.998898361532229,0.0298850883946755,0.903929377050813,170,-23.53,"2 20","4244 4266",19,"84.21%","84.21%","CDS",NA,NA,NA,NA,NA
"12369","Cluster_4080","Peve_00015721",-0.999206561952058,0.0253618162499516,0.872109822299967,175,-23.87,"2 20","19072 19093",18,"83.33%","88.89%","CDS","P35546","Proto-oncogene tyrosine-protein kinase receptor Ret (EC 2.7.10.1) (Proto-oncogene c-Ret) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment]","Mus musculus (Mouse)","activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; anatomical structure morphogenesis [GO:0009653]; cellular response to retinoic acid [GO:0071300]; embryonic epithelial tube formation [GO:0001838]; enteric nervous system development [GO:0048484]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; innervation [GO:0060384]; MAPK cascade [GO:0000165]; membrane protein proteolysis [GO:0033619]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; neuron cell-cell adhesion [GO:0007158]; neuron differentiation [GO:0030182]; neuron maturation [GO:0042551]; Peyer's patch morphogenesis [GO:0061146]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell migration [GO:0030335]; positive regulation of cell size [GO:0045793]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of gene expression [GO:0010628]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of metanephric glomerulus development [GO:0072300]; positive regulation of neuron maturation [GO:0014042]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; positive regulation of protein kinase B signaling [GO:0051897]; regulation of axonogenesis [GO:0050770]; regulation of cell adhesion [GO:0030155]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; retina development in camera-type eye [GO:0060041]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; ureter maturation [GO:0035799]; ureteric bud development [GO:0001657]","GO:0000165; GO:0001657; GO:0001755; GO:0001838; GO:0004714; GO:0005509; GO:0005524; GO:0005769; GO:0005886; GO:0006919; GO:0007156; GO:0007158; GO:0007169; GO:0007399; GO:0009410; GO:0009653; GO:0010008; GO:0010628; GO:0010976; GO:0014042; GO:0030155; GO:0030182; GO:0030335; GO:0030424; GO:0030425; GO:0033141; GO:0033619; GO:0033630; GO:0033674; GO:0035799; GO:0035860; GO:0042551; GO:0043025; GO:0043235; GO:0043410; GO:0045121; GO:0045793; GO:0045893; GO:0048265; GO:0048484; GO:0050770; GO:0051897; GO:0060041; GO:0060384; GO:0061146; GO:0071300; GO:0072300; GO:0098797; GO:2001241"
"12374","Cluster_4080","Peve_00015911",-0.999376658725259,0.0224791882994187,0.83791231209107,167,-21.08,"2 21","2734 2757",21,"71.43%","85.71%","CDS",NA,NA,NA,NA,NA
"12406","Cluster_4080","Peve_00017494",0.997741273347202,0.0427965479072764,0.915285127771048,156,-20.29,"2 21","535 557",21,"71.43%","85.71%","CDS",NA,NA,NA,NA,NA
"12407","Cluster_4080","Peve_00017682",-0.997058648097944,0.0488399400893447,0.948902825232569,164,-20.3,"2 19","1606 1626",17,"82.35%","88.24%","CDS",NA,NA,NA,NA,NA
"12409","Cluster_4080","Peve_00017835",0.998633668363016,0.0332830137632564,0.909359886114279,162,-21.73,"2 16","4636 4658",15,"86.67%","93.33%","CDS",NA,NA,NA,NA,NA
"12445","Cluster_4080","Peve_00019789",-0.999355096644234,0.0228647144397872,0.842545105232163,161,-20.51,"2 21","3205 3226",20,"80.00%","80.00%","CDS",NA,NA,NA,NA,NA
"12485","Cluster_4080","Peve_00022013",-0.997406235601708,0.0458621382726491,0.934400033667991,153,-20.18,"2 19","25718 25745",23,"65.22%","73.91%","CDS","Q14BI7","ATP-dependent RNA helicase TDRD9 (EC 3.6.4.13) (Tudor domain-containing protein 9)","Mus musculus (Mouse)","cell differentiation [GO:0030154]; DNA methylation involved in gamete generation [GO:0043046]; fertilization [GO:0009566]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; negative regulation of transposition [GO:0010529]; piRNA processing [GO:0034587]; spermatogenesis [GO:0007283]","GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007140; GO:0007141; GO:0007283; GO:0009566; GO:0010529; GO:0016887; GO:0030154; GO:0034587; GO:0043046; GO:0071547"
"12594","Cluster_4080","Peve_00027166",0.99929968757124,0.0238268365839392,0.854412577141166,163,-21.19,"2 21","11717 11739",20,"75.00%","80.00%","CDS","Q86TZ1","Tetratricopeptide repeat protein 6 (TPR repeat protein 6)","Homo sapiens (Human)","",""
"12617","Cluster_4080","Peve_00028046",-0.998817341146261,0.0309647569613873,0.903929377050813,158,-20.63,"2 21","4141 4164",21,"76.19%","76.19%","CDS","P28476","Gamma-aminobutyric acid receptor subunit rho-2 (GABA(A) receptor subunit rho-2) (GABA(C) receptor)","Homo sapiens (Human)","chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; visual perception [GO:0007601]","GO:0004890; GO:0005231; GO:0005254; GO:0005886; GO:0007165; GO:0007214; GO:0007268; GO:0007601; GO:0019904; GO:0030594; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:0098982; GO:1902476; GO:1902711; GO:1904315"
"12670","Cluster_4080","Peve_00031400",-0.996950551911195,0.0497297376498826,0.9522653317698,163,-20.13,"2 21","609 634",23,"73.91%","73.91%","CDS",NA,NA,NA,NA,NA
"12677","Cluster_4080","Peve_00032019",-0.999998527738398,0.00109241503020378,0.275560959970807,174,-21.59,"2 21","2191 2211",19,"84.21%","89.47%","CDS","Q4U0G1","CLIP-associating protein 1-A (Cytoplasmic linker-associated protein 1-A) (XCLASP1)","Xenopus laevis (African clawed frog)","cell cycle [GO:0007049]; cell division [GO:0051301]; microtubule anchoring [GO:0034453]; microtubule nucleation [GO:0007020]; microtubule organizing center organization [GO:0031023]; regulation of cellular component organization [GO:0051128]","GO:0000776; GO:0005794; GO:0005815; GO:0005819; GO:0005874; GO:0007020; GO:0007049; GO:0031023; GO:0034453; GO:0051128; GO:0051301"
"12716","Cluster_4080","Peve_00034256",-0.997042840627744,0.0489710670892613,0.949405675019865,160,-20.78,"2 18","1796 1818",17,"76.47%","88.24%","CDS","Q5GH73","XK-related protein 6","Homo sapiens (Human)","apoptotic process involved in development [GO:1902742]; engulfment of apoptotic cell [GO:0043652]; phosphatidylserine exposure on apoptotic cell surface [GO:0070782]","GO:0005886; GO:0016020; GO:0043652; GO:0070782; GO:1902742"
"12743","Cluster_4080","Peve_00035796",-0.999045638011453,0.0278154591389635,0.899357024842471,160,-21.3,"2 21","60275 60296",19,"63.16%","84.21%","CDS","Q91ZX7","Prolow-density lipoprotein receptor-related protein 1 (LRP-1) (Alpha-2-macroglobulin receptor) (A2MR) (CD antigen CD91) [Cleaved into: Low-density lipoprotein receptor-related protein 1 85 kDa subunit (LRP-85); Low-density lipoprotein receptor-related protein 1 515 kDa subunit (LRP-515); Low-density lipoprotein receptor-related protein 1 intracellular domain (LRPICD)]","Mus musculus (Mouse)","amyloid-beta clearance [GO:0097242]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; amyloid-beta clearance by transcytosis [GO:0150093]; aorta morphogenesis [GO:0035909]; apoptotic cell clearance [GO:0043277]; astrocyte activation involved in immune response [GO:0002265]; cardiac septum development [GO:0003279]; cell population proliferation [GO:0008283]; cellular lipid catabolic process [GO:0044242]; cellular response to amyloid-beta [GO:1904646]; chemoattraction of axon [GO:0061642]; cholesterol metabolic process [GO:0008203]; coronary vasculature development [GO:0060976]; enzyme-linked receptor protein signaling pathway [GO:0007167]; lysosomal transport [GO:0007041]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell death [GO:0060548]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of gene expression [GO:0010629]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron projection development [GO:0010977]; negative regulation of pathway-restricted SMAD protein phosphorylation [GO:0060394]; negative regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000587]; negative regulation of SMAD protein signal transduction [GO:0060392]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of Wnt signaling pathway [GO:0030178]; phagocytosis [GO:0006909]; positive regulation of amyloid-beta clearance [GO:1900223]; positive regulation of axon extension [GO:0045773]; positive regulation of axon extension involved in regeneration [GO:0048691]; positive regulation of cell death [GO:0010942]; positive regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000343]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of cholesterol import [GO:1904109]; positive regulation of cholesterol transport [GO:0032376]; positive regulation of collateral sprouting of injured axon [GO:0048694]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of endocytosis [GO:0045807]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of lipid transport [GO:0032370]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phagocytosis [GO:0050766]; positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein transport [GO:0051222]; positive regulation of Schwann cell migration [GO:1900149]; positive regulation of transcytosis [GO:1904300]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cholesterol transport [GO:0032374]; regulation of phospholipase A2 activity [GO:0032429]; regulation of pulmonary blood vessel remodeling [GO:1905109]; transport across blood-brain barrier [GO:0150104]","GO:0002020; GO:0002265; GO:0003279; GO:0005102; GO:0005509; GO:0005634; GO:0005768; GO:0005769; GO:0005794; GO:0005856; GO:0005886; GO:0005905; GO:0006898; GO:0006909; GO:0007041; GO:0007167; GO:0007204; GO:0007205; GO:0008203; GO:0008283; GO:0009897; GO:0010629; GO:0010812; GO:0010875; GO:0010942; GO:0010976; GO:0010977; GO:0014912; GO:0015026; GO:0016020; GO:0016323; GO:0016964; GO:0030136; GO:0030178; GO:0030425; GO:0030512; GO:0031623; GO:0032050; GO:0032092; GO:0032370; GO:0032374; GO:0032376; GO:0032429; GO:0032593; GO:0032956; GO:0034185; GO:0035774; GO:0035909; GO:0038024; GO:0043025; GO:0043066; GO:0043235; GO:0043277; GO:0043524; GO:0044242; GO:0044295; GO:0044877; GO:0045177; GO:0045773; GO:0045807; GO:0048691; GO:0048694; GO:0050766; GO:0051222; GO:0051481; GO:0051895; GO:0060392; GO:0060394; GO:0060548; GO:0060976; GO:0061642; GO:0062136; GO:0070374; GO:0097242; GO:0150093; GO:0150094; GO:0150104; GO:1900149; GO:1900223; GO:1903078; GO:1904109; GO:1904300; GO:1904646; GO:1904754; GO:1905109; GO:1905167; GO:2000343; GO:2000587"
"12786","Cluster_4080","Peve_00038235",0.999939235636971,0.00701813624141062,0.573710369894872,155,-20.48,"2 21","20367 20391",22,"63.64%","77.27%","CDS",NA,NA,NA,NA,NA
"12867","Cluster_4080","Peve_00042598",0.999998740813851,0.00101027623087008,0.259287951467205,170,-23.35,"2 19","187 208",17,"76.47%","94.12%","CDS","Q8IYQ7","Threonine synthase-like 1 (TSH1)","Homo sapiens (Human)","","GO:0005737"
"12889","Cluster_4080","Peve_00043869",-0.999525297608678,0.0196165672785278,0.799010461456448,162,-23.71,"2 21","5620 5640",19,"73.68%","84.21%","CDS","Q6P7A9","Lysosomal alpha-glucosidase (EC 3.2.1.20) (Acid maltase)","Rattus norvegicus (Rat)","cardiac muscle contraction [GO:0060048]; diaphragm contraction [GO:0002086]; glycogen catabolic process [GO:0005980]; glycogen metabolic process [GO:0005977]; glycophagy [GO:0061723]; heart morphogenesis [GO:0003007]; locomotory behavior [GO:0007626]; lysosome organization [GO:0007040]; muscle cell cellular homeostasis [GO:0046716]; neuromuscular process controlling balance [GO:0050885]; neuromuscular process controlling posture [GO:0050884]; regulation of the force of heart contraction [GO:0002026]; striated muscle contraction [GO:0006941]; tissue development [GO:0009888]; vacuolar sequestering [GO:0043181]","GO:0002026; GO:0002086; GO:0003007; GO:0004553; GO:0004558; GO:0005764; GO:0005765; GO:0005977; GO:0005980; GO:0006941; GO:0007040; GO:0007626; GO:0009888; GO:0016020; GO:0030246; GO:0032450; GO:0043181; GO:0043202; GO:0046716; GO:0050884; GO:0050885; GO:0060048; GO:0061723; GO:0090599; GO:0120282"
"12899","Cluster_4080","Peve_00044186",-0.998724970832171,0.0321515071827361,0.907547563764044,171,-21.95,"2 21","15769 15791",20,"80.00%","85.00%","CDS","Q9GK13","Methylmalonyl-CoA mutase, mitochondrial (MCM) (EC 5.4.99.2) (Methylmalonyl-CoA isomerase)","Bos taurus (Bovine)","propionate metabolic process, methylmalonyl pathway [GO:0019678]","GO:0003924; GO:0004494; GO:0005737; GO:0005739; GO:0005759; GO:0019678; GO:0031419; GO:0042802; GO:0042803; GO:0046872"
"12925","Cluster_4080","Peve_00045195",-0.999995246146368,0.0019629904910923,0.362847063101065,154,-20.07,"2 20","5199 5225",23,"65.22%","73.91%","CDS","O60235","Transmembrane protease serine 11D (EC 3.4.21.-) (Airway trypsin-like protease) [Cleaved into: Transmembrane protease serine 11D non-catalytic chain; Transmembrane protease serine 11D catalytic chain]","Homo sapiens (Human)","proteolysis [GO:0006508]; respiratory gaseous exchange by respiratory system [GO:0007585]","GO:0004252; GO:0005576; GO:0005886; GO:0006508; GO:0007585; GO:0008233; GO:0070062"
"12980","Cluster_4115","Peve_00004184",-0.999876450878514,0.0100073576944104,0.621311970928136,166,-20.09,"2 20","15666 15688",19,"73.68%","89.47%","CDS","D3ZTD8","Semaphorin-5A (Semaphorin-F) (Sema F)","Rattus norvegicus (Rat)","axon extension [GO:0048675]; axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:0002043]; branching involved in blood vessel morphogenesis [GO:0001569]; branching morphogenesis of an epithelial tube [GO:0048754]; cell chemotaxis [GO:0060326]; detection of light stimulus involved in visual perception [GO:0050908]; diencephalon development [GO:0021536]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of cell adhesion [GO:0007162]; negative regulation of endothelial cell apoptotic process [GO:2000352]; neural crest cell migration [GO:0001755]; neuron projection extension [GO:1990138]; neuron projection guidance [GO:0097485]; positive chemotaxis [GO:0050918]; positive regulation of actin filament depolymerization [GO:0030836]; positive regulation of angiogenesis [GO:0045766]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell migration [GO:0030335]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of protein kinase B signaling [GO:0051897]; semaphorin-plexin signaling pathway [GO:0071526]; signal clustering [GO:1990256]","GO:0001569; GO:0001755; GO:0001938; GO:0002043; GO:0007162; GO:0007411; GO:0007413; GO:0008046; GO:0016020; GO:0021536; GO:0030215; GO:0030335; GO:0030836; GO:0035373; GO:0043395; GO:0045499; GO:0045545; GO:0045766; GO:0048675; GO:0048754; GO:0048842; GO:0048843; GO:0050908; GO:0050918; GO:0051897; GO:0060326; GO:0071526; GO:0090263; GO:0097485; GO:1990138; GO:1990256; GO:2000352; GO:2001028"
"13021","Cluster_4115","Peve_00006584",-0.999747628800907,0.0143029015872161,0.729378959833813,150,-23.05,"2 21","12669 12693",22,"63.64%","77.27%","CDS","A0A0R4IBK5","E3 ubiquitin-protein ligase rnf213-alpha (EC 2.3.2.27) (EC 3.6.4.-) (E3 ubiquitin-lipopolysaccharide ligase rnf213-alpha) (EC 2.3.2.-) (Mysterin-A) (Mysterin-alpha) (RING finger protein 213-A) (RING finger protein 213-alpha)","Danio rerio (Zebrafish) (Brachydanio rerio)","blood circulation [GO:0008015]; defense response to bacterium [GO:0042742]; immune system process [GO:0002376]; lipid droplet formation [GO:0140042]; lipid ubiquitination [GO:0120323]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; protein K63-linked ubiquitination [GO:0070534]; regulation of lipid metabolic process [GO:0019216]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]; xenophagy [GO:0098792]","GO:0002040; GO:0002376; GO:0004842; GO:0005524; GO:0005730; GO:0005811; GO:0005829; GO:0006511; GO:0008015; GO:0016887; GO:0019216; GO:0042742; GO:0046872; GO:0061630; GO:0070534; GO:0098792; GO:0120323; GO:0140042; GO:2000051"
"13022","Cluster_4115","Peve_00006584",-0.999747628800907,0.0143029015872161,0.729378959833813,150,-23.05,"2 21","12975 12999",22,"63.64%","77.27%","CDS","A0A0R4IBK5","E3 ubiquitin-protein ligase rnf213-alpha (EC 2.3.2.27) (EC 3.6.4.-) (E3 ubiquitin-lipopolysaccharide ligase rnf213-alpha) (EC 2.3.2.-) (Mysterin-A) (Mysterin-alpha) (RING finger protein 213-A) (RING finger protein 213-alpha)","Danio rerio (Zebrafish) (Brachydanio rerio)","blood circulation [GO:0008015]; defense response to bacterium [GO:0042742]; immune system process [GO:0002376]; lipid droplet formation [GO:0140042]; lipid ubiquitination [GO:0120323]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; protein K63-linked ubiquitination [GO:0070534]; regulation of lipid metabolic process [GO:0019216]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]; xenophagy [GO:0098792]","GO:0002040; GO:0002376; GO:0004842; GO:0005524; GO:0005730; GO:0005811; GO:0005829; GO:0006511; GO:0008015; GO:0016887; GO:0019216; GO:0042742; GO:0046872; GO:0061630; GO:0070534; GO:0098792; GO:0120323; GO:0140042; GO:2000051"
"13023","Cluster_4115","Peve_00006584",-0.999747628800907,0.0143029015872161,0.729378959833813,158,-20.57,"2 20","21595 21617",19,"73.68%","78.95%","CDS","A0A0R4IBK5","E3 ubiquitin-protein ligase rnf213-alpha (EC 2.3.2.27) (EC 3.6.4.-) (E3 ubiquitin-lipopolysaccharide ligase rnf213-alpha) (EC 2.3.2.-) (Mysterin-A) (Mysterin-alpha) (RING finger protein 213-A) (RING finger protein 213-alpha)","Danio rerio (Zebrafish) (Brachydanio rerio)","blood circulation [GO:0008015]; defense response to bacterium [GO:0042742]; immune system process [GO:0002376]; lipid droplet formation [GO:0140042]; lipid ubiquitination [GO:0120323]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; protein K63-linked ubiquitination [GO:0070534]; regulation of lipid metabolic process [GO:0019216]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]; xenophagy [GO:0098792]","GO:0002040; GO:0002376; GO:0004842; GO:0005524; GO:0005730; GO:0005811; GO:0005829; GO:0006511; GO:0008015; GO:0016887; GO:0019216; GO:0042742; GO:0046872; GO:0061630; GO:0070534; GO:0098792; GO:0120323; GO:0140042; GO:2000051"
"13024","Cluster_4115","Peve_00006584",-0.999747628800907,0.0143029015872161,0.729378959833813,158,-20.57,"2 20","30226 30248",19,"73.68%","78.95%","CDS","A0A0R4IBK5","E3 ubiquitin-protein ligase rnf213-alpha (EC 2.3.2.27) (EC 3.6.4.-) (E3 ubiquitin-lipopolysaccharide ligase rnf213-alpha) (EC 2.3.2.-) (Mysterin-A) (Mysterin-alpha) (RING finger protein 213-A) (RING finger protein 213-alpha)","Danio rerio (Zebrafish) (Brachydanio rerio)","blood circulation [GO:0008015]; defense response to bacterium [GO:0042742]; immune system process [GO:0002376]; lipid droplet formation [GO:0140042]; lipid ubiquitination [GO:0120323]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; protein K63-linked ubiquitination [GO:0070534]; regulation of lipid metabolic process [GO:0019216]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]; xenophagy [GO:0098792]","GO:0002040; GO:0002376; GO:0004842; GO:0005524; GO:0005730; GO:0005811; GO:0005829; GO:0006511; GO:0008015; GO:0016887; GO:0019216; GO:0042742; GO:0046872; GO:0061630; GO:0070534; GO:0098792; GO:0120323; GO:0140042; GO:2000051"
"13025","Cluster_4115","Peve_00006632",-0.99980442800439,0.0125908639931623,0.69030974741484,167,-20.18,"2 21","6252 6274",20,"75.00%","85.00%","CDS","O00268","Transcription initiation factor TFIID subunit 4 (RNA polymerase II TBP-associated factor subunit C) (TBP-associated factor 4) (Transcription initiation factor TFIID 130 kDa subunit) (TAF(II)130) (TAFII-130) (TAFII130) (Transcription initiation factor TFIID 135 kDa subunit) (TAF(II)135) (TAFII-135) (TAFII135)","Homo sapiens (Human)","DNA-templated transcription initiation [GO:0006352]; histone H3 acetylation [GO:0043966]; monoubiquitinated histone deubiquitination [GO:0035521]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; mRNA transcription by RNA polymerase II [GO:0042789]; ovarian follicle development [GO:0001541]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; protein phosphorylation [GO:0006468]; regulation of DNA repair [GO:0006282]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription by RNA polymerase II [GO:0006366]; transcription initiation at RNA polymerase II promoter [GO:0006367]","GO:0000785; GO:0001541; GO:0001673; GO:0003677; GO:0005634; GO:0005654; GO:0005669; GO:0005829; GO:0006282; GO:0006352; GO:0006357; GO:0006366; GO:0006367; GO:0006468; GO:0017162; GO:0032991; GO:0033276; GO:0035521; GO:0035522; GO:0042789; GO:0043966; GO:0045893; GO:0046982; GO:0051123; GO:0060261; GO:0071339"
"13029","Cluster_4115","Peve_00006979",-0.998530137261281,0.0345212665811469,0.909359886114279,153,-21.64,"2 21","11830 11858",26,"69.23%","73.08%","CDS","K7Z9Q9","Nematocyst expressed protein 6 (NEP-6) (NEP6) (EC 3.4.24.-) (Astacin-like metalloprotease toxin)","Nematostella vectensis (Starlet sea anemone)","proteolysis [GO:0006508]","GO:0004222; GO:0005576; GO:0006508; GO:0008270; GO:0042151; GO:0090729"
"13042","Cluster_4115","Peve_00007814",-0.999587054165567,0.0182960193839233,0.782669382293497,162,-21.56,"2 21","4840 4864",22,"68.18%","86.36%","CDS","G3V9H8","Proto-oncogene tyrosine-protein kinase receptor Ret (EC 2.7.10.1) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment]","Rattus norvegicus (Rat)","cellular response to retinoic acid [GO:0071300]; embryonic epithelial tube formation [GO:0001838]; enteric nervous system development [GO:0048484]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; innervation [GO:0060384]; MAPK cascade [GO:0000165]; membrane protein proteolysis [GO:0033619]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; neuron cell-cell adhesion [GO:0007158]; neuron differentiation [GO:0030182]; neuron maturation [GO:0042551]; Peyer's patch morphogenesis [GO:0061146]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell migration [GO:0030335]; positive regulation of cell size [GO:0045793]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of metanephric glomerulus development [GO:0072300]; positive regulation of neuron maturation [GO:0014042]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; positive regulation of protein kinase B signaling [GO:0051897]; regulation of axonogenesis [GO:0050770]; regulation of cell adhesion [GO:0030155]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; retina development in camera-type eye [GO:0060041]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; ureter maturation [GO:0035799]; ureteric bud development [GO:0001657]","GO:0000165; GO:0001657; GO:0001755; GO:0001838; GO:0004714; GO:0005509; GO:0005524; GO:0005769; GO:0005886; GO:0007156; GO:0007158; GO:0007169; GO:0007399; GO:0009410; GO:0010008; GO:0010628; GO:0010976; GO:0014042; GO:0030155; GO:0030182; GO:0030335; GO:0030424; GO:0030425; GO:0033141; GO:0033619; GO:0033630; GO:0033674; GO:0035799; GO:0035860; GO:0042551; GO:0043025; GO:0043235; GO:0043410; GO:0045121; GO:0045793; GO:0045893; GO:0048265; GO:0048484; GO:0050770; GO:0051897; GO:0060041; GO:0060384; GO:0061146; GO:0071300; GO:0072300; GO:0098797"
"13047","Cluster_4115","Peve_00008020",-0.999844732028352,0.0112186779245671,0.654163278594465,166,-20.68,"2 21","14894 14914",19,"73.68%","89.47%","CDS","Q3V050","Multidrug and toxin extrusion protein 2 (MATE-2) (mMATE-2) (H(+)/organic cation antiporter kidney-specific) (Solute carrier family 47 member 2)","Mus musculus (Mouse)","organic cation transport [GO:0015695]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]","GO:0005886; GO:0015101; GO:0015179; GO:0015297; GO:0015299; GO:0015695; GO:0016020; GO:0016323; GO:0016324; GO:0022857; GO:0042910; GO:0061459; GO:1990961"
"13078","Cluster_4115","Peve_00009844",-0.999212697173606,0.0252635585306647,0.871317023606713,161,-21.74,"2 21","1035 1056",20,"80.00%","80.00%","CDS","O34678","Uncharacterized oxidoreductase YtbE (EC 1.-.-.-)","Bacillus subtilis (strain 168)","","GO:0016491"
"13123","Cluster_4115","Peve_00012652",-0.999793718708922,0.0129310117729925,0.698606267633189,169,-22.8,"2 19","3677 3700",19,"78.95%","89.47%","CDS","Q9BT22","Chitobiosyldiphosphodolichol beta-mannosyltransferase (EC 2.4.1.142) (Asparagine-linked glycosylation protein 1 homolog) (Beta-1,4-mannosyltransferase) (GDP-Man:GlcNAc2-PP-dolichol mannosyltransferase) (GDP-mannose-dolichol diphosphochitobiose mannosyltransferase) (Mannosyltransferase-1) (MT-1) (hMat-1)","Homo sapiens (Human)","dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; protein glycosylation [GO:0006486]","GO:0000030; GO:0004578; GO:0005783; GO:0005789; GO:0006486; GO:0006488; GO:0016020"
"13125","Cluster_4115","Peve_00012675",-0.999427644522255,0.0215401517719704,0.825375642876058,161,-20.38,"2 21","3591 3612",20,"75.00%","85.00%","CDS","P17972","Potassium voltage-gated channel protein Shaw (Shaw2)","Drosophila melanogaster (Fruit fly)","potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765]; sleep [GO:0030431]","GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0008076; GO:0016020; GO:0022843; GO:0030424; GO:0030431; GO:0032590; GO:0032809; GO:0034765; GO:0051260; GO:0071805"
"13141","Cluster_4115","Peve_00013797",0.997419073679286,0.0457484490353859,0.933976570634822,148,-20.68,"2 17","12268 12289",15,"66.67%","80.00%","CDS","Q9H270","Vacuolar protein sorting-associated protein 11 homolog (hVPS11) (RING finger protein 108)","Homo sapiens (Human)","autophagy [GO:0006914]; endosomal vesicle fusion [GO:0034058]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; organelle fusion [GO:0048284]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein ubiquitination [GO:0016567]; regulation of organelle assembly [GO:1902115]; regulation of protein stability [GO:0031647]; regulation of SNARE complex assembly [GO:0035542]; vacuole organization [GO:0007033]; vesicle docking involved in exocytosis [GO:0006904]","GO:0000166; GO:0005764; GO:0005765; GO:0005768; GO:0005769; GO:0005770; GO:0005776; GO:0006886; GO:0006904; GO:0006914; GO:0007032; GO:0007033; GO:0008333; GO:0010008; GO:0016567; GO:0019904; GO:0019905; GO:0030136; GO:0030139; GO:0030674; GO:0030897; GO:0031647; GO:0031902; GO:0033147; GO:0033263; GO:0034058; GO:0035542; GO:0045732; GO:0046872; GO:0048284; GO:0061630; GO:1902115; GO:1903955; GO:2000643"
"13268","Cluster_589","Peve_00000388",-0.99908203483763,0.0272798167389145,0.893954905948901,153,-20.16,"2 18","606 627",16,"68.75%","81.25%","CDS","Q6P988","Palmitoleoyl-protein carboxylesterase NOTUM (EC 3.1.1.98) (hNOTUM)","Homo sapiens (Human)","bone development [GO:0060348]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of Wnt signaling pathway [GO:0030178]; protein depalmitoleylation [GO:1990697]; regulation of bone mineralization [GO:0030500]; Wnt signaling pathway [GO:0016055]","GO:0004629; GO:0005576; GO:0005788; GO:0016055; GO:0030178; GO:0030500; GO:0060348; GO:0090090; GO:1990697; GO:1990699"
"13270","Cluster_589","Peve_00000404",-0.999785556767188,0.0131843600602164,0.704152747004529,155,-21.18,"2 21","42266 42289",21,"66.67%","76.19%","CDS","Q0KL02","Triple functional domain protein (EC 2.7.11.1)","Mus musculus (Mouse)","axon guidance [GO:0007411]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of fat cell differentiation [GO:0045599]; neuron projection morphogenesis [GO:0048812]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; protein phosphorylation [GO:0006468]","GO:0004674; GO:0005085; GO:0005524; GO:0005737; GO:0005769; GO:0006468; GO:0007411; GO:0019898; GO:0019899; GO:0042995; GO:0045599; GO:0048786; GO:0048812; GO:0050804; GO:0098685; GO:0098794; GO:0098978; GO:0099170; GO:0106310"
"13344","Cluster_589","Peve_00001538",-0.999928007864221,0.00763906587701203,0.573710369894872,159,-23.55,"2 20","4032 4053",18,"72.22%","77.78%","CDS","B1AVH7","TBC1 domain family member 2A","Mus musculus (Mouse)","activation of GTPase activity [GO:0090630]; positive regulation of GTPase activity [GO:0043547]","GO:0005096; GO:0005654; GO:0005829; GO:0005886; GO:0030054; GO:0031410; GO:0043547; GO:0045296; GO:0070161; GO:0090630"
"13348","Cluster_589","Peve_00001529",-0.999983125832285,0.00369834065949377,0.533166802342694,155,-23.55,"2 12","4073 4094",10,"100.00%","100.00%","CDS","Q9CXR1","Dehydrogenase/reductase SDR family member 7 (EC 1.1.1.-) (Retinal short-chain dehydrogenase/reductase 4) (retSDR4) (Short chain dehydrogenase/reductase family 34C member 1) (Protein SDR34C1)","Mus musculus (Mouse)","","GO:0004090; GO:0005789; GO:0016616; GO:0052650"
"13366","Cluster_589","Peve_00001905",-0.999880668455908,0.0098350612688182,0.615776980998388,148,-21.08,"2 14","2581 2603",13,"76.92%","92.31%","CDS","Q920A6","Retinoid-inducible serine carboxypeptidase (EC 3.4.16.-) (Serine carboxypeptidase 1)","Rattus norvegicus (Rat)","blood vessel diameter maintenance [GO:0097746]; negative regulation of blood pressure [GO:0045776]; proteolysis [GO:0006508]; retinoic acid metabolic process [GO:0042573]","GO:0004185; GO:0005576; GO:0005829; GO:0006508; GO:0042573; GO:0045776; GO:0097746"
"13373","Cluster_589","Peve_00000035",-0.997855251545262,0.0417023908348541,0.909359886114279,149,-20.55,"2 20","21960 21985",22,"68.18%","72.73%","CDS","F8WK50",NA,NA,NA,NA
"13379","Cluster_589","Peve_00001787",-0.999947166297972,0.00654413958551676,0.573710369894872,155,-23.55,"2 12","17895 17916",10,"100.00%","100.00%","CDS","Q58DA0","26S proteasome non-ATPase regulatory subunit 4 (26S proteasome regulatory subunit RPN10)","Bos taurus (Bovine)","proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]","GO:0005634; GO:0005829; GO:0008540; GO:0022624; GO:0031593; GO:0043161"
"13380","Cluster_589","Peve_00002096",-0.998981183536662,0.0287395508786692,0.903929377050813,140,-20.46,"2 9","24617 24638",7,"100.00%","100.00%","CDS","Q9JID6","Long-chain-fatty-acid--CoA ligase 1 (EC 6.2.1.3) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain acyl-CoA synthetase 1) (LACS 1) (Palmitoyl-CoA ligase) (Phytanate--CoA ligase) (EC 6.2.1.24)","Cavia porcellus (Guinea pig)","long-chain fatty acid metabolic process [GO:0001676]; very long-chain fatty acid metabolic process [GO:0000038]","GO:0000038; GO:0001676; GO:0004467; GO:0005524; GO:0005741; GO:0005778; GO:0005783; GO:0005789; GO:0047676; GO:0050197; GO:0070251"
"13381","Cluster_589","Peve_00002096",-0.998981183536662,0.0287395508786692,0.903929377050813,174,-26.78,"2 21","29806 29826",19,"84.21%","89.47%","CDS","Q9JID6","Long-chain-fatty-acid--CoA ligase 1 (EC 6.2.1.3) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain acyl-CoA synthetase 1) (LACS 1) (Palmitoyl-CoA ligase) (Phytanate--CoA ligase) (EC 6.2.1.24)","Cavia porcellus (Guinea pig)","long-chain fatty acid metabolic process [GO:0001676]; very long-chain fatty acid metabolic process [GO:0000038]","GO:0000038; GO:0001676; GO:0004467; GO:0005524; GO:0005741; GO:0005778; GO:0005783; GO:0005789; GO:0047676; GO:0050197; GO:0070251"
"13390","Cluster_589","Peve_00002249",-0.998449405815817,0.0354568646881138,0.909359886114279,146,-22.11,"2 21","17578 17605",25,"64.00%","68.00%","CDS",NA,NA,NA,NA,NA
"13394","Cluster_589","Peve_00001835",-0.999446677970449,0.0211789355546999,0.821402964913383,154,-30.52,"2 21","424 453",27,"66.67%","70.37%","CDS","Q8C5P5","5'-nucleotidase domain-containing protein 1 (EC 3.1.3.-) (Cytosolic 5'-nucleotidase II-like protein 1)","Mus musculus (Mouse)","","GO:0008253; GO:0046872"
"13435","Cluster_589","Peve_00002659",-0.999266042083102,0.0243925535392527,0.860691627780599,151,-20.47,"2 21","12666 12688",20,"70.00%","70.00%","CDS","B9U3F2","Protein dispatched homolog 3 (Patched domain-containing protein 2) (Thyroid hormone receptor up-regulated protein 1) (TRUP1)","Gallus gallus (Chicken)","cell differentiation [GO:0030154]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; negative regulation of neuron differentiation [GO:0045665]; positive regulation of lipid metabolic process [GO:0045834]; positive regulation of neural precursor cell proliferation [GO:2000179]; response to hormone [GO:0009725]","GO:0005737; GO:0005783; GO:0005789; GO:0008203; GO:0009725; GO:0016020; GO:0030154; GO:0030659; GO:0031965; GO:0042632; GO:0045665; GO:0045834; GO:2000179"
"13468","Cluster_589","Peve_00003439",-0.999980738177473,0.00395134096014511,0.54328949385489,161,-23.5,"2 18","8296 8317",16,"68.75%","93.75%","CDS","P11029","Acetyl-CoA carboxylase (ACC) (EC 6.4.1.2) [Includes: Biotin carboxylase (EC 6.3.4.14)]","Gallus gallus (Chicken)","epigenetic regulation of gene expression [GO:0040029]; fatty acid biosynthetic process [GO:0006633]; malonyl-CoA biosynthetic process [GO:2001295]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; regulation of biological quality [GO:0065008]; response to carbohydrate [GO:0009743]; response to fatty acid [GO:0070542]; response to thyroid hormone [GO:0097066]; transport [GO:0006810]","GO:0003989; GO:0004075; GO:0005102; GO:0005524; GO:0005737; GO:0005739; GO:0006633; GO:0006810; GO:0009374; GO:0009743; GO:0010628; GO:0032810; GO:0040029; GO:0045893; GO:0046872; GO:0046966; GO:0050692; GO:0065008; GO:0070542; GO:0097066; GO:2001295"
"13479","Cluster_589","Peve_00003610",-0.999328962832057,0.0233234449403613,0.848644972258352,165,-25.29,"2 20","13241 13261",18,"83.33%","83.33%","CDS","P18293","Atrial natriuretic peptide receptor 1 (EC 4.6.1.2) (Atrial natriuretic peptide receptor type A) (ANP-A) (ANPR-A) (NPR-A) (Guanylate cyclase A) (GC-A)","Mus musculus (Mouse)","blood vessel diameter maintenance [GO:0097746]; cell surface receptor signaling pathway [GO:0007166]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; dopamine metabolic process [GO:0042417]; intracellular signal transduction [GO:0035556]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of cGMP-mediated signaling [GO:0010753]; protein phosphorylation [GO:0006468]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of blood pressure [GO:0008217]; signal transduction [GO:0007165]","GO:0001653; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005886; GO:0006182; GO:0006468; GO:0007165; GO:0007166; GO:0007168; GO:0008217; GO:0010753; GO:0016941; GO:0017046; GO:0019934; GO:0035556; GO:0042417; GO:0042562; GO:0043235; GO:0048662; GO:0097746; GO:1990620"
"13502","Cluster_589","Peve_00003922",-0.999972698911671,0.00470420337225242,0.551398425649056,151,-20.51,"2 21","19453 19478",23,"65.22%","69.57%","CDS","Q9D032","Single-stranded DNA-binding protein 3 (Lck-associated signal transducer) (Sequence-specific single-stranded-DNA-binding protein)","Mus musculus (Mouse)","cell differentiation [GO:0030154]; head development [GO:0060322]; head morphogenesis [GO:0060323]; hematopoietic progenitor cell differentiation [GO:0002244]; mesendoderm development [GO:0048382]; midbrain-hindbrain boundary initiation [GO:0021547]; positive regulation of anterior head development [GO:2000744]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; prechordal plate formation [GO:0021501]; protein-containing complex assembly [GO:0065003]","GO:0002244; GO:0003697; GO:0003713; GO:0005634; GO:0005667; GO:0008284; GO:0021501; GO:0021547; GO:0030154; GO:0032991; GO:0045893; GO:0045944; GO:0048382; GO:0060322; GO:0060323; GO:0065003; GO:2000744"
"13509","Cluster_589","Peve_00004241",0.999725519885309,0.0149162790118723,0.741060622317634,155,-23.55,"2 12","15551 15572",10,"100.00%","100.00%","CDS",NA,NA,NA,NA,NA
"13516","Cluster_589","Peve_00004323",-0.997216726294282,0.0475087780886808,0.943238620332273,144,-20.14,"2 20","10718 10742",22,"68.18%","68.18%","CDS","Q6RFZ7","Pleckstrin homology domain-containing family G member 5 (PH domain-containing family G member 5) (Neuronal RhoA GEF protein) (Transcript highly enriched in cortex and hippocampus)","Rattus norvegicus (Rat)","endothelial cell chemotaxis [GO:0035767]; endothelial cell migration [GO:0043542]; regulation of protein catabolic process at presynapse, modulating synaptic transmission [GO:0099575]; regulation protein catabolic process at presynapse [GO:0140251]; Rho protein signal transduction [GO:0007266]","GO:0005085; GO:0005737; GO:0005886; GO:0005911; GO:0007266; GO:0030027; GO:0030139; GO:0030424; GO:0035767; GO:0043542; GO:0045202; GO:0048471; GO:0098793; GO:0099575; GO:0140251"
"13537","Cluster_589","Peve_00004712",-0.999587847267624,0.0182784401020463,0.782669382293497,150,-20.28,"2 11","9849 9870",9,"100.00%","100.00%","CDS","O35474","EGF-like repeat and discoidin I-like domain-containing protein 3 (Developmentally-regulated endothelial cell locus 1 protein) (Integrin-binding protein DEL1)","Mus musculus (Mouse)","cell adhesion [GO:0007155]; positive regulation of cell-substrate adhesion [GO:0010811]","GO:0005509; GO:0005576; GO:0007155; GO:0010811"
"13639","Cluster_589","Peve_00006541",-0.998797162930987,0.0312278485462182,0.903929377050813,155,-23.93,"2 12","9229 9250",10,"100.00%","100.00%","CDS","Q9SSA4",NA,NA,NA,NA
"13643","Cluster_589","Peve_00000003",0.999999238634054,0.000785582630254667,0.239778920002343,158,-22.32,"2 20","1386 1408",19,"68.42%","84.21%","CDS","O35654","DNA polymerase delta subunit 2 (DNA polymerase delta subunit p50)","Mus musculus (Mouse)","DNA biosynthetic process [GO:0071897]; DNA replication [GO:0006260]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA-templated DNA replication [GO:0006261]; error-prone translesion synthesis [GO:0042276]","GO:0003677; GO:0005654; GO:0006260; GO:0006261; GO:0006271; GO:0016035; GO:0042276; GO:0042575; GO:0043625; GO:0071897"
"13650","Cluster_589","Peve_00006234",-0.998186646628078,0.0383444040360386,0.909359886114279,147,-20.11,"2 12","37004 37025",10,"90.00%","90.00%","CDS","Q8IVV2","Lipoxygenase homology domain-containing protein 1","Homo sapiens (Human)","sensory perception of sound [GO:0007605]","GO:0007605; GO:0032420"
"13687","Cluster_589","Peve_00007386",-0.99829893378936,0.0371378974490168,0.909359886114279,159,-20.78,"2 19","23307 23326",17,"76.47%","88.24%","CDS","Q13619","Cullin-4A (CUL-4A)","Homo sapiens (Human)","cell population proliferation [GO:0008283]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to UV [GO:0034644]; DNA repair [GO:0006281]; G1/S transition of mitotic cell cycle [GO:0000082]; hemopoiesis [GO:0030097]; in utero embryonic development [GO:0001701]; intrinsic apoptotic signaling pathway [GO:0097193]; negative regulation of granulocyte differentiation [GO:0030853]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of DNA damage checkpoint [GO:2000001]; regulation of nucleotide-excision repair [GO:2000819]; regulation of protein metabolic process [GO:0051246]; rhythmic process [GO:0048511]; ribosome biogenesis [GO:0042254]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; somatic stem cell population maintenance [GO:0035019]","GO:0000082; GO:0001701; GO:0005634; GO:0005654; GO:0006281; GO:0006974; GO:0008283; GO:0008284; GO:0016567; GO:0030097; GO:0030674; GO:0030853; GO:0031146; GO:0031461; GO:0031464; GO:0031625; GO:0034644; GO:0035019; GO:0042254; GO:0043161; GO:0048511; GO:0051246; GO:0080008; GO:0097193; GO:1900087; GO:2000001; GO:2000819"
"13690","Cluster_589","Peve_00007420",-0.999164233414202,0.0260296228053412,0.880395372085238,159,-22.31,"2 21","13479 13501",20,"75.00%","75.00%","CDS","Q68UT7","Hormonally up-regulated neu tumor-associated kinase (EC 2.7.11.1)","Pan troglodytes (Chimpanzee)","intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]","GO:0004674; GO:0005524; GO:0006468; GO:0035556; GO:0106310"
"13723","Cluster_589","Peve_00008033",-0.99781958887419,0.0420477981551328,0.910836595233947,155,-23.55,"2 12","833 854",10,"100.00%","100.00%","CDS","Q9Z0R4","Intersectin-1 (EH and SH3 domains protein 1)","Mus musculus (Mouse)","clathrin-dependent synaptic vesicle endocytosis [GO:0150007]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; exocytosis [GO:0006887]; negative regulation of neuron apoptotic process [GO:0043524]; neuron apoptotic process [GO:0051402]; positive regulation of caveolin-mediated endocytosis [GO:2001288]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of growth hormone secretion [GO:0060124]; positive regulation of protein kinase B signaling [GO:0051897]; protein localization [GO:0008104]; protein transport [GO:0015031]; regulation of modification of postsynaptic actin cytoskeleton [GO:1905274]; regulation of postsynapse organization [GO:0099175]; small GTPase mediated signal transduction [GO:0007264]; synaptic vesicle endocytosis [GO:0048488]","GO:0005085; GO:0005509; GO:0005635; GO:0005737; GO:0005829; GO:0005886; GO:0005905; GO:0006887; GO:0006897; GO:0007264; GO:0008104; GO:0015031; GO:0016197; GO:0019209; GO:0030027; GO:0030139; GO:0043025; GO:0043197; GO:0043524; GO:0044305; GO:0045202; GO:0048488; GO:0051402; GO:0051897; GO:0055037; GO:0060090; GO:0060124; GO:0060999; GO:0070064; GO:0097440; GO:0097708; GO:0098833; GO:0098871; GO:0098978; GO:0099175; GO:0150007; GO:1905274; GO:2001288"
"13785","Cluster_589","Peve_00009118",-0.999996395310917,0.00170934276007991,0.362847063101065,158,-23.1,"2 21","15044 15064",19,"68.42%","84.21%","CDS",NA,NA,NA,NA,NA
"13815","Cluster_589","Peve_00009537",-0.997692016354942,0.0432608500055966,0.918350840181857,152,-23.49,"2 14","24529 24551",13,"84.62%","92.31%","CDS","P54762","Ephrin type-B receptor 1 (EC 2.7.10.1) (ELK) (EPH tyrosine kinase 2) (EPH-like kinase 6) (EK6) (hEK6) (Neuronally-expressed EPH-related tyrosine kinase) (NET) (Tyrosine-protein kinase receptor EPH-2)","Homo sapiens (Human)","angiogenesis [GO:0001525]; axon guidance [GO:0007411]; camera-type eye morphogenesis [GO:0048593]; cell chemotaxis [GO:0060326]; cell-substrate adhesion [GO:0031589]; central nervous system projection neuron axonogenesis [GO:0021952]; dendritic spine development [GO:0060996]; dendritic spine morphogenesis [GO:0060997]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; ephrin receptor signaling pathway [GO:0048013]; establishment of cell polarity [GO:0030010]; hindbrain tangential cell migration [GO:0021934]; immunological synapse formation [GO:0001771]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of satellite cell differentiation [GO:1902725]; negative regulation of skeletal muscle satellite cell proliferation [GO:1902723]; neural precursor cell proliferation [GO:0061351]; neurogenesis [GO:0022008]; optic nerve morphogenesis [GO:0021631]; positive regulation of kinase activity [GO:0033674]; positive regulation of synapse assembly [GO:0051965]; protein autophosphorylation [GO:0046777]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of JNK cascade [GO:0046328]; regulation of neuron death [GO:1901214]; retinal ganglion cell axon guidance [GO:0031290]; skeletal muscle satellite cell activation [GO:0014719]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]","GO:0001525; GO:0001771; GO:0004714; GO:0005005; GO:0005524; GO:0005576; GO:0005783; GO:0005829; GO:0005886; GO:0007169; GO:0007411; GO:0008046; GO:0014719; GO:0021631; GO:0021934; GO:0021952; GO:0022008; GO:0030010; GO:0030424; GO:0030425; GO:0031290; GO:0031589; GO:0031901; GO:0032433; GO:0033674; GO:0043005; GO:0043235; GO:0044877; GO:0045121; GO:0046328; GO:0046777; GO:0048013; GO:0048593; GO:0050804; GO:0050965; GO:0051965; GO:0060326; GO:0060996; GO:0060997; GO:0061351; GO:0070062; GO:0070372; GO:0098978; GO:1901214; GO:1902723; GO:1902725"
"13818","Cluster_589","Peve_00009560",-0.999329024199359,0.0233223783156091,0.848644972258352,156,-21.33,"2 19","11849 11869",17,"76.47%","82.35%","CDS","Q02218","2-oxoglutarate dehydrogenase complex component E1 (E1o) (OGDC-E1) (OGDH-E1) (EC 1.2.4.2) (2-oxoglutarate dehydrogenase, mitochondrial) (Alpha-ketoglutarate dehydrogenase) (Alpha-KGDH-E1) (Thiamine diphosphate (ThDP)-dependent 2-oxoglutarate dehydrogenase)","Homo sapiens (Human)","2-oxoglutarate metabolic process [GO:0006103]; cerebellar cortex development [GO:0021695]; generation of precursor metabolites and energy [GO:0006091]; glycolytic process [GO:0006096]; hippocampus development [GO:0021766]; histone succinylation [GO:0106077]; NADH metabolic process [GO:0006734]; olfactory bulb mitral cell layer development [GO:0061034]; pyramidal neuron development [GO:0021860]; striatum development [GO:0021756]; succinyl-CoA metabolic process [GO:0006104]; tangential migration from the subventricular zone to the olfactory bulb [GO:0022028]; thalamus development [GO:0021794]; tricarboxylic acid cycle [GO:0006099]","GO:0004591; GO:0005634; GO:0005739; GO:0005759; GO:0006091; GO:0006096; GO:0006099; GO:0006103; GO:0006104; GO:0006734; GO:0021695; GO:0021756; GO:0021766; GO:0021794; GO:0021860; GO:0022028; GO:0030976; GO:0031072; GO:0031966; GO:0034602; GO:0045252; GO:0046872; GO:0051087; GO:0061034; GO:0106077"
"13880","Cluster_589","Peve_00010789",-0.999232776560249,0.0249392749233984,0.86745289293403,151,-22.9,"2 12","23936 23957",10,"90.00%","100.00%","CDS",NA,NA,NA,NA,NA
"13881","Cluster_589","Peve_00010789",-0.999232776560249,0.0249392749233984,0.86745289293403,154,-21.88,"2 18","33449 33468",16,"81.25%","81.25%","CDS",NA,NA,NA,NA,NA
"13883","Cluster_589","Peve_00010793",-0.999994709169113,0.0020708910558741,0.364311022785359,148,-21.28,"2 21","31802 31823",19,"63.16%","68.42%","CDS","P69527","Aminopeptidase O (AP-O) (EC 3.4.11.-)","Rattus norvegicus (Rat)","proteolysis [GO:0006508]","GO:0005730; GO:0006508; GO:0008270; GO:0070006"
"13886","Cluster_589","Peve_00009990",-0.999175061941466,0.0258604245822689,0.878501136000008,164,-23.04,"2 21","875 896",19,"68.42%","84.21%","CDS","D3ZAT9","Failed axon connections homolog","Rattus norvegicus (Rat)","","GO:0005737; GO:0016020"
"13891","Cluster_589","Peve_00010869",-0.998079664911893,0.039459643129889,0.909359886114279,158,-25.24,"2 21","5208 5232",22,"72.73%","77.27%","CDS","A0A1U9YHZ9","Cytochrome P450 monooxygenase verC (EC 1.-.-.-) (Verticillin biosynthesis cluster protein C)","Clonostachys rogersoniana","","GO:0004497; GO:0005506; GO:0016020; GO:0016705; GO:0020037"
"13922","Cluster_589","Peve_00011539",-0.998233319205703,0.0378475807060832,0.909359886114279,151,-21.69,"2 14","4289 4309",12,"91.67%","91.67%","CDS","Q92546","RAB6A-GEF complex partner protein 2 (Retrograde Golgi transport protein RGP1 homolog)","Homo sapiens (Human)","negative regulation of protein catabolic process [GO:0042177]; positive regulation of GTPase activity [GO:0043547]; retrograde transport, endosome to Golgi [GO:0042147]","GO:0000139; GO:0005085; GO:0005829; GO:0005886; GO:0016020; GO:0031267; GO:0032588; GO:0032991; GO:0034066; GO:0042147; GO:0042177; GO:0043547"
"13928","Cluster_589","Peve_00011766",0.999699471908932,0.0156080459251346,0.755215913266851,153,-21.78,"2 20","2406 2429",20,"70.00%","80.00%","CDS",NA,NA,NA,NA,NA
"13960","Cluster_589","Peve_00012512",-0.999625065689112,0.0174335681460817,0.782669382293497,155,-23.55,"2 12","7509 7530",10,"100.00%","100.00%","CDS","Q92541","RNA polymerase-associated protein RTF1 homolog","Homo sapiens (Human)","blastocyst growth [GO:0001832]; endodermal cell fate commitment [GO:0001711]; histone H3-K4 trimethylation [GO:0080182]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone H3-K4 methylation [GO:0051571]; stem cell population maintenance [GO:0019827]; transcription elongation by RNA polymerase II promoter [GO:0006368]; Wnt signaling pathway [GO:0016055]","GO:0000122; GO:0001711; GO:0001832; GO:0003697; GO:0003723; GO:0005654; GO:0005730; GO:0006368; GO:0016055; GO:0016593; GO:0019827; GO:0051571; GO:0080182; GO:1990269"
"13977","Cluster_589","Peve_00012952",0.9999039238855,0.0088248292997023,0.583837684785988,145,-21.15,"2 16","24286 24312",19,"73.68%","73.68%","CDS","P46023","G-protein coupled receptor GRL101","Lymnaea stagnalis (Great pond snail) (Helix stagnalis)","","GO:0004930; GO:0005886"
"14001","Cluster_589","Peve_00013326",-0.999852555868755,0.0109323670007376,0.647820986329688,142,-20.8,"2 20","29747 29775",25,"60.00%","64.00%","CDS","D4G3R4","tRNA(Glu)-specific nuclease WapA (EC 3.1.-.-) (Cell wall-associated protein) (RNase WapA) (Toxin WapA)","Bacillus subtilis subsp. natto (strain BEST195)","tRNA catabolic process [GO:0016078]","GO:0004519; GO:0004549; GO:0005576; GO:0016078; GO:0090729"
"14002","Cluster_589","Peve_00013326",-0.999852555868755,0.0109323670007376,0.647820986329688,155,-22.9,"2 20","10384 10405",18,"66.67%","77.78%","CDS","D4G3R4","tRNA(Glu)-specific nuclease WapA (EC 3.1.-.-) (Cell wall-associated protein) (RNase WapA) (Toxin WapA)","Bacillus subtilis subsp. natto (strain BEST195)","tRNA catabolic process [GO:0016078]","GO:0004519; GO:0004549; GO:0005576; GO:0016078; GO:0090729"
"14003","Cluster_589","Peve_00013326",-0.999852555868755,0.0109323670007376,0.647820986329688,159,-20.01,"2 20","21273 21294",18,"61.11%","88.89%","CDS","D4G3R4","tRNA(Glu)-specific nuclease WapA (EC 3.1.-.-) (Cell wall-associated protein) (RNase WapA) (Toxin WapA)","Bacillus subtilis subsp. natto (strain BEST195)","tRNA catabolic process [GO:0016078]","GO:0004519; GO:0004549; GO:0005576; GO:0016078; GO:0090729"
"14004","Cluster_589","Peve_00013326",-0.999852555868755,0.0109323670007376,0.647820986329688,171,-22.09,"2 20","54588 54609",18,"72.22%","94.44%","CDS","D4G3R4","tRNA(Glu)-specific nuclease WapA (EC 3.1.-.-) (Cell wall-associated protein) (RNase WapA) (Toxin WapA)","Bacillus subtilis subsp. natto (strain BEST195)","tRNA catabolic process [GO:0016078]","GO:0004519; GO:0004549; GO:0005576; GO:0016078; GO:0090729"
"14021","Cluster_589","Peve_00013778",-0.999143355797822,0.0263527758842851,0.884249165328432,151,-22.44,"2 21","15836 15858",20,"70.00%","70.00%","CDS","Q26619","cAMP-dependent protein kinase type II regulatory subunit","Strongylocentrotus purpuratus (Purple sea urchin)","negative regulation of cAMP-dependent protein kinase activity [GO:2000480]","GO:0004862; GO:0005737; GO:0005952; GO:0030552; GO:0034236; GO:2000480"
"14023","Cluster_589","Peve_00013831",-0.998607432161838,0.0336011168386757,0.909359886114279,153,-20.31,"2 17","2738 2757",15,"80.00%","86.67%","CDS",NA,NA,NA,NA,NA
"14027","Cluster_589","Peve_00013835",-0.999640099755155,0.0170804464428046,0.782312023486667,149,-21.32,"2 21","62397 62423",24,"66.67%","75.00%","CDS",NA,NA,NA,NA,NA
"14028","Cluster_589","Peve_00013835",-0.999640099755155,0.0170804464428046,0.782312023486667,155,-20.56,"2 21","36347 36369",20,"65.00%","80.00%","CDS",NA,NA,NA,NA,NA
"14029","Cluster_589","Peve_00013835",-0.999640099755155,0.0170804464428046,0.782312023486667,155,-21.34,"2 12","29439 29460",10,"100.00%","100.00%","CDS",NA,NA,NA,NA,NA
"14032","Cluster_589","Peve_00013933",0.99738806395724,0.0460225803266885,0.935124938815665,160,-23.84,"2 20","29 48",18,"72.22%","88.89%","CDS","Q8TB22","Spermatogenesis-associated protein 20 (Sperm-specific protein 411) (Ssp411)","Homo sapiens (Human)","carbohydrate metabolic process [GO:0005975]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283]","GO:0005576; GO:0005975; GO:0007283; GO:0030154"
"14054","Cluster_589","Peve_00014141",-0.999771117558368,0.0136210204052954,0.714322965451251,151,-21.81,"2 12","4650 4671",10,"90.00%","100.00%","CDS","P08842","Steryl-sulfatase (EC 3.1.6.2) (Arylsulfatase C) (ASC) (Estrone sulfatase) (Steroid sulfatase) (Steryl-sulfate sulfohydrolase)","Homo sapiens (Human)","epidermis development [GO:0008544]; female pregnancy [GO:0007565]; steroid catabolic process [GO:0006706]","GO:0004065; GO:0004773; GO:0005764; GO:0005768; GO:0005783; GO:0005788; GO:0005789; GO:0005794; GO:0005886; GO:0006706; GO:0007565; GO:0008484; GO:0008544; GO:0016020; GO:0043231; GO:0046872"
"14057","Cluster_589","Peve_00013491",-0.999122952793073,0.0266648013275948,0.887262532171098,158,-20.64,"2 21","157 180",21,"71.43%","80.95%","CDS","Q8WXD9","Caskin-1 (CASK-interacting protein 1)","Homo sapiens (Human)","signal transduction [GO:0007165]","GO:0005737; GO:0007165; GO:0016020; GO:0042802"
"14059","Cluster_589","Peve_00014398",-0.999822631423906,0.011990571412601,0.674878265873359,155,-23.55,"2 12","6816 6837",10,"100.00%","100.00%","CDS","P31696","Agrin [Cleaved into: Agrin N-terminal 110 kDa subunit; Agrin C-terminal 110 kDa subunit; Agrin C-terminal 90 kDa fragment (C90); Agrin C-terminal 22 kDa fragment (C22)]","Gallus gallus (Chicken)","actin cytoskeleton reorganization [GO:0031532]; brain development [GO:0007420]; cell differentiation [GO:0030154]; filopodium assembly [GO:0046847]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; negative regulation of neuron projection development [GO:0010977]; nervous system development [GO:0007399]; neuromuscular junction development [GO:0007528]; neuron cell-cell adhesion [GO:0007158]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; positive regulation of synaptic assembly at neuromuscular junction [GO:0045887]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor clustering [GO:0043113]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]","GO:0002162; GO:0005509; GO:0005539; GO:0005576; GO:0005604; GO:0005615; GO:0005886; GO:0007158; GO:0007213; GO:0007399; GO:0007420; GO:0007528; GO:0008201; GO:0010977; GO:0030154; GO:0030297; GO:0030424; GO:0030548; GO:0031012; GO:0031532; GO:0031594; GO:0033691; GO:0035374; GO:0038023; GO:0043113; GO:0043236; GO:0043237; GO:0043395; GO:0043547; GO:0045121; GO:0045178; GO:0045202; GO:0045887; GO:0045944; GO:0046847; GO:0050840; GO:0051491; GO:0071340; GO:0098684; GO:0098965; GO:0098978"
"14068","Cluster_589","Peve_00014560",-0.997728095293297,0.0429212571353912,0.916288292153006,153,-21.82,"2 20","11563 11583",18,"66.67%","83.33%","CDS","Q9GZV8","PR domain zinc finger protein 14 (EC 2.1.1.-) (PR domain-containing protein 14)","Homo sapiens (Human)","cell fate specification [GO:0001708]; cell morphogenesis [GO:0000902]; embryo implantation [GO:0007566]; fertilization [GO:0009566]; fibroblast growth factor receptor signaling pathway [GO:0008543]; germ cell development [GO:0007281]; germ-line stem cell population maintenance [GO:0030718]; histone H3-R26 methylation [GO:0034972]; homeostasis of number of cells within a tissue [GO:0048873]; inactivation of paternal X chromosome [GO:0060817]; inner cell mass cell fate commitment [GO:0001827]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of flagellated sperm motility [GO:1902093]; positive regulation of stem cell population maintenance [GO:1902459]; regulation of DNA methylation [GO:0044030]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000122; GO:0000902; GO:0000977; GO:0001708; GO:0001827; GO:0003723; GO:0005634; GO:0005654; GO:0006357; GO:0007281; GO:0007566; GO:0008168; GO:0008543; GO:0009566; GO:0010468; GO:0030718; GO:0031490; GO:0034972; GO:0040037; GO:0044030; GO:0046872; GO:0048873; GO:0060817; GO:1902093; GO:1902459"
"14069","Cluster_589","Peve_00014560",-0.997728095293297,0.0429212571353912,0.916288292153006,168,-26.6,"2 21","20304 20325",19,"68.42%","89.47%","CDS","Q9GZV8","PR domain zinc finger protein 14 (EC 2.1.1.-) (PR domain-containing protein 14)","Homo sapiens (Human)","cell fate specification [GO:0001708]; cell morphogenesis [GO:0000902]; embryo implantation [GO:0007566]; fertilization [GO:0009566]; fibroblast growth factor receptor signaling pathway [GO:0008543]; germ cell development [GO:0007281]; germ-line stem cell population maintenance [GO:0030718]; histone H3-R26 methylation [GO:0034972]; homeostasis of number of cells within a tissue [GO:0048873]; inactivation of paternal X chromosome [GO:0060817]; inner cell mass cell fate commitment [GO:0001827]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of flagellated sperm motility [GO:1902093]; positive regulation of stem cell population maintenance [GO:1902459]; regulation of DNA methylation [GO:0044030]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000122; GO:0000902; GO:0000977; GO:0001708; GO:0001827; GO:0003723; GO:0005634; GO:0005654; GO:0006357; GO:0007281; GO:0007566; GO:0008168; GO:0008543; GO:0009566; GO:0010468; GO:0030718; GO:0031490; GO:0034972; GO:0040037; GO:0044030; GO:0046872; GO:0048873; GO:0060817; GO:1902093; GO:1902459"
"14141","Cluster_589","Peve_00015640",-0.998674298211381,0.0327843088431138,0.909359886114279,166,-25.39,"2 21","2780 2800",19,"78.95%","84.21%","CDS",NA,NA,NA,NA,NA
"14194","Cluster_589","Peve_00016798",-0.998993337809364,0.0285675790922425,0.903929377050813,151,-21,"2 18","683 707",19,"73.68%","78.95%","CDS",NA,NA,NA,NA,NA
"14211","Cluster_589","Peve_00017180",-0.99953411064578,0.0194336052474065,0.796664198789063,155,-23.41,"2 12","16552 16573",10,"100.00%","100.00%","CDS","Q9QZD4","DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4)","Mus musculus (Mouse)","cellular response to UV [GO:0034644]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; negative regulation of double-stranded telomeric DNA binding [GO:1905768]; negative regulation of protection from non-homologous end joining at telomere [GO:1905765]; negative regulation of telomere maintenance [GO:0032205]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair involved in interstrand cross-link repair [GO:1901255]; nucleotide-excision repair, DNA incision, 3'-to lesion [GO:0006295]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; regulation of autophagy [GO:0010506]; resolution of meiotic recombination intermediates [GO:0000712]; response to UV [GO:0009411]; telomere maintenance [GO:0000723]; telomeric DNA-containing double minutes formation [GO:0061819]; UV protection [GO:0009650]","GO:0000014; GO:0000109; GO:0000110; GO:0000712; GO:0000723; GO:0000724; GO:0000781; GO:0001094; GO:0003677; GO:0003684; GO:0003697; GO:0004520; GO:0005634; GO:0006281; GO:0006289; GO:0006295; GO:0006296; GO:0006303; GO:0008022; GO:0009411; GO:0009650; GO:0010506; GO:0032205; GO:0034644; GO:0042802; GO:0047485; GO:0061819; GO:0070522; GO:1901255; GO:1904357; GO:1905765; GO:1905768; GO:1990599; GO:1990841"
"14256","Cluster_589","Peve_00017997",-0.998300622150393,0.0371194573895678,0.909359886114279,157,-20.26,"2 20","15894 15914",18,"77.78%","77.78%","CDS","E9PSK7","C-Jun-amino-terminal kinase-interacting protein 3 (JIP-3) (JNK-interacting protein 3) (JNK MAP kinase scaffold protein 3)","Rattus norvegicus (Rat)","anterograde axonal protein transport [GO:0099641]; axon development [GO:0061564]; axon guidance [GO:0007411]; axon regeneration [GO:0031103]; forebrain development [GO:0030900]; in utero embryonic development [GO:0001701]; JNK cascade [GO:0007254]; lung alveolus development [GO:0048286]; lung morphogenesis [GO:0060425]; negative regulation of apoptotic process [GO:0043066]; neuron projection development [GO:0031175]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of neuron migration [GO:2001224]; post-embryonic development [GO:0009791]; protein localization [GO:0008104]; protein stabilization [GO:0050821]; regulation of gene expression [GO:0010468]; regulation of JNK cascade [GO:0046328]; respiratory gaseous exchange by respiratory system [GO:0007585]; vesicle-mediated transport [GO:0016192]","GO:0000139; GO:0001701; GO:0005078; GO:0005737; GO:0005790; GO:0005886; GO:0007254; GO:0007411; GO:0007585; GO:0008104; GO:0008432; GO:0009791; GO:0010468; GO:0016192; GO:0019894; GO:0030159; GO:0030424; GO:0030425; GO:0030426; GO:0030673; GO:0030900; GO:0031103; GO:0031175; GO:0031410; GO:0031434; GO:0031435; GO:0043005; GO:0043066; GO:0043507; GO:0044297; GO:0045666; GO:0046328; GO:0046330; GO:0048286; GO:0048471; GO:0050821; GO:0060425; GO:0061564; GO:0099641; GO:1904115; GO:2001224"
"14283","Cluster_589","Peve_00018700",-0.999441541479478,0.0212770196606704,0.82289133055867,153,-20.17,"2 20","8535 8558",20,"65.00%","85.00%","CDS",NA,NA,NA,NA,NA
"14292","Cluster_589","Peve_00018779",-0.999955310845228,0.00601863225853882,0.573710369894872,163,-22.58,"2 20","6396 6417",18,"72.22%","83.33%","CDS",NA,NA,NA,NA,NA
"14306","Cluster_589","Peve_00018907",-0.999777949171651,0.0134161948226009,0.709934960002653,151,-20.7,"2 21","27135 27159",22,"59.09%","77.27%","CDS","Q7Z460","CLIP-associating protein 1 (Cytoplasmic linker-associated protein 1) (Multiple asters homolog 1) (Protein Orbit homolog 1) (hOrbit1)","Homo sapiens (Human)","astral microtubule organization [GO:0030953]; cell division [GO:0051301]; establishment of epithelial cell polarity [GO:0090162]; establishment of mitotic spindle localization [GO:0040001]; establishment of spindle orientation [GO:0051294]; establishment or maintenance of cell polarity [GO:0007163]; exit from mitosis [GO:0010458]; Golgi organization [GO:0007030]; microtubule anchoring [GO:0034453]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; microtubule nucleation [GO:0007020]; microtubule organizing center organization [GO:0031023]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of microtubule polymerization or depolymerization [GO:0031111]; negative regulation of stress fiber assembly [GO:0051497]; negative regulation of wound healing, spreading of epidermal cells [GO:1903690]; positive regulation of basement membrane assembly involved in embryonic body morphogenesis [GO:1904261]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of exocytosis [GO:0045921]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of microtubule polymerization [GO:0031116]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of focal adhesion assembly [GO:0051893]; regulation of gastrulation [GO:0010470]; regulation of microtubule cytoskeleton organization [GO:0070507]; vesicle targeting [GO:0006903]","GO:0000226; GO:0000776; GO:0001578; GO:0002162; GO:0005794; GO:0005813; GO:0005815; GO:0005828; GO:0005829; GO:0005876; GO:0005881; GO:0005938; GO:0006903; GO:0007020; GO:0007026; GO:0007030; GO:0007052; GO:0007163; GO:0008017; GO:0010458; GO:0010470; GO:0010634; GO:0010717; GO:0016020; GO:0030953; GO:0030981; GO:0031023; GO:0031111; GO:0031116; GO:0031592; GO:0034453; GO:0035371; GO:0040001; GO:0043515; GO:0045180; GO:0045921; GO:0051010; GO:0051294; GO:0051301; GO:0051497; GO:0051893; GO:0070507; GO:0072686; GO:0090091; GO:0090162; GO:0090307; GO:1903690; GO:1904261"
"14307","Cluster_589","Peve_00018950",-0.999807400018563,0.0124948259803537,0.688437055323061,151,-20.43,"2 21","12349 12371",20,"70.00%","70.00%","CDS","Q8BW94","Dynein axonemal heavy chain 3 (Axonemal beta dynein heavy chain 3) (Ciliary dynein heavy chain 3)","Mus musculus (Mouse)","cilium movement [GO:0003341]; microtubule-based movement [GO:0007018]","GO:0003341; GO:0005524; GO:0005874; GO:0007018; GO:0008569; GO:0030286; GO:0036156; GO:0045505; GO:0051959; GO:0097729"
"14349","Cluster_589","Peve_00019866",-0.998329663228134,0.0368008298358006,0.909359886114279,159,-21.1,"2 19","4476 4497",18,"77.78%","88.89%","CDS","Q4V7T8","Ropporin-1-like protein","Xenopus laevis (African clawed frog)","","GO:0031514"
"14364","Cluster_589","Peve_00020262",-0.99785634131814,0.0416917909524945,0.909359886114279,155,-23.79,"2 12","14061 14082",10,"100.00%","100.00%","CDS",NA,NA,NA,NA,NA
"14376","Cluster_589","Peve_00020426",-0.999957293079344,0.00588363598503261,0.570680688799154,155,-23.55,"2 12","14533 14554",10,"100.00%","100.00%","CDS","Q7RTX7","Cation channel sperm-associated protein 4 (CatSper4)","Homo sapiens (Human)","establishment of localization in cell [GO:0051649]; flagellated sperm motility [GO:0030317]; regulation of ion transmembrane transport [GO:0034765]; sodium ion transport [GO:0006814]; sperm capacitation [GO:0048240]","GO:0001669; GO:0005227; GO:0005245; GO:0005886; GO:0006814; GO:0030317; GO:0034765; GO:0036128; GO:0048240; GO:0051649; GO:0097228"
"14411","Cluster_589","Peve_00020859",-0.996961236510919,0.0496424958855588,0.9519960538532,150,-20.5,"2 15","8237 8258",13,"76.92%","84.62%","CDS","Q8CBC7",NA,NA,NA,NA
"14412","Cluster_589","Peve_00020859",-0.996961236510919,0.0496424958855588,0.9519960538532,155,-22.1,"2 20","20579 20600",18,"66.67%","77.78%","CDS","Q8CBC7",NA,NA,NA,NA
"14423","Cluster_589","Peve_00021321",-0.999608964288524,0.0178039958559197,0.782669382293497,152,-20.67,"2 13","2184 2205",11,"90.91%","90.91%","CDS","Q9ES87","Prostasin (EC 3.4.21.-) (Channel-activating protease 1) (CAP1) (Serine protease 8) [Cleaved into: Prostasin light chain; Prostasin heavy chain]","Rattus norvegicus (Rat)","hair follicle development [GO:0001942]; positive regulation of sodium ion transmembrane transport [GO:1902307]; positive regulation of sodium ion transport [GO:0010765]; proteolysis [GO:0006508]; response to mineralocorticoid [GO:0051385]; response to peptide hormone [GO:0043434]; response to xenobiotic stimulus [GO:0009410]; transepithelial transport [GO:0070633]","GO:0001942; GO:0004252; GO:0005615; GO:0005886; GO:0006508; GO:0009410; GO:0010765; GO:0017080; GO:0019897; GO:0043434; GO:0045121; GO:0051385; GO:0070633; GO:1902307"
"14493","Cluster_589","Peve_00023009",-0.999888189689019,0.00952006897884497,0.606638706706886,158,-21.52,"2 21","23274 23294",19,"68.42%","84.21%","CDS","Q9BXW9","Fanconi anemia group D2 protein (Protein FACD2)","Homo sapiens (Human)","brain morphogenesis [GO:0048854]; cellular response to oxidative stress [GO:0034599]; double-strand break repair involved in meiotic recombination [GO:1990918]; gamete generation [GO:0007276]; homologous chromosome pairing at meiosis [GO:0007129]; interstrand cross-link repair [GO:0036297]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; neuronal stem cell population maintenance [GO:0097150]; regulation of CD40 signaling pathway [GO:2000348]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of inflammatory response [GO:0050727]; regulation of regulatory T cell differentiation [GO:0045589]; response to gamma radiation [GO:0010332]","GO:0000785; GO:0000793; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0007129; GO:0007276; GO:0010332; GO:0016604; GO:0031573; GO:0034599; GO:0036297; GO:0045589; GO:0048854; GO:0050727; GO:0051090; GO:0070182; GO:0097150; GO:1990391; GO:1990918; GO:2000348"
"14502","Cluster_589","Peve_00023210",-0.999777306658689,0.0134355916697332,0.710394865680069,155,-23.55,"2 12","2260 2281",10,"100.00%","100.00%","CDS","Q9LP51","CBL-interacting serine/threonine-protein kinase 18 (EC 2.7.11.1) (SNF1-related kinase 3.20) (SOS2-like protein kinase PKS22)","Arabidopsis thaliana (Mouse-ear cress)","protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]","GO:0004674; GO:0005524; GO:0006468; GO:0007165; GO:0106310"
"14527","Cluster_589","Peve_00023658",-0.999935069797174,0.00725472326117394,0.573710369894872,157,-26.02,"2 20","11813 11836",20,"75.00%","80.00%","CDS","P34528","Putative serine protease K12H4.7 (EC 3.4.-.-)","Caenorhabditis elegans","innate immune response [GO:0045087]; proteolysis [GO:0006508]","GO:0006508; GO:0008236; GO:0008239; GO:0045087"
"14548","Cluster_589","Peve_00023919",-0.99985376195666,0.0108875609000238,0.647758385899893,161,-20.86,"2 18","6956 6977",16,"68.75%","93.75%","CDS",NA,NA,NA,NA,NA
"14554","Cluster_589","Peve_00024001",-0.999351520326823,0.022928031864249,0.843538272975541,147,-20.51,"2 21","94663 94688",23,"56.52%","73.91%","CDS","Q9UPN3","Microtubule-actin cross-linking factor 1, isoforms 1/2/3/4/5 (620 kDa actin-binding protein) (ABP620) (Actin cross-linking family protein 7) (Macrophin-1) (Trabeculin-alpha)","Homo sapiens (Human)","Golgi to plasma membrane protein transport [GO:0043001]; intermediate filament cytoskeleton organization [GO:0045104]; positive regulation of axon extension [GO:0045773]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of cell migration [GO:0030334]; regulation of epithelial cell migration [GO:0010632]; regulation of focal adhesion assembly [GO:0051893]; regulation of microtubule-based process [GO:0032886]; regulation of neuron projection arborization [GO:0150011]; Wnt signaling pathway [GO:0016055]; wound healing [GO:0042060]","GO:0003723; GO:0003779; GO:0005198; GO:0005509; GO:0005737; GO:0005794; GO:0005856; GO:0005874; GO:0005886; GO:0010632; GO:0015629; GO:0016020; GO:0016055; GO:0030177; GO:0030334; GO:0032587; GO:0032886; GO:0042060; GO:0043001; GO:0045104; GO:0045296; GO:0045773; GO:0051011; GO:0051015; GO:0051893; GO:0150011"
"14557","Cluster_589","Peve_00024022",-0.999959954319607,0.00569736979190693,0.561651935893748,165,-26.24,"2 21","1967 1989",21,"80.95%","80.95%","CDS","Q920F3","KH domain-containing, RNA-binding, signal transduction-associated protein 2 (Sam68-like mammalian protein 1) (SLM-1) (rSLM-1)","Rattus norvegicus (Rat)","mRNA processing [GO:0006397]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of mRNA splicing, via spliceosome [GO:0048024]","GO:0000381; GO:0003729; GO:0005634; GO:0006397; GO:0008143; GO:0008266; GO:0017124; GO:0042169; GO:0048024"
"14562","Cluster_589","Peve_00024151",-0.998853181277421,0.0304918673324897,0.903929377050813,158,-23.94,"2 21","16494 16514",19,"73.68%","78.95%","CDS","P27393","Collagen alpha-2(IV) chain","Ascaris suum (Pig roundworm) (Ascaris lumbricoides)","anatomical structure development [GO:0048856]","GO:0005201; GO:0005576; GO:0005581; GO:0005604; GO:0048856"
"14567","Cluster_589","Peve_00024196",-0.999884477330218,0.00967682551674024,0.611343259425713,159,-23.62,"2 21","11578 11600",20,"65.00%","85.00%","CDS","Q3TIV5","Zinc finger CCCH domain-containing protein 15 (DRG family-regulatory protein 1) (Epo-immediate response gene protein FM22)","Mus musculus (Mouse)","cytokine-mediated signaling pathway [GO:0019221]; cytoplasmic translation [GO:0002181]; positive regulation of GTPase activity [GO:0043547]","GO:0002181; GO:0005634; GO:0005829; GO:0019221; GO:0043547; GO:0046872"
"14612","Cluster_589","Peve_00024584",-0.99705953567446,0.0488325669958464,0.948900092293838,168,-25.12,"2 21","9581 9602",19,"63.16%","94.74%","CDS","A1L252","Ran-binding protein 9 (RanBP9)","Danio rerio (Zebrafish) (Brachydanio rerio)","cell surface receptor signaling pathway [GO:0007166]; cytoskeleton organization [GO:0007010]; retina development in camera-type eye [GO:0060041]","GO:0005634; GO:0005737; GO:0005886; GO:0007010; GO:0007166; GO:0060041"
"14671","Cluster_589","Peve_00026073",-0.997524165059795,0.0448069733359102,0.929433050844325,164,-26.78,"2 21","6585 6606",19,"73.68%","78.95%","CDS","O60879","Protein diaphanous homolog 2 (Diaphanous-related formin-2) (DRF2)","Homo sapiens (Human)","actin filament polymerization [GO:0030041]; female gamete generation [GO:0007292]; oogenesis [GO:0048477]","GO:0003779; GO:0005102; GO:0005730; GO:0005769; GO:0005783; GO:0005829; GO:0005884; GO:0007292; GO:0030041; GO:0031267; GO:0043231; GO:0048477"
"14723","Cluster_589","Peve_00026823",-0.999206634909042,0.0253606500537378,0.872109822299967,162,-25.21,"2 20","77454 77476",19,"68.42%","89.47%","CDS","Q9WUU9","Germinal-center associated nuclear protein (GANP) (EC 2.3.1.48) (GC-associated DNA primase)","Mus musculus (Mouse)","mRNA export from nucleus [GO:0006406]; nucleosome organization [GO:0034728]; poly(A)+ mRNA export from nucleus [GO:0016973]; protein transport [GO:0015031]; somatic hypermutation of immunoglobulin genes [GO:0016446]","GO:0003676; GO:0003682; GO:0004402; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005829; GO:0006406; GO:0010484; GO:0015031; GO:0016446; GO:0016973; GO:0031965; GO:0034728; GO:0042393; GO:0044615; GO:0070390"
"14731","Cluster_589","Peve_00026919",-0.99967165119342,0.0163145359755303,0.769678756304143,163,-25.41,"2 16","5880 5901",14,"78.57%","100.00%","CDS","Q8N5G2","Macoilin (Macoilin-1) (Transmembrane protein 57)","Homo sapiens (Human)","brain development [GO:0007420]; chemotaxis [GO:0006935]; neuronal signal transduction [GO:0023041]","GO:0005634; GO:0006935; GO:0007420; GO:0008017; GO:0023041; GO:0030424; GO:0030867; GO:0031965; GO:0044306; GO:0045202"
"14748","Cluster_589","Peve_00027092",-0.999032384036177,0.0280079716781816,0.900535408784329,159,-21.19,"2 21","1073 1095",20,"70.00%","80.00%","CDS","Q15836","Vesicle-associated membrane protein 3 (VAMP-3) (Cellubrevin) (CEB) (Synaptobrevin-3)","Homo sapiens (Human)","calcium-ion regulated exocytosis [GO:0017156]; cellular response to type II interferon [GO:0071346]; exocytosis [GO:0006887]; Golgi to plasma membrane protein transport [GO:0043001]; membrane fusion [GO:0061025]; negative regulation of secretion by cell [GO:1903531]; positive regulation of receptor recycling [GO:0001921]; protein-containing complex assembly [GO:0065003]; retrograde transport, endosome to Golgi [GO:0042147]; SNARE complex assembly [GO:0035493]; substrate adhesion-dependent cell spreading [GO:0034446]; vesicle docking involved in exocytosis [GO:0006904]; vesicle fusion [GO:0006906]; vesicle-mediated transport [GO:0016192]","GO:0001921; GO:0005484; GO:0005829; GO:0005886; GO:0006887; GO:0006904; GO:0006906; GO:0009986; GO:0016020; GO:0016192; GO:0017075; GO:0017156; GO:0019905; GO:0030133; GO:0030136; GO:0030141; GO:0030669; GO:0030670; GO:0031201; GO:0031901; GO:0032588; GO:0034446; GO:0035493; GO:0042147; GO:0043001; GO:0043005; GO:0043231; GO:0045202; GO:0048471; GO:0055037; GO:0055038; GO:0061025; GO:0065003; GO:0071346; GO:1903531"
"14761","Cluster_589","Peve_00027364",-0.999589838554501,0.0182342281155101,0.782669382293497,171,-30.88,"2 21","6009 6032",21,"76.19%","85.71%","CDS","Q32N90","MBT domain-containing protein 1","Xenopus laevis (African clawed frog)","chromatin organization [GO:0006325]; double-strand break repair via homologous recombination [GO:0000724]; regulation of DNA-templated transcription [GO:0006355]","GO:0000724; GO:0005634; GO:0006325; GO:0006355; GO:0008270; GO:0035064; GO:0035267"
"14783","Cluster_589","Peve_00027784",-0.999886982142555,0.00957134004917052,0.608817017563522,162,-24.35,"2 20","74 96",19,"73.68%","84.21%","CDS",NA,NA,NA,NA,NA
"14791","Cluster_589","Peve_00027984",-0.999076479898258,0.0273622449372687,0.894374732389502,163,-23.13,"2 21","1144 1166",20,"70.00%","85.00%","CDS","A7SLW1","Branched-chain-amino-acid aminotransferase (EC 2.6.1.42)","Nematostella vectensis (Starlet sea anemone)","leucine biosynthetic process [GO:0009098]; valine biosynthetic process [GO:0009099]","GO:0004084; GO:0005739; GO:0009098; GO:0009099; GO:0050048; GO:0052654; GO:0052655; GO:0052656"
"14805","Cluster_589","Peve_00028312",-0.999574579742918,0.0185703291440558,0.782669382293497,151,-20.31,"2 21","39394 39416",20,"70.00%","70.00%","CDS","A2VEC9","SCO-spondin (SCO-spondin pseudogene)","Homo sapiens (Human)","cell adhesion [GO:0007155]; positive regulation of immune system process [GO:0002684]; positive regulation of response to stimulus [GO:0048584]","GO:0002684; GO:0005615; GO:0007155; GO:0030414; GO:0031012; GO:0048584"
"14806","Cluster_589","Peve_00028312",-0.999574579742918,0.0185703291440558,0.782669382293497,155,-23.93,"2 12","8879 8900",10,"100.00%","100.00%","CDS","A2VEC9","SCO-spondin (SCO-spondin pseudogene)","Homo sapiens (Human)","cell adhesion [GO:0007155]; positive regulation of immune system process [GO:0002684]; positive regulation of response to stimulus [GO:0048584]","GO:0002684; GO:0005615; GO:0007155; GO:0030414; GO:0031012; GO:0048584"
"14813","Cluster_589","Peve_00028439",0.998146330451858,0.0387684455398104,0.909359886114279,154,-21.46,"2 20","21365 21387",19,"68.42%","78.95%","CDS","Q8TD57","Dynein axonemal heavy chain 3 (Axonemal beta dynein heavy chain 3) (HsADHC3) (Ciliary dynein heavy chain 3) (Dnahc3-b)","Homo sapiens (Human)","cilium-dependent cell motility [GO:0060285]; microtubule-based movement [GO:0007018]","GO:0003777; GO:0005524; GO:0005858; GO:0005874; GO:0007018; GO:0008569; GO:0030286; GO:0045505; GO:0051959; GO:0060285; GO:0097729"
"14814","Cluster_589","Peve_00028439",0.998146330451858,0.0387684455398104,0.909359886114279,156,-20.64,"2 21","27112 27133",19,"63.16%","78.95%","CDS","Q8TD57","Dynein axonemal heavy chain 3 (Axonemal beta dynein heavy chain 3) (HsADHC3) (Ciliary dynein heavy chain 3) (Dnahc3-b)","Homo sapiens (Human)","cilium-dependent cell motility [GO:0060285]; microtubule-based movement [GO:0007018]","GO:0003777; GO:0005524; GO:0005858; GO:0005874; GO:0007018; GO:0008569; GO:0030286; GO:0045505; GO:0051959; GO:0060285; GO:0097729"
"14815","Cluster_589","Peve_00028439",0.998146330451858,0.0387684455398104,0.909359886114279,157,-22.93,"2 14","10575 10596",12,"83.33%","100.00%","CDS","Q8TD57","Dynein axonemal heavy chain 3 (Axonemal beta dynein heavy chain 3) (HsADHC3) (Ciliary dynein heavy chain 3) (Dnahc3-b)","Homo sapiens (Human)","cilium-dependent cell motility [GO:0060285]; microtubule-based movement [GO:0007018]","GO:0003777; GO:0005524; GO:0005858; GO:0005874; GO:0007018; GO:0008569; GO:0030286; GO:0045505; GO:0051959; GO:0060285; GO:0097729"
"14870","Cluster_589","Peve_00029564",-0.997056019656118,0.0488617680288714,0.948986088425024,154,-27.02,"2 21","3810 3835",23,"60.87%","82.61%","CDS",NA,NA,NA,NA,NA
"14924","Cluster_589","Peve_00028686",-0.998297465612058,0.0371539252592634,0.909359886114279,168,-26.71,"2 21","9877 9898",19,"78.95%","78.95%","CDS","Q9YGY0","Axin-1 (Axis inhibition protein 1) (xAxin)","Xenopus laevis (African clawed frog)","negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification [GO:2000054]; positive regulation of JNK cascade [GO:0046330]; Wnt signaling pathway [GO:0016055]","GO:0005634; GO:0005737; GO:0005886; GO:0016055; GO:0042803; GO:0046330; GO:0090090; GO:2000054"
"14927","Cluster_589","Peve_00030794",-0.997644305172583,0.0437058858615953,0.921295277281368,145,-24.08,"2 20","1096 1124",25,"64.00%","68.00%","CDS","P16157","Ankyrin-1 (ANK-1) (Ankyrin-R) (Erythrocyte ankyrin)","Homo sapiens (Human)","cytoskeleton organization [GO:0007010]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165]","GO:0005198; GO:0005200; GO:0005829; GO:0005856; GO:0005886; GO:0006887; GO:0006888; GO:0007010; GO:0007165; GO:0008093; GO:0009898; GO:0014731; GO:0016323; GO:0016529; GO:0019899; GO:0019903; GO:0030507; GO:0031430; GO:0043005; GO:0044325; GO:0045199; GO:0051117; GO:0072659"
"14928","Cluster_589","Peve_00031069",-0.999998494006473,0.00110485866962805,0.277435798056123,168,-26.73,"2 21","609 628",19,"84.21%","89.47%","CDS","Q9JM13","Rab5 GDP/GTP exchange factor (Rabex-5)","Mus musculus (Mouse)","dendritic transport [GO:0098935]; establishment of localization in cell [GO:0051649]; Kit signaling pathway [GO:0038109]; mast cell degranulation [GO:0043303]; mast cell migration [GO:0097531]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of Kit signaling pathway [GO:1900235]; negative regulation of leukocyte migration [GO:0002686]; negative regulation of mast cell activation [GO:0033004]; negative regulation of mast cell cytokine production [GO:0032764]; negative regulation of mast cell degranulation [GO:0043305]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of receptor-mediated endocytosis [GO:0048261]; protein phosphorylation [GO:0006468]; protein targeting to membrane [GO:0006612]; Ras protein signal transduction [GO:0007265]; receptor-mediated endocytosis [GO:0006898]; regulation of Fc receptor mediated stimulatory signaling pathway [GO:0060368]","GO:0001933; GO:0002686; GO:0003677; GO:0005085; GO:0005730; GO:0005769; GO:0005829; GO:0006468; GO:0006612; GO:0006898; GO:0007265; GO:0008270; GO:0030139; GO:0030425; GO:0031267; GO:0031982; GO:0032715; GO:0032764; GO:0033004; GO:0038109; GO:0043303; GO:0043305; GO:0046580; GO:0048261; GO:0050728; GO:0051649; GO:0055037; GO:0060368; GO:0061630; GO:0097531; GO:0098935; GO:1900235"
"14941","Cluster_589","Peve_00031348",-0.999396101484241,0.0221257988667709,0.832893428623956,156,-20.64,"2 21","3005 3026",19,"68.42%","73.68%","CDS",NA,NA,NA,NA,NA
"14946","Cluster_589","Peve_00031401",0.998108703054888,0.0391600694548189,0.909359886114279,151,-20.12,"2 21","34671 34695",22,"63.64%","72.73%","CDS","A0A0R4IC37","Cleavage and polyadenylation specificity factor subunit 1 (Cleavage and polyadenylation specific factor 1)","Danio rerio (Zebrafish) (Brachydanio rerio)","definitive hemopoiesis [GO:0060216]; mRNA polyadenylation [GO:0006378]; retinal ganglion cell axon guidance [GO:0031290]","GO:0003676; GO:0005634; GO:0005654; GO:0005847; GO:0006378; GO:0031290; GO:0060216"
"14947","Cluster_589","Peve_00031401",0.998108703054888,0.0391600694548189,0.909359886114279,153,-20.89,"2 18","7883 7904",16,"68.75%","81.25%","CDS","A0A0R4IC37","Cleavage and polyadenylation specificity factor subunit 1 (Cleavage and polyadenylation specific factor 1)","Danio rerio (Zebrafish) (Brachydanio rerio)","definitive hemopoiesis [GO:0060216]; mRNA polyadenylation [GO:0006378]; retinal ganglion cell axon guidance [GO:0031290]","GO:0003676; GO:0005634; GO:0005654; GO:0005847; GO:0006378; GO:0031290; GO:0060216"
"14954","Cluster_589","Peve_00031585",-0.9976593899819,0.0435656698968128,0.920311455812568,162,-24.3,"2 21","6610 6630",19,"73.68%","84.21%","CDS","Q9XSK8","Tumor protein p73 (p53-like transcription factor) (p53-related protein)","Chlorocebus aethiops (Green monkey) (Cercopithecus aethiops)","apoptotic process [GO:0006915]; cell cycle [GO:0007049]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein tetramerization [GO:0051262]","GO:0000976; GO:0000981; GO:0005634; GO:0005737; GO:0006915; GO:0007049; GO:0045944; GO:0046872; GO:0051262"
"15001","Cluster_589","Peve_00032544",-0.999481814417645,0.020495406622061,0.811311640546993,156,-21.82,"2 20","1314 1335",19,"78.95%","78.95%","CDS","Q17R14","Unconventional myosin-Id","Bos taurus (Bovine)","cellular localization [GO:0051641]; early endosome to recycling endosome transport [GO:0061502]; protein transport [GO:0015031]","GO:0000146; GO:0005516; GO:0005524; GO:0005768; GO:0005769; GO:0005790; GO:0005829; GO:0005903; GO:0005938; GO:0015031; GO:0016323; GO:0016459; GO:0030424; GO:0030673; GO:0031410; GO:0043005; GO:0043025; GO:0043204; GO:0043209; GO:0048306; GO:0051015; GO:0051641; GO:0061502; GO:0097440"
"15056","Cluster_589","Peve_00033832",-0.996995037508954,0.0493654910801766,0.950602150282626,165,-24.72,"2 18","2570 2591",16,"81.25%","87.50%","CDS","Q91WC3","Long-chain-fatty-acid--CoA ligase 6 (EC 6.2.1.3) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain acyl-CoA synthetase 6) (LACS 6)","Mus musculus (Mouse)","fatty acid transport [GO:0015908]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; neuroblast proliferation [GO:0007405]; phospholipid biosynthetic process [GO:0008654]; positive regulation of long-chain fatty acid import across plasma membrane [GO:0010747]; positive regulation of neuron projection development [GO:0010976]; triglyceride biosynthetic process [GO:0019432]; very long-chain fatty acid metabolic process [GO:0000038]","GO:0000038; GO:0001676; GO:0004467; GO:0005524; GO:0005634; GO:0005739; GO:0005741; GO:0005778; GO:0005783; GO:0005789; GO:0007405; GO:0008654; GO:0010747; GO:0010976; GO:0015908; GO:0016020; GO:0019432; GO:0019899; GO:0035338; GO:0042803; GO:0047676"
"15124","Cluster_589","Peve_00035302",-0.997050387361796,0.0489085087732169,0.949245450063721,158,-23.15,"2 21","11641 11664",21,"66.67%","85.71%","CDS","A7SFP1","Leucine-rich repeat protein soc-2 homolog","Nematostella vectensis (Starlet sea anemone)","positive regulation of Ras protein signal transduction [GO:0046579]; signal transduction [GO:0007165]","GO:0007165; GO:0046579"
"15127","Cluster_589","Peve_00035430",-0.998833073220515,0.0307580759903037,0.903929377050813,151,-22.31,"2 21","4260 4282",20,"65.00%","75.00%","CDS","Q9NRM2","Zinc finger protein 277 (Nuclear receptor-interacting factor 4)","Homo sapiens (Human)","cellular response to hydrogen peroxide [GO:0070301]; regulation of cellular senescence [GO:2000772]","GO:0000978; GO:0005634; GO:0046872; GO:0070301; GO:2000772"
"15153","Cluster_589","Peve_00035839",-0.999999999503679,2.00574810710951e-05,0.0131777650637095,151,-20.38,"2 16","8701 8722",14,"71.43%","85.71%","CDS","P59750","Merlin (Moesin-ezrin-radixin-like protein) (Neurofibromin-2) (Schwannomin)","Papio anubis (Olive baboon)","actin cytoskeleton organization [GO:0030036]; cell-cell junction organization [GO:0045216]; ectoderm development [GO:0007398]; hippocampus development [GO:0021766]; lens fiber cell differentiation [GO:0070306]; MAPK cascade [GO:0000165]; mesoderm formation [GO:0001707]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of osteoblast proliferation [GO:0033689]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of Schwann cell proliferation [GO:0010626]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; odontogenesis of dentin-containing tooth [GO:0042475]; osteoblast proliferation [GO:0033687]; positive regulation of cell differentiation [GO:0045597]; positive regulation of stress fiber assembly [GO:0051496]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of hippo signaling [GO:0035330]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of protein localization to nucleus [GO:1900180]; regulation of protein stability [GO:0031647]; regulation of stem cell proliferation [GO:0072091]; Schwann cell proliferation [GO:0014010]","GO:0000165; GO:0001707; GO:0001726; GO:0003779; GO:0005730; GO:0005769; GO:0005829; GO:0005912; GO:0006469; GO:0007398; GO:0010626; GO:0014010; GO:0021766; GO:0022408; GO:0030027; GO:0030036; GO:0030175; GO:0030864; GO:0031647; GO:0032154; GO:0033687; GO:0033689; GO:0035330; GO:0042475; GO:0042532; GO:0042981; GO:0043005; GO:0043409; GO:0044297; GO:0045177; GO:0045216; GO:0045597; GO:0048471; GO:0051496; GO:0051726; GO:0070306; GO:0072091; GO:1900180; GO:2000177"
"15159","Cluster_589","Peve_00035882",-0.997065128093373,0.0487860852220372,0.948498055920838,164,-24.35,"2 18","3168 3190",17,"82.35%","88.24%","CDS","O43747","AP-1 complex subunit gamma-1 (Adaptor protein complex AP-1 subunit gamma-1) (Adaptor-related protein complex 1 subunit gamma-1) (Clathrin assembly protein complex 1 gamma-1 large chain) (Gamma1-adaptin) (Golgi adaptor HA1/AP1 adaptin subunit gamma-1)","Homo sapiens (Human)","basolateral protein secretion [GO:0110010]; endosome to melanosome transport [GO:0035646]; Golgi to lysosome transport [GO:0090160]; Golgi to vacuole transport [GO:0006896]; intracellular protein transport [GO:0006886]; melanosome assembly [GO:1903232]; melanosome organization [GO:0032438]; platelet dense granule organization [GO:0060155]; positive regulation of natural killer cell degranulation [GO:0043323]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; vesicle-mediated transport [GO:0016192]","GO:0000139; GO:0005737; GO:0005765; GO:0005769; GO:0005794; GO:0005829; GO:0005905; GO:0006886; GO:0006896; GO:0016020; GO:0016192; GO:0019894; GO:0030121; GO:0030136; GO:0030659; GO:0030665; GO:0030742; GO:0031267; GO:0032438; GO:0032588; GO:0035615; GO:0035646; GO:0043231; GO:0043323; GO:0045954; GO:0048471; GO:0055037; GO:0060155; GO:0090160; GO:0110010; GO:0140312; GO:1903232"
"15189","Cluster_589","Peve_00036365",-0.998965392859537,0.0289614503733394,0.903929377050813,149,-21.03,"2 14","1128 1149",12,"83.33%","83.33%","CDS","Q8K337","Type II inositol 1,4,5-trisphosphate 5-phosphatase (EC 3.1.3.36) (Inositol polyphosphate-5-phosphatase B) (Phosphoinositide 5-phosphatase) (5PTase)","Mus musculus (Mouse)","flagellated sperm motility [GO:0030317]; in utero embryonic development [GO:0001701]; inositol phosphate dephosphorylation [GO:0046855]; phosphatidylinositol dephosphorylation [GO:0046856]; regulation of protein processing [GO:0070613]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283]","GO:0001701; GO:0004439; GO:0004445; GO:0005793; GO:0005829; GO:0007165; GO:0007283; GO:0016020; GO:0030317; GO:0030670; GO:0031901; GO:0046855; GO:0046856; GO:0046872; GO:0052658; GO:0070613"
"15190","Cluster_589","Peve_00036365",-0.998965392859537,0.0289614503733394,0.903929377050813,160,-24.58,"2 19","3653 3673",17,"76.47%","88.24%","CDS","Q8K337","Type II inositol 1,4,5-trisphosphate 5-phosphatase (EC 3.1.3.36) (Inositol polyphosphate-5-phosphatase B) (Phosphoinositide 5-phosphatase) (5PTase)","Mus musculus (Mouse)","flagellated sperm motility [GO:0030317]; in utero embryonic development [GO:0001701]; inositol phosphate dephosphorylation [GO:0046855]; phosphatidylinositol dephosphorylation [GO:0046856]; regulation of protein processing [GO:0070613]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283]","GO:0001701; GO:0004439; GO:0004445; GO:0005793; GO:0005829; GO:0007165; GO:0007283; GO:0016020; GO:0030317; GO:0030670; GO:0031901; GO:0046855; GO:0046856; GO:0046872; GO:0052658; GO:0070613"
"15199","Cluster_589","Peve_00036728",-0.99983803306911,0.0114581409192838,0.660322078232589,153,-21.02,"2 16","35177 35201",17,"82.35%","82.35%","CDS","Q5XPI4","E3 ubiquitin-protein ligase RNF123 (EC 2.3.2.27) (Kip1 ubiquitination-promoting complex protein 1) (RING finger protein 123) (RING-type E3 ubiquitin transferase RNF123)","Homo sapiens (Human)","proteolysis involved in protein catabolic process [GO:0051603]","GO:0004842; GO:0005737; GO:0005829; GO:0031965; GO:0046872; GO:0051603"
"15220","Cluster_589","Peve_00036931",-0.997510697025279,0.0449287288934107,0.929989129351794,155,-23.93,"2 12","1600 1621",10,"100.00%","100.00%","CDS",NA,NA,NA,NA,NA
"15226","Cluster_589","Peve_00037142",-0.997740919047806,0.0427999055313171,0.915308660158613,153,-20.68,"2 17","485 506",16,"81.25%","87.50%","CDS",NA,NA,NA,NA,NA
"15227","Cluster_589","Peve_00037142",-0.997740919047806,0.0427999055313171,0.915308660158613,154,-23.11,"2 21","5733 5760",25,"68.00%","72.00%","CDS",NA,NA,NA,NA,NA
"15228","Cluster_589","Peve_00037143",-0.999906073477919,0.00872554657337131,0.580392122221314,158,-23.26,"2 21","8354 8374",19,"73.68%","78.95%","CDS",NA,NA,NA,NA,NA
"15236","Cluster_589","Peve_00037071",-0.996979263784725,0.0494949519124735,0.951128005711722,155,-23.45,"2 21","3516 3538",20,"70.00%","75.00%","CDS","Q9DDA9","Protein kinase C and casein kinase substrate in neurons protein 2 (x-PACSIN2)","Xenopus laevis (African clawed frog)","actin cytoskeleton organization [GO:0030036]; caveola assembly [GO:0070836]; endocytosis [GO:0006897]; plasma membrane tubulation [GO:0097320]","GO:0005769; GO:0005856; GO:0005901; GO:0006897; GO:0030036; GO:0032587; GO:0055038; GO:0070300; GO:0070836; GO:0097320"
"15266","Cluster_589","Peve_00037538",-0.998807256137127,0.031096527330944,0.903929377050813,155,-21.61,"2 17","43952 43974",16,"81.25%","81.25%","CDS","O54991","Contactin-associated protein 1 (Caspr) (Caspr1) (MHDNIV) (NCP1) (Neurexin IV) (Neurexin-4) (Paranodin)","Mus musculus (Mouse)","axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; central nervous system myelination [GO:0022010]; cytoskeleton organization [GO:0007010]; mitochondrion organization [GO:0007005]; myelination [GO:0042552]; myelination in peripheral nervous system [GO:0022011]; neuromuscular junction development, skeletal muscle fiber [GO:0098529]; neuromuscular process [GO:0050905]; neuromuscular process controlling balance [GO:0050885]; neuromuscular process controlling posture [GO:0050884]; neuron projection development [GO:0031175]; neuron projection morphogenesis [GO:0048812]; neuronal action potential propagation [GO:0019227]; paranodal junction assembly [GO:0030913]; paranodal junction maintenance [GO:1990227]; postsynaptic density organization [GO:0097106]; protein localization to juxtaparanode region of axon [GO:0071205]; protein localization to paranode region of axon [GO:0002175]; regulation of synapse maturation [GO:0090128]","GO:0002175; GO:0005886; GO:0005918; GO:0007005; GO:0007010; GO:0007155; GO:0007409; GO:0016020; GO:0017124; GO:0019227; GO:0022010; GO:0022011; GO:0030424; GO:0030913; GO:0031175; GO:0033010; GO:0033270; GO:0042552; GO:0043209; GO:0048786; GO:0048812; GO:0050884; GO:0050885; GO:0050905; GO:0071205; GO:0090128; GO:0097106; GO:0098529; GO:0098978; GO:1990227"
"15267","Cluster_589","Peve_00037538",-0.998807256137127,0.031096527330944,0.903929377050813,155,-21.61,"2 17","44413 44435",16,"81.25%","81.25%","CDS","O54991","Contactin-associated protein 1 (Caspr) (Caspr1) (MHDNIV) (NCP1) (Neurexin IV) (Neurexin-4) (Paranodin)","Mus musculus (Mouse)","axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; central nervous system myelination [GO:0022010]; cytoskeleton organization [GO:0007010]; mitochondrion organization [GO:0007005]; myelination [GO:0042552]; myelination in peripheral nervous system [GO:0022011]; neuromuscular junction development, skeletal muscle fiber [GO:0098529]; neuromuscular process [GO:0050905]; neuromuscular process controlling balance [GO:0050885]; neuromuscular process controlling posture [GO:0050884]; neuron projection development [GO:0031175]; neuron projection morphogenesis [GO:0048812]; neuronal action potential propagation [GO:0019227]; paranodal junction assembly [GO:0030913]; paranodal junction maintenance [GO:1990227]; postsynaptic density organization [GO:0097106]; protein localization to juxtaparanode region of axon [GO:0071205]; protein localization to paranode region of axon [GO:0002175]; regulation of synapse maturation [GO:0090128]","GO:0002175; GO:0005886; GO:0005918; GO:0007005; GO:0007010; GO:0007155; GO:0007409; GO:0016020; GO:0017124; GO:0019227; GO:0022010; GO:0022011; GO:0030424; GO:0030913; GO:0031175; GO:0033010; GO:0033270; GO:0042552; GO:0043209; GO:0048786; GO:0048812; GO:0050884; GO:0050885; GO:0050905; GO:0071205; GO:0090128; GO:0097106; GO:0098529; GO:0098978; GO:1990227"
"15268","Cluster_589","Peve_00037538",-0.998807256137127,0.031096527330944,0.903929377050813,155,-21.7,"2 20","21437 21458",18,"61.11%","83.33%","CDS","O54991","Contactin-associated protein 1 (Caspr) (Caspr1) (MHDNIV) (NCP1) (Neurexin IV) (Neurexin-4) (Paranodin)","Mus musculus (Mouse)","axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; central nervous system myelination [GO:0022010]; cytoskeleton organization [GO:0007010]; mitochondrion organization [GO:0007005]; myelination [GO:0042552]; myelination in peripheral nervous system [GO:0022011]; neuromuscular junction development, skeletal muscle fiber [GO:0098529]; neuromuscular process [GO:0050905]; neuromuscular process controlling balance [GO:0050885]; neuromuscular process controlling posture [GO:0050884]; neuron projection development [GO:0031175]; neuron projection morphogenesis [GO:0048812]; neuronal action potential propagation [GO:0019227]; paranodal junction assembly [GO:0030913]; paranodal junction maintenance [GO:1990227]; postsynaptic density organization [GO:0097106]; protein localization to juxtaparanode region of axon [GO:0071205]; protein localization to paranode region of axon [GO:0002175]; regulation of synapse maturation [GO:0090128]","GO:0002175; GO:0005886; GO:0005918; GO:0007005; GO:0007010; GO:0007155; GO:0007409; GO:0016020; GO:0017124; GO:0019227; GO:0022010; GO:0022011; GO:0030424; GO:0030913; GO:0031175; GO:0033010; GO:0033270; GO:0042552; GO:0043209; GO:0048786; GO:0048812; GO:0050884; GO:0050885; GO:0050905; GO:0071205; GO:0090128; GO:0097106; GO:0098529; GO:0098978; GO:1990227"
"15300","Cluster_589","Peve_00036939",-0.998665116899834,0.0328976640349452,0.909359886114279,161,-24.26,"2 20","2826 2846",18,"77.78%","83.33%","CDS","P25867","Ubiquitin-conjugating enzyme E2-17 kDa (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme D1) (Protein effete) (Ubiquitin carrier protein) (Ubiquitin-protein ligase)","Drosophila melanogaster (Fruit fly)","anaphase-promoting complex-dependent catabolic process [GO:0031145]; chromosome organization [GO:0051276]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor cell differentiation [GO:0001751]; female germ-line stem cell asymmetric division [GO:0048132]; germ-line stem cell population maintenance [GO:0030718]; male meiotic nuclear division [GO:0007140]; mitotic cell cycle [GO:0000278]; negative regulation of smoothened signaling pathway [GO:0045879]; neuron remodeling [GO:0016322]; peptidoglycan recognition protein signaling pathway [GO:0061057]; protein linear polyubiquitination [GO:0097039]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of protein stability [GO:0031647]; regulation of R7 cell differentiation [GO:0045676]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0000209; GO:0000278; GO:0001745; GO:0001751; GO:0005524; GO:0005634; GO:0005829; GO:0006511; GO:0007140; GO:0016322; GO:0016567; GO:0030718; GO:0031145; GO:0031625; GO:0031647; GO:0045676; GO:0045879; GO:0048132; GO:0051276; GO:0061057; GO:0061631; GO:0097039"
"15308","Cluster_589","Peve_00038083",-0.99930576829184,0.02372315639259,0.852710447681109,153,-22.29,"2 14","3883 3904",12,"83.33%","91.67%","CDS","A0JPQ9","Chitinase domain-containing protein 1","Rattus norvegicus (Rat)","carbohydrate metabolic process [GO:0005975]; innate immune response [GO:0045087]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]","GO:0005576; GO:0005615; GO:0005764; GO:0005770; GO:0005802; GO:0005975; GO:0008061; GO:0045087; GO:0070492; GO:1900016"
"15318","Cluster_589","Peve_00038409",-0.999186863532982,0.0256747529162409,0.876388672460388,168,-22.68,"2 21","30624 30645",19,"78.95%","78.95%","CDS","Q0IHW8","Clustered mitochondria protein homolog","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","intracellular distribution of mitochondria [GO:0048312]; mitochondrion organization [GO:0007005]","GO:0003729; GO:0005737; GO:0007005; GO:0048312"
"15319","Cluster_589","Peve_00038381",-0.997824775952123,0.0419977355083024,0.910535005294959,162,-23.46,"2 21","1791 1811",19,"73.68%","84.21%","CDS","P63081","V-type proton ATPase 16 kDa proteolipid subunit c (V-ATPase 16 kDa proteolipid subunit c) (Vacuolar proton pump 16 kDa proteolipid subunit c)","Rattus norvegicus (Rat)","negative regulation of autophagic cell death [GO:1904093]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of Wnt signaling pathway [GO:0030177]","GO:0000220; GO:0005764; GO:0005794; GO:0008021; GO:0016020; GO:0030177; GO:0030665; GO:0030672; GO:0031625; GO:0033176; GO:0046961; GO:0070374; GO:1902495; GO:1904093; GO:1904949"
"15322","Cluster_589","Peve_00038399",-0.999121107324343,0.0266928445164863,0.887761277390521,153,-21.91,"2 19","32950 32973",19,"73.68%","73.68%","CDS",NA,NA,NA,NA,NA
"15325","Cluster_589","Peve_00036956",-0.998056688305508,0.0396950824876416,0.909359886114279,163,-26.01,"2 21","11463 11485",20,"75.00%","80.00%","CDS","Q5F471","Serine/threonine-protein phosphatase 6 regulatory subunit 3 (SAPS domain family member 3)","Gallus gallus (Chicken)","regulation of phosphoprotein phosphatase activity [GO:0043666]","GO:0005634; GO:0005829; GO:0019888; GO:0019903; GO:0043666"
"15330","Cluster_589","Peve_00038545",-0.999984274571916,0.00357023602887492,0.52296348009917,155,-21.64,"2 16","34333 34354",14,"78.57%","85.71%","CDS",NA,NA,NA,NA,NA
"15331","Cluster_589","Peve_00038545",-0.999984274571916,0.00357023602887492,0.52296348009917,155,-21.64,"2 16","41141 41162",14,"78.57%","85.71%","CDS",NA,NA,NA,NA,NA
"15353","Cluster_589","Peve_00036966",-0.997544099912725,0.0446261468380649,0.928133778105176,158,-23.98,"2 20","76 98",19,"73.68%","78.95%","CDS",NA,NA,NA,NA,NA
"15381","Cluster_589","Peve_00036987",-0.999964196617774,0.00538714225743854,0.551398425649056,175,-30.53,"2 21","773 796",21,"80.95%","85.71%","CDS",NA,NA,NA,NA,NA
"15404","Cluster_589","Peve_00039910",-0.997528607450278,0.0447667401252105,0.929124691165952,163,-23.88,"2 21","6070 6092",20,"70.00%","85.00%","CDS","P58027","Amine oxidase [flavin-containing] A (EC 1.4.3.21) (EC 1.4.3.4) (Monoamine oxidase type A) (MAO-A)","Canis lupus familiaris (Dog) (Canis familiaris)","catecholamine metabolic process [GO:0006584]; neurotransmitter catabolic process [GO:0042135]","GO:0005739; GO:0005741; GO:0006584; GO:0008131; GO:0042135; GO:0050660; GO:0052595; GO:0052596; GO:0097621"
"15405","Cluster_589","Peve_00039806",-0.997836125155212,0.0418879912592066,0.909699887923376,157,-22.32,"2 21","19358 19379",20,"75.00%","80.00%","CDS","Q84M95","Probable serine/threonine-protein kinase PBL28 (EC 2.7.11.1) (PBS1-like protein 28)","Arabidopsis thaliana (Mouse-ear cress)","defense response [GO:0006952]; protein phosphorylation [GO:0006468]","GO:0000976; GO:0004674; GO:0005524; GO:0005886; GO:0006468; GO:0006952; GO:0106310"
"15413","Cluster_589","Peve_00040028",-0.998577594827018,0.0339592644007571,0.909359886114279,155,-23.41,"2 12","19339 19360",10,"100.00%","100.00%","CDS","Q9NYQ6","Cadherin EGF LAG seven-pass G-type receptor 1 (Cadherin family member 9) (Flamingo homolog 2) (hFmi2)","Homo sapiens (Human)","apical protein localization [GO:0045176]; cell-cell adhesion [GO:0098609]; central nervous system development [GO:0007417]; establishment of body hair planar orientation [GO:0048105]; establishment of planar polarity [GO:0001736]; establishment of planar polarity of embryonic epithelium [GO:0042249]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; lateral sprouting involved in lung morphogenesis [GO:0060490]; neural tube closure [GO:0001843]; neuron migration [GO:0001764]; orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis [GO:0060488]; planar dichotomous subdivision of terminal units involved in lung branching morphogenesis [GO:0060489]; protein localization involved in establishment of planar polarity [GO:0090251]; regulation of actin cytoskeleton organization [GO:0032956]; Rho protein signal transduction [GO:0007266]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]","GO:0001736; GO:0001764; GO:0001843; GO:0004930; GO:0005509; GO:0005654; GO:0005886; GO:0007156; GO:0007266; GO:0007417; GO:0016020; GO:0032956; GO:0042249; GO:0045176; GO:0048105; GO:0060071; GO:0060488; GO:0060489; GO:0060490; GO:0090251; GO:0098609"
"15419","Cluster_589","Peve_00040009",-0.999293986677338,0.0239236325741865,0.855610912323647,155,-21.51,"2 12","1125 1146",10,"100.00%","100.00%","CDS",NA,NA,NA,NA,NA
"15465","Cluster_589","Peve_00040857",-0.999803825754728,0.0126102360468861,0.69089496211305,155,-23.41,"2 12","34798 34819",10,"100.00%","100.00%","CDS","Q9P2J5","Leucine--tRNA ligase, cytoplasmic (EC 6.1.1.4) (Leucyl-tRNA synthetase) (LeuRS)","Homo sapiens (Human)","cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to leucine [GO:0071233]; cellular response to leucine starvation [GO:1990253]; glutaminyl-tRNA aminoacylation [GO:0006425]; leucyl-tRNA aminoacylation [GO:0006429]; positive regulation of GTPase activity [GO:0043547]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; regulation of cell size [GO:0008361]; tRNA aminoacylation for protein translation [GO:0006418]","GO:0002161; GO:0004819; GO:0004823; GO:0005096; GO:0005524; GO:0005737; GO:0005764; GO:0005783; GO:0005829; GO:0006418; GO:0006425; GO:0006429; GO:0008361; GO:0012505; GO:0016604; GO:0017101; GO:0032008; GO:0034198; GO:0043547; GO:0071230; GO:0071233; GO:1904263; GO:1990253"
"15469","Cluster_589","Peve_00041013",-0.997768884296408,0.0425340705521016,0.913643277704532,151,-25.53,"2 21","1147 1171",22,"59.09%","77.27%","CDS","P35556","Fibrillin-2 [Cleaved into: Placensin]","Homo sapiens (Human)","anatomical structure morphogenesis [GO:0009653]; bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583]","GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0009653; GO:0030023; GO:0030326; GO:0030501; GO:0031012; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:0062023; GO:1901163"
"15472","Cluster_589","Peve_00041060",-0.99900949229162,0.0283373937535365,0.903124690393816,156,-25.08,"2 13","1051 1072",11,"90.91%","100.00%","CDS","Q6P0C6","LHFPL tetraspan subfamily member 2a protein","Danio rerio (Zebrafish) (Brachydanio rerio)","development of primary female sexual characteristics [GO:0046545]; development of primary male sexual characteristics [GO:0046546]; positive regulation of fertilization [GO:1905516]; single fertilization [GO:0007338]","GO:0007338; GO:0016020; GO:0046545; GO:0046546; GO:1905516"
"15482","Cluster_589","Peve_00041178",0.998539575899744,0.0344102228351361,0.909359886114279,162,-25.32,"2 21","7298 7324",24,"70.83%","79.17%","CDS",NA,NA,NA,NA,NA
"15483","Cluster_589","Peve_00041178",0.998539575899744,0.0344102228351361,0.909359886114279,162,-26.84,"2 21","1024 1050",24,"70.83%","79.17%","CDS",NA,NA,NA,NA,NA
"15489","Cluster_589","Peve_00041309",-0.99798821144982,0.0403886300754286,0.909359886114279,150,-20.07,"2 15","4706 4727",13,"69.23%","92.31%","CDS","Q3ZCF5","Ornithine aminotransferase, mitochondrial (EC 2.6.1.13) (Ornithine--oxo-acid aminotransferase)","Bos taurus (Bovine)","L-proline biosynthetic process [GO:0055129]","GO:0004587; GO:0005759; GO:0030170; GO:0042802; GO:0050155; GO:0055129"
"15502","Cluster_589","Peve_00041525",-0.999765542200734,0.013785926177826,0.718611308062303,158,-28.63,"2 21","26220 26245",23,"73.91%","73.91%","CDS","P07207","Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein]","Drosophila melanogaster (Fruit fly)","actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222]","GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048"
"15515","Cluster_589","Peve_00041486",-0.999783179861348,0.0132572295746792,0.706310704847038,151,-20.43,"2 21","4748 4770",20,"70.00%","70.00%","CDS","Q99JW4","LIM and senescent cell antigen-like-containing domain protein 1 (Particularly interesting new Cys-His protein 1) (PINCH-1)","Mus musculus (Mouse)","cell-cell adhesion [GO:0098609]; cell-cell junction organization [GO:0045216]; cell-matrix adhesion [GO:0007160]; cholangiocyte proliferation [GO:1990705]; chordate embryonic development [GO:0043009]; establishment of protein localization [GO:0045184]; establishment or maintenance of cell polarity [GO:0007163]; hepatocyte apoptotic process [GO:0097284]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of cholangiocyte proliferation [GO:1904055]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of hepatocyte apoptotic process [GO:1903944]; negative regulation of hepatocyte proliferation [GO:2000346]; negative regulation of neural precursor cell proliferation [GO:2000178]; neural precursor cell proliferation [GO:0061351]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of gene expression [GO:0010628]; positive regulation of GTPase activity [GO:0043547]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; tumor necrosis factor-mediated signaling pathway [GO:0033209]","GO:0005737; GO:0005886; GO:0005911; GO:0005925; GO:0007160; GO:0007163; GO:0007229; GO:0008270; GO:0010628; GO:0010811; GO:0019901; GO:0032991; GO:0033209; GO:0043009; GO:0043547; GO:0044877; GO:0045184; GO:0045216; GO:0045892; GO:0048471; GO:0051894; GO:0061351; GO:0097284; GO:0098609; GO:1900026; GO:1901224; GO:1903944; GO:1904055; GO:1990705; GO:2000178; GO:2000346; GO:2001046"
"15522","Cluster_589","Peve_00041875",-0.999706181714714,0.0154328155265098,0.751559768011606,155,-22.2,"2 12","23794 23815",10,"100.00%","100.00%","CDS","Q6PCL9","Poly(A) polymerase gamma (PAP-gamma) (EC 2.7.7.19) (Polynucleotide adenylyltransferase gamma) (SRP RNA 3'-adenylating enzyme) (Signal recognition particle RNA-adenylating enzyme) (SRP RNA-adenylating enzyme)","Mus musculus (Mouse)","mRNA polyadenylation [GO:0006378]; RNA polyadenylation [GO:0043631]","GO:0003723; GO:0004652; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0006378; GO:0016604; GO:0043631; GO:0046872"
"15532","Cluster_589","Peve_00042017",-0.999385177691432,0.0223250367837388,0.835635226341236,155,-21.07,"2 21","13385 13409",22,"63.64%","77.27%","CDS","Q13614","Myotubularin-related protein 2 (Phosphatidylinositol-3,5-bisphosphate 3-phosphatase) (EC 3.1.3.95) (Phosphatidylinositol-3-phosphate phosphatase) (EC 3.1.3.64)","Homo sapiens (Human)","dendritic spine maintenance [GO:0097062]; inositol phosphate dephosphorylation [GO:0046855]; myelin assembly [GO:0032288]; negative regulation of endocytosis [GO:0045806]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of myelination [GO:0031642]; negative regulation of receptor catabolic process [GO:2000645]; negative regulation of receptor internalization [GO:0002091]; neuron development [GO:0048666]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; positive regulation of early endosome to late endosome transport [GO:2000643]; protein dephosphorylation [GO:0006470]; regulation of phosphatidylinositol dephosphorylation [GO:0060304]","GO:0002091; GO:0004438; GO:0005634; GO:0005737; GO:0005774; GO:0005829; GO:0006470; GO:0006661; GO:0008021; GO:0008138; GO:0014069; GO:0030424; GO:0030425; GO:0031642; GO:0031901; GO:0032288; GO:0042802; GO:0043197; GO:0043231; GO:0045806; GO:0046855; GO:0046856; GO:0048471; GO:0048666; GO:0052629; GO:0060304; GO:0070062; GO:0090394; GO:0097060; GO:0097062; GO:2000643; GO:2000645"
"15539","Cluster_589","Peve_00041749",-0.99787477055967,0.0415121261197676,0.909359886114279,155,-23.55,"2 12","12314 12335",10,"100.00%","100.00%","CDS","Q8BKX6","Serine/threonine-protein kinase SMG1 (SMG-1) (EC 2.7.11.1) (Lambda/iota protein kinase C-interacting protein) (Lambda-interacting protein) (Nonsense mediated mRNA decay-associated PI3K-related kinase SMG1)","Mus musculus (Mouse)","DNA repair [GO:0006281]; negative regulation of macroautophagy [GO:0016242]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; peptidyl-serine phosphorylation [GO:0018105]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of response to DNA damage stimulus [GO:2001020]; regulation of telomere maintenance [GO:0032204]; TOR signaling [GO:0031929]","GO:0000184; GO:0004674; GO:0004697; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006281; GO:0006468; GO:0016242; GO:0018105; GO:0031929; GO:0031931; GO:0031932; GO:0032204; GO:0033391; GO:0042162; GO:0046777; GO:0046854; GO:0046872; GO:0106310; GO:2001020"
"15569","Cluster_589","Peve_00042902",-0.999894247471614,0.00925857881553049,0.598206644113041,156,-20.02,"2 17","12383 12404",15,"73.33%","86.67%","CDS","Q5ZJ54","T-complex protein 1 subunit zeta (TCP-1-zeta) (CCT-zeta)","Gallus gallus (Chicken)","protein folding [GO:0006457]","GO:0005524; GO:0005832; GO:0006457; GO:0016887; GO:0051082; GO:0140662"
"15573","Cluster_589","Peve_00042905",-0.999625976379842,0.0174123814581667,0.782669382293497,156,-21.49,"2 17","4476 4497",15,"80.00%","80.00%","CDS","Q9VKA4","Probable G-protein coupled receptor CG31760","Drosophila melanogaster (Fruit fly)","","GO:0004930; GO:0005886"
"15574","Cluster_589","Peve_00042906",-0.99799654661434,0.0403048469112576,0.909359886114279,155,-23.41,"2 12","3177 3198",10,"100.00%","100.00%","CDS","Q9UKT8","F-box/WD repeat-containing protein 2 (F-box and WD-40 domain-containing protein 2) (Protein MD6)","Homo sapiens (Human)","protein modification process [GO:0036211]; proteolysis [GO:0006508]","GO:0004842; GO:0005829; GO:0006508; GO:0036211"
"15578","Cluster_589","Peve_00042937",-0.999999785578752,0.000416897257778453,0.224454777561094,153,-21.52,"2 14","8489 8510",12,"83.33%","91.67%","CDS",NA,NA,NA,NA,NA
"15579","Cluster_589","Peve_00042937",-0.999999785578752,0.000416897257778453,0.224454777561094,155,-21.82,"2 12","15265 15286",10,"100.00%","100.00%","CDS",NA,NA,NA,NA,NA
"15583","Cluster_589","Peve_00043039",-0.999975784536428,0.00443039441481932,0.54328949385489,151,-20.02,"2 12","62406 62427",10,"90.00%","100.00%","CDS","P27884","Voltage-dependent P/Q-type calcium channel subunit alpha-1A (Brain calcium channel I) (BI) (Calcium channel, L type, alpha-1 polypeptide isoform 4) (Voltage-gated calcium channel subunit alpha Cav2.1)","Oryctolagus cuniculus (Rabbit)","calcium ion transmembrane transport [GO:0070588]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of ion transmembrane transport [GO:0034765]","GO:0005245; GO:0005886; GO:0005891; GO:0007204; GO:0008022; GO:0034765; GO:0046872; GO:0070588"
"15615","Cluster_589","Peve_00043949",-0.999465915219043,0.0208074832265374,0.816390317707038,159,-24.42,"2 20","3345 3366",18,"61.11%","88.89%","CDS","Q92508","Piezo-type mechanosensitive ion channel component 1 (Membrane protein induced by beta-amyloid treatment) (Mib) (Protein FAM38A)","Homo sapiens (Human)","cation transport [GO:0006812]; cellular response to mechanical stimulus [GO:0071260]; detection of mechanical stimulus [GO:0050982]; positive regulation of cell-cell adhesion mediated by integrin [GO:0033634]; positive regulation of integrin activation [GO:0033625]; positive regulation of myotube differentiation [GO:0010831]; regulation of membrane potential [GO:0042391]","GO:0005261; GO:0005783; GO:0005789; GO:0005886; GO:0006812; GO:0008381; GO:0010831; GO:0016020; GO:0031258; GO:0033116; GO:0033625; GO:0033634; GO:0042391; GO:0050982; GO:0071260"
"15787","Cluster_796","Peve_00001819",0.998906823578492,0.0297700675484845,0.903929377050813,158,-21.2,"2 20","680 702",19,"73.68%","78.95%","CDS","Q8R151","NFX1-type zinc finger-containing protein 1","Mus musculus (Mouse)","activation of innate immune response [GO:0002218]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of viral genome replication [GO:0045071]; RNA-mediated heterochromatin formation [GO:0031048]","GO:0002218; GO:0003723; GO:0004386; GO:0005741; GO:0008270; GO:0010494; GO:0031048; GO:0031380; GO:0042742; GO:0045071; GO:0045087; GO:0051607"
"15788","Cluster_796","Peve_00001819",0.998906823578492,0.0297700675484845,0.903929377050813,159,-23.48,"2 20","705 726",18,"72.22%","77.78%","CDS","Q8R151","NFX1-type zinc finger-containing protein 1","Mus musculus (Mouse)","activation of innate immune response [GO:0002218]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of viral genome replication [GO:0045071]; RNA-mediated heterochromatin formation [GO:0031048]","GO:0002218; GO:0003723; GO:0004386; GO:0005741; GO:0008270; GO:0010494; GO:0031048; GO:0031380; GO:0042742; GO:0045071; GO:0045087; GO:0051607"
"15792","Cluster_796","Peve_00002405",0.999465467582815,0.020816201937894,0.816419796298782,159,-21.63,"2 21","2487 2509",20,"75.00%","75.00%","CDS",NA,NA,NA,NA,NA
"15836","Cluster_796","Peve_00003564",0.998855998692393,0.0304543821236996,0.903929377050813,161,-25.43,"2 19","825 847",18,"77.78%","83.33%","CDS","P90994","Glutathione-independent glyoxalase DJR-1.1 (EC 4.2.1.130) (Protein DJ-1 homolog 1)","Caenorhabditis elegans","cellular response to glyoxal [GO:0036471]; cellular response to methylglyoxal [GO:0097238]; glycolate biosynthetic process [GO:0046295]; glyoxal metabolic process [GO:1903189]; lactate biosynthetic process [GO:0019249]; methylglyoxal metabolic process [GO:0009438]; negative regulation of neuron death [GO:1901215]; response to oxidative stress [GO:0006979]; response to toxic substance [GO:0009636]","GO:0005634; GO:0005737; GO:0005739; GO:0006979; GO:0009438; GO:0009636; GO:0019172; GO:0019249; GO:0036471; GO:0046295; GO:0097238; GO:1901215; GO:1903189"
"15843","Cluster_796","Peve_00003302",0.998226961786262,0.0379156371127279,0.909359886114279,165,-22.73,"2 18","370 391",16,"81.25%","87.50%","CDS","Q7TSG1","Centrosomal protein of 120 kDa (Cep120) (Coiled-coil domain-containing protein 100)","Mus musculus (Mouse)","astral microtubule organization [GO:0030953]; cell population proliferation [GO:0008283]; centrosome cycle [GO:0007098]; cerebral cortex development [GO:0021987]; interkinetic nuclear migration [GO:0022027]; microtubule cytoskeleton organization [GO:0000226]; neurogenesis [GO:0022008]; positive regulation of centriole elongation [GO:1903724]; positive regulation of centrosome duplication [GO:0010825]; positive regulation of cilium assembly [GO:0045724]; positive regulation of establishment of protein localization [GO:1904951]; regulation of microtubule-based process [GO:0032886]; regulation of protein localization [GO:0032880]","GO:0000226; GO:0005737; GO:0005813; GO:0005814; GO:0007098; GO:0008022; GO:0008283; GO:0010825; GO:0021987; GO:0022008; GO:0022027; GO:0030953; GO:0032880; GO:0032886; GO:0045724; GO:1903724; GO:1904951"
"15844","Cluster_796","Peve_00003302",0.998226961786262,0.0379156371127279,0.909359886114279,170,-25.85,"2 20","8357 8380",20,"80.00%","85.00%","CDS","Q7TSG1","Centrosomal protein of 120 kDa (Cep120) (Coiled-coil domain-containing protein 100)","Mus musculus (Mouse)","astral microtubule organization [GO:0030953]; cell population proliferation [GO:0008283]; centrosome cycle [GO:0007098]; cerebral cortex development [GO:0021987]; interkinetic nuclear migration [GO:0022027]; microtubule cytoskeleton organization [GO:0000226]; neurogenesis [GO:0022008]; positive regulation of centriole elongation [GO:1903724]; positive regulation of centrosome duplication [GO:0010825]; positive regulation of cilium assembly [GO:0045724]; positive regulation of establishment of protein localization [GO:1904951]; regulation of microtubule-based process [GO:0032886]; regulation of protein localization [GO:0032880]","GO:0000226; GO:0005737; GO:0005813; GO:0005814; GO:0007098; GO:0008022; GO:0008283; GO:0010825; GO:0021987; GO:0022008; GO:0022027; GO:0030953; GO:0032880; GO:0032886; GO:0045724; GO:1903724; GO:1904951"
"15852","Cluster_796","Peve_00003917",0.999626324993561,0.017404264339196,0.782669382293497,161,-26.26,"2 20","5850 5876",23,"73.91%","78.26%","CDS",NA,NA,NA,NA,NA
"15855","Cluster_796","Peve_00003987",0.997067200526471,0.0487688488234394,0.9484938778958,149,-22.14,"2 21","7673 7692",19,"68.42%","73.68%","CDS","F4IYM4","Protein DEFECTIVE IN EXINE FORMATION 1","Arabidopsis thaliana (Mouse-ear cress)","cell wall organization [GO:0071555]; pollen exine formation [GO:0010584]; pollen wall assembly [GO:0010208]","GO:0000137; GO:0005509; GO:0005783; GO:0005829; GO:0005886; GO:0010208; GO:0010584; GO:0016020; GO:0071555"
"15868","Cluster_796","Peve_00004183",0.999177291635325,0.0258254475535218,0.878144618656955,165,-23.89,"2 20","1070 1090",18,"83.33%","83.33%","CDS",NA,NA,NA,NA,NA
"15908","Cluster_796","Peve_00004847",0.999938723829808,0.00704763080771654,0.573710369894872,150,-20.66,"2 21","6267 6287",19,"68.42%","73.68%","CDS","Q49B93","Sodium-coupled monocarboxylate transporter 2 (Electroneutral sodium monocarboxylate cotransporter) (Low-affinity sodium-lactate cotransporter) (Solute carrier family 5 member 12)","Mus musculus (Mouse)","sodium ion transport [GO:0006814]","GO:0005654; GO:0005886; GO:0006814; GO:0015129; GO:0015293; GO:0016324"
"15924","Cluster_796","Peve_00005087",0.99852948442121,0.0345289339261551,0.909359886114279,158,-24.69,"2 21","30000 30026",24,"70.83%","75.00%","CDS","A2AJ88","Patatin-like phospholipase domain-containing protein 7 (EC 3.1.1.-) (EC 3.1.1.5) (Neuropathy target esterase-related esterase) (NRE) (NTE-related esterase)","Mus musculus (Mouse)","phosphatidylcholine catabolic process [GO:0034638]","GO:0004622; GO:0005783; GO:0005789; GO:0005811; GO:0034638; GO:0102545"
"15931","Cluster_796","Peve_00005282",0.999216124702012,0.0252084988049993,0.870844476309606,154,-23.01,"2 21","352 372",19,"73.68%","73.68%","CDS","A1L1W9","Monocarboxylate transporter 10 (MCT 10) (Solute carrier family 16 member 10)","Danio rerio (Zebrafish) (Brachydanio rerio)","aromatic amino acid transport [GO:0015801]; thyroid hormone transport [GO:0070327]","GO:0005302; GO:0015173; GO:0015192; GO:0015196; GO:0015349; GO:0015801; GO:0016020; GO:0016323; GO:0070327"
"15948","Cluster_796","Peve_00004716",0.999155814489371,0.0261604147169285,0.88215006671225,160,-21.97,"2 21","6510 6531",19,"73.68%","73.68%","CDS","O35474","EGF-like repeat and discoidin I-like domain-containing protein 3 (Developmentally-regulated endothelial cell locus 1 protein) (Integrin-binding protein DEL1)","Mus musculus (Mouse)","cell adhesion [GO:0007155]; positive regulation of cell-substrate adhesion [GO:0010811]","GO:0005509; GO:0005576; GO:0007155; GO:0010811"
"15955","Cluster_796","Peve_00005764",0.997349443062599,0.0463617331849258,0.937527087266077,152,-21.1,"2 19","4704 4727",19,"73.68%","78.95%","CDS","Q8IY22","C-Maf-inducing protein (c-Mip) (Truncated c-Maf-inducing protein) (Tc-Mip)","Homo sapiens (Human)","in utero embryonic development [GO:0001701]","GO:0001701; GO:0005654; GO:0005829"
"15964","Cluster_796","Peve_00006089",0.997686227424772,0.0433150908007001,0.91864596019626,150,-20.08,"2 20","13650 13673",20,"70.00%","70.00%","CDS","B0JZG0","Solute carrier family 23 member 2 (Na(+)/L-ascorbic acid transporter 2) (Sodium-dependent vitamin C transporter 2)","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","sodium ion transport [GO:0006814]","GO:0006814; GO:0015229; GO:0015293; GO:0098590"
"15978","Cluster_796","Peve_00006527",0.999861274283444,0.0106042175759821,0.639852969602429,157,-20.88,"2 21","20816 20838",21,"76.19%","76.19%","CDS","Q9H251","Cadherin-23 (Otocadherin)","Homo sapiens (Human)","auditory receptor cell stereocilium organization [GO:0060088]; calcium ion transport [GO:0006816]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; equilibrioception [GO:0050957]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; locomotory behavior [GO:0007626]; photoreceptor cell maintenance [GO:0045494]; post-embryonic animal organ morphogenesis [GO:0048563]; regulation of cytosolic calcium ion concentration [GO:0051480]; response to stimulus [GO:0050896]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601]","GO:0001917; GO:0005509; GO:0005813; GO:0006816; GO:0007156; GO:0007601; GO:0007605; GO:0007626; GO:0016020; GO:0016339; GO:0016342; GO:0032420; GO:0032426; GO:0045296; GO:0045494; GO:0048563; GO:0050896; GO:0050953; GO:0050957; GO:0051480; GO:0060088; GO:0060091; GO:0098683; GO:0098684; GO:0098742"
"16024","Cluster_796","Peve_00007538",0.997223297346734,0.0474526370163822,0.942888539658333,155,-22.37,"2 19","6501 6520",17,"76.47%","82.35%","CDS","Q5A8K2","Alanine--tRNA ligase (EC 6.1.1.7) (Alanyl-tRNA synthetase) (AlaRS)","Candida albicans (strain SC5314 / ATCC MYA-2876) (Yeast)","alanyl-tRNA aminoacylation [GO:0006419]; mitochondrial alanyl-tRNA aminoacylation [GO:0070143]; tRNA modification [GO:0006400]","GO:0000049; GO:0002161; GO:0004813; GO:0005524; GO:0005737; GO:0005739; GO:0006400; GO:0006419; GO:0008270; GO:0016597; GO:0070143"
"16025","Cluster_796","Peve_00007538",0.997223297346734,0.0474526370163822,0.942888539658333,155,-22.37,"2 19","9301 9320",17,"76.47%","82.35%","CDS","Q5A8K2","Alanine--tRNA ligase (EC 6.1.1.7) (Alanyl-tRNA synthetase) (AlaRS)","Candida albicans (strain SC5314 / ATCC MYA-2876) (Yeast)","alanyl-tRNA aminoacylation [GO:0006419]; mitochondrial alanyl-tRNA aminoacylation [GO:0070143]; tRNA modification [GO:0006400]","GO:0000049; GO:0002161; GO:0004813; GO:0005524; GO:0005737; GO:0005739; GO:0006400; GO:0006419; GO:0008270; GO:0016597; GO:0070143"
"16166","Cluster_796","Peve_00011165",0.999614579643084,0.0176756907745432,0.782669382293497,160,-23.44,"2 13","5180 5201",11,"100.00%","100.00%","CDS",NA,NA,NA,NA,NA
"16167","Cluster_796","Peve_00011299",0.999469239597005,0.0207426189429382,0.815244448838541,163,-27.82,"2 21","61810 61832",20,"75.00%","80.00%","CDS",NA,NA,NA,NA,NA
"16205","Cluster_796","Peve_00012067",0.999880217269511,0.00985363702675541,0.616189877019716,153,-22.39,"2 20","1751 1774",20,"75.00%","75.00%","CDS","P97846","Contactin-associated protein 1 (Caspr) (Caspr1) (Neurexin IV) (Neurexin-4) (Paranodin) (p190)","Rattus norvegicus (Rat)","axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; central nervous system myelination [GO:0022010]; cytoskeleton organization [GO:0007010]; mitochondrion organization [GO:0007005]; myelination [GO:0042552]; myelination in peripheral nervous system [GO:0022011]; neuromuscular junction development, skeletal muscle fiber [GO:0098529]; neuromuscular process [GO:0050905]; neuromuscular process controlling balance [GO:0050885]; neuromuscular process controlling posture [GO:0050884]; neuron projection development [GO:0031175]; neuron projection morphogenesis [GO:0048812]; neuronal action potential propagation [GO:0019227]; paranodal junction assembly [GO:0030913]; paranodal junction maintenance [GO:1990227]; postsynaptic density organization [GO:0097106]; protein localization to juxtaparanode region of axon [GO:0071205]; protein localization to paranode region of axon [GO:0002175]; regulation of synapse maturation [GO:0090128]","GO:0002175; GO:0007005; GO:0007010; GO:0007155; GO:0007409; GO:0016020; GO:0017124; GO:0019227; GO:0022010; GO:0022011; GO:0030424; GO:0030913; GO:0031175; GO:0033010; GO:0033270; GO:0042552; GO:0048786; GO:0048812; GO:0050884; GO:0050885; GO:0050905; GO:0071205; GO:0090128; GO:0097106; GO:0098529; GO:0098978; GO:1990227"
"16232","Cluster_796","Peve_00012780",0.999398003365372,0.0220909270698022,0.832346845851212,152,-22.72,"2 18","17767 17790",18,"72.22%","77.78%","CDS","P20735","Glutathione hydrolase 1 proenzyme (EC 3.4.19.13) (Gamma-glutamyltransferase 1) (Gamma-glutamyltranspeptidase 1) (GGT 1) (EC 2.3.2.2) (Leukotriene-C4 hydrolase) (EC 3.4.19.14) (CD antigen CD224) [Cleaved into: Glutathione hydrolase 1 heavy chain; Glutathione hydrolase 1 light chain]","Sus scrofa (Pig)","glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; glutathione catabolic process [GO:0006751]; zymogen activation [GO:0031638]","GO:0002951; GO:0005886; GO:0006536; GO:0006750; GO:0006751; GO:0031638; GO:0036374; GO:0102953; GO:0103068"
"16248","Cluster_796","Peve_00013567",0.999437004579206,0.0213632798510106,0.823948557854313,153,-20.32,"2 19","21327 21351",20,"70.00%","75.00%","CDS","Q03701","CCAAT/enhancer-binding protein zeta (CCAAT-box-binding transcription factor) (CBF) (CCAAT-binding factor)","Homo sapiens (Human)","positive regulation of transcription by RNA polymerase II [GO:0045944]","GO:0003713; GO:0003723; GO:0005634; GO:0016602; GO:0045944"
"16263","Cluster_796","Peve_00013835",0.99796247257867,0.0406462627328843,0.909359886114279,163,-20.44,"2 21","37855 37877",20,"75.00%","80.00%","CDS",NA,NA,NA,NA,NA
"16264","Cluster_796","Peve_00013835",0.99796247257867,0.0406462627328843,0.909359886114279,163,-20.44,"2 21","41784 41806",20,"75.00%","80.00%","CDS",NA,NA,NA,NA,NA
"16268","Cluster_796","Peve_00013537",0.998658860227375,0.032974687712477,0.909359886114279,162,-21.96,"2 21","4299 4319",19,"78.95%","78.95%","CDS",NA,NA,NA,NA,NA
"16278","Cluster_796","Peve_00014158",0.99872883403273,0.0321027520963933,0.907109338565727,146,-20.58,"2 20","11485 11507",19,"63.16%","73.68%","CDS","A8E7C5","Phosphatidylinositide phosphatase SAC2 (EC 3.1.3.25) (Inositol polyphosphate 5-phosphatase F) (Sac domain-containing inositol phosphatase 2) (Sac domain-containing phosphoinositide 4-phosphatase 2) (hSAC2)","Danio rerio (Zebrafish) (Brachydanio rerio)","clathrin-dependent endocytosis [GO:0072583]; phosphatidylinositol dephosphorylation [GO:0046856]; regulation of endocytic recycling [GO:2001135]","GO:0005769; GO:0005905; GO:0008934; GO:0042803; GO:0043812; GO:0045334; GO:0046856; GO:0052832; GO:0052833; GO:0055037; GO:0072583; GO:2001135"
"16285","Cluster_796","Peve_00014504",-0.998184766923426,0.0383642786220211,0.909359886114279,150,-22.09,"2 21","7116 7132",19,"73.68%","73.68%","CDS","Q570Y9","DEP domain-containing mTOR-interacting protein (DEP domain-containing protein 6)","Mus musculus (Mouse)","intracellular signal transduction [GO:0035556]; negative regulation of cell size [GO:0045792]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of TOR signaling [GO:0032007]; negative regulation of TORC1 signaling [GO:1904262]; negative regulation of TORC2 signaling [GO:1903940]; regulation of extrinsic apoptotic signaling pathway [GO:2001236]","GO:0006469; GO:0032007; GO:0035556; GO:0045792; GO:1903940; GO:1904262; GO:2001236"
"16386","Cluster_796","Peve_00016520",-0.999291205491492,0.0239707127888751,0.856164162085951,149,-20.6,"2 20","1455 1480",22,"68.18%","72.73%","CDS",NA,NA,NA,NA,NA
"16405","Cluster_796","Peve_00017768",0.997539179225125,0.0446708496942226,0.928382133004496,146,-21.97,"2 21","7765 7789",22,"68.18%","68.18%","CDS","Q8CGF6","WD repeat-containing protein 47 (Neuronal enriched MAP interacting protein) (Nemitin)","Mus musculus (Mouse)","adult locomotory behavior [GO:0008344]; anterior commissure morphogenesis [GO:0021960]; autophagy [GO:0006914]; brain development [GO:0007420]; cerebral cortex development [GO:0021987]; cerebral cortex radial glia-guided migration [GO:0021801]; corpus callosum development [GO:0022038]; detection of hot stimulus involved in thermoception [GO:0120168]; locomotory behavior [GO:0007626]; microtubule cytoskeleton organization [GO:0000226]; motor behavior [GO:0061744]; negative regulation of microtubule depolymerization [GO:0007026]; neural precursor cell proliferation [GO:0061351]; neuron projection development [GO:0031175]; neuronal stem cell population maintenance [GO:0097150]","GO:0000226; GO:0005737; GO:0005874; GO:0006914; GO:0007026; GO:0007420; GO:0007626; GO:0008344; GO:0021801; GO:0021960; GO:0021987; GO:0022038; GO:0030424; GO:0030425; GO:0030426; GO:0031175; GO:0043005; GO:0043025; GO:0044877; GO:0047485; GO:0061351; GO:0061744; GO:0097150; GO:0120168"
"16415","Cluster_796","Peve_00018006",0.999947127706681,0.00654652918637522,0.573710369894872,153,-22.91,"2 21","7676 7695",19,"68.42%","78.95%","CDS","P61291","Proteasome activator complex subunit 3 (Activator of multicatalytic protease subunit 3) (Proteasome activator 28 subunit gamma) (PA28g) (PA28gamma)","Sus scrofa (Pig)","apoptotic process [GO:0006915]; cell cycle [GO:0007049]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive regulation of endopeptidase activity [GO:0010950]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of proteasomal protein catabolic process [GO:0061136]","GO:0002039; GO:0005654; GO:0005737; GO:0006915; GO:0007049; GO:0008537; GO:0010950; GO:0061133; GO:0061136; GO:0097371; GO:2000045; GO:2001237"
"16453","Cluster_796","Peve_00018843",0.999875921852262,0.0100287605540851,0.622145995500794,142,-23.14,"2 21","3549 3577",26,"61.54%","65.38%","CDS","Q499Y0","Exportin-4","Xenopus laevis (African clawed frog)","protein transport [GO:0015031]","GO:0005049; GO:0005634; GO:0005737; GO:0015031"
"16463","Cluster_796","Peve_00018950",0.997477004983485,0.0452318831953428,0.931751799954478,159,-21.6,"2 21","26685 26708",21,"71.43%","76.19%","CDS","Q8BW94","Dynein axonemal heavy chain 3 (Axonemal beta dynein heavy chain 3) (Ciliary dynein heavy chain 3)","Mus musculus (Mouse)","cilium movement [GO:0003341]; microtubule-based movement [GO:0007018]","GO:0003341; GO:0005524; GO:0005874; GO:0007018; GO:0008569; GO:0030286; GO:0036156; GO:0045505; GO:0051959; GO:0097729"
"16493","Cluster_796","Peve_00019270",0.999970454473499,0.00489375312637141,0.551398425649056,200,-44.77,"2 21","4515 4536",19,"100.00%","100.00%","CDS",NA,NA,NA,NA,NA
"16539","Cluster_796","Peve_00020859",0.99991937319529,0.00808421329013364,0.573710369894872,145,-20.61,"2 18","17535 17556",16,"68.75%","68.75%","CDS","Q8CBC7",NA,NA,NA,NA
"16553","Cluster_796","Peve_00021252",-0.999173333875069,0.0258875001330152,0.878746116748851,156,-21.43,"2 21","1285 1304",19,"78.95%","78.95%","CDS",NA,NA,NA,NA,NA
"16554","Cluster_796","Peve_00021264",0.997162801221593,0.047967019964389,0.945590536869992,148,-20.99,"2 21","41113 41138",24,"70.83%","70.83%","CDS","O15050","TPR and ankyrin repeat-containing protein 1 (Lupus brain antigen 1 homolog)","Homo sapiens (Human)","",""
"16555","Cluster_796","Peve_00021264",0.997162801221593,0.047967019964389,0.945590536869992,154,-22.28,"2 20","39131 39154",20,"70.00%","75.00%","CDS","O15050","TPR and ankyrin repeat-containing protein 1 (Lupus brain antigen 1 homolog)","Homo sapiens (Human)","",""
"16556","Cluster_796","Peve_00021291",0.997541134302608,0.0446530937966655,0.928257810831701,163,-23.32,"2 21","6109 6131",20,"75.00%","80.00%","CDS","Q32LP4","Sodium-driven chloride bicarbonate exchanger (Solute carrier family 4 member 10)","Bos taurus (Bovine)","bicarbonate transport [GO:0015701]; brain morphogenesis [GO:0048854]; ion homeostasis [GO:0050801]; locomotory exploration behavior [GO:0035641]; multicellular organism growth [GO:0035264]; post-embryonic development [GO:0009791]; proton transmembrane transport [GO:1902600]; pyramidal neuron development [GO:0021860]; regulation of intracellular pH [GO:0051453]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; response to light stimulus [GO:0009416]; transmembrane transport [GO:0055085]; visual perception [GO:0007601]","GO:0005886; GO:0007601; GO:0008510; GO:0009416; GO:0009791; GO:0015701; GO:0016323; GO:0016324; GO:0021860; GO:0022857; GO:0030425; GO:0035264; GO:0035641; GO:0036477; GO:0043025; GO:0043204; GO:0043679; GO:0045202; GO:0048172; GO:0048854; GO:0050801; GO:0051453; GO:0055085; GO:0097440; GO:0097441; GO:0097442; GO:0098794; GO:0140892; GO:1902600"
"16561","Cluster_796","Peve_00020888",0.999984936983132,0.0034942312800772,0.516028655133572,143,-20.98,"2 21","7593 7621",26,"61.54%","61.54%","CDS","Q8N264","Rho GTPase-activating protein 24 (Filamin-A-associated RhoGAP) (FilGAP) (RAC1- and CDC42-specific GTPase-activating protein of 72 kDa) (RC-GAP72) (Rho-type GTPase-activating protein 24) (RhoGAP of 73 kDa) (Sarcoma antigen NY-SAR-88) (p73RhoGAP)","Homo sapiens (Human)","activation of GTPase activity [GO:0090630]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; negative regulation of Rac protein signal transduction [GO:0035021]; negative regulation of ruffle assembly [GO:1900028]; signal transduction [GO:0007165]; wound healing, spreading of epidermal cells [GO:0035313]","GO:0001525; GO:0005096; GO:0005737; GO:0005856; GO:0005912; GO:0005925; GO:0007165; GO:0030154; GO:0035021; GO:0035313; GO:0042995; GO:0090630; GO:1900028"
"16571","Cluster_796","Peve_00021878",0.997752634359215,0.0426887420878948,0.914691543244598,151,-20.3,"2 21","12767 12786",20,"75.00%","75.00%","CDS","E9Q634","Unconventional myosin-Ie (Unconventional myosin 1E)","Mus musculus (Mouse)","actin filament organization [GO:0007015]; endocytosis [GO:0006897]; glomerular basement membrane development [GO:0032836]; glomerular filtration [GO:0003094]; hemopoiesis [GO:0030097]; in utero embryonic development [GO:0001701]; kidney development [GO:0001822]; nitrogen compound metabolic process [GO:0006807]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; podocyte development [GO:0072015]; post-embryonic hemopoiesis [GO:0035166]; vasculogenesis [GO:0001570]; vesicle transport along actin filament [GO:0030050]","GO:0000146; GO:0001570; GO:0001701; GO:0001822; GO:0003094; GO:0005516; GO:0005524; GO:0005737; GO:0005856; GO:0005886; GO:0005902; GO:0005903; GO:0005912; GO:0006807; GO:0006897; GO:0007015; GO:0015629; GO:0016459; GO:0016887; GO:0030050; GO:0030097; GO:0031982; GO:0032437; GO:0032836; GO:0032991; GO:0035091; GO:0035166; GO:0044877; GO:0045334; GO:0048008; GO:0051015; GO:0072015"
"16592","Cluster_796","Peve_00022240",0.998510728175668,0.0347484966903348,0.909359886114279,146,-20.07,"2 20","1957 1979",19,"68.42%","68.42%","CDS",NA,NA,NA,NA,NA
"16608","Cluster_796","Peve_00022876",0.997463790305685,0.0453502338779849,0.932382960211634,149,-22.79,"2 21","33312 33336",22,"72.73%","72.73%","CDS","Q9JHU4","Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)","Mus musculus (Mouse)","cell division [GO:0051301]; cilium movement [GO:0003341]; cytoplasmic microtubule organization [GO:0031122]; establishment of spindle localization [GO:0051293]; microtubule-based movement [GO:0007018]; minus-end-directed vesicle transport along microtubule [GO:0072382]; mitotic cell cycle [GO:0000278]; nuclear migration [GO:0007097]; P-body assembly [GO:0033962]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of intracellular transport [GO:0032388]; positive regulation of spindle assembly [GO:1905832]; regulation of metaphase plate congression [GO:0090235]; regulation of mitotic spindle organization [GO:0060236]; retrograde axonal transport [GO:0008090]; stress granule assembly [GO:0034063]","GO:0000278; GO:0002177; GO:0003341; GO:0005524; GO:0005635; GO:0005737; GO:0005813; GO:0005868; GO:0005874; GO:0005881; GO:0005938; GO:0007018; GO:0007097; GO:0008090; GO:0008569; GO:0030175; GO:0030286; GO:0030424; GO:0031122; GO:0032388; GO:0033962; GO:0034063; GO:0043025; GO:0045505; GO:0051293; GO:0051301; GO:0051959; GO:0060236; GO:0072382; GO:0090235; GO:0120162; GO:1904115; GO:1905832"
"16741","Cluster_796","Peve_00026073",0.999794078297198,0.0129197358397774,0.6983004053542,164,-20.81,"2 21","18176 18197",19,"73.68%","78.95%","CDS","O60879","Protein diaphanous homolog 2 (Diaphanous-related formin-2) (DRF2)","Homo sapiens (Human)","actin filament polymerization [GO:0030041]; female gamete generation [GO:0007292]; oogenesis [GO:0048477]","GO:0003779; GO:0005102; GO:0005730; GO:0005769; GO:0005783; GO:0005829; GO:0005884; GO:0007292; GO:0030041; GO:0031267; GO:0043231; GO:0048477"
"16757","Cluster_796","Peve_00026597",0.99930424184617,0.023749225802111,0.85317692934954,151,-21.64,"2 18","2813 2833",16,"75.00%","81.25%","CDS","P22027","ATP synthase subunit s, mitochondrial (ATP synthase-coupling factor B) (FB) (Distal membrane arm assembly complex 2-like protein) (Mitochondrial ATP synthase regulatory component factor B)","Bos taurus (Bovine)","ATP biosynthetic process [GO:0006754]; proton transmembrane transport [GO:1902600]","GO:0005737; GO:0005743; GO:0006754; GO:0045263; GO:0046872; GO:1902600"
"16766","Cluster_796","Peve_00026823",0.99870790080121,0.0323660591219525,0.909244498015575,170,-26.68,"2 21","87700 87724",22,"81.82%","81.82%","CDS","Q9WUU9","Germinal-center associated nuclear protein (GANP) (EC 2.3.1.48) (GC-associated DNA primase)","Mus musculus (Mouse)","mRNA export from nucleus [GO:0006406]; nucleosome organization [GO:0034728]; poly(A)+ mRNA export from nucleus [GO:0016973]; protein transport [GO:0015031]; somatic hypermutation of immunoglobulin genes [GO:0016446]","GO:0003676; GO:0003682; GO:0004402; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005829; GO:0006406; GO:0010484; GO:0015031; GO:0016446; GO:0016973; GO:0031965; GO:0034728; GO:0042393; GO:0044615; GO:0070390"
"16796","Cluster_796","Peve_00027528",0.997445198830811,0.0455162190256704,0.933081084148054,165,-28.56,"2 20","311 334",20,"80.00%","85.00%","CDS",NA,NA,NA,NA,NA
"16799","Cluster_796","Peve_00027704",0.999428282268221,0.0215281467469597,0.825175158091499,162,-21.26,"2 21","697 717",19,"78.95%","78.95%","CDS",NA,NA,NA,NA,NA
"16806","Cluster_796","Peve_00027784",0.997140486812467,0.0481553691265201,0.945590536869992,154,-21.51,"2 20","10107 10130",20,"70.00%","75.00%","CDS",NA,NA,NA,NA,NA
"16830","Cluster_796","Peve_00028320",0.999195193052596,0.0255428945461616,0.874749654447263,147,-23.89,"2 21","3030 3047",19,"68.42%","73.68%","CDS","Q8K2C7","Protein OS-9","Mus musculus (Mouse)","endoplasmic reticulum unfolded protein response [GO:0030968]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; protein retention in ER lumen [GO:0006621]; protein targeting [GO:0006605]; protein ubiquitination [GO:0016567]; response to endoplasmic reticulum stress [GO:0034976]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0002020; GO:0005783; GO:0005788; GO:0006511; GO:0006605; GO:0006621; GO:0016567; GO:0030246; GO:0030433; GO:0030968; GO:0030970; GO:0034976; GO:1904153"
"16847","Cluster_796","Peve_00028552",0.997584742184647,0.0442552011106836,0.925509732146748,155,-26.61,"2 21","85 107",20,"70.00%","75.00%","CDS",NA,NA,NA,NA,NA
"16883","Cluster_796","Peve_00029553",0.997579534055322,0.044302909403768,0.925966041019024,153,-23.18,"2 20","5168 5188",18,"72.22%","77.78%","CDS","Q9QYE5","Protein jagged-2 (Jagged2)","Mus musculus (Mouse)","auditory receptor cell fate commitment [GO:0009912]; cell differentiation [GO:0030154]; cell fate determination [GO:0001709]; epithelial cell apoptotic process involved in palatal shelf morphogenesis [GO:1990134]; gamma-delta T cell differentiation [GO:0042492]; in utero embryonic development [GO:0001701]; morphogenesis of embryonic epithelium [GO:0016331]; Notch signaling pathway [GO:0007219]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of Notch signaling pathway [GO:0045747]; regulation of cell adhesion [GO:0030155]; regulation of cell population proliferation [GO:0042127]; respiratory system process [GO:0003016]; sensory perception of sound [GO:0007605]; skeletal system development [GO:0001501]; spermatogenesis [GO:0007283]; T cell differentiation [GO:0030217]; thymic T cell selection [GO:0045061]","GO:0001501; GO:0001701; GO:0001709; GO:0003016; GO:0005112; GO:0005509; GO:0005886; GO:0007219; GO:0007283; GO:0007605; GO:0008083; GO:0009912; GO:0016020; GO:0016331; GO:0030154; GO:0030155; GO:0030217; GO:0042127; GO:0042475; GO:0042492; GO:0045061; GO:0045747; GO:0048471; GO:1990134"
"16886","Cluster_796","Peve_00029337",0.999786507142086,0.0131551111881724,0.70385628957585,145,-22.58,"2 10","14196 14217",8,"100.00%","100.00%","CDS","Q6DIR8","Paladin","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","","GO:0005829"
"16887","Cluster_796","Peve_00029613",0.99908589935091,0.0272223251762608,0.89352352371634,165,-21.2,"2 19","16357 16379",18,"83.33%","83.33%","CDS","P49283","Protein Malvolio","Drosophila melanogaster (Fruit fly)","copper ion homeostasis [GO:0055070]; copper ion import [GO:0015677]; iron ion homeostasis [GO:0055072]; iron ion transmembrane transport [GO:0034755]; manganese ion homeostasis [GO:0055071]; metal ion transport [GO:0030001]; positive regulation of iron ion transmembrane transport [GO:0034761]; response to manganese ion [GO:0010042]; sensory perception of sweet taste [GO:0050916]; transition metal ion homeostasis [GO:0055076]; transition metal ion transport [GO:0000041]; viral entry into host cell [GO:0046718]","GO:0000041; GO:0005375; GO:0005381; GO:0005384; GO:0005768; GO:0005886; GO:0010042; GO:0015086; GO:0015293; GO:0015677; GO:0016020; GO:0016324; GO:0030001; GO:0034755; GO:0034761; GO:0046718; GO:0050916; GO:0055070; GO:0055071; GO:0055072; GO:0055076"
"16948","Cluster_796","Peve_00031279",-0.999788315113122,0.0130992885452887,0.702492819331413,150,-20.56,"2 21","4638 4663",23,"65.22%","73.91%","CDS",NA,NA,NA,NA,NA
"16950","Cluster_796","Peve_00031401",-0.999574748753192,0.0185666397208717,0.782669382293497,157,-22.95,"2 20","38656 38679",20,"75.00%","80.00%","CDS","A0A0R4IC37","Cleavage and polyadenylation specificity factor subunit 1 (Cleavage and polyadenylation specific factor 1)","Danio rerio (Zebrafish) (Brachydanio rerio)","definitive hemopoiesis [GO:0060216]; mRNA polyadenylation [GO:0006378]; retinal ganglion cell axon guidance [GO:0031290]","GO:0003676; GO:0005634; GO:0005654; GO:0005847; GO:0006378; GO:0031290; GO:0060216"
"16959","Cluster_796","Peve_00031438",0.999463033231593,0.0208635525823051,0.817190070029867,150,-20.02,"2 19","13339 13360",17,"70.59%","70.59%","CDS","Q9WV92","Band 4.1-like protein 3 (4.1B) (Differentially expressed in adenocarcinoma of the lung protein 1) (DAL-1) (DAL1P) (mDAL-1) (Erythrocyte membrane protein band 4.1-like 3) [Cleaved into: Band 4.1-like protein 3, N-terminally processed]","Mus musculus (Mouse)","actomyosin structure organization [GO:0031032]; apoptotic process [GO:0006915]; axon development [GO:0061564]; cortical actin cytoskeleton organization [GO:0030866]; cortical cytoskeleton organization [GO:0030865]; myelin maintenance [GO:0043217]; neuron projection morphogenesis [GO:0048812]; paranodal junction assembly [GO:0030913]; paranodal junction maintenance [GO:1990227]; protein localization to juxtaparanode region of axon [GO:0071205]; protein localization to paranode region of axon [GO:0002175]; protein localization to plasma membrane [GO:0072659]; regulation of cell shape [GO:0008360]","GO:0002175; GO:0003779; GO:0005200; GO:0005829; GO:0005856; GO:0005886; GO:0005911; GO:0006915; GO:0008360; GO:0014069; GO:0030054; GO:0030865; GO:0030866; GO:0030913; GO:0031032; GO:0033270; GO:0043217; GO:0044224; GO:0048812; GO:0061564; GO:0071205; GO:0072659; GO:0106006; GO:1990227"
"16962","Cluster_796","Peve_00031436",0.998066590605977,0.0395937858906724,0.909359886114279,159,-22.12,"2 20","2372 2393",18,"72.22%","77.78%","CDS","Q0P5B1","Peroxisomal membrane protein PEX13 (Peroxin-13)","Bos taurus (Bovine)","cerebral cortex cell migration [GO:0021795]; fatty acid alpha-oxidation [GO:0001561]; locomotory behavior [GO:0007626]; microtubule-based peroxisome localization [GO:0060152]; neuron migration [GO:0001764]; protein import into peroxisome matrix, docking [GO:0016560]; suckling behavior [GO:0001967]","GO:0001561; GO:0001764; GO:0001967; GO:0005778; GO:0007626; GO:0008320; GO:0016560; GO:0021795; GO:0060152; GO:1990429"
"16970","Cluster_796","Peve_00031940",-0.999663016871668,0.0165276609923165,0.773377054133803,155,-20.27,"2 21","16569 16587",19,"78.95%","78.95%","CDS","Q90WU3","ATP-dependent RNA helicase DDX1 (EC 3.6.4.13) (DEAD box protein 1)","Gallus gallus (Chicken)","DNA duplex unwinding [GO:0032508]; double-strand break repair [GO:0006302]; mRNA processing [GO:0006397]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]","GO:0003677; GO:0003682; GO:0003712; GO:0003724; GO:0004518; GO:0004527; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006302; GO:0006388; GO:0006397; GO:0008143; GO:0016887; GO:0032508; GO:0033677; GO:0072669"
"16987","Cluster_796","Peve_00032517",0.999294723514205,0.0239111437943281,0.855533940161032,150,-20.5,"2 19","12745 12764",17,"76.47%","82.35%","CDS","B3EWZ6","MAM and LDL-receptor class A domain-containing protein 2 (Skeletal organic matrix MAM and LDL-receptor 2) (SOM MAM and LDL-receptor 2)","Acropora millepora (Staghorn coral) (Heteropora millepora)","","GO:0005576; GO:0016020"
"17004","Cluster_796","Peve_00032741",0.998858866440977,0.0304161798288484,0.903929377050813,152,-21.16,"2 19","247 267",17,"76.47%","76.47%","CDS",NA,NA,NA,NA,NA
"17032","Cluster_796","Peve_00033364",0.999260034938896,0.0244921839031936,0.862029780817471,143,-24.72,"2 21","13975 14000",23,"60.87%","65.22%","CDS","P22045","9,11-endoperoxide prostaglandin H2 reductase (EC 1.1.1.-) (Prostaglandin F2-alpha synthase)","Leishmania major","prostaglandin biosynthetic process [GO:0001516]","GO:0000166; GO:0001516; GO:0005737; GO:0036130"
"17046","Cluster_796","Peve_00033615",0.997011540117915,0.0492296843450919,0.950396228648067,149,-21.33,"2 21","14876 14901",23,"69.57%","73.91%","CDS","Q4KKX4","Nuclear receptor corepressor 1 (N-CoR) (N-CoR1) (xN-CoR)","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","chromatin organization [GO:0006325]; negative regulation of DNA-templated transcription [GO:0045892]; rhythmic process [GO:0048511]","GO:0003677; GO:0005634; GO:0006325; GO:0045892; GO:0048511"
"17048","Cluster_796","Peve_00033936",0.999380858601722,0.022403323633518,0.836588264687313,149,-22.6,"2 21","292 311",19,"68.42%","73.68%","CDS","Q5R592","DNA-directed RNA polymerases I, II, and III subunit RPABC2 (RNA polymerases I, II, and III subunit ABC2) (DNA-directed RNA polymerase II subunit F) (RPB6 homolog)","Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)","transcription by RNA polymerase II [GO:0006366]","GO:0003677; GO:0003899; GO:0005634; GO:0005665; GO:0006366"
"17082","Cluster_796","Peve_00034383",-0.999988382607111,0.00306866782499649,0.477058746205851,152,-20.76,"2 19","1299 1322",19,"73.68%","78.95%","CDS","P26686","Serine-arginine protein 55 (SRP55) (52 kDa bracketing protein) (B52 protein) (Protein enhancer of deformed)","Drosophila melanogaster (Fruit fly)","defense response to virus [GO:0051607]; mitotic cell cycle [GO:0000278]; mitotic G1/S transition checkpoint signaling [GO:0044819]; mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of mRNA 3'-end processing [GO:0031440]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of transcriptional start site selection at RNA polymerase II promoter [GO:0001178]; RNA splicing [GO:0008380]","GO:0000278; GO:0000381; GO:0000398; GO:0000791; GO:0001178; GO:0003723; GO:0003729; GO:0005634; GO:0005700; GO:0008380; GO:0010468; GO:0016607; GO:0031440; GO:0044819; GO:0048024; GO:0051607; GO:0071011; GO:0071013"
"17095","Cluster_796","Peve_00034882",0.999032467114065,0.0280067690996117,0.900518559487794,155,-22.05,"2 21","60065 60087",20,"70.00%","75.00%","CDS","B3EWZ3","Coadhesin","Acropora millepora (Staghorn coral) (Heteropora millepora)","","GO:0016020"
"17129","Cluster_796","Peve_00035917",0.999981018293529,0.00392250435471787,0.54328949385489,153,-21.21,"2 20","1614 1637",20,"75.00%","75.00%","CDS",NA,NA,NA,NA,NA
"17149","Cluster_796","Peve_00036254",0.999880035047393,0.00986112935939381,0.61624048679314,158,-22.92,"2 21","17798 17821",21,"76.19%","76.19%","CDS","Q9V410","Leucine-zipper-like transcriptional regulator 1 homolog","Drosophila melanogaster (Fruit fly)","gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of Ras protein signal transduction [GO:0046580]; positive regulation of glycogen metabolic process [GO:0070875]; protein ubiquitination [GO:0016567]; sleep [GO:0030431]; triglyceride homeostasis [GO:0070328]","GO:0005794; GO:0007214; GO:0016567; GO:0030431; GO:0046580; GO:0070328; GO:0070875"
"17166","Cluster_796","Peve_00036728",0.997360080379969,0.0462685682564016,0.936911796713976,149,-22.71,"2 21","10938 10962",22,"68.18%","77.27%","CDS","Q5XPI4","E3 ubiquitin-protein ligase RNF123 (EC 2.3.2.27) (Kip1 ubiquitination-promoting complex protein 1) (RING finger protein 123) (RING-type E3 ubiquitin transferase RNF123)","Homo sapiens (Human)","proteolysis involved in protein catabolic process [GO:0051603]","GO:0004842; GO:0005737; GO:0005829; GO:0031965; GO:0046872; GO:0051603"
"17167","Cluster_796","Peve_00036728",0.997360080379969,0.0462685682564016,0.936911796713976,149,-22.71,"2 21","11009 11033",22,"68.18%","77.27%","CDS","Q5XPI4","E3 ubiquitin-protein ligase RNF123 (EC 2.3.2.27) (Kip1 ubiquitination-promoting complex protein 1) (RING finger protein 123) (RING-type E3 ubiquitin transferase RNF123)","Homo sapiens (Human)","proteolysis involved in protein catabolic process [GO:0051603]","GO:0004842; GO:0005737; GO:0005829; GO:0031965; GO:0046872; GO:0051603"
"17170","Cluster_796","Peve_00036754",0.998289056177381,0.0372455967032224,0.909359886114279,155,-20.93,"2 12","2868 2889",10,"100.00%","100.00%","CDS","Q14161","ARF GTPase-activating protein GIT2 (ARF GAP GIT2) (Cool-interacting tyrosine-phosphorylated protein 2) (CAT-2) (CAT2) (G protein-coupled receptor kinase-interactor 2) (GRK-interacting protein 2)","Homo sapiens (Human)","brain development [GO:0007420]; regulation of ARF protein signal transduction [GO:0032012]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; synaptic vesicle recycling [GO:0036465]","GO:0005096; GO:0005654; GO:0005925; GO:0007420; GO:0008277; GO:0031267; GO:0032012; GO:0036465; GO:0045202; GO:0046872; GO:0098793"
"17181","Cluster_796","Peve_00037143",0.997039206619985,0.0490011626023253,0.949533023346653,160,-22.53,"2 21","3083 3105",21,"80.95%","80.95%","CDS",NA,NA,NA,NA,NA
"17201","Cluster_796","Peve_00037461",0.999848047205772,0.0110982618086229,0.650685374622803,151,-20.46,"2 21","520 543",21,"66.67%","71.43%","CDS","Q54AX5","Leucine-rich repeat protein lrrA","Dictyostelium discoideum (Social amoeba)","aggregation involved in sorocarp development [GO:0031152]; cell-cell adhesion [GO:0098609]; cell-substrate adhesion [GO:0031589]; chemotaxis to cAMP [GO:0043327]; chemotaxis to folate [GO:0043326]; culmination involved in sorocarp development [GO:0031154]; establishment or maintenance of cell polarity [GO:0007163]; regulation of actin filament polymerization [GO:0030833]","GO:0005737; GO:0007163; GO:0030833; GO:0031152; GO:0031154; GO:0031589; GO:0043326; GO:0043327; GO:0045335; GO:0098609"
"17202","Cluster_796","Peve_00037461",0.999848047205772,0.0110982618086229,0.650685374622803,151,-20.46,"2 21","652 675",21,"66.67%","71.43%","CDS","Q54AX5","Leucine-rich repeat protein lrrA","Dictyostelium discoideum (Social amoeba)","aggregation involved in sorocarp development [GO:0031152]; cell-cell adhesion [GO:0098609]; cell-substrate adhesion [GO:0031589]; chemotaxis to cAMP [GO:0043327]; chemotaxis to folate [GO:0043326]; culmination involved in sorocarp development [GO:0031154]; establishment or maintenance of cell polarity [GO:0007163]; regulation of actin filament polymerization [GO:0030833]","GO:0005737; GO:0007163; GO:0030833; GO:0031152; GO:0031154; GO:0031589; GO:0043326; GO:0043327; GO:0045335; GO:0098609"
"17203","Cluster_796","Peve_00037461",0.999848047205772,0.0110982618086229,0.650685374622803,151,-20.46,"2 21","790 813",21,"66.67%","71.43%","CDS","Q54AX5","Leucine-rich repeat protein lrrA","Dictyostelium discoideum (Social amoeba)","aggregation involved in sorocarp development [GO:0031152]; cell-cell adhesion [GO:0098609]; cell-substrate adhesion [GO:0031589]; chemotaxis to cAMP [GO:0043327]; chemotaxis to folate [GO:0043326]; culmination involved in sorocarp development [GO:0031154]; establishment or maintenance of cell polarity [GO:0007163]; regulation of actin filament polymerization [GO:0030833]","GO:0005737; GO:0007163; GO:0030833; GO:0031152; GO:0031154; GO:0031589; GO:0043326; GO:0043327; GO:0045335; GO:0098609"
"17204","Cluster_796","Peve_00037461",0.999848047205772,0.0110982618086229,0.650685374622803,151,-20.46,"2 21","928 951",21,"66.67%","71.43%","CDS","Q54AX5","Leucine-rich repeat protein lrrA","Dictyostelium discoideum (Social amoeba)","aggregation involved in sorocarp development [GO:0031152]; cell-cell adhesion [GO:0098609]; cell-substrate adhesion [GO:0031589]; chemotaxis to cAMP [GO:0043327]; chemotaxis to folate [GO:0043326]; culmination involved in sorocarp development [GO:0031154]; establishment or maintenance of cell polarity [GO:0007163]; regulation of actin filament polymerization [GO:0030833]","GO:0005737; GO:0007163; GO:0030833; GO:0031152; GO:0031154; GO:0031589; GO:0043326; GO:0043327; GO:0045335; GO:0098609"
"17205","Cluster_796","Peve_00037461",0.999848047205772,0.0110982618086229,0.650685374622803,151,-22.32,"2 21","1756 1779",21,"66.67%","71.43%","CDS","Q54AX5","Leucine-rich repeat protein lrrA","Dictyostelium discoideum (Social amoeba)","aggregation involved in sorocarp development [GO:0031152]; cell-cell adhesion [GO:0098609]; cell-substrate adhesion [GO:0031589]; chemotaxis to cAMP [GO:0043327]; chemotaxis to folate [GO:0043326]; culmination involved in sorocarp development [GO:0031154]; establishment or maintenance of cell polarity [GO:0007163]; regulation of actin filament polymerization [GO:0030833]","GO:0005737; GO:0007163; GO:0030833; GO:0031152; GO:0031154; GO:0031589; GO:0043326; GO:0043327; GO:0045335; GO:0098609"
"17206","Cluster_796","Peve_00037461",0.999848047205772,0.0110982618086229,0.650685374622803,151,-33.18,"2 21","1335 1365",28,"64.29%","64.29%","CDS","Q54AX5","Leucine-rich repeat protein lrrA","Dictyostelium discoideum (Social amoeba)","aggregation involved in sorocarp development [GO:0031152]; cell-cell adhesion [GO:0098609]; cell-substrate adhesion [GO:0031589]; chemotaxis to cAMP [GO:0043327]; chemotaxis to folate [GO:0043326]; culmination involved in sorocarp development [GO:0031154]; establishment or maintenance of cell polarity [GO:0007163]; regulation of actin filament polymerization [GO:0030833]","GO:0005737; GO:0007163; GO:0030833; GO:0031152; GO:0031154; GO:0031589; GO:0043326; GO:0043327; GO:0045335; GO:0098609"
"17207","Cluster_796","Peve_00037461",0.999848047205772,0.0110982618086229,0.650685374622803,151,-33.18,"2 21","1611 1641",28,"64.29%","64.29%","CDS","Q54AX5","Leucine-rich repeat protein lrrA","Dictyostelium discoideum (Social amoeba)","aggregation involved in sorocarp development [GO:0031152]; cell-cell adhesion [GO:0098609]; cell-substrate adhesion [GO:0031589]; chemotaxis to cAMP [GO:0043327]; chemotaxis to folate [GO:0043326]; culmination involved in sorocarp development [GO:0031154]; establishment or maintenance of cell polarity [GO:0007163]; regulation of actin filament polymerization [GO:0030833]","GO:0005737; GO:0007163; GO:0030833; GO:0031152; GO:0031154; GO:0031589; GO:0043326; GO:0043327; GO:0045335; GO:0098609"
"17208","Cluster_796","Peve_00037461",0.999848047205772,0.0110982618086229,0.650685374622803,151,-35.19,"2 21","1197 1227",28,"64.29%","64.29%","CDS","Q54AX5","Leucine-rich repeat protein lrrA","Dictyostelium discoideum (Social amoeba)","aggregation involved in sorocarp development [GO:0031152]; cell-cell adhesion [GO:0098609]; cell-substrate adhesion [GO:0031589]; chemotaxis to cAMP [GO:0043327]; chemotaxis to folate [GO:0043326]; culmination involved in sorocarp development [GO:0031154]; establishment or maintenance of cell polarity [GO:0007163]; regulation of actin filament polymerization [GO:0030833]","GO:0005737; GO:0007163; GO:0030833; GO:0031152; GO:0031154; GO:0031589; GO:0043326; GO:0043327; GO:0045335; GO:0098609"
"17209","Cluster_796","Peve_00037461",0.999848047205772,0.0110982618086229,0.650685374622803,158,-23.1,"2 21","1489 1512",21,"71.43%","80.95%","CDS","Q54AX5","Leucine-rich repeat protein lrrA","Dictyostelium discoideum (Social amoeba)","aggregation involved in sorocarp development [GO:0031152]; cell-cell adhesion [GO:0098609]; cell-substrate adhesion [GO:0031589]; chemotaxis to cAMP [GO:0043327]; chemotaxis to folate [GO:0043326]; culmination involved in sorocarp development [GO:0031154]; establishment or maintenance of cell polarity [GO:0007163]; regulation of actin filament polymerization [GO:0030833]","GO:0005737; GO:0007163; GO:0030833; GO:0031152; GO:0031154; GO:0031589; GO:0043326; GO:0043327; GO:0045335; GO:0098609"
"17210","Cluster_796","Peve_00037461",0.999848047205772,0.0110982618086229,0.650685374622803,159,-23.44,"2 21","382 405",21,"71.43%","76.19%","CDS","Q54AX5","Leucine-rich repeat protein lrrA","Dictyostelium discoideum (Social amoeba)","aggregation involved in sorocarp development [GO:0031152]; cell-cell adhesion [GO:0098609]; cell-substrate adhesion [GO:0031589]; chemotaxis to cAMP [GO:0043327]; chemotaxis to folate [GO:0043326]; culmination involved in sorocarp development [GO:0031154]; establishment or maintenance of cell polarity [GO:0007163]; regulation of actin filament polymerization [GO:0030833]","GO:0005737; GO:0007163; GO:0030833; GO:0031152; GO:0031154; GO:0031589; GO:0043326; GO:0043327; GO:0045335; GO:0098609"
"17211","Cluster_796","Peve_00037461",0.999848047205772,0.0110982618086229,0.650685374622803,162,-26.61,"2 21","253 276",21,"76.19%","80.95%","CDS","Q54AX5","Leucine-rich repeat protein lrrA","Dictyostelium discoideum (Social amoeba)","aggregation involved in sorocarp development [GO:0031152]; cell-cell adhesion [GO:0098609]; cell-substrate adhesion [GO:0031589]; chemotaxis to cAMP [GO:0043327]; chemotaxis to folate [GO:0043326]; culmination involved in sorocarp development [GO:0031154]; establishment or maintenance of cell polarity [GO:0007163]; regulation of actin filament polymerization [GO:0030833]","GO:0005737; GO:0007163; GO:0030833; GO:0031152; GO:0031154; GO:0031589; GO:0043326; GO:0043327; GO:0045335; GO:0098609"
"17231","Cluster_796","Peve_00037776",0.999479239377096,0.0205462722495551,0.812435710552529,153,-20.62,"2 20","4257 4284",24,"70.83%","70.83%","CDS","Q0V9W6","BTB/POZ domain-containing protein 6","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","","GO:0005737"
"17232","Cluster_796","Peve_00037776",0.999479239377096,0.0205462722495551,0.812435710552529,153,-20.62,"2 20","5618 5645",24,"70.83%","70.83%","CDS","Q0V9W6","BTB/POZ domain-containing protein 6","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","","GO:0005737"
"17251","Cluster_796","Peve_00038086",0.99928607481456,0.0240573237932185,0.856569794819485,155,-24.7,"2 20","7701 7722",18,"66.67%","77.78%","CDS",NA,NA,NA,NA,NA
"17278","Cluster_796","Peve_00038655",0.997432993613974,0.0456248597186151,0.93332862243605,152,-20.99,"2 20","5725 5750",22,"72.73%","77.27%","CDS","H9D1R1","Thioredoxin domain-containing protein 12 (EC 1.8.4.2)","Epinephelus coioides (Orange-spotted grouper) (Epinephelus nebulosus)","defense response to virus [GO:0051607]","GO:0005788; GO:0009055; GO:0019153; GO:0051607"
"17281","Cluster_796","Peve_00038764",0.999984165927141,0.00358254796236332,0.524089804097317,162,-25.28,"2 21","17511 17534",21,"76.19%","80.95%","CDS","Q6DIC0","Probable global transcription activator SNF2L2 (EC 3.6.4.-) (ATP-dependent helicase SMARCA2) (BRG1-associated factor 190B) (BAF190B) (Protein brahma homolog) (SNF2-alpha) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 2)","Mus musculus (Mouse)","aortic smooth muscle cell differentiation [GO:0035887]; cell population proliferation [GO:0008283]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; fibroblast proliferation [GO:0048144]; hematopoietic stem cell homeostasis [GO:0061484]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of fibroblast proliferation [GO:0048147]; nervous system development [GO:0007399]; nucleosome assembly [GO:0006334]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000785; GO:0000976; GO:0003677; GO:0003682; GO:0003713; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0006325; GO:0006334; GO:0006338; GO:0006357; GO:0007399; GO:0008094; GO:0008283; GO:0008284; GO:0008285; GO:0016514; GO:0016787; GO:0030071; GO:0030308; GO:0035060; GO:0035887; GO:0042393; GO:0043231; GO:0045111; GO:0045582; GO:0045596; GO:0045597; GO:0045663; GO:0045892; GO:0045893; GO:0045944; GO:0048144; GO:0048147; GO:0061484; GO:0070316; GO:0071564; GO:0071565; GO:0140092; GO:0140288; GO:0140658; GO:1902459; GO:2000045; GO:2000781; GO:2000819"
"17283","Cluster_796","Peve_00036964",0.997077513398696,0.0486829862370013,0.94805481250488,153,-21.1,"2 19","18208 18232",20,"70.00%","75.00%","CDS","Q80TN7","Neuron navigator 3 (Pore membrane and/or filament-interacting-like protein 1)","Mus musculus (Mouse)","negative regulation of cell migration [GO:0030336]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of microtubule depolymerization [GO:0007026]; nervous system development [GO:0007399]; neurogenesis [GO:0022008]; positive regulation of microtubule polymerization [GO:0031116]","GO:0005524; GO:0005634; GO:0005635; GO:0005640; GO:0007026; GO:0007399; GO:0008017; GO:0016887; GO:0022008; GO:0030336; GO:0031116; GO:0032703; GO:1990752"
"17288","Cluster_796","Peve_00038927",0.999994129428633,0.00218140105711895,0.379078774249685,152,-20.95,"2 21","18204 18225",19,"63.16%","73.68%","CDS","Q14832","Metabotropic glutamate receptor 3 (mGluR3)","Homo sapiens (Human)","chemical synaptic transmission [GO:0007268]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; gene expression [GO:0010467]; negative regulation of adenylate cyclase activity [GO:0007194]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; regulation of synaptic transmission, glutamatergic [GO:0051966]","GO:0001640; GO:0001641; GO:0004930; GO:0005246; GO:0005886; GO:0007194; GO:0007216; GO:0007268; GO:0008066; GO:0010467; GO:0014069; GO:0030424; GO:0042734; GO:0043197; GO:0045211; GO:0051966; GO:0097110; GO:0097449; GO:0098978; GO:0099170"
"17289","Cluster_796","Peve_00038927",0.999994129428633,0.00218140105711895,0.379078774249685,152,-20.95,"2 21","21996 22017",19,"63.16%","73.68%","CDS","Q14832","Metabotropic glutamate receptor 3 (mGluR3)","Homo sapiens (Human)","chemical synaptic transmission [GO:0007268]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; gene expression [GO:0010467]; negative regulation of adenylate cyclase activity [GO:0007194]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; regulation of synaptic transmission, glutamatergic [GO:0051966]","GO:0001640; GO:0001641; GO:0004930; GO:0005246; GO:0005886; GO:0007194; GO:0007216; GO:0007268; GO:0008066; GO:0010467; GO:0014069; GO:0030424; GO:0042734; GO:0043197; GO:0045211; GO:0051966; GO:0097110; GO:0097449; GO:0098978; GO:0099170"
"17302","Cluster_796","Peve_00039069",0.997317016749437,0.0466445867445898,0.938976395895687,151,-20.66,"2 21","8777 8799",20,"70.00%","70.00%","CDS","P60027","General transcription factor IIH subunit 4 (Basic transcription factor 2 52 kDa subunit) (BTF2 p52) (General transcription factor IIH polypeptide 4) (TFIIH basal transcription factor complex p52 subunit)","Pan troglodytes (Chimpanzee)","nucleotide-excision repair [GO:0006289]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; transcription by RNA polymerase II [GO:0006366]","GO:0000438; GO:0000439; GO:0001671; GO:0003690; GO:0005634; GO:0005669; GO:0005675; GO:0006289; GO:0006366; GO:0016251; GO:0016607; GO:0070816"
"17324","Cluster_796","Peve_00039735",0.99924851937578,0.0246820492900172,0.864470993738875,155,-22.05,"2 21","35431 35453",20,"70.00%","75.00%","CDS","Q9Y2G3","Phospholipid-transporting ATPase IF (EC 7.6.2.1) (ATPase IR) (ATPase class VI type 11B) (P4-ATPase flippase complex alpha subunit ATP11B)","Homo sapiens (Human)","aminophospholipid transport [GO:0015917]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; phospholipid translocation [GO:0045332]","GO:0000287; GO:0005524; GO:0005637; GO:0005783; GO:0005802; GO:0005886; GO:0006811; GO:0015075; GO:0015917; GO:0016020; GO:0016887; GO:0031901; GO:0034220; GO:0035577; GO:0045332; GO:0055037; GO:0055038; GO:0090555; GO:0090556; GO:0140326; GO:1990531"
"17329","Cluster_796","Peve_00039588",0.999983457432514,0.0036618215569645,0.529730745706329,157,-24.38,"2 21","33361 33386",23,"73.91%","78.26%","CDS",NA,NA,NA,NA,NA
"17336","Cluster_796","Peve_00040059",0.999626870838226,0.0173915472885537,0.782669382293497,161,-20.69,"2 18","322 343",16,"81.25%","81.25%","CDS",NA,NA,NA,NA,NA
"17362","Cluster_796","Peve_00040756",0.999742717620937,0.0144414052132105,0.731897665835973,154,-21.19,"2 21","13954 13978",22,"68.18%","77.27%","CDS","Q80TE4","Signal-induced proliferation-associated 1-like protein 2 (SIPA1-like protein 2)","Mus musculus (Mouse)","activation of GTPase activity [GO:0090630]; regulation of small GTPase mediated signal transduction [GO:0051056]","GO:0005096; GO:0005737; GO:0051056; GO:0090630"
"17368","Cluster_796","Peve_00040912",-0.999920563539171,0.00802431444871135,0.573710369894872,176,-22.4,"2 21","5226 5247",19,"84.21%","84.21%","CDS",NA,NA,NA,NA,NA
"17377","Cluster_796","Peve_00041095",0.999868996931266,0.0103048244251447,0.629647545468991,170,-21,"2 21","14717 14737",19,"84.21%","84.21%","CDS","Q8IS64","Endothelin-converting enzyme homolog (ECE) (EC 3.4.24.-)","Locusta migratoria (Migratory locust)","proteolysis [GO:0006508]","GO:0004175; GO:0004222; GO:0005886; GO:0006508; GO:0008270"
"17416","Cluster_796","Peve_00041750",0.99983472343522,0.0115746199867111,0.663496317927119,151,-22.39,"2 21","12668 12685",19,"73.68%","73.68%","CDS","Q8BKX6","Serine/threonine-protein kinase SMG1 (SMG-1) (EC 2.7.11.1) (Lambda/iota protein kinase C-interacting protein) (Lambda-interacting protein) (Nonsense mediated mRNA decay-associated PI3K-related kinase SMG1)","Mus musculus (Mouse)","DNA repair [GO:0006281]; negative regulation of macroautophagy [GO:0016242]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; peptidyl-serine phosphorylation [GO:0018105]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of response to DNA damage stimulus [GO:2001020]; regulation of telomere maintenance [GO:0032204]; TOR signaling [GO:0031929]","GO:0000184; GO:0004674; GO:0004697; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006281; GO:0006468; GO:0016242; GO:0018105; GO:0031929; GO:0031931; GO:0031932; GO:0032204; GO:0033391; GO:0042162; GO:0046777; GO:0046854; GO:0046872; GO:0106310; GO:2001020"
"17417","Cluster_796","Peve_00041750",0.99983472343522,0.0115746199867111,0.663496317927119,159,-21.09,"2 21","11059 11081",20,"75.00%","75.00%","CDS","Q8BKX6","Serine/threonine-protein kinase SMG1 (SMG-1) (EC 2.7.11.1) (Lambda/iota protein kinase C-interacting protein) (Lambda-interacting protein) (Nonsense mediated mRNA decay-associated PI3K-related kinase SMG1)","Mus musculus (Mouse)","DNA repair [GO:0006281]; negative regulation of macroautophagy [GO:0016242]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; peptidyl-serine phosphorylation [GO:0018105]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of response to DNA damage stimulus [GO:2001020]; regulation of telomere maintenance [GO:0032204]; TOR signaling [GO:0031929]","GO:0000184; GO:0004674; GO:0004697; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006281; GO:0006468; GO:0016242; GO:0018105; GO:0031929; GO:0031931; GO:0031932; GO:0032204; GO:0033391; GO:0042162; GO:0046777; GO:0046854; GO:0046872; GO:0106310; GO:2001020"
"17423","Cluster_796","Peve_00042419",0.998150011594241,0.0387299200197762,0.909359886114279,157,-20.95,"2 21","8844 8868",22,"77.27%","77.27%","CDS",NA,NA,NA,NA,NA
"17430","Cluster_796","Peve_00042649",0.999999352596528,0.000724407029937386,0.239778920002343,155,-25.28,"2 21","129 151",20,"70.00%","75.00%","CDS",NA,NA,NA,NA,NA
"17450","Cluster_796","Peve_00042940",0.999893013165731,0.00931245444676547,0.600139271338457,175,-28.05,"2 21","22514 22536",20,"85.00%","85.00%","CDS","Q8IPH9","Slowpoke-binding protein","Drosophila melanogaster (Fruit fly)","modulation of chemical synaptic transmission [GO:0050804]; negative regulation of ATP-dependent activity [GO:0032780]; negative regulation of ion transport [GO:0043271]; neuromuscular synaptic transmission [GO:0007274]; regulation of membrane potential [GO:0042391]; response to starvation [GO:0042594]","GO:0004672; GO:0005737; GO:0005886; GO:0007274; GO:0032780; GO:0042391; GO:0042594; GO:0043271; GO:0045202; GO:0050804"
"17451","Cluster_796","Peve_00043040",0.997958237792955,0.0406884946615009,0.909359886114279,163,-22.61,"2 17","9183 9205",16,"87.50%","87.50%","CDS","P02459","Collagen alpha-1(II) chain (Alpha-1 type II collagen)","Bos taurus (Bovine)","anterior head development [GO:0097065]; cartilage condensation [GO:0001502]; cartilage development involved in endochondral bone morphogenesis [GO:0060351]; cellular response to BMP stimulus [GO:0071773]; central nervous system development [GO:0007417]; chondrocyte differentiation [GO:0002062]; collagen fibril organization [GO:0030199]; embryonic skeletal joint morphogenesis [GO:0060272]; endochondral ossification [GO:0001958]; extracellular matrix organization [GO:0030198]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; heart morphogenesis [GO:0003007]; inner ear morphogenesis [GO:0042472]; limb bud formation [GO:0060174]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; notochord development [GO:0030903]; otic vesicle development [GO:0071599]; proteoglycan metabolic process [GO:0006029]; regulation of gene expression [GO:0010468]; roof of mouth development [GO:0060021]; sensory perception of sound [GO:0007605]; skeletal system development [GO:0001501]; tissue homeostasis [GO:0001894]; visual perception [GO:0007601]","GO:0001501; GO:0001502; GO:0001894; GO:0001958; GO:0002062; GO:0003007; GO:0005201; GO:0005576; GO:0005581; GO:0005585; GO:0005592; GO:0005604; GO:0005615; GO:0005737; GO:0006029; GO:0007417; GO:0007601; GO:0007605; GO:0010468; GO:0030198; GO:0030199; GO:0030903; GO:0031012; GO:0042289; GO:0042472; GO:0042802; GO:0043394; GO:0046872; GO:0048407; GO:0060021; GO:0060174; GO:0060272; GO:0060351; GO:0062023; GO:0071599; GO:0071773; GO:0097065; GO:0097192; GO:2001240"
"17471","Cluster_796","Peve_00043455",0.999999734253511,0.000464118519054011,0.239778920002343,148,-20.7,"2 21","16364 16385",19,"63.16%","68.42%","CDS","P91309","Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase (EC 2.7.4.24) (InsP6 and PP-IP5 kinase)","Caenorhabditis elegans","inositol metabolic process [GO:0006020]; inositol phosphate biosynthetic process [GO:0032958]; phosphorylation [GO:0016310]","GO:0000827; GO:0000828; GO:0000829; GO:0000832; GO:0005524; GO:0005737; GO:0005829; GO:0006020; GO:0016310; GO:0032958; GO:0033857; GO:0052723; GO:0052724"
"17483","Cluster_796","Peve_00044008",0.997859048240646,0.0416654499063484,0.909359886114279,160,-21.65,"2 21","7820 7842",21,"80.95%","80.95%","CDS",NA,NA,NA,NA,NA
"17490","Cluster_796","Peve_00043688",0.997883962349723,0.0414222254288143,0.909359886114279,149,-21.34,"2 19","2694 2718",20,"70.00%","70.00%","CDS","Q6NXT4","Zinc transporter 6 (ZnT-6) (Solute carrier family 30 member 6)","Homo sapiens (Human)","cellular zinc ion homeostasis [GO:0006882]; insulin processing [GO:0030070]; regulation of zinc ion transport [GO:0071579]; zinc ion import into Golgi lumen [GO:1904257]; zinc ion import into organelle [GO:0062111]; zinc ion transmembrane transport [GO:0071577]; zinc ion transport [GO:0006829]","GO:0000139; GO:0005385; GO:0005794; GO:0006829; GO:0006882; GO:0015297; GO:0030070; GO:0032588; GO:0062111; GO:0071577; GO:0071579; GO:1904257"
"17499","Cluster_796","Peve_00044304",0.999409654250644,0.0218760903670763,0.830089015811238,155,-22.5,"2 17","1510 1532",16,"81.25%","81.25%","CDS",NA,NA,NA,NA,NA
"17500","Cluster_796","Peve_00044304",0.999409654250644,0.0218760903670763,0.830089015811238,155,-22.5,"2 17","2313 2335",16,"81.25%","81.25%","CDS",NA,NA,NA,NA,NA
"17554","Cluster_10060","Peve_00029974",0.999736312730338,0.0146200630686234,0.734958779208245,167,-21.66,"2 21","359 381",20,"75.00%","85.00%","5UTR",NA,NA,NA,NA,NA
"17558","Cluster_10060","Peve_00040742",-0.999019150266648,0.0281988803309955,0.902129556693968,166,-20.16,"2 21","204 224",19,"73.68%","89.47%","5UTR",NA,NA,NA,NA,NA
"17606","Cluster_10934","Peve_00008185",0.99960187302587,0.0179647150151243,0.782669382293497,146,-23.41,"2 21","504 521",19,"68.42%","78.95%","5UTR",NA,NA,NA,NA,NA
"17612","Cluster_10934","Peve_00009398",0.998758250045998,0.0317290557481573,0.903929377050813,155,-23.23,"2 21","51 75",22,"63.64%","77.27%","5UTR",NA,NA,NA,NA,NA
"17631","Cluster_10934","Peve_00019390",0.998758250045999,0.0317290557481559,0.903929377050813,162,-21.88,"2 20","405 427",19,"73.68%","84.21%","5UTR",NA,NA,NA,NA,NA
"17644","Cluster_10934","Peve_00025441",0.999999242056246,0.00078381512101461,0.239778920002343,147,-20.08,"2 17","882 904",16,"75.00%","75.00%","5UTR",NA,NA,NA,NA,NA
"17645","Cluster_10934","Peve_00025440",0.999990991243872,0.00270226453852998,0.439065053827702,147,-20.08,"2 17","882 904",16,"75.00%","75.00%","5UTR",NA,NA,NA,NA,NA
"17661","Cluster_10934","Peve_00040130",0.998758250045998,0.0317290557481573,0.903929377050813,160,-20.06,"2 20","942 961",18,"77.78%","83.33%","5UTR",NA,NA,NA,NA,NA
"17715","Cluster_11134","Peve_00001620",0.999331428228842,0.0232805554536455,0.848115847217852,162,-25.57,"2 21","114 140",24,"70.83%","79.17%","5UTR","Q0VD42","TLC domain-containing protein 5 (Transmembrane protein 136)","Bos taurus (Bovine)","","GO:0016020"
"17718","Cluster_11134","Peve_00002001",0.997882460106254,0.0414369314993325,0.909359886114279,160,-20.3,"2 17","930 951",15,"73.33%","93.33%","5UTR",NA,NA,NA,NA,NA
"17733","Cluster_11134","Peve_00004498",-0.997520581789295,0.0448393995312029,0.929559323183572,150,-20.56,"2 17","909 929",15,"73.33%","86.67%","5UTR","S8FGV1","Laccase-2 (EC 1.10.3.2) (FpLCC2)","Fomitopsis pinicola (strain FP-58527) (Brown rot fungus)","","GO:0005507; GO:0005576; GO:0016682"
"18096","Cluster_11135","Peve_00016052",0.999263211767585,0.024439545782064,0.861227763182295,162,-23.61,"2 20","111 133",19,"73.68%","84.21%","5UTR","A4FUY7","Molybdopterin synthase catalytic subunit (EC 2.8.1.12) (Molybdenum cofactor synthesis protein 2 large subunit) (Molybdenum cofactor synthesis protein 2B) (MOCS2B)","Bos taurus (Bovine)","Mo-molybdopterin cofactor biosynthetic process [GO:0006777]","GO:0005829; GO:0006777; GO:0016607; GO:0019008; GO:0030366"
"18097","Cluster_11135","Peve_00016434",0.99900571383746,0.0283914000687859,0.903496866948401,170,-20.86,"2 21","918 938",19,"78.95%","89.47%","5UTR","Q5EBP3","Armadillo repeat-containing protein 5","Mus musculus (Mouse)","adrenal cortex development [GO:0035801]; anatomical structure morphogenesis [GO:0009653]; CD4-positive, alpha-beta T cell differentiation [GO:0043367]; defense response to virus [GO:0051607]; gastrulation [GO:0007369]; hemopoiesis [GO:0030097]; in utero embryonic development [GO:0001701]; mesoderm formation [GO:0001707]; regulation of steroid biosynthetic process [GO:0050810]; T cell proliferation [GO:0042098]","GO:0001701; GO:0001707; GO:0005654; GO:0005737; GO:0005829; GO:0005925; GO:0007369; GO:0009653; GO:0016020; GO:0030097; GO:0035801; GO:0042098; GO:0043367; GO:0050810; GO:0051607"
"18105","Cluster_11135","Peve_00020772",0.998797404481802,0.0312247122096777,0.903929377050813,146,-20.94,"2 21","264 290",24,"62.50%","70.83%","5UTR",NA,NA,NA,NA,NA
"18117","Cluster_11135","Peve_00023991",0.999999420671888,0.000685263252555419,0.239778920002343,160,-22.38,"2 18","538 560",17,"82.35%","82.35%","5UTR","P34152","Focal adhesion kinase 1 (FADK 1) (EC 2.7.10.2) (Focal adhesion kinase-related nonkinase) (FRNK) (Protein-tyrosine kinase 2) (p125FAK) (pp125FAK)","Mus musculus (Mouse)","angiogenesis [GO:0001525]; axonogenesis [GO:0007409]; blood vessel development [GO:0001568]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; cellular chloride ion homeostasis [GO:0030644]; cellular response to transforming growth factor beta stimulus [GO:0071560]; central nervous system neuron axonogenesis [GO:0021955]; endothelial cell migration [GO:0043542]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; extracellular matrix organization [GO:0030198]; growth hormone receptor signaling pathway [GO:0060396]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; JNK cascade [GO:0007254]; MAPK cascade [GO:0000165]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of anoikis [GO:2000811]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of axonogenesis [GO:0050771]; negative regulation of cell migration [GO:0030336]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of organ growth [GO:0046621]; negative regulation of synapse assembly [GO:0051964]; neuron migration [GO:0001764]; nuclear migration [GO:0007097]; organ growth [GO:0035265]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of macrophage proliferation [GO:0120041]; positive regulation of phagocytosis [GO:0050766]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of synaptic transmission [GO:0050806]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; positive regulation of wound healing [GO:0090303]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of cell adhesion [GO:0030155]; regulation of cell adhesion mediated by integrin [GO:0033628]; regulation of cell population proliferation [GO:0042127]; regulation of cell shape [GO:0008360]; regulation of epithelial cell migration [GO:0010632]; regulation of focal adhesion assembly [GO:0051893]; regulation of modification of postsynaptic actin cytoskeleton [GO:1905274]; regulation of osteoblast differentiation [GO:0045667]; regulation of protein phosphorylation [GO:0001932]; regulation of substrate adhesion-dependent cell spreading [GO:1900024]; signal complex assembly [GO:0007172]; transforming growth factor beta receptor signaling pathway [GO:0007179]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vasculogenesis [GO:0001570]; vasodilation [GO:0042311]","GO:0000165; GO:0000226; GO:0001525; GO:0001568; GO:0001570; GO:0001725; GO:0001764; GO:0001932; GO:0001934; GO:0003779; GO:0004713; GO:0004715; GO:0004725; GO:0005102; GO:0005178; GO:0005524; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0005925; GO:0005938; GO:0006468; GO:0007097; GO:0007169; GO:0007172; GO:0007173; GO:0007179; GO:0007229; GO:0007254; GO:0007409; GO:0008284; GO:0008360; GO:0008432; GO:0010507; GO:0010613; GO:0010632; GO:0010634; GO:0010718; GO:0010759; GO:0010763; GO:0014068; GO:0014704; GO:0014911; GO:0016323; GO:0016324; GO:0016477; GO:0016604; GO:0018108; GO:0019901; GO:0019902; GO:0019903; GO:0021955; GO:0022408; GO:0030027; GO:0030154; GO:0030155; GO:0030198; GO:0030307; GO:0030335; GO:0030336; GO:0030644; GO:0031234; GO:0033628; GO:0035265; GO:0036064; GO:0038083; GO:0042127; GO:0042169; GO:0042311; GO:0042383; GO:0042802; GO:0043066; GO:0043197; GO:0043231; GO:0043542; GO:0043548; GO:0044877; GO:0045087; GO:0045202; GO:0045667; GO:0045785; GO:0045860; GO:0046621; GO:0046777; GO:0048013; GO:0048471; GO:0048661; GO:0050766; GO:0050771; GO:0050806; GO:0051893; GO:0051897; GO:0051964; GO:0060252; GO:0060396; GO:0071560; GO:0090303; GO:0098794; GO:0098978; GO:0120041; GO:0140677; GO:1900024; GO:1905274; GO:2000060; GO:2000811"
"18140","Cluster_11135","Peve_00030840",0.999931466060162,0.00745333172287407,0.573710369894872,151,-22.1,"2 21","619 643",22,"63.64%","72.73%","5UTR",NA,NA,NA,NA,NA
"18182","Cluster_1167","Peve_00001485",0.999909726776791,0.00855416971793915,0.573710369894872,155,-21.98,"2 16","285 306",14,"78.57%","85.71%","5UTR",NA,NA,NA,NA,NA
"18183","Cluster_1167","Peve_00001544",0.999909726776791,0.00855416971793915,0.573710369894872,154,-23.08,"2 21","464 484",19,"63.16%","84.21%","5UTR","O35474","EGF-like repeat and discoidin I-like domain-containing protein 3 (Developmentally-regulated endothelial cell locus 1 protein) (Integrin-binding protein DEL1)","Mus musculus (Mouse)","cell adhesion [GO:0007155]; positive regulation of cell-substrate adhesion [GO:0010811]","GO:0005509; GO:0005576; GO:0007155; GO:0010811"
"18189","Cluster_1167","Peve_00003269",0.999909726776791,0.00855416971793915,0.573710369894872,150,-21.09,"2 21","46 69",21,"66.67%","76.19%","5UTR",NA,NA,NA,NA,NA
"18200","Cluster_1167","Peve_00005255",0.999909726776791,0.00855416971793915,0.573710369894872,150,-25.11,"2 19","455 476",17,"64.71%","76.47%","5UTR",NA,NA,NA,NA,NA
"18202","Cluster_1167","Peve_00005406",0.999909726776791,0.00855416971793389,0.573710369894872,147,-20.88,"2 21","126 148",20,"65.00%","70.00%","5UTR",NA,NA,NA,NA,NA
"18214","Cluster_1167","Peve_00007142",0.999909726776791,0.00855416971793389,0.573710369894872,156,-22.04,"2 18","665 687",17,"76.47%","82.35%","5UTR",NA,NA,NA,NA,NA
"18218","Cluster_1167","Peve_00007689",0.999909726776791,0.00855416971793915,0.573710369894872,150,-25.62,"2 19","312 333",17,"64.71%","76.47%","5UTR",NA,NA,NA,NA,NA
"18235","Cluster_1167","Peve_00010286",0.999909726776791,0.00855416971793915,0.573710369894872,153,-20.95,"2 16","104 124",14,"85.71%","85.71%","5UTR",NA,NA,NA,NA,NA
"18245","Cluster_1167","Peve_00014260",0.999909726776791,0.00855416971793915,0.573710369894872,159,-23.98,"2 21","696 718",20,"75.00%","75.00%","5UTR",NA,NA,NA,NA,NA
"18253","Cluster_1167","Peve_00015576",0.999909726776791,0.00855416971793915,0.573710369894872,152,-23.21,"2 13","745 766",11,"90.91%","90.91%","5UTR",NA,NA,NA,NA,NA
"18255","Cluster_1167","Peve_00015940",0.998461753312847,0.0353153733346753,0.909359886114279,140,-24.8,"2 9","385 406",7,"100.00%","100.00%","5UTR",NA,NA,NA,NA,NA
"18257","Cluster_1167","Peve_00016445",0.999909726776791,0.00855416971793915,0.573710369894872,143,-23.75,"2 17","332 359",21,"61.90%","71.43%","5UTR","Q9UHC3","Acid-sensing ion channel 3 (ASIC3) (hASIC3) (Amiloride-sensitive cation channel 3) (Neuronal amiloride-sensitive cation channel 3) (Testis sodium channel 1) (hTNaC1)","Homo sapiens (Human)","detection of chemical stimulus involved in sensory perception of pain [GO:0050968]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; response to acidic pH [GO:0010447]; response to heat [GO:0009408]; sensory perception [GO:0007600]; sensory perception of sour taste [GO:0050915]; signal transduction [GO:0007165]; sodium ion transmembrane transport [GO:0035725]","GO:0005261; GO:0005272; GO:0005886; GO:0007165; GO:0007600; GO:0009408; GO:0010447; GO:0015280; GO:0035725; GO:0042931; GO:0044736; GO:0048471; GO:0050915; GO:0050965; GO:0050966; GO:0050968"
"18261","Cluster_1167","Peve_00017626",0.999909726776791,0.00855416971793915,0.573710369894872,144,-21.59,"2 13","859 880",11,"81.82%","81.82%","5UTR","Q7TQP6","Serine/threonine-protein kinase TNNI3K (EC 2.7.11.1) (Cardiac ankyrin repeat kinase) (TNNI3-interacting kinase)","Rattus norvegicus (Rat)","bundle of His cell to Purkinje myocyte communication [GO:0086069]; protein phosphorylation [GO:0006468]; regulation of cardiac conduction [GO:1903779]; regulation of cardiac muscle contraction [GO:0055117]; regulation of heart rate [GO:0002027]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0002027; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0006357; GO:0006468; GO:0008022; GO:0031013; GO:0046872; GO:0055117; GO:0061629; GO:0086069; GO:0106310; GO:1903779"
"18267","Cluster_1167","Peve_00018177",0.999909726776791,0.00855416971793915,0.573710369894872,151,-24.56,"2 19","16 35",17,"76.47%","76.47%","5UTR",NA,NA,NA,NA,NA
"18268","Cluster_1167","Peve_00018177",0.999909726776791,0.00855416971793915,0.573710369894872,151,-24.56,"2 19","246 265",17,"76.47%","76.47%","5UTR",NA,NA,NA,NA,NA
"18277","Cluster_1167","Peve_00019541",0.998816193083452,0.0309797857569469,0.903929377050813,160,-27.23,"2 21","579 600",19,"68.42%","78.95%","5UTR","O18638","Out at first protein","Drosophila virilis (Fruit fly)","",""
"18289","Cluster_1167","Peve_00021333",0.999909726776791,0.00855416971793915,0.573710369894872,160,-25.15,"2 21","389 410",19,"68.42%","78.95%","5UTR","Q924H0","Neuropeptide FF receptor 2 (G-protein coupled receptor 74) (Neuropeptide NPFF receptor)","Mus musculus (Mouse)","G protein-coupled receptor signaling pathway [GO:0007186]; regulation of adenylate cyclase activity [GO:0045761]; regulation of cAMP-dependent protein kinase activity [GO:2000479]; regulation of MAPK cascade [GO:0043408]","GO:0004930; GO:0005886; GO:0007186; GO:0008188; GO:0015629; GO:0031628; GO:0042277; GO:0043408; GO:0045761; GO:2000479"
"18290","Cluster_1167","Peve_00021330",0.999909726776791,0.00855416971793915,0.573710369894872,156,-24.35,"2 21","392 413",19,"63.16%","78.95%","5UTR","Q924H0","Neuropeptide FF receptor 2 (G-protein coupled receptor 74) (Neuropeptide NPFF receptor)","Mus musculus (Mouse)","G protein-coupled receptor signaling pathway [GO:0007186]; regulation of adenylate cyclase activity [GO:0045761]; regulation of cAMP-dependent protein kinase activity [GO:2000479]; regulation of MAPK cascade [GO:0043408]","GO:0004930; GO:0005886; GO:0007186; GO:0008188; GO:0015629; GO:0031628; GO:0042277; GO:0043408; GO:0045761; GO:2000479"
"18292","Cluster_1167","Peve_00021718",0.999909726776791,0.00855416971793389,0.573710369894872,144,-22.08,"2 21","817 838",19,"57.89%","68.42%","5UTR",NA,NA,NA,NA,NA
"18293","Cluster_1167","Peve_00021718",0.999909726776791,0.00855416971793389,0.573710369894872,146,-24.73,"2 21","693 718",23,"60.87%","73.91%","5UTR",NA,NA,NA,NA,NA
"18319","Cluster_1167","Peve_00026489",0.999909726776791,0.00855416971793389,0.573710369894872,147,-23.25,"2 21","781 803",20,"65.00%","70.00%","5UTR",NA,NA,NA,NA,NA
"18331","Cluster_1167","Peve_00029605",0.999850651123434,0.011002756609976,0.648044327003451,153,-25.03,"2 21","120 145",23,"73.91%","73.91%","5UTR","Q9Y2W6","Tudor and KH domain-containing protein (Tudor domain-containing protein 2)","Homo sapiens (Human)","fertilization [GO:0009566]; male meiotic nuclear division [GO:0007140]; P granule organization [GO:0030719]; piRNA processing [GO:0034587]; spermatogenesis [GO:0007283]","GO:0003723; GO:0005739; GO:0007140; GO:0007283; GO:0009566; GO:0030719; GO:0034587; GO:0043186; GO:0071546; GO:0071547"
"18332","Cluster_1167","Peve_00029642",0.999990221588804,0.00281533203902639,0.450074017033431,155,-21.97,"2 16","869 890",14,"78.57%","85.71%","5UTR",NA,NA,NA,NA,NA
"18354","Cluster_1167","Peve_00034549",0.998849404223647,0.0305420482403264,0.903929377050813,146,-22.61,"2 13","211 231",11,"90.91%","90.91%","5UTR","P49285","Melatonin receptor type 1A (Mel-1A-R) (Mel1a receptor) (CKA)","Gallus gallus (Chicken)","adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; circadian rhythm [GO:0007623]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of glucose import [GO:0046325]; negative regulation of glycolytic process [GO:0045820]","GO:0004930; GO:0005886; GO:0007186; GO:0007193; GO:0007623; GO:0008502; GO:0042562; GO:0043235; GO:0045820; GO:0046325; GO:1904408"
"18359","Cluster_1167","Peve_00035161",0.999909726776791,0.00855416971793915,0.573710369894872,146,-22.6,"2 21","673 697",22,"68.18%","68.18%","5UTR",NA,NA,NA,NA,NA
"18365","Cluster_1167","Peve_00036721",0.999909726776791,0.00855416971793915,0.573710369894872,142,-20.46,"2 16","658 680",15,"73.33%","73.33%","5UTR",NA,NA,NA,NA,NA
"18367","Cluster_1167","Peve_00036723",0.999909726776791,0.00855416971793389,0.573710369894872,142,-20.46,"2 16","658 680",15,"73.33%","73.33%","5UTR",NA,NA,NA,NA,NA
"18371","Cluster_1167","Peve_00037343",0.999909726776791,0.00855416971793915,0.573710369894872,153,-26.24,"2 20","219 242",20,"70.00%","80.00%","5UTR",NA,NA,NA,NA,NA
"18383","Cluster_1167","Peve_00040549",0.999909726776791,0.00855416971793389,0.573710369894872,152,-23.21,"2 13","59 80",11,"90.91%","90.91%","5UTR",NA,NA,NA,NA,NA
"18388","Cluster_1167","Peve_00041552",0.999909726776791,0.00855416971793915,0.573710369894872,152,-20.28,"2 21","91 112",19,"63.16%","73.68%","5UTR",NA,NA,NA,NA,NA
"18391","Cluster_1167","Peve_00042134",0.999909726776791,0.00855416971793915,0.573710369894872,142,-20.81,"2 20","363 386",20,"65.00%","65.00%","5UTR","Q91909","Mast/stem cell growth factor receptor-related protein Kit (EC 2.7.10.1) (Kit-related kinase 1) (xKrk1) (Tyrosine-protein kinase kit)","Xenopus laevis (African clawed frog)","Fc receptor signaling pathway [GO:0038093]; Kit signaling pathway [GO:0038109]","GO:0004714; GO:0005524; GO:0005886; GO:0019955; GO:0038093; GO:0038109; GO:0046872"
"18392","Cluster_1167","Peve_00042228",0.999990792524351,0.00273190594675139,0.442041167784887,146,-21.74,"2 11","153 174",9,"88.89%","100.00%","5UTR","Q5R481","Septin-7","Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)","cell cycle [GO:0007049]; cell differentiation [GO:0030154]; cell division [GO:0051301]; cilium assembly [GO:0060271]; regulation of embryonic cell shape [GO:0016476]; spermatogenesis [GO:0007283]","GO:0000776; GO:0005525; GO:0005819; GO:0005930; GO:0007049; GO:0007283; GO:0016476; GO:0030154; GO:0030496; GO:0031105; GO:0031514; GO:0032154; GO:0051301; GO:0060271"
"18396","Cluster_1167","Peve_00043379",0.999909726776791,0.00855416971793389,0.573710369894872,149,-21.78,"2 14","403 424",12,"83.33%","83.33%","5UTR","Q8L7C8","Protein REDUCED WALL ACETYLATION 1 (EC 2.3.1.-)","Arabidopsis thaliana (Mouse-ear cress)","carbohydrate metabolic process [GO:0005975]; plant-type secondary cell wall biogenesis [GO:0009834]; xylan acetylation [GO:1990937]; xylan biosynthetic process [GO:0045492]; xylan metabolic process [GO:0045491]; xyloglucan metabolic process [GO:0010411]","GO:0000139; GO:0005794; GO:0005975; GO:0009834; GO:0010411; GO:0016407; GO:0016491; GO:0045491; GO:0045492; GO:1990937"
"18406","Cluster_1167","Peve_00045222",0.998907226375474,0.0297645814333626,0.903929377050813,155,-26.85,"2 17","756 778",16,"81.25%","81.25%","5UTR",NA,NA,NA,NA,NA
"18424","Cluster_13502","Peve_00001711",0.997844556977271,0.0418062711782376,0.909359886114279,159,-22.48,"2 18","500 520",16,"75.00%","93.75%","5UTR",NA,NA,NA,NA,NA
"18427","Cluster_13502","Peve_00003720",0.997844556977271,0.0418062711782387,0.909359886114279,192,-35.54,"2 21","283 304",19,"89.47%","100.00%","5UTR",NA,NA,NA,NA,NA
"18436","Cluster_13502","Peve_00015657",0.997844556977271,0.0418062711782397,0.909359886114279,165,-20.12,"2 20","920 943",20,"80.00%","85.00%","5UTR","O08730","Glycogenin-1 (GN-1) (GN1) (EC 2.4.1.186)","Rattus norvegicus (Rat)","glycogen biosynthetic process [GO:0005978]","GO:0005536; GO:0005978; GO:0008466; GO:0016757; GO:0030145; GO:0042803; GO:0102751"
"18459","Cluster_13502","Peve_00033788",0.997844556977271,0.0418062711782387,0.909359886114279,154,-21.17,"2 20","540 562",19,"68.42%","78.95%","5UTR",NA,NA,NA,NA,NA
"18471","Cluster_13502","Peve_00043584",0.999808930883123,0.0124450682944078,0.68680754891219,169,-20.45,"2 19","198 220",18,"83.33%","88.89%","5UTR",NA,NA,NA,NA,NA
"18512","Cluster_14999","Peve_00001876",0.999298315087297,0.0238501759994235,0.854711273077389,162,-20.06,"2 15","614 635",13,"92.31%","92.31%","5UTR","Q6NUE2","Carbonyl reductase family member 4 (EC 1.-.-.-) (3-ketoacyl-[acyl-carrier-protein] reductase beta subunit) (KAR beta subunit) (3-oxoacyl-[acyl-carrier-protein] reductase) (EC 1.1.1.-) (Quinone reductase CBR4)","Xenopus laevis (African clawed frog)","fatty acid biosynthetic process [GO:0006633]; protein heterotetramerization [GO:0051290]","GO:0004316; GO:0005759; GO:0006633; GO:0051290; GO:1990204"
"18524","Cluster_14999","Peve_00006544",-0.999322492966855,0.0234356254044225,0.849930477652765,160,-20.25,"2 17","644 665",15,"80.00%","86.67%","5UTR","Q9ZQ31","Serine/threonine-protein kinase STY13 (EC 2.7.11.1) (AtSTYPK) (Serine/threonine/tyrosine-protein kinase 13)","Arabidopsis thaliana (Mouse-ear cress)","protein phosphorylation [GO:0006468]; regulation of embryonic development [GO:0045995]; seed oilbody biogenesis [GO:0010344]; signal transduction [GO:0007165]","GO:0004672; GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005737; GO:0006468; GO:0007165; GO:0010344; GO:0045995; GO:0106310"
"18560","Cluster_14999","Peve_00022361",0.999976158554056,0.00439604651623863,0.54328949385489,157,-21.9,"2 19","173 197",20,"75.00%","75.00%","5UTR","P98160","Basement membrane-specific heparan sulfate proteoglycan core protein (HSPG) (Perlecan) (PLC) [Cleaved into: Endorepellin; LG3 peptide]","Homo sapiens (Human)","angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; brain development [GO:0007420]; cell differentiation [GO:0030154]; circulatory system development [GO:0072359]; inflammatory response [GO:0006954]; lipid metabolic process [GO:0006629]; negative regulation of amyloid fibril formation [GO:1905907]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell death [GO:0060548]; receptor-mediated endocytosis [GO:0006898]; tissue development [GO:0009888]","GO:0001525; GO:0001540; GO:0005178; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005796; GO:0005886; GO:0005925; GO:0006629; GO:0006898; GO:0006954; GO:0007420; GO:0008022; GO:0009887; GO:0009888; GO:0016525; GO:0030021; GO:0030154; GO:0043202; GO:0050750; GO:0060548; GO:0062023; GO:0070062; GO:0072359; GO:0098797; GO:1905907"
"18593","Cluster_14999","Peve_00035813",0.999446977031752,0.0211732108231167,0.821343827072112,154,-20.38,"2 21","30 58",26,"69.23%","69.23%","5UTR",NA,NA,NA,NA,NA
"18602","Cluster_14999","Peve_00039396",0.998919516701524,0.0295966980402007,0.903929377050813,174,-21.61,"2 19","50 71",17,"82.35%","94.12%","5UTR","Q6DGL2","NF-kappa-B inhibitor-interacting Ras-like protein 2 (I-kappa-B-interacting Ras-like protein 2) (Kappa B-Ras protein 2) (KappaB-Ras2)","Danio rerio (Zebrafish) (Brachydanio rerio)","I-kappaB kinase/NF-kappaB signaling [GO:0007249]; Ral protein signal transduction [GO:0032484]; surfactant homeostasis [GO:0043129]","GO:0003924; GO:0005525; GO:0005737; GO:0007249; GO:0032484; GO:0032794; GO:0043129"
"18611","Cluster_14999","Peve_00042650",0.997296425206163,0.0468233205724549,0.939470798087631,146,-22.06,"2 21","305 333",26,"61.54%","69.23%","5UTR","P07850","Sulfite oxidase (EC 1.8.3.1)","Gallus gallus (Chicken)","sulfur compound metabolic process [GO:0006790]","GO:0005739; GO:0005758; GO:0006790; GO:0008482; GO:0020037; GO:0030151; GO:0043546"
"18648","Cluster_15726","Peve_00011436",-0.999947726180961,0.00650937254330571,0.573710369894872,159,-21.33,"2 19","411 430",17,"82.35%","82.35%","5UTR",NA,NA,NA,NA,NA
"18652","Cluster_15726","Peve_00012489",1,0,0,147,-20.21,"2 21","881 898",19,"68.42%","73.68%","5UTR",NA,NA,NA,NA,NA
"18660","Cluster_15726","Peve_00013682",0.999429765887112,0.0215001929584108,0.825175158091499,147,-20.04,"2 20","688 709",18,"61.11%","72.22%","5UTR","B8VIU6","Uncharacterized skeletal organic matrix protein 5 (Uncharacterized SOMP-5)","Acropora millepora (Staghorn coral) (Heteropora millepora)","","GO:0005576"
"18670","Cluster_15726","Peve_00015888",1,1.34157585525081e-08,8.89340150118664e-06,160,-23.08,"2 21","885 906",19,"73.68%","73.68%","5UTR","Q9TV36","Fibrillin-1 [Cleaved into: Asprosin]","Sus scrofa (Pig)","activation of protein kinase A activity [GO:0034199]; anatomical structure morphogenesis [GO:0009653]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; protein kinase A signaling [GO:0010737]","GO:0001527; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0008201; GO:0009653; GO:0010737; GO:0031012; GO:0034199; GO:0042593"
"18672","Cluster_15726","Peve_00016106",1,9.48637384723993e-09,6.86838308108347e-06,165,-21.29,"2 14","849 870",12,"100.00%","100.00%","5UTR","Q95LU3","Fibrinogen C domain-containing protein 1","Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)","","GO:0008061; GO:0016020; GO:0046872"
"18673","Cluster_15726","Peve_00016876",1,1.34157585525081e-08,8.89340150118664e-06,160,-20.05,"2 21","302 323",19,"68.42%","78.95%","5UTR",NA,NA,NA,NA,NA
"18686","Cluster_15726","Peve_00021185",-0.999137171835302,0.0264477364816598,0.885091958128636,160,-24.78,"2 21","609 630",19,"73.68%","73.68%","5UTR","Q4R562","Beta-arrestin-1 (Arrestin beta-1)","Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)","negative regulation of Notch signaling pathway [GO:0045746]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of receptor internalization [GO:0002092]; protein transport [GO:0015031]; signal transduction [GO:0007165]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0001934; GO:0002092; GO:0005634; GO:0005905; GO:0006511; GO:0007165; GO:0015031; GO:0031143; GO:0031410; GO:0045746"
"18702","Cluster_15726","Peve_00025028",-0.998577868479122,0.0339559968102885,0.909359886114279,151,-20.82,"2 17","399 421",16,"75.00%","81.25%","5UTR",NA,NA,NA,NA,NA
"18716","Cluster_15726","Peve_00028583",1,9.48637384723993e-09,6.86838308108347e-06,157,-20.54,"2 19","657 680",19,"73.68%","78.95%","5UTR",NA,NA,NA,NA,NA
"18733","Cluster_15726","Peve_00031471",-0.999762972739619,0.0138612644080488,0.719823225073345,158,-22.99,"2 21","226 251",23,"69.57%","78.26%","5UTR",NA,NA,NA,NA,NA
"18748","Cluster_15726","Peve_00034900",-0.997904126995256,0.0412243184290208,0.909359886114279,149,-21.02,"2 21","71 98",25,"68.00%","72.00%","5UTR",NA,NA,NA,NA,NA
"18754","Cluster_15726","Peve_00037737",-0.999593925615707,0.0181431468379987,0.782669382293497,146,-20.27,"2 11","800 821",9,"88.89%","100.00%","5UTR","Q3ZCH0","Stress-70 protein, mitochondrial (75 kDa glucose-regulated protein) (GRP-75) (Heat shock 70 kDa protein 9)","Bos taurus (Bovine)","cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; erythrocyte differentiation [GO:0030218]; iron-sulfur cluster assembly [GO:0016226]; negative regulation of erythrocyte differentiation [GO:0045647]; negative regulation of hematopoietic stem cell differentiation [GO:1902037]; negative regulation of hemopoiesis [GO:1903707]; protein export from nucleus [GO:0006611]; protein refolding [GO:0042026]; regulation of erythrocyte differentiation [GO:0045646]","GO:0005524; GO:0005730; GO:0005737; GO:0005739; GO:0006611; GO:0016226; GO:0016887; GO:0030218; GO:0031072; GO:0031625; GO:0034620; GO:0042026; GO:0042645; GO:0044183; GO:0045646; GO:0045647; GO:0051082; GO:0051085; GO:0051787; GO:0140662; GO:1902037; GO:1903707"
"18772","Cluster_15726","Peve_00045142",1,1.34157585525081e-08,8.89340150118664e-06,158,-20.18,"2 19","287 308",17,"70.59%","82.35%","5UTR","O54991","Contactin-associated protein 1 (Caspr) (Caspr1) (MHDNIV) (NCP1) (Neurexin IV) (Neurexin-4) (Paranodin)","Mus musculus (Mouse)","axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; central nervous system myelination [GO:0022010]; cytoskeleton organization [GO:0007010]; mitochondrion organization [GO:0007005]; myelination [GO:0042552]; myelination in peripheral nervous system [GO:0022011]; neuromuscular junction development, skeletal muscle fiber [GO:0098529]; neuromuscular process [GO:0050905]; neuromuscular process controlling balance [GO:0050885]; neuromuscular process controlling posture [GO:0050884]; neuron projection development [GO:0031175]; neuron projection morphogenesis [GO:0048812]; neuronal action potential propagation [GO:0019227]; paranodal junction assembly [GO:0030913]; paranodal junction maintenance [GO:1990227]; postsynaptic density organization [GO:0097106]; protein localization to juxtaparanode region of axon [GO:0071205]; protein localization to paranode region of axon [GO:0002175]; regulation of synapse maturation [GO:0090128]","GO:0002175; GO:0005886; GO:0005918; GO:0007005; GO:0007010; GO:0007155; GO:0007409; GO:0016020; GO:0017124; GO:0019227; GO:0022010; GO:0022011; GO:0030424; GO:0030913; GO:0031175; GO:0033010; GO:0033270; GO:0042552; GO:0043209; GO:0048786; GO:0048812; GO:0050884; GO:0050885; GO:0050905; GO:0071205; GO:0090128; GO:0097106; GO:0098529; GO:0098978; GO:1990227"
"18779","Cluster_15890","Peve_00008072",-0.998282282435782,0.0373192738625068,0.909359886114279,176,-20.71,"2 21","307 328",19,"78.95%","89.47%","5UTR",NA,NA,NA,NA,NA
"18826","Cluster_16738","Peve_00007806",0.999974190676381,0.00457387578917121,0.54328949385489,161,-20.31,"2 14","320 341",12,"91.67%","100.00%","5UTR",NA,NA,NA,NA,NA
"18976","Cluster_2787","Peve_00014228",0.997036573432838,0.0490229581666764,0.949574829383869,154,-21.98,"2 21","447 467",19,"68.42%","78.95%","5UTR",NA,NA,NA,NA,NA
"18977","Cluster_2787","Peve_00014228",0.997036573432838,0.0490229581666764,0.949574829383869,161,-20.26,"2 19","825 847",18,"77.78%","83.33%","5UTR",NA,NA,NA,NA,NA
"19023","Cluster_2787","Peve_00019695",0.998742428996946,0.0319305869438654,0.905632568744263,163,-21.71,"2 21","199 221",20,"75.00%","80.00%","5UTR","Q91YK2","Ribosomal RNA processing protein 1 homolog B (RRP1-like protein B)","Mus musculus (Mouse)","apoptotic process [GO:0006915]; cellular response to virus [GO:0098586]; mRNA processing [GO:0006397]; negative regulation of GTPase activity [GO:0034260]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of apoptotic process [GO:0043065]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]; rRNA processing [GO:0006364]","GO:0000791; GO:0000792; GO:0001652; GO:0003713; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0006364; GO:0006397; GO:0006915; GO:0008380; GO:0030687; GO:0030688; GO:0034260; GO:0043065; GO:0043484; GO:0043923; GO:0045944; GO:0098586"
"19053","Cluster_2787","Peve_00023931",0.997268981044785,0.0470604815083167,0.940685113548625,148,-21,"2 20","696 720",22,"68.18%","72.73%","5UTR","P50549","ETS translocation variant 1 (Ets-related protein 81)","Homo sapiens (Human)","axon guidance [GO:0007411]; cell differentiation [GO:0030154]; mechanosensory behavior [GO:0007638]; muscle organ development [GO:0007517]; peripheral nervous system neuron development [GO:0048935]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]","GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0003700; GO:0005634; GO:0006357; GO:0006366; GO:0007411; GO:0007517; GO:0007638; GO:0030154; GO:0045944; GO:0048935; GO:1990837"
"19062","Cluster_2787","Peve_00025086",-0.999963153550721,0.00546505171493988,0.551398425649056,152,-21.52,"2 21","585 604",19,"73.68%","78.95%","5UTR",NA,NA,NA,NA,NA
"19130","Cluster_2787","Peve_00036122",0.998020559760609,0.0400624940598234,0.909359886114279,158,-23.01,"2 21","595 615",19,"73.68%","78.95%","5UTR",NA,NA,NA,NA,NA
"19137","Cluster_2787","Peve_00037061",-0.999649545771953,0.0168547943103946,0.778328904052462,150,-21.21,"2 21","349 373",22,"68.18%","72.73%","5UTR","Q92820","Gamma-glutamyl hydrolase (EC 3.4.19.9) (Conjugase) (GH) (Gamma-Glu-X carboxypeptidase)","Homo sapiens (Human)","tetrahydrofolylpolyglutamate metabolic process [GO:0046900]","GO:0005576; GO:0005615; GO:0005634; GO:0005773; GO:0008238; GO:0008242; GO:0034722; GO:0035578; GO:0035580; GO:0042470; GO:0046900; GO:0070062; GO:1904724"
"19145","Cluster_2787","Peve_00039122",0.997623736355649,0.0438963560597039,0.922643131738102,158,-21.8,"2 21","666 691",23,"69.57%","78.26%","5UTR","Q9BYE2","Transmembrane protease serine 13 (EC 3.4.21.-) (Membrane-type mosaic serine protease) (Mosaic serine protease)","Homo sapiens (Human)","proteolysis [GO:0006508]","GO:0004252; GO:0005044; GO:0006508; GO:0016020; GO:0072562"
"19157","Cluster_2787","Peve_00042177",0.999318127749319,0.0235110112931456,0.850665296699579,152,-21.18,"2 21","347 368",19,"68.42%","68.42%","5UTR","Q96LK0","Centrosomal protein of 19 kDa (Cep19)","Homo sapiens (Human)","cilium assembly [GO:0060271]; microtubule anchoring at centrosome [GO:0034454]; vesicle targeting, trans-Golgi to periciliary membrane compartment [GO:0097712]","GO:0000922; GO:0005654; GO:0005737; GO:0005813; GO:0005814; GO:0005929; GO:0034454; GO:0036064; GO:0060271; GO:0097712"
"19175","Cluster_2854","Peve_00000377",0.997896558563532,0.0412987102322654,0.909359886114279,148,-20.88,"2 14","173 196",14,"78.57%","85.71%","5UTR","Q55DA0","ABC transporter G family member 22 (ABC transporter ABCG.22)","Dictyostelium discoideum (Social amoeba)","aggregation involved in sorocarp development [GO:0031152]; cell motility [GO:0048870]; sorocarp morphogenesis [GO:0031288]; transmembrane transport [GO:0055085]","GO:0005524; GO:0016020; GO:0016887; GO:0031152; GO:0031288; GO:0042626; GO:0048870; GO:0055085; GO:0140359"
"19178","Cluster_2854","Peve_00001268",0.999962448044095,0.00551712420276981,0.551398425649056,159,-21.31,"2 20","162 183",18,"72.22%","77.78%","5UTR",NA,NA,NA,NA,NA
"19198","Cluster_2854","Peve_00004417",0.998804655877086,0.031130411862649,0.903929377050813,160,-20.55,"2 19","748 771",19,"78.95%","84.21%","5UTR",NA,NA,NA,NA,NA
"19225","Cluster_2854","Peve_00011018",-0.999898831254468,0.00905569870901151,0.591707940755134,146,-20.55,"2 21","100 126",24,"66.67%","66.67%","5UTR",NA,NA,NA,NA,NA
"19229","Cluster_2854","Peve_00011155",0.999983740199231,0.00363039030884399,0.527140119669662,153,-21.61,"2 14","478 499",12,"83.33%","91.67%","5UTR",NA,NA,NA,NA,NA
"19233","Cluster_2854","Peve_00013972",0.999962448044095,0.00551712420276981,0.551398425649056,166,-20.5,"2 21","65 85",19,"73.68%","89.47%","5UTR","Q9VBW3","Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14)","Drosophila melanogaster (Fruit fly)","calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of kinase activity [GO:0033674]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; wound healing [GO:0042060]","GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007156; GO:0007169; GO:0014068; GO:0016339; GO:0033674; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0090303"
"19253","Cluster_2854","Peve_00018828",0.998059288344699,0.0396685101306057,0.909359886114279,163,-21.24,"2 21","889 912",21,"76.19%","76.19%","5UTR",NA,NA,NA,NA,NA
"19263","Cluster_2854","Peve_00023071",0.999962448044095,0.00551712420276166,0.551398425649056,167,-20.56,"2 20","420 441",18,"77.78%","83.33%","5UTR",NA,NA,NA,NA,NA
"19275","Cluster_2854","Peve_00024587",-0.997501684128481,0.0450100248602691,0.930633997430282,159,-20.29,"2 20","562 583",18,"61.11%","88.89%","5UTR","Q9VCA2","Organic cation transporter protein","Drosophila melanogaster (Fruit fly)","apoptotic process [GO:0006915]; ion transport [GO:0006811]","GO:0006811; GO:0006915; GO:0016020; GO:0022857"
"19317","Cluster_2854","Peve_00035329",0.998029698096393,0.0399698798387951,0.909359886114279,150,-20.22,"2 15","853 874",13,"76.92%","84.62%","5UTR",NA,NA,NA,NA,NA
"19337","Cluster_2854","Peve_00039198",-0.997118363096831,0.0483413856135186,0.946447951505117,149,-22.41,"2 21","76 98",21,"66.67%","76.19%","5UTR","O75897","Sulfotransferase 1C4 (ST1C4) (EC 2.8.2.1) (Sulfotransferase 1C2) (SULT1C#2)","Homo sapiens (Human)","3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; doxorubicin metabolic process [GO:0044598]; ethanol catabolic process [GO:0006068]; flavonoid metabolic process [GO:0009812]; sulfation [GO:0051923]; xenobiotic metabolic process [GO:0006805]","GO:0004062; GO:0005737; GO:0005829; GO:0006068; GO:0006805; GO:0008146; GO:0009812; GO:0044598; GO:0050427; GO:0051923"
"19391","Cluster_2882","Peve_00010433",-0.99813899500858,0.0388451018771475,0.909359886114279,147,-21.44,"2 21","121 147",24,"62.50%","66.67%","5UTR","Q6NSI8","SANT and BTB domain regulator of class switch recombination (SANT and BTB domain regulator of CSR)","Homo sapiens (Human)","isotype switching [GO:0045190]","GO:0042802; GO:0045190"
"19398","Cluster_2882","Peve_00012142",-0.997089131731783,0.0485860732748588,0.947668828184205,169,-23.55,"2 19","372 395",19,"78.95%","89.47%","5UTR","Q12834","Cell division cycle protein 20 homolog (p55CDC)","Homo sapiens (Human)","anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell differentiation [GO:0030154]; cell division [GO:0051301]; mitotic sister chromatid cohesion [GO:0007064]; mitotic spindle assembly [GO:0090307]; mitotic spindle assembly checkpoint signaling [GO:0007094]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; nervous system development [GO:0007399]; positive regulation of anaphase-promoting complex-dependent catabolic process [GO:1905786]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of synapse maturation [GO:0090129]; positive regulation of synaptic plasticity [GO:0031915]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; protein ubiquitination [GO:0016567]; regulation of dendrite development [GO:0050773]; regulation of meiotic cell cycle [GO:0051445]; regulation of meiotic nuclear division [GO:0040020]; regulation of mitotic cell cycle [GO:0007346]","GO:0000922; GO:0005654; GO:0005680; GO:0005813; GO:0005819; GO:0005829; GO:0007064; GO:0007094; GO:0007346; GO:0007399; GO:0008022; GO:0008284; GO:0010997; GO:0016567; GO:0019899; GO:0030154; GO:0031145; GO:0031915; GO:0033597; GO:0040020; GO:0042826; GO:0048471; GO:0050773; GO:0051301; GO:0051444; GO:0051445; GO:0090129; GO:0090307; GO:1904668; GO:1905786; GO:1990757"
"19432","Cluster_2882","Peve_00023391",-0.999656503413255,0.0166866349892639,0.775337211553618,162,-24.47,"2 15","257 278",13,"84.62%","100.00%","5UTR","Q1PSW8","E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (mLin41) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71)","Mus musculus (Mouse)","3'-UTR-mediated mRNA destabilization [GO:0061158]; cellular response to organic substance [GO:0071310]; fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA metabolic process [GO:0010586]; miRNA processing [GO:0035196]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; negative regulation of translation [GO:0017148]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; positive regulation of miRNA-mediated gene silencing [GO:2000637]; post-transcriptional regulation of gene expression [GO:0010608]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; regulation of miRNA-mediated gene silencing [GO:0060964]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of protein metabolic process [GO:0051246]; stem cell proliferation [GO:0072089]","GO:0000082; GO:0000209; GO:0000932; GO:0001843; GO:0004842; GO:0008270; GO:0008543; GO:0010586; GO:0010608; GO:0017148; GO:0021915; GO:0030371; GO:0035196; GO:0035198; GO:0035278; GO:0043161; GO:0051246; GO:0051865; GO:0060964; GO:0061158; GO:0061630; GO:0071310; GO:0072089; GO:2000177; GO:2000637"
"19450","Cluster_2882","Peve_00031436",-0.998016621951657,0.0401023366876437,0.909359886114279,166,-22.51,"2 21","763 788",23,"73.91%","82.61%","5UTR","Q0P5B1","Peroxisomal membrane protein PEX13 (Peroxin-13)","Bos taurus (Bovine)","cerebral cortex cell migration [GO:0021795]; fatty acid alpha-oxidation [GO:0001561]; locomotory behavior [GO:0007626]; microtubule-based peroxisome localization [GO:0060152]; neuron migration [GO:0001764]; protein import into peroxisome matrix, docking [GO:0016560]; suckling behavior [GO:0001967]","GO:0001561; GO:0001764; GO:0001967; GO:0005778; GO:0007626; GO:0008320; GO:0016560; GO:0021795; GO:0060152; GO:1990429"
"19496","Cluster_29","Peve_00013718",0.999652457614836,0.0167846228939752,0.776954707475336,155,-20.25,"2 20","449 467",18,"72.22%","83.33%","5UTR",NA,NA,NA,NA,NA
"19504","Cluster_29","Peve_00020075",-0.99757215116682,0.0443704514965721,0.926335665692565,159,-20.95,"2 21","842 864",20,"65.00%","85.00%","5UTR",NA,NA,NA,NA,NA
"19565","Cluster_4079","Peve_00013396",-0.999820977218369,0.0120463575804017,0.676535186799302,156,-20.02,"2 21","84 105",19,"63.16%","78.95%","5UTR","Q925Q3","Mitochondrial sodium/calcium exchanger protein (Na(+)/K(+)/Ca(2+)-exchange protein 6) (Sodium/calcium exchanger protein, mitochondrial) (Sodium/potassium/calcium exchanger 6) (Solute carrier family 24 member 6) (Solute carrier family 8 member B1)","Mus musculus (Mouse)","calcium export from the mitochondrion [GO:0099093]; calcium ion transmembrane transport [GO:0070588]; cation transport [GO:0006812]; cellular calcium ion homeostasis [GO:0006874]; glucose homeostasis [GO:0042593]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of insulin secretion [GO:0050796]; regulation of lymphocyte chemotaxis [GO:1901623]; regulation of store-operated calcium entry [GO:2001256]; response to stimulus [GO:0050896]; sodium ion transmembrane transport [GO:0035725]","GO:0005432; GO:0005739; GO:0005743; GO:0005886; GO:0006812; GO:0006851; GO:0006874; GO:0008324; GO:0016020; GO:0030061; GO:0031966; GO:0035725; GO:0042383; GO:0042593; GO:0042802; GO:0042803; GO:0050796; GO:0050896; GO:0051480; GO:0051560; GO:0070588; GO:0086036; GO:0086038; GO:0099093; GO:1901623; GO:2001256"
"19572","Cluster_4079","Peve_00015748",-0.999044377811527,0.0278338206502373,0.899469696283718,171,-21.11,"2 20","653 674",18,"83.33%","83.33%","5UTR","P0CI65","Nephrocystin-3","Danio rerio (Zebrafish) (Brachydanio rerio)","cilium assembly [GO:0060271]; convergent extension [GO:0060026]; determination of left/right symmetry [GO:0007368]; heart jogging [GO:0003146]; kidney development [GO:0001822]; Kupffer's vesicle development [GO:0070121]; left/right pattern formation [GO:0060972]; pronephros development [GO:0048793]; visual perception [GO:0007601]; Wnt signaling pathway [GO:0016055]","GO:0001822; GO:0003146; GO:0005929; GO:0007368; GO:0007601; GO:0016055; GO:0048793; GO:0060026; GO:0060271; GO:0060972; GO:0070121; GO:0097543; GO:0097546"
"19589","Cluster_4079","Peve_00022789",0.999909031516669,0.0085870479919059,0.575101679046124,154,-21.51,"2 20","62 85",20,"60.00%","85.00%","5UTR",NA,NA,NA,NA,NA
"19629","Cluster_4079","Peve_00035192",-0.998775289031826,0.03151056991983,0.903929377050813,158,-20.23,"2 20","417 439",19,"68.42%","84.21%","5UTR","Q80XJ3","Tetratricopeptide repeat protein 28 (TPR repeat protein 28)","Mus musculus (Mouse)","cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0005737; GO:0005813; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301; GO:0072686; GO:0097431; GO:1990023"
"19638","Cluster_4079","Peve_00038009",-0.999936297068816,0.00718583323943983,0.573710369894872,146,-20.12,"2 20","13 35",19,"63.16%","73.68%","5UTR","P15178","Aspartate--tRNA ligase, cytoplasmic (EC 6.1.1.12) (Aspartyl-tRNA synthetase) (AspRS)","Rattus norvegicus (Rat)","aspartyl-tRNA aminoacylation [GO:0006422]","GO:0003723; GO:0004815; GO:0005524; GO:0005737; GO:0005829; GO:0006422; GO:0017101; GO:0045202"
"19673","Cluster_4080","Peve_00006985",-0.998052429938545,0.0397385645947719,0.909359886114279,165,-20.75,"2 20","758 781",20,"75.00%","90.00%","5UTR","Q9H4G4","Golgi-associated plant pathogenesis-related protein 1 (GAPR-1) (Golgi-associated PR-1 protein) (Glioma pathogenesis-related protein 2) (GliPR 2)","Homo sapiens (Human)","positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]","GO:0000139; GO:0005615; GO:0010634; GO:0010718; GO:0042803; GO:0070062; GO:0070374"
"19687","Cluster_4080","Peve_00011705",0.998232761629708,0.037853554466726,0.909359886114279,161,-21.13,"2 21","615 638",22,"77.27%","77.27%","5UTR",NA,NA,NA,NA,NA
"19693","Cluster_4080","Peve_00013087",-0.999999672229045,0.000515442667547547,0.239778920002343,162,-20.91,"2 15","566 587",13,"84.62%","100.00%","5UTR","Q7TN88","Polycystic kidney disease protein 1-like 2 (PC1-like 2 protein) (Polycystin-1L2)","Mus musculus (Mouse)","detection of mechanical stimulus [GO:0050982]","GO:0001965; GO:0005262; GO:0005509; GO:0016020; GO:0030246; GO:0050982"
"19765","Cluster_4080","Peve_00035886",-0.999981340367671,0.00388908412218857,0.54328949385489,161,-20.29,"2 21","329 350",20,"75.00%","85.00%","5UTR","Q6DE14","Transcription factor E2F4 (E2F-4)","Xenopus laevis (African clawed frog)","centriole assembly [GO:0098534]; motile cilium assembly [GO:0044458]; multi-ciliated epithelial cell differentiation [GO:1903251]; positive regulation of transcription by RNA polymerase II [GO:0045944]","GO:0000978; GO:0003700; GO:0005634; GO:0005667; GO:0044458; GO:0045944; GO:0046983; GO:0098534; GO:1903251"
"19772","Cluster_4080","Peve_00037697",-0.999168966643069,0.0259558006313078,0.879507868160642,172,-21.91,"2 19","957 977",17,"88.24%","94.12%","5UTR","O62742","Sterol carrier protein 2 (SCP-2) (Acetyl-CoA C-myristoyltransferase) (EC 2.3.1.155) (Non-specific lipid-transfer protein) (NSL-TP) (Propanoyl-CoA C-acyltransferase) (EC 2.3.1.176) (SCP-2/3-oxoacyl-CoA thiolase) (SCP-2/thiolase) (EC 2.3.1.16) (SCP-chi) (SCPX) (Sterol carrier protein X) (SCP-X)","Oryctolagus cuniculus (Rabbit)","bile acid metabolic process [GO:0008206]; fatty acid beta-oxidation [GO:0006635]; intracellular cholesterol transport [GO:0032367]; lipid transport [GO:0006869]; regulation of phospholipid biosynthetic process [GO:0071071]","GO:0003988; GO:0005737; GO:0005739; GO:0005777; GO:0005782; GO:0005783; GO:0006635; GO:0006869; GO:0008206; GO:0008289; GO:0032367; GO:0033814; GO:0050632; GO:0050633; GO:0071071; GO:0120019; GO:0120020"
"19775","Cluster_4080","Peve_00036963",0.999351594621176,0.0229267182870592,0.843538272975541,167,-21.47,"2 20","777 798",18,"77.78%","83.33%","5UTR","Q8WU76","Sec1 family domain-containing protein 2 (Syntaxin-binding protein 1-like 1)","Homo sapiens (Human)","intracellular protein transport [GO:0006886]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport [GO:0016192]","GO:0005886; GO:0006886; GO:0006904; GO:0016192; GO:0019905; GO:0030141"
"19788","Cluster_4080","Peve_00043526",0.998465344822469,0.0352741113828147,0.909359886114279,161,-20.29,"2 18","577 598",16,"75.00%","87.50%","5UTR",NA,NA,NA,NA,NA
"19873","Cluster_4629","Peve_00001326",-0.997041811903654,0.0489795884758296,0.949444666171571,150,-20.45,"2 21","296 316",19,"68.42%","73.68%","5UTR","Q505F5","Leucine-rich repeat-containing protein 47","Mus musculus (Mouse)","phenylalanyl-tRNA aminoacylation [GO:0006432]","GO:0003723; GO:0004826; GO:0006432"
"19878","Cluster_4629","Peve_00002365",0.997938030915672,0.0408894104551393,0.909359886114279,140,-21.96,"2 9","1 17",7,"100.00%","100.00%","5UTR",NA,NA,NA,NA,NA
"19879","Cluster_4629","Peve_00002477",0.997938030915672,0.0408894104551393,0.909359886114279,161,-23.63,"2 21","861 885",22,"77.27%","81.82%","5UTR",NA,NA,NA,NA,NA
"19896","Cluster_4629","Peve_00005452",0.997938030915672,0.0408894104551393,0.909359886114279,172,-30.34,"2 21","633 654",19,"73.68%","89.47%","5UTR","Q9FGB1",NA,NA,NA,NA
"19922","Cluster_4629","Peve_00009813",0.997938030915672,0.0408894104551393,0.909359886114279,161,-21.15,"2 18","183 204",16,"75.00%","87.50%","5UTR",NA,NA,NA,NA,NA
"19971","Cluster_4629","Peve_00015601",0.997938030915672,0.0408894104551393,0.909359886114279,147,-22.68,"2 21","251 276",23,"60.87%","69.57%","5UTR",NA,NA,NA,NA,NA
"19999","Cluster_4629","Peve_00019915",0.997938030915672,0.0408894104551393,0.909359886114279,152,-22.41,"2 21","816 837",19,"57.89%","78.95%","5UTR",NA,NA,NA,NA,NA
"20034","Cluster_4629","Peve_00024444",-0.999839766742431,0.0113966510517457,0.658396521887265,146,-20.47,"2 19","197 215",17,"70.59%","76.47%","5UTR","Q9QYP0","Multiple epidermal growth factor-like domains protein 8 (Multiple EGF-like domains protein 8) (Epidermal growth factor-like protein 4) (EGF-like protein 4)","Rattus norvegicus (Rat)","animal organ morphogenesis [GO:0009887]; BMP signaling pathway [GO:0030509]; cell migration involved in gastrulation [GO:0042074]; coronary vasculature development [GO:0060976]; craniofacial suture morphogenesis [GO:0097094]; determination of digestive tract left/right asymmetry [GO:0071907]; determination of heart left/right asymmetry [GO:0061371]; determination of left/right symmetry [GO:0007368]; embryonic heart tube left/right pattern formation [GO:0060971]; embryonic heart tube morphogenesis [GO:0003143]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; epiboly involved in gastrulation with mouth forming second [GO:0055113]; fasciculation of sensory neuron axon [GO:0097155]; left/right pattern formation [GO:0060972]; limb morphogenesis [GO:0035108]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of axon extension involved in axon guidance [GO:0048842]; regulation of gene expression [GO:0010468]; tissue development [GO:0009888]","GO:0003143; GO:0005509; GO:0005634; GO:0007368; GO:0009887; GO:0009888; GO:0010468; GO:0016020; GO:0030326; GO:0030509; GO:0035108; GO:0042074; GO:0045879; GO:0048704; GO:0048842; GO:0055113; GO:0060971; GO:0060972; GO:0060976; GO:0061371; GO:0071907; GO:0097094; GO:0097155"
"20055","Cluster_4629","Peve_00027295",-0.998044922586829,0.0398151065215797,0.909359886114279,167,-25.95,"2 21","449 472",21,"71.43%","85.71%","5UTR","Q9NTJ4","Alpha-mannosidase 2C1 (EC 3.2.1.24) (Alpha mannosidase 6A8B) (Alpha-D-mannoside mannohydrolase) (Mannosidase alpha class 2C member 1)","Homo sapiens (Human)","mannose metabolic process [GO:0006013]; oligosaccharide catabolic process [GO:0009313]","GO:0004559; GO:0005654; GO:0005829; GO:0006013; GO:0009313; GO:0030246; GO:0046872"
"20077","Cluster_4629","Peve_00030606",0.99730289693183,0.0467672197087773,0.939470798087631,158,-24.39,"2 20","967 989",19,"68.42%","84.21%","5UTR","Q9VCA2","Organic cation transporter protein","Drosophila melanogaster (Fruit fly)","apoptotic process [GO:0006915]; ion transport [GO:0006811]","GO:0006811; GO:0006915; GO:0016020; GO:0022857"
"20111","Cluster_4629","Peve_00035367",0.997938030915672,0.0408894104551393,0.909359886114279,162,-24.89,"2 20","50 72",19,"78.95%","78.95%","5UTR",NA,NA,NA,NA,NA
"20131","Cluster_4629","Peve_00036785",0.997938030915672,0.0408894104551393,0.909359886114279,162,-24.92,"2 21","572 597",23,"73.91%","78.26%","5UTR","Q17LW0","Myosin-VIIa (Protein crinkled)","Aedes aegypti (Yellowfever mosquito) (Culex aegypti)","actin filament-based movement [GO:0030048]; antennal morphogenesis [GO:0048800]; chaeta morphogenesis [GO:0008407]; imaginal disc-derived wing hair organization [GO:0035317]; sensory perception of sound [GO:0007605]","GO:0000146; GO:0003779; GO:0005524; GO:0005737; GO:0007605; GO:0008407; GO:0016459; GO:0030048; GO:0032027; GO:0035317; GO:0048800; GO:0071944; GO:0120025"
"20143","Cluster_4629","Peve_00036947",0.99868990037373,0.0325907764753561,0.909359886114279,164,-26.7,"2 21","765 786",19,"73.68%","78.95%","5UTR",NA,NA,NA,NA,NA
"20175","Cluster_4629","Peve_00042151",0.997938030915672,0.0408894104551393,0.909359886114279,157,-24.55,"2 14","624 645",12,"91.67%","91.67%","5UTR",NA,NA,NA,NA,NA
"20177","Cluster_4629","Peve_00042435",0.997262417278732,0.0471170262500777,0.94113497813925,157,-21.66,"2 21","660 679",19,"73.68%","78.95%","5UTR",NA,NA,NA,NA,NA
"20186","Cluster_4629","Peve_00043768",0.997938030915673,0.0408894104551382,0.909359886114279,146,-20.9,"2 20","932 955",20,"60.00%","75.00%","5UTR",NA,NA,NA,NA,NA
"20202","Cluster_4629","Peve_00043615",0.999186729228898,0.0256768734393112,0.876415971818516,152,-21.26,"2 19","146 170",20,"70.00%","80.00%","5UTR","P55006","Retinol dehydrogenase 7 (EC 1.1.1.105) (Retinol dehydrogenase 3) (Retinol dehydrogenase type III) (RODH III)","Rattus norvegicus (Rat)","retinol metabolic process [GO:0042572]; steroid metabolic process [GO:0008202]","GO:0004745; GO:0005783; GO:0008202; GO:0016491; GO:0042572; GO:0043231"
"20223","Cluster_4735","Peve_00004731",-0.999783900702665,0.0132351729066914,0.705702184467113,165,-23.35,"2 20","440 460",18,"83.33%","83.33%","5UTR","Q6DEW6","RNA exonuclease 4 (EC 3.1.-.-) (Exonuclease XPMC2) (Prevents mitotic catastrophe 2 protein)","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","rRNA processing [GO:0006364]","GO:0003676; GO:0005634; GO:0006364; GO:0008408"
"20228","Cluster_4735","Peve_00006174",-0.998701518193497,0.032445917538854,0.909359886114279,163,-22.3,"2 20","64 85",18,"72.22%","83.33%","5UTR",NA,NA,NA,NA,NA
"20282","Cluster_4735","Peve_00025044",-0.999885283611896,0.00964299640621119,0.610514562090407,151,-20.32,"2 21","710 727",19,"73.68%","73.68%","5UTR","Q04073","DNA-binding protein P3A2","Strongylocentrotus purpuratus (Purple sea urchin)","regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000978; GO:0000981; GO:0005634; GO:0006357"
"20300","Cluster_4735","Peve_00033287",-0.998878569589875,0.0301523995600735,0.903929377050813,147,-20.12,"2 12","895 916",10,"90.00%","90.00%","5UTR","Q9R1L5","Microtubule-associated serine/threonine-protein kinase 1 (EC 2.7.11.1) (Syntrophin-associated serine/threonine-protein kinase)","Mus musculus (Mouse)","brain development [GO:0007420]; cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]","GO:0000287; GO:0004674; GO:0005524; GO:0005737; GO:0005856; GO:0005886; GO:0006468; GO:0007010; GO:0007420; GO:0008017; GO:0016020; GO:0018105; GO:0030424; GO:0030425; GO:0035556; GO:0043005; GO:0043025; GO:0106310"
"20302","Cluster_4735","Peve_00034069",0.99999940598563,0.000693894776259953,0.239778920002343,148,-20.37,"2 20","547 571",22,"63.64%","77.27%","5UTR",NA,NA,NA,NA,NA
"20303","Cluster_4735","Peve_00034189",-0.999325369433971,0.0233858169858483,0.84919156053953,159,-25.02,"2 16","457 478",14,"78.57%","92.86%","5UTR","Q6P3D0","U8 snoRNA-decapping enzyme (EC 3.6.1.62) (IDP phosphatase) (IDPase) (EC 3.6.1.64) (Inosine diphosphate phosphatase) (Nucleoside diphosphate-linked moiety X motif 16) (Nudix motif 16) (m7GpppN-mRNA hydrolase)","Mus musculus (Mouse)","chromosome organization [GO:0051276]; dITP catabolic process [GO:0035863]; mRNA catabolic process [GO:0006402]; NAD-cap decapping [GO:0110155]; negative regulation of rRNA processing [GO:2000233]; positive regulation of cell cycle process [GO:0090068]; RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]; sno(s)RNA catabolic process [GO:0016077]","GO:0000166; GO:0000287; GO:0003729; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006402; GO:0008235; GO:0016077; GO:0030145; GO:0030515; GO:0031404; GO:0035863; GO:0035870; GO:0042802; GO:0042803; GO:0050072; GO:0050897; GO:0051276; GO:0090068; GO:0090502; GO:0097383; GO:0110152; GO:0110155; GO:0140933; GO:1990003; GO:1990174; GO:2000233"
"20306","Cluster_4735","Peve_00035232",0.99999940598563,0.000693894776195108,0.239778920002343,156,-21.28,"2 21","707 728",19,"63.16%","78.95%","5UTR",NA,NA,NA,NA,NA
"20336","Cluster_4735","Peve_00042498",0.999891079350943,0.00939624156020117,0.602954859488328,150,-21.28,"2 19","563 584",17,"64.71%","76.47%","5UTR",NA,NA,NA,NA,NA
"20516","Cluster_5882","Peve_00036264",0.997786572068102,0.0423650724088565,0.91271866035762,167,-20.17,"2 21","518 540",20,"75.00%","85.00%","5UTR",NA,NA,NA,NA,NA
"20590","Cluster_589","Peve_00008377",-0.999957293079344,0.00588363598502496,0.570680688799154,155,-20.03,"2 21","84 106",20,"70.00%","75.00%","5UTR",NA,NA,NA,NA,NA
"20595","Cluster_589","Peve_00009458",-0.998175220682579,0.0384650550931703,0.909359886114279,160,-23.47,"2 19","629 649",17,"76.47%","88.24%","5UTR","Q14674","Separin (EC 3.4.22.49) (Caspase-like protein ESPL1) (Extra spindle poles-like 1 protein) (Separase)","Homo sapiens (Human)","apoptotic process [GO:0006915]; establishment of mitotic spindle localization [GO:0040001]; homologous chromosome segregation [GO:0045143]; meiotic chromosome separation [GO:0051307]; meiotic spindle organization [GO:0000212]; mitotic cytokinesis [GO:0000281]; mitotic sister chromatid segregation [GO:0000070]; negative regulation of sister chromatid cohesion [GO:0045875]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; proteolysis [GO:0006508]","GO:0000070; GO:0000212; GO:0000281; GO:0003824; GO:0004197; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0006508; GO:0006915; GO:0008234; GO:0040001; GO:0045143; GO:0045842; GO:0045875; GO:0051307; GO:0072686"
"20623","Cluster_589","Peve_00015066",-0.999604063448837,0.0179152242682217,0.782669382293497,155,-23.55,"2 12","597 618",10,"100.00%","100.00%","5UTR","P42674","Blastula protease 10 (EC 3.4.24.-)","Paracentrotus lividus (Common sea urchin)","proteolysis [GO:0006508]","GO:0004222; GO:0005615; GO:0005938; GO:0006508; GO:0008270; GO:0048471"
"20660","Cluster_589","Peve_00021093",-0.999211152128301,0.025288338918848,0.871601074988914,160,-21.67,"2 21","304 325",19,"68.42%","78.95%","5UTR","P98133","Fibrillin-1 (MP340) [Cleaved into: Asprosin]","Bos taurus (Bovine)","activation of protein kinase A activity [GO:0034199]; anatomical structure morphogenesis [GO:0009653]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; protein kinase A signaling [GO:0010737]","GO:0001527; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0008201; GO:0009653; GO:0010737; GO:0031012; GO:0034199; GO:0042593"
"20710","Cluster_589","Peve_00028238",-0.999566973841129,0.0187356109725696,0.784805430107369,156,-21.84,"2 18","536 558",17,"76.47%","82.35%","5UTR","P28575","Actin-binding protein IPP (Intracisternal A particle-promoted polypeptide) (IPP) (Murine IAP-promoted placenta-expressed protein) (Protein MIPP)","Mus musculus (Mouse)","","GO:0003779; GO:0005737; GO:0005856"
"20723","Cluster_589","Peve_00029556",-0.997545167599482,0.0446164413451834,0.928064198164883,162,-23.25,"2 21","60 80",19,"73.68%","84.21%","5UTR",NA,NA,NA,NA,NA
"20728","Cluster_589","Peve_00030695",0.99896776402964,0.0289282378876426,0.903929377050813,156,-20.29,"2 19","914 934",17,"76.47%","82.35%","5UTR","Q9IA76","60S ribosomal protein L31","Paralichthys olivaceus (Bastard halibut) (Hippoglossus olivaceus)","translation [GO:0006412]","GO:0003735; GO:0005737; GO:0005840; GO:0006412; GO:1990904"
"20749","Cluster_589","Peve_00033813",-0.999435010130582,0.0214010903728724,0.824328633796369,152,-21.27,"2 20","103 127",22,"68.18%","77.27%","5UTR","Q07076","Annexin A7 (Annexin VII) (Annexin-7) (Synexin)","Mus musculus (Mouse)","autophagy [GO:0006914]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; establishment of localization in cell [GO:0051649]; glial cell proliferation [GO:0014009]; hemostasis [GO:0007599]; insulin secretion [GO:0030073]; ion channel modulating, G protein-coupled receptor signaling pathway [GO:0099105]; ligand-gated ion channel signaling pathway [GO:1990806]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathway [GO:0007207]; positive regulation of insulin secretion [GO:0032024]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]","GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005737; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007207; GO:0007599; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014009; GO:0014070; GO:0030073; GO:0031982; GO:0032024; GO:0042584; GO:0045202; GO:0048306; GO:0051592; GO:0051649; GO:0061025; GO:0062023; GO:0099105; GO:1990806"
"20765","Cluster_589","Peve_00035839",-0.999999999503679,2.00574810710951e-05,0.0131777650637095,150,-20.84,"2 11","718 739",9,"100.00%","100.00%","5UTR","P59750","Merlin (Moesin-ezrin-radixin-like protein) (Neurofibromin-2) (Schwannomin)","Papio anubis (Olive baboon)","actin cytoskeleton organization [GO:0030036]; cell-cell junction organization [GO:0045216]; ectoderm development [GO:0007398]; hippocampus development [GO:0021766]; lens fiber cell differentiation [GO:0070306]; MAPK cascade [GO:0000165]; mesoderm formation [GO:0001707]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of osteoblast proliferation [GO:0033689]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of Schwann cell proliferation [GO:0010626]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; odontogenesis of dentin-containing tooth [GO:0042475]; osteoblast proliferation [GO:0033687]; positive regulation of cell differentiation [GO:0045597]; positive regulation of stress fiber assembly [GO:0051496]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of hippo signaling [GO:0035330]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of protein localization to nucleus [GO:1900180]; regulation of protein stability [GO:0031647]; regulation of stem cell proliferation [GO:0072091]; Schwann cell proliferation [GO:0014010]","GO:0000165; GO:0001707; GO:0001726; GO:0003779; GO:0005730; GO:0005769; GO:0005829; GO:0005912; GO:0006469; GO:0007398; GO:0010626; GO:0014010; GO:0021766; GO:0022408; GO:0030027; GO:0030036; GO:0030175; GO:0030864; GO:0031647; GO:0032154; GO:0033687; GO:0033689; GO:0035330; GO:0042475; GO:0042532; GO:0042981; GO:0043005; GO:0043409; GO:0044297; GO:0045177; GO:0045216; GO:0045597; GO:0048471; GO:0051496; GO:0051726; GO:0070306; GO:0072091; GO:1900180; GO:2000177"
"20794","Cluster_589","Peve_00042524",-0.998208451660281,0.0381130974955327,0.909359886114279,152,-21.01,"2 13","778 799",11,"90.91%","90.91%","5UTR",NA,NA,NA,NA,NA
"20810","Cluster_589","Peve_00044403",-0.999992423016843,0.00247824110430817,0.414802988923135,158,-24.6,"2 16","799 822",16,"81.25%","87.50%","5UTR",NA,NA,NA,NA,NA
"20815","Cluster_589","Peve_00044772",-0.997856253350184,0.0416926466893275,0.909359886114279,151,-21.14,"2 14","859 879",12,"91.67%","91.67%","5UTR","Q91XW8","Inactive peptidyl-prolyl cis-trans isomerase FKBP6 (Inactive PPIase FKBP6) (36 kDa FK506-binding protein) (36 kDa FKBP) (FKBP-36) (FK506-binding protein 6) (FKBP-6) (Immunophilin FKBP36)","Mus musculus (Mouse)","cell differentiation [GO:0030154]; DNA methylation involved in gamete generation [GO:0043046]; meiotic cell cycle [GO:0051321]; piRNA processing [GO:0034587]; positive regulation of viral genome replication [GO:0045070]; protein folding [GO:0006457]; RNA-mediated gene silencing [GO:0031047]; spermatogenesis [GO:0007283]","GO:0000795; GO:0005654; GO:0005737; GO:0005829; GO:0006457; GO:0007283; GO:0030154; GO:0031047; GO:0034587; GO:0042802; GO:0043046; GO:0045070; GO:0051321; GO:0051879"
"20818","Cluster_6255","Peve_00003999",-0.999977919419974,0.00423059214486466,0.54328949385489,159,-21.18,"2 21","805 831",24,"66.67%","75.00%","5UTR",NA,NA,NA,NA,NA
"20859","Cluster_6904","Peve_00007262",-0.997139931185431,0.048160049624566,0.945590536869992,161,-23.17,"2 19","934 956",18,"77.78%","83.33%","5UTR","Q02763","Angiopoietin-1 receptor (EC 2.7.10.1) (Endothelial tyrosine kinase) (Tunica interna endothelial cell kinase) (Tyrosine kinase with Ig and EGF homology domains-2) (Tyrosine-protein kinase receptor TEK) (Tyrosine-protein kinase receptor TIE-2) (hTIE2) (p140 TEK) (CD antigen CD202b)","Homo sapiens (Human)","angiogenesis [GO:0001525]; cell-cell signaling [GO:0007267]; definitive hemopoiesis [GO:0060216]; endothelial cell proliferation [GO:0001935]; glomerulus vasculature development [GO:0072012]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of inflammatory response [GO:0050728]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; protein autophosphorylation [GO:0046777]; regulation of endothelial cell apoptotic process [GO:2000351]; regulation of establishment or maintenance of cell polarity [GO:0032878]; regulation of vascular permeability [GO:0043114]; signal transduction [GO:0007165]; sprouting angiogenesis [GO:0002040]; substrate adhesion-dependent cell spreading [GO:0034446]; Tie signaling pathway [GO:0048014]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]","GO:0001525; GO:0001934; GO:0001935; GO:0001938; GO:0002040; GO:0004672; GO:0004713; GO:0004714; GO:0005524; GO:0005576; GO:0005737; GO:0005886; GO:0005902; GO:0005911; GO:0005925; GO:0007165; GO:0007169; GO:0007267; GO:0007507; GO:0009925; GO:0009986; GO:0010595; GO:0014068; GO:0016323; GO:0016324; GO:0016525; GO:0018108; GO:0032878; GO:0033674; GO:0034446; GO:0034451; GO:0038023; GO:0042802; GO:0043066; GO:0043114; GO:0043235; GO:0043410; GO:0043552; GO:0045121; GO:0045766; GO:0046777; GO:0048014; GO:0050728; GO:0051894; GO:0051897; GO:0060216; GO:0060347; GO:0070374; GO:0072012; GO:1902533; GO:2000251; GO:2000351; GO:2000352"
"20867","Cluster_6904","Peve_00010915",-0.999463001694963,0.0208641652974758,0.817190070029867,149,-20.54,"2 18","961 982",16,"68.75%","75.00%","5UTR","Q6AZS2","Polycomb protein eed-B (Xeed-B) (psXEED)","Xenopus laevis (African clawed frog)","chromatin organization [GO:0006325]","GO:0006325; GO:0035098"
"20870","Cluster_6904","Peve_00011228",-0.997022666930234,0.0491379058163316,0.94992237160644,152,-20.13,"2 15","300 320",13,"84.62%","92.31%","5UTR","Q6GPE5","Protein fem-1 homolog B (FEM1b) (FEM1-beta)","Xenopus laevis (African clawed frog)","apoptotic process [GO:0006915]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of DNA damage checkpoint [GO:2000001]; ubiquitin-dependent protein catabolic process via the C-end degron rule pathway [GO:0140627]","GO:0005634; GO:0005737; GO:0006915; GO:0016567; GO:0031462; GO:0043161; GO:0140627; GO:1990756; GO:2000001"
"20920","Cluster_6904","Peve_00021519",-0.999968700996602,0.00503687888605023,0.551398425649056,155,-20.16,"2 18","692 712",16,"81.25%","81.25%","5UTR",NA,NA,NA,NA,NA
"20922","Cluster_6904","Peve_00021626",-0.998711375947948,0.0323224956188328,0.909244498015575,162,-21.14,"2 15","17 38",13,"92.31%","92.31%","5UTR","Q2VJ60","E3 ubiquitin-protein ligase RNF19A (EC 2.3.2.31) (Double ring-finger protein) (Dorfin) (RING finger protein 19A)","Sus scrofa (Pig)","positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; regulation of protein catabolic process at postsynapse, modulating synaptic transmission [GO:0099576]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0000151; GO:0000209; GO:0005737; GO:0005815; GO:0006511; GO:0016020; GO:0031624; GO:0032436; GO:0046872; GO:0061630; GO:0098686; GO:0098794; GO:0098978; GO:0099576"
"20978","Cluster_6904","Peve_00037342",-0.998706114075126,0.0323884342508462,0.909244498015575,156,-21.91,"2 20","960 982",20,"75.00%","80.00%","5UTR",NA,NA,NA,NA,NA
"20980","Cluster_6904","Peve_00037704",-0.998219553343417,0.0379947911463899,0.909359886114279,155,-21.07,"2 19","756 777",18,"77.78%","83.33%","5UTR",NA,NA,NA,NA,NA
"21010","Cluster_6904","Peve_00042648",-0.999469703920853,0.0207335430475651,0.81520158559417,161,-21.69,"2 19","672 694",18,"72.22%","88.89%","5UTR","A5PMX1","Zinc transporter 7 (ZnT-7) (Solute carrier family 30 member 7)","Danio rerio (Zebrafish) (Brachydanio rerio)","cellular zinc ion homeostasis [GO:0006882]; metal ion transport [GO:0030001]; zinc ion import into Golgi lumen [GO:1904257]; zinc ion transport [GO:0006829]","GO:0005385; GO:0005794; GO:0006829; GO:0006882; GO:0016020; GO:0030001; GO:0031410; GO:0046873; GO:1904257"
"21067","Cluster_6905","Peve_00021945",-0.999971374472759,0.00481695849265739,0.551398425649056,157,-26.54,"2 20","406 426",18,"77.78%","77.78%","5UTR",NA,NA,NA,NA,NA
"21111","Cluster_6905","Peve_00042462",-0.999901669120146,0.00892778333881972,0.587136688814728,164,-26.63,"2 17","809 830",15,"86.67%","86.67%","5UTR","Q96AY4","Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio)","Homo sapiens (Human)","cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0000922; GO:0005737; GO:0005815; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301"
"21137","Cluster_6906","Peve_00006922",0.999971311671877,0.00482223952987791,0.551398425649056,162,-26.98,"2 20","746 772",23,"73.91%","73.91%","5UTR","Q9NTG1","Polycystin family receptor for egg jelly (PKD and REJ homolog) (Polycystic kidney disease and receptor for egg jelly-related protein)","Homo sapiens (Human)","acrosome reaction [GO:0007340]; detection of mechanical stimulus [GO:0050982]","GO:0005262; GO:0005509; GO:0007340; GO:0016020; GO:0050982"
"21280","Cluster_6906","Peve_00042534",-0.999911200410267,0.00848406162211117,0.573710369894872,154,-20.14,"2 16","501 523",15,"80.00%","86.67%","5UTR",NA,NA,NA,NA,NA
"21286","Cluster_6906","Peve_00043593",-0.997871906088051,0.0415401024981488,0.909359886114279,153,-21.26,"2 19","666 690",20,"65.00%","80.00%","5UTR",NA,NA,NA,NA,NA
"21292","Cluster_6914","Peve_00000232",-0.99998857382088,0.00304330898553907,0.474160259106401,162,-22.04,"2 17","22 41",15,"86.67%","93.33%","5UTR",NA,NA,NA,NA,NA
"21335","Cluster_6914","Peve_00023691",0.998994743896135,0.0285476174462189,0.903929377050813,150,-21.36,"2 20","553 569",18,"72.22%","77.78%","5UTR","P36836","Solute carrier family 15 member 1 (Intestinal H(+)/peptide cotransporter) (Oligopeptide transporter, small intestine isoform) (Peptide transporter 1)","Oryctolagus cuniculus (Rabbit)","dipeptide import across plasma membrane [GO:0140206]; protein transport [GO:0015031]; tripeptide import across plasma membrane [GO:0140207]","GO:0015031; GO:0015333; GO:0016020; GO:0016324; GO:0042937; GO:0071916; GO:0140206; GO:0140207"
"21372","Cluster_6914","Peve_00042248",-0.99760688237923,0.0440518133990858,0.923915229231156,146,-20.01,"2 20","25 48",21,"61.90%","71.43%","5UTR","Q96AY4","Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio)","Homo sapiens (Human)","cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0000922; GO:0005737; GO:0005815; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301"
"21391","Cluster_7053","Peve_00007907",0.998593755293202,0.0337657560132954,0.909359886114279,154,-22.29,"2 21","150 177",25,"64.00%","76.00%","5UTR",NA,NA,NA,NA,NA
"21399","Cluster_7053","Peve_00014221",-0.999884527015562,0.00967474429161349,0.611343259425713,159,-20.72,"2 21","630 654",22,"72.73%","72.73%","5UTR",NA,NA,NA,NA,NA
"21427","Cluster_7053","Peve_00043872",-0.999374953775323,0.0225099128069867,0.838257076229427,144,-20.36,"2 18","376 400",19,"57.89%","78.95%","5UTR","P35555","Fibrillin-1 [Cleaved into: Asprosin]","Homo sapiens (Human)","activation of protein kinase A activity [GO:0034199]; anatomical structure morphogenesis [GO:0009653]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; positive regulation of appetite [GO:0032100]; post-embryonic eye morphogenesis [GO:0048050]; protein kinase A signaling [GO:0010737]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501]","GO:0001501; GO:0001527; GO:0001656; GO:0005178; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005788; GO:0006006; GO:0007507; GO:0008201; GO:0009653; GO:0010737; GO:0030023; GO:0031012; GO:0032100; GO:0033627; GO:0034199; GO:0035582; GO:0035583; GO:0042593; GO:0042802; GO:0043010; GO:0044877; GO:0045671; GO:0048048; GO:0048050; GO:0062023; GO:0071560; GO:1990314; GO:2001205"
"21491","Cluster_7855","Peve_00025803",-0.998338998790929,0.0366978166950436,0.909359886114279,175,-22.08,"2 21","824 847",21,"76.19%","90.48%","5UTR","Q6Q0C0","E3 ubiquitin-protein ligase TRAF7 (EC 2.3.2.27) (RING finger and WD repeat-containing protein 1) (RING finger protein 119) (RING-type E3 ubiquitin transferase TRAF7) (TNF receptor-associated factor 7)","Homo sapiens (Human)","apoptotic process [GO:0006915]; Notch signaling pathway [GO:0007219]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of MAPK cascade [GO:0043410]; protein ubiquitination [GO:0016567]; regulation of ERK1 and ERK2 cascade [GO:0070372]; ribosomal large subunit assembly [GO:0000027]","GO:0000027; GO:0000151; GO:0004842; GO:0005730; GO:0005886; GO:0006915; GO:0007219; GO:0008270; GO:0016567; GO:0031410; GO:0043231; GO:0043410; GO:0070372; GO:2001235"
"21515","Cluster_796","Peve_00000718",0.998052856721296,0.0397342088666192,0.909359886114279,158,-21.02,"2 20","915 937",19,"73.68%","78.95%","5UTR","Q8IWZ3","Ankyrin repeat and KH domain-containing protein 1 (HIV-1 Vpr-binding ankyrin repeat protein) (Multiple ankyrin repeats single KH domain) (hMASK)","Homo sapiens (Human)","innate immune response [GO:0045087]","GO:0003723; GO:0005737; GO:0045087"
"21567","Cluster_796","Peve_00012591",0.999716689332843,0.01515433341596,0.745846175256963,140,-21.31,"2 9","107 128",7,"100.00%","100.00%","5UTR","Q8INF0","Soluble guanylate cyclase 88E (EC 4.6.1.2)","Drosophila melanogaster (Fruit fly)","cGMP-mediated signaling [GO:0019934]; nitric oxide-cGMP-mediated signaling pathway [GO:0038060]; response to hypoxia [GO:0001666]; response to oxygen levels [GO:0070482]; response to reactive oxygen species [GO:0000302]","GO:0000302; GO:0001666; GO:0003924; GO:0004383; GO:0005525; GO:0008074; GO:0019825; GO:0019826; GO:0019899; GO:0019934; GO:0020037; GO:0038060; GO:0042803; GO:0046872; GO:0046982; GO:0070025; GO:0070026; GO:0070482"
"21619","Cluster_796","Peve_00026480",0.997091645416707,0.0485650802695336,0.947582413903802,154,-22.4,"2 21","754 774",19,"73.68%","73.68%","5UTR",NA,NA,NA,NA,NA
"21625","Cluster_796","Peve_00028200",-0.999345888781346,0.0230273835955368,0.844611056711255,153,-22.06,"2 19","523 546",19,"68.42%","78.95%","5UTR",NA,NA,NA,NA,NA
"21662","Cluster_796","Peve_00035430",0.999102854913975,0.0269686331853911,0.890748160714267,140,-22.48,"2 9","181 202",7,"100.00%","100.00%","5UTR","Q9NRM2","Zinc finger protein 277 (Nuclear receptor-interacting factor 4)","Homo sapiens (Human)","cellular response to hydrogen peroxide [GO:0070301]; regulation of cellular senescence [GO:2000772]","GO:0000978; GO:0005634; GO:0046872; GO:0070301; GO:2000772"
"21678","Cluster_796","Peve_00036964",0.997077513398696,0.0486829862370013,0.94805481250488,151,-20.54,"2 21","403 428",23,"60.87%","73.91%","5UTR","Q80TN7","Neuron navigator 3 (Pore membrane and/or filament-interacting-like protein 1)","Mus musculus (Mouse)","negative regulation of cell migration [GO:0030336]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of microtubule depolymerization [GO:0007026]; nervous system development [GO:0007399]; neurogenesis [GO:0022008]; positive regulation of microtubule polymerization [GO:0031116]","GO:0005524; GO:0005634; GO:0005635; GO:0005640; GO:0007026; GO:0007399; GO:0008017; GO:0016887; GO:0022008; GO:0030336; GO:0031116; GO:0032703; GO:1990752"
"21719","Cluster_8634","Peve_00008072",0.999978963950975,0.00412931457669044,0.54328949385489,167,-21.28,"2 18","774 794",16,"87.50%","93.75%","5UTR",NA,NA,NA,NA,NA
"21731","Cluster_8634","Peve_00018391",0.998840656587306,0.030657951802389,0.903929377050813,168,-23.21,"2 18","785 809",19,"84.21%","84.21%","5UTR","Q9CQI7","U2 small nuclear ribonucleoprotein B'' (U2 snRNP B'')","Mus musculus (Mouse)","mRNA splicing, via spliceosome [GO:0000398]","GO:0000398; GO:0001650; GO:0005634; GO:0005681; GO:0005685; GO:0005686; GO:0016607; GO:0030532; GO:0030619; GO:0036464; GO:0070990; GO:0071005; GO:0071007; GO:0071013"
"21736","Cluster_8634","Peve_00013384",0.999374263578392,0.0225223387727307,0.83828463858421,167,-21.89,"2 21","266 289",21,"76.19%","80.95%","5UTR",NA,NA,NA,NA,NA
"21745","Cluster_8634","Peve_00025850",0.999912402411178,0.00842644454811202,0.573710369894872,167,-21.25,"2 21","466 488",20,"75.00%","85.00%","5UTR","O54990","Prominin-1 (Antigen AC133 homolog) (Prominin-like protein 1) (CD antigen CD133)","Mus musculus (Mouse)","camera-type eye photoreceptor cell differentiation [GO:0060219]; glomerular parietal epithelial cell differentiation [GO:0072139]; photoreceptor cell maintenance [GO:0045494]; podocyte differentiation [GO:0072112]; positive regulation of nephron tubule epithelial cell differentiation [GO:2000768]; retina layer formation [GO:0010842]; retina morphogenesis in camera-type eye [GO:0060042]","GO:0001750; GO:0005615; GO:0005783; GO:0005793; GO:0005886; GO:0005902; GO:0005903; GO:0005929; GO:0009986; GO:0010842; GO:0015485; GO:0016324; GO:0031528; GO:0032420; GO:0042622; GO:0042805; GO:0042995; GO:0045296; GO:0045494; GO:0060042; GO:0060219; GO:0070062; GO:0071914; GO:0072112; GO:0072139; GO:2000768"
"21767","Cluster_8634","Peve_00038875",0.99912526170216,0.0266296742754265,0.887027605960946,171,-23.07,"2 21","935 957",20,"80.00%","85.00%","5UTR","Q9CSN1","SNW domain-containing protein 1 (Nuclear protein SkiP) (Ski-interacting protein)","Mus musculus (Mouse)","cellular response to retinoic acid [GO:0071300]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of neurogenesis [GO:0050769]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; positive regulation of vitamin D receptor signaling pathway [GO:0070564]; regulation of retinoic acid receptor signaling pathway [GO:0048385]; regulation of vitamin D receptor signaling pathway [GO:0070562]; retinoic acid receptor signaling pathway [GO:0048384]; skeletal muscle cell differentiation [GO:0035914]","GO:0000122; GO:0000398; GO:0000785; GO:0003713; GO:0003714; GO:0005112; GO:0005634; GO:0005654; GO:0005681; GO:0005737; GO:0008024; GO:0016363; GO:0016604; GO:0016607; GO:0016922; GO:0019899; GO:0030511; GO:0035914; GO:0042771; GO:0042809; GO:0042974; GO:0043923; GO:0045892; GO:0045944; GO:0046332; GO:0048026; GO:0048384; GO:0048385; GO:0050681; GO:0050769; GO:0051571; GO:0070562; GO:0070564; GO:0071007; GO:0071013; GO:0071141; GO:0071300"
"21772","Cluster_8634","Peve_00041049",0.998453622764511,0.0354086057088602,0.909359886114279,169,-20.66,"2 18","804 825",16,"87.50%","87.50%","5UTR","Q9Y5X5","Neuropeptide FF receptor 2 (G-protein coupled receptor 74) (G-protein coupled receptor HLWAR77) (Neuropeptide G-protein coupled receptor)","Homo sapiens (Human)","detection of abiotic stimulus [GO:0009582]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of adenylate cyclase activity [GO:0045761]; regulation of cAMP-dependent protein kinase activity [GO:2000479]; regulation of MAPK cascade [GO:0043408]","GO:0004930; GO:0005886; GO:0007186; GO:0008188; GO:0009582; GO:0015629; GO:0031628; GO:0042277; GO:0043408; GO:0045761; GO:2000479"
"21822","Cluster_8884","Peve_00026145",0.997253647308052,0.047192471195222,0.941791888778827,153,-20.15,"2 20","649 673",22,"68.18%","77.27%","5UTR",NA,NA,NA,NA,NA
"21828","Cluster_8884","Peve_00028555",-0.997387077455361,0.0460312744260222,0.935169468683523,166,-20.49,"2 19","605 625",17,"76.47%","88.24%","5UTR",NA,NA,NA,NA,NA
"21891","Cluster_8887","Peve_00015062",-0.99991446441509,0.00832667533146618,0.573710369894872,153,-24.97,"2 20","572 594",20,"70.00%","80.00%","5UTR","P55115","Zinc metalloproteinase nas-15 (EC 3.4.24.-) (Nematode astacin 15)","Caenorhabditis elegans","proteolysis [GO:0006508]","GO:0004222; GO:0005576; GO:0006508; GO:0008270"
"21926","Cluster_8887","Peve_00032682",-0.99825928797896,0.0375683052200161,0.909359886114279,162,-23.29,"2 20","214 235",19,"73.68%","84.21%","5UTR","O15381","Nuclear valosin-containing protein-like (NVLp) (Nuclear VCP-like protein)","Homo sapiens (Human)","positive regulation of protein binding [GO:0032092]; positive regulation of telomerase activity [GO:0051973]; regulation of protein localization to nucleolus [GO:1904749]; ribosomal large subunit biogenesis [GO:0042273]; ribosome biogenesis [GO:0042254]; rRNA processing [GO:0006364]","GO:0003723; GO:0005524; GO:0005634; GO:0005654; GO:0005697; GO:0005730; GO:0006364; GO:0016020; GO:0016887; GO:0032092; GO:0042254; GO:0042273; GO:0051973; GO:1904749; GO:1990275"
"21941","Cluster_8887","Peve_00044134",-0.999836960200136,0.0114960286738644,0.661528833813137,155,-23.35,"2 12","486 506",10,"100.00%","100.00%","5UTR","Q6ITT3","Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase C (EC 2.4.1.145) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase IVc) (GnT-IVc) (N-acetylglucosaminyltransferase IVc) (UDP-N-acetylglucosamine: alpha-1,3-D-mannoside beta-1,4-N-acetylglucosaminyltransferase IVc)","Sus scrofa (Pig)","protein N-linked glycosylation [GO:0006487]","GO:0000139; GO:0006487; GO:0008375; GO:0008454; GO:0046872"
"22002","Cluster_8888","Peve_00038750",-0.999995310085062,0.00194974481237643,0.362847063101065,160,-20.8,"2 19","518 541",20,"75.00%","85.00%","5UTR","Q9WVK8","Cholesterol 24-hydroxylase (CH24H) (EC 1.14.14.25) (Cholesterol 24-monooxygenase) (Cholesterol 24S-hydroxylase) (Cytochrome P450 46A1)","Mus musculus (Mouse)","cholesterol catabolic process [GO:0006707]; progesterone metabolic process [GO:0042448]; protein localization to membrane raft [GO:1903044]; regulation of long-term synaptic potentiation [GO:1900271]; xenobiotic metabolic process [GO:0006805]","GO:0005506; GO:0005789; GO:0006707; GO:0006805; GO:0008395; GO:0020037; GO:0030425; GO:0033781; GO:0042448; GO:0062184; GO:0098793; GO:0098794; GO:1900271; GO:1903044"
"22006","Cluster_8888","Peve_00040567",-0.999850946843342,0.0109918578760632,0.647820986329688,154,-22.08,"2 20","501 518",18,"77.78%","83.33%","5UTR",NA,NA,NA,NA,NA
"22036","Cluster_8988","Peve_00011634",0.99725770910753,0.0471575439540669,0.941529418834028,154,-21.75,"2 20","650 673",20,"60.00%","85.00%","5UTR",NA,NA,NA,NA,NA
"22043","Cluster_8988","Peve_00012869",-0.997041894647782,0.0489789031235421,0.949444666171571,163,-20.13,"2 21","344 366",20,"70.00%","85.00%","5UTR",NA,NA,NA,NA,NA
"22061","Cluster_8988","Peve_00018542",0.999797047339721,0.0128262541271408,0.695994506963882,168,-21.61,"2 21","238 259",19,"73.68%","84.21%","5UTR",NA,NA,NA,NA,NA
"22081","Cluster_8988","Peve_00030038",-0.999550307649831,0.0190927790579351,0.790551218379749,163,-20.03,"2 20","475 496",18,"61.11%","94.44%","5UTR",NA,NA,NA,NA,NA
"22086","Cluster_8988","Peve_00033284",0.998215951089572,0.0380332192580478,0.909359886114279,169,-22.25,"2 18","618 639",16,"81.25%","93.75%","5UTR",NA,NA,NA,NA,NA
"22114","Cluster_9149","Peve_00000825",0.999999240744832,0.000784492916512268,0.239778920002343,151,-21.47,"2 21","27 49",20,"60.00%","80.00%","5UTR","Q8IW35","Centrosomal protein of 97 kDa (Cep97) (Leucine-rich repeat and IQ domain-containing protein 2)","Homo sapiens (Human)","cell projection organization [GO:0030030]; negative regulation of cilium assembly [GO:1902018]; regulation of mitotic spindle assembly [GO:1901673]","GO:0005516; GO:0005813; GO:0005814; GO:0005829; GO:0030030; GO:0032991; GO:1901673; GO:1902018"
"22132","Cluster_9149","Peve_00002320",-0.998696026270262,0.0325144749625038,0.909359886114279,150,-21.69,"2 11","318 339",9,"100.00%","100.00%","5UTR","Q8NDA2","Hemicentin-2","Homo sapiens (Human)","axon guidance [GO:0007411]; cell adhesion [GO:0007155]","GO:0005509; GO:0005615; GO:0007155; GO:0007411; GO:0031012; GO:0032154; GO:0062023"
"22136","Cluster_9149","Peve_00003234",0.999997860909741,0.0013167694840572,0.317099882619675,156,-23.76,"2 18","827 849",17,"76.47%","82.35%","5UTR","Q01528","Hemagglutinin/amebocyte aggregation factor (18K-LAF)","Limulus polyphemus (Atlantic horseshoe crab)","","GO:0005576"
"22144","Cluster_9149","Peve_00004521",-0.997395120221082,0.0459603451867603,0.934642337937236,161,-26.99,"2 21","656 677",20,"75.00%","85.00%","5UTR",NA,NA,NA,NA,NA
"22145","Cluster_9149","Peve_00004512",-0.999408825461995,0.021891442456906,0.830089015811238,161,-26.99,"2 21","383 404",20,"75.00%","85.00%","5UTR","Q91ZA8","Notch-regulated ankyrin repeat-containing protein","Mus musculus (Mouse)","blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:0002043]; branching involved in blood vessel morphogenesis [GO:0001569]; endothelial cell proliferation [GO:0001935]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of Notch signaling pathway involved in somitogenesis [GO:1902367]; negative regulation of T cell differentiation [GO:0045581]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; regulation of cell-cell adhesion [GO:0022407]; somite rostral/caudal axis specification [GO:0032525]; sprouting angiogenesis [GO:0002040]; T cell differentiation [GO:0030217]; vascular endothelial cell proliferation [GO:0101023]","GO:0000122; GO:0001569; GO:0001935; GO:0001938; GO:0002040; GO:0002043; GO:0007219; GO:0022407; GO:0030217; GO:0032525; GO:0045581; GO:0045746; GO:0090263; GO:0101023; GO:1902367; GO:1905564"
"22225","Cluster_9149","Peve_00012208",-0.999327894094028,0.0233420128583658,0.848872825778705,150,-21.59,"2 18","863 882",16,"75.00%","81.25%","5UTR","Q9NZJ4","Sacsin (DnaJ homolog subfamily C member 29) (DNAJC29)","Homo sapiens (Human)","negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457]","GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0030424; GO:0030425; GO:0030544; GO:0042802; GO:0051087; GO:0070628; GO:0070852; GO:0090084"
"22227","Cluster_9149","Peve_00012302",-0.999865571060301,0.0104386989464617,0.634381120973208,146,-20.99,"2 12","30 52",11,"90.91%","90.91%","5UTR",NA,NA,NA,NA,NA
"22229","Cluster_9149","Peve_00012404",0.999998523194906,0.00109409936293585,0.275560959970807,145,-20.88,"2 20","505 531",23,"65.22%","69.57%","5UTR",NA,NA,NA,NA,NA
"22246","Cluster_9149","Peve_00014451",1,0,0,146,-20.35,"2 20","308 330",19,"63.16%","73.68%","5UTR",NA,NA,NA,NA,NA
"22273","Cluster_9149","Peve_00016786",1,0,0,171,-24.95,"2 21","576 598",20,"80.00%","85.00%","5UTR",NA,NA,NA,NA,NA
"22276","Cluster_9149","Peve_00016830",0.997175508499252,0.0478594310724678,0.945152902495684,154,-21.98,"2 20","735 762",24,"66.67%","70.83%","5UTR","O94923","D-glucuronyl C5-epimerase (EC 5.1.3.17) (Heparan sulfate C5-epimerase) (Hsepi) (Heparin/heparan sulfate:glucuronic acid C5-epimerase) (Heparosan-N-sulfate-glucuronate 5-epimerase)","Homo sapiens (Human)","heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparin biosynthetic process [GO:0030210]","GO:0000139; GO:0005509; GO:0005794; GO:0015012; GO:0016857; GO:0030210; GO:0042803; GO:0047464"
"22285","Cluster_9149","Peve_00017781",0.99695799908616,0.0496689462152669,0.952044988713482,145,-20.9,"2 19","128 146",17,"76.47%","76.47%","5UTR",NA,NA,NA,NA,NA
"22319","Cluster_9149","Peve_00020492",-0.999191159467906,0.0256068319396386,0.875231632834556,159,-24.41,"2 21","944 966",20,"70.00%","80.00%","5UTR",NA,NA,NA,NA,NA
"22344","Cluster_9149","Peve_00022773",1,0,0,160,-24.25,"2 19","196 216",17,"76.47%","88.24%","5UTR","Q8VCK5","Kelch-like protein 20 (Kelch-like ECT2-interacting protein)","Mus musculus (Mouse)","Golgi to endosome transport [GO:0006895]; negative regulation of apoptotic process [GO:0043066]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K33-linked ubiquitination [GO:1990390]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]","GO:0003779; GO:0004842; GO:0005737; GO:0005794; GO:0005802; GO:0005829; GO:0006895; GO:0015031; GO:0016567; GO:0016605; GO:0019964; GO:0030424; GO:0030425; GO:0031463; GO:0043066; GO:0043161; GO:0048471; GO:1990390"
"22345","Cluster_9149","Peve_00022813",-0.998924716861794,0.0295253777049622,0.903929377050813,159,-21.13,"2 21","739 764",23,"69.57%","73.91%","5UTR",NA,NA,NA,NA,NA
"22356","Cluster_9149","Peve_00023808",-0.998460036492421,0.0353350804494513,0.909359886114279,147,-20.45,"2 12","916 937",10,"80.00%","100.00%","5UTR",NA,NA,NA,NA,NA
"22369","Cluster_9149","Peve_00024938",1,0,0,156,-22.67,"2 21","885 906",19,"63.16%","78.95%","5UTR","A2AJ88","Patatin-like phospholipase domain-containing protein 7 (EC 3.1.1.-) (EC 3.1.1.5) (Neuropathy target esterase-related esterase) (NRE) (NTE-related esterase)","Mus musculus (Mouse)","phosphatidylcholine catabolic process [GO:0034638]","GO:0004622; GO:0005783; GO:0005789; GO:0005811; GO:0034638; GO:0102545"
"22385","Cluster_9149","Peve_00026617",1,0,0,143,-20.34,"2 14","140 160",12,"75.00%","91.67%","5UTR",NA,NA,NA,NA,NA
"22386","Cluster_9149","Peve_00026617",1,0,0,143,-20.34,"2 14","456 476",12,"75.00%","91.67%","5UTR",NA,NA,NA,NA,NA
"22412","Cluster_9149","Peve_00028917",1,0,0,145,-20.4,"2 20","426 454",25,"64.00%","68.00%","5UTR","Q6DG99","BTB/POZ domain-containing protein KCTD6","Danio rerio (Zebrafish) (Brachydanio rerio)","protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]","GO:0016567; GO:0051260"
"22492","Cluster_9149","Peve_00036859",-0.996982195269473,0.0494709177037855,0.950846381223965,160,-23.52,"2 21","813 834",19,"63.16%","84.21%","5UTR","Q9CZR2","N-acetylated-alpha-linked acidic dipeptidase 2 (EC 3.4.17.21) (Glutamate carboxypeptidase III) (GCPIII) (N-acetylaspartylglutamate peptidase II) (NAAG-peptidase II) (N-acetylated-alpha-linked acidic dipeptidase II) (NAALADase II)","Mus musculus (Mouse)","neurotransmitter catabolic process [GO:0042135]; proteolysis [GO:0006508]","GO:0004180; GO:0004181; GO:0005886; GO:0006508; GO:0008233; GO:0016020; GO:0016805; GO:0042135; GO:0046872; GO:0050129"
"22514","Cluster_9149","Peve_00038692",1,0,0,152,-25.61,"2 17","294 313",15,"86.67%","86.67%","5UTR",NA,NA,NA,NA,NA
"22517","Cluster_9149","Peve_00038822",-0.997148176496447,0.0480905459806356,0.945590536869992,147,-22.28,"2 21","694 719",23,"60.87%","69.57%","5UTR","Q8VHI5","Vitrin (Akhirin)","Mus musculus (Mouse)","extracellular matrix organization [GO:0030198]; positive regulation of cell-substrate adhesion [GO:0010811]; spinal cord development [GO:0021510]","GO:0005539; GO:0005576; GO:0005614; GO:0010811; GO:0021510; GO:0030198; GO:0031012; GO:0062023"
"22531","Cluster_9149","Peve_00040250",1,9.48637384723993e-09,6.86838308108347e-06,147,-22.85,"2 12","920 941",10,"80.00%","100.00%","5UTR",NA,NA,NA,NA,NA
"22552","Cluster_9149","Peve_00042525",-0.999972017506869,0.00476254767800266,0.551398425649056,160,-21,"2 21","593 614",19,"68.42%","78.95%","5UTR","Q5ZI57","Trafficking protein particle complex subunit 3","Gallus gallus (Chicken)","endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]","GO:0005783; GO:0005829; GO:0006888; GO:0006891; GO:0030008; GO:0033106"
"22578","Cluster_9149","Peve_00045047",-0.999996728114699,0.00162852441741808,0.362847063101065,164,-29.67,"2 17","266 287",15,"80.00%","93.33%","5UTR",NA,NA,NA,NA,NA
"22586","Cluster_9983","Peve_00016482",-0.999812133109256,0.0123403376847463,0.684071498890361,159,-22.76,"2 20","799 816",18,"77.78%","83.33%","5UTR","E9Q3T6","PR domain zinc finger protein 14 (EC 2.1.1.-) (PR domain-containing protein 14)","Mus musculus (Mouse)","cell fate specification [GO:0001708]; cell morphogenesis [GO:0000902]; embryo implantation [GO:0007566]; epigenetic regulation of gene expression [GO:0040029]; fertilization [GO:0009566]; fibroblast growth factor receptor signaling pathway [GO:0008543]; germ cell development [GO:0007281]; germ-line stem cell population maintenance [GO:0030718]; histone H3-R26 methylation [GO:0034972]; homeostasis of number of cells within a tissue [GO:0048873]; inactivation of paternal X chromosome [GO:0060817]; inner cell mass cell fate commitment [GO:0001827]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of flagellated sperm motility [GO:1902093]; positive regulation of stem cell population maintenance [GO:1902459]; regulation of DNA methylation [GO:0044030]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; stem cell population maintenance [GO:0019827]","GO:0000122; GO:0000902; GO:0000977; GO:0001227; GO:0001708; GO:0001827; GO:0003723; GO:0005634; GO:0005654; GO:0006357; GO:0007281; GO:0007566; GO:0008168; GO:0008543; GO:0009566; GO:0010468; GO:0019827; GO:0030718; GO:0031490; GO:0034972; GO:0040029; GO:0040037; GO:0044030; GO:0046872; GO:0048873; GO:0060817; GO:1902093; GO:1902459"
